UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

FORM 10-QQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 30, 20172023

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-33376No. 814-00732

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

Maryland 20-8700615

(State or other jurisdiction of


incorporation or organization)

 

(I.R.S. Employer


Identification No.)

Number)

 

535 Madison Avenue

New York, New York

10022
(Address of principal executive office)(Zip Code)

535 Madison Avenue

New York, New York 10022

(Address of principal executive offices)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each classTrading Symbol(s)Name of each exchange on which
registered
Common Stock, par value $0.001 per shareSARThe New York Stock Exchange
6.00% Notes due 2027SATThe New York Stock Exchange
8.00% Notes due 2027SAJThe New York Stock Exchange
8.125% Notes due 2027SAYThe New York Stock Exchange
8.50% Notes due 2027SAZThe New York Stock Exchange

Indicate by check mark whether the registrantRegistrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrantRegistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.days: Yes ☒   No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large accelerated filerAccelerated filer
Large Accelerated FilerNon-accelerated filerSmaller reporting company
 Emerging growth companyAccelerated Filer
Non-Accelerated FilerSmaller Reporting Company
Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.Act

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

The number of outstanding common shares of the registrant’s common stock, $0.001 par value, outstandingregistrant as of January 10, 20188, 2024 was 6,257,029.13,653,476

 

 

 


TABLE OF CONTENTS

 

Page
PART I.FINANCIAL INFORMATION1
   
Item 1.Consolidated Financial Statements1
 Page 

PART I.

FINANCIAL INFORMATION3
Item 1.Consolidated Financial Statements3
Consolidated Statements of Assets and Liabilities as of November 30, 20172023 (unaudited) and February 28, 201720231
  3
 Consolidated Statements of Operations for the three months and nine months ended November, 30, 20172023 (unaudited) and November 30, 20162022 (unaudited)2
  4
 Consolidated Schedules of Investments as of November 30, 2017 (unaudited) and February 28, 20175
Consolidated Statements of Changes in Net Assets for thethree and nine months ended November 30, 20172023 (unaudited) and November 30, 20162022 (unaudited)3
  7
 Consolidated Statements of Cash Flows for the nine months ended November 30, 20172023 (unaudited) and November 30, 20162022 (unaudited)4
  
8Consolidated Schedules of Investments as of November 30, 2023 (unaudited) and February 28, 20235
 
 Notes to Consolidated Financial Statements as of November 30, 20172023 (unaudited)27
  9
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations109
  36
Item 3.Quantitative and Qualitative Disclosures About Market Risk150
  
61Item 4.Controls and Procedures151
 
PART II.OTHER INFORMATION152
Item 4.Controls and Procedures  
61Item 1.Legal Proceedings152
 
Item 1A.Risk Factors152
PART II.OTHER INFORMATION  62
Item 1.2.Legal Proceedings62
Item 1A.Risk Factors62
Item 2.Unregistered Sales of Equity Securities, and Use of Proceeds, and Issuer Purchase of Equity Securities153
  
62Item 3.Defaults Upon Senior Securities153
 
Item 4.Mine Safety Disclosures153
Item 3.Defaults Upon Senior Securities  
62Item 5.Other Information153
 
Item 6.Exhibits154
Item 4.Mine Safety Disclosures  62
Item 5.Other Information62
Item 6.Exhibits63
Signatures65159

i

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

   As of 
   November 30, 2017  February 28, 2017 
   (unaudited)    

ASSETS

   

Investments at fair value

   

Non-control/Non-affiliate investments (amortized cost of $299,321,359 and $251,198,896, respectively)

  $295,371,210  $242,531,514 

Control investments (amortized cost of $38,943,193 and $49,283,536, respectively)

   43,466,477   50,129,799 
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $338,264,552 and $300,482,432, respectively)

   338,837,687   292,661,313 

Cash and cash equivalents

   680,065   9,306,543 

Cash and cash equivalents, reserve accounts

   8,037,715   12,781,425 

Interest receivable (net of reserve of $1,373,118 and $157,560, respectively)

   3,288,960   3,294,450 

Management and incentive fee receivable

   266,005   171,106 

Other assets

   706,648   183,346 

Receivable from unsettled trades

   97,041   253,041 
  

 

 

  

 

 

 

Total assets

  $351,914,121  $318,651,224 
  

 

 

  

 

 

 

LIABILITIES

   

Revolving credit facility

  $1,000,000  $—   

Deferred debt financing costs, revolving credit facility

   (720,258  (437,183

SBA debentures payable

   134,660,000   112,660,000 

Deferred debt financing costs, SBA debentures payable

   (2,666,620  (2,508,280

Notes payable

   74,450,500   74,450,500 

Deferred debt financing costs, notes payable

   (2,414,200  (2,689,511

Base management and incentive fees payable

   5,194,845   5,814,692 

Accounts payable and accrued expenses

   1,200,514   852,987 

Interest and debt fees payable

   1,982,347   2,764,237 

Directors fees payable

   —     51,500 

Due to manager

   380,770   397,505 
  

 

 

  

 

 

 

Total liabilities

  $213,067,898  $191,356,447 
  

 

 

  

 

 

 

Commitments and contingencies (See Note 7)

   

NET ASSETS

   

Common stock, par value $.001, 100,000,000 common shares authorized, 6,149,582 and 5,794,600 common shares issued and outstanding, respectively

  $6,150  $5,795 

Capital in excess of par value

   198,211,630   190,483,931 

Distribution in excess of net investment income

   (26,649,881  (27,737,348

Accumulated net realized loss from investments and derivatives

   (33,294,811  (27,636,482

Accumulated net unrealized appreciation (depreciation) on investments and derivatives

   573,135   (7,821,119
  

 

 

  

 

 

 

Total net assets

   138,846,223   127,294,777 
  

 

 

  

 

 

 

Total liabilities and net assets

  $351,914,121  $318,651,224 
  

 

 

  

 

 

 

NET ASSET VALUE PER SHARE

  $22.58  $21.97 
  

 

 

  

 

 

 
  November 30,
2023
  February 28,
2023
 
  (unaudited)    
ASSETS      
Investments at fair value      
Non-control/Non-affiliate investments (amortized cost of $983,711,569 and $819,966,208, respectively) $976,440,074  $828,028,800 
Affiliate investments (amortized cost of $45,834,741 and $25,722,320, respectively)  47,128,397   28,305,871 
Control investments (amortized cost of $118,317,634 and $120,800,829, respectively)  90,470,138   116,255,582 
Total investments at fair value (amortized cost of $1,147,863,944 and $966,489,357, respectively)  1,114,038,609   972,590,253 
Cash and cash equivalents  21,386,880   65,746,494 
Cash and cash equivalents, reserve accounts  25,639,619   30,329,779 
Interest receivable (net of reserve of $6,951,408 and $2,217,300, respectively)  9,235,919   8,159,951 
Management fee receivable  364,032   363,809 
Other assets  932,383   531,337 
Current tax receivable  99,676   436,551 
Total assets $1,171,697,118  $1,078,158,174 
         
LIABILITIES        
Revolving credit facility $35,000,000  $32,500,000 
Deferred debt financing costs, revolving credit facility  (996,961)  (1,344,005)
SBA debentures payable  205,000,000   202,000,000 
Deferred debt financing costs, SBA debentures payable  (5,789,246)  (4,923,488)
8.75% Notes Payable 2024  20,000,000   - 
Discount on 8.75% notes payable 2024  (251,521)  - 
Deferred debt financing costs, 8.75% notes payable 2024  (10,576)  - 
7.00% Notes Payable 2025  12,000,000   12,000,000 
Discount on 7.00% notes payable 2025  (222,781)  (304,946)
Deferred debt financing costs, 7.00% notes payable 2025  (28,165)  (40,118)
7.75% Notes Payable 2025  5,000,000   5,000,000 
Deferred debt financing costs, 7.75% notes payable 2025  (88,206)  (129,528)
4.375% Notes Payable 2026  175,000,000   175,000,000 
Premium on 4.375% notes payable 2026  641,310   830,824 
Deferred debt financing costs, 4.375% notes payable 2026  (1,918,155)  (2,552,924)
4.35% Notes Payable 2027  75,000,000   75,000,000 
Discount on 4.35% notes payable 2027  (330,619)  (408,932)
Deferred debt financing costs, 4.35% notes payable 2027  (1,119,041)  (1,378,515)
6.25% Notes Payable 2027  15,000,000   15,000,000 
Deferred debt financing costs, 6.25% notes payable 2027  (291,226)  (344,949)
6.00% Notes Payable 2027  105,500,000   105,500,000 
Discount on 6.00% notes payable 2027  (132,538)  (159,334)
Deferred debt financing costs, 6.00% notes payable 2027  (2,399,002)  (2,926,637)
8.00% Notes Payable 2027  46,000,000   46,000,000 
Deferred debt financing costs, 8.00% notes payable 2027  (1,360,960)  (1,622,376)
8.125% Notes Payable 2027  60,375,000   60,375,000 
Deferred debt financing costs, 8.125% notes payable 2027  (1,665,155)  (1,944,536)
8.50% Notes Payable 2028  57,500,000   - 
Deferred debt financing costs, 8.50% notes payable 2028  (1,781,486)  - 
Base management and incentive fees payable  8,139,713   12,114,878 
Deferred tax liability  3,422,306   2,816,572 
Accounts payable and accrued expenses  2,086,243   1,464,343 
Interest and debt fees payable  4,609,435   3,652,936 
Directors fees payable  -   14,932 
Due to manager  250,000   10,935 
Total liabilities  812,138,369   731,200,132 
         
Commitments and contingencies (See Note 9)        
         
NET ASSETS        
Common stock, par value $0.001, 100,000,000 common shares authorized, 13,114,977 and 11,890,500 common shares issued and outstanding, respectively  13,115   11,891 
Capital in excess of par value  356,698,595   321,893,806 
Total distributable earnings  2,847,039   25,052,345 
Total net assets  359,558,749   346,958,042 
Total liabilities and net assets $1,171,697,118  $1,078,158,174 
NET ASSET VALUE PER SHARE $27.42  $29.18 

See accompanying notes to consolidated financial statements.


Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

   For the three months
ended
November 30, 2017
  For the three months
ended
November 30, 2016
  For the nine months
ended
November 30, 2017
  For the nine months
ended
November 30, 2016
 

INVESTMENT INCOME

     

Interest from investments

     

Non-control/Non-affiliate investments

  $7,036,743  $6,787,898  $20,140,933  $19,969,849 

Payment-in-kind interest income from Non-control/Non-affiliate investments

   301,213   169,332   823,443   482,687 

Control investments

   1,017,821   498,599   3,849,287   1,587,925 

Payment-in-kind interest income from Control investments

   535,031   —     1,004,764   —   
  

 

 

  

 

 

  

 

 

  

 

 

 

Total interest income

   8,890,808   7,455,829   25,818,427   22,040,461 

Interest from cash and cash equivalents

   6,777   6,239   20,351   16,426 

Management fee income

   376,446   375,218   1,128,084   1,123,559 

Incentive fee income

   209,434   —     477,087   —   

Other income

   42,265   605,009   1,042,895   1,618,238 
  

 

 

  

 

 

  

 

 

  

 

 

 

Total investment income

   9,525,730   8,442,295   28,486,844   24,798,684 
  

 

 

  

 

 

  

 

 

  

 

 

 

OPERATING EXPENSES

     

Interest and debt financing expenses

   2,758,900   2,369,108   8,245,350   7,106,869 

Base management fees

   1,485,415   1,219,916   4,358,230   3,649,867 

Professional fees

   388,210   330,197   1,179,913   991,723 

Administrator expenses

   437,500   341,667   1,208,333   991,667 

Incentive management fees

   1,054,618   394,509   2,940,350   2,331,241 

Insurance

   64,577   68,985   196,907   210,301 

Directors fees and expenses

   43,000   66,000   154,000   192,422 

General & administrative

   299,627   224,579   784,071   741,743 

Excise tax expense (credit)

   —     —     (14,738  —   

Other expense

   (21,628  8,460   23,417   21,647 
  

 

 

  

 

 

  

 

 

  

 

 

 

Total operating expenses

   6,510,219   5,023,421   19,075,833   16,237,480 
  

 

 

  

 

 

  

 

 

  

 

 

 

NET INVESTMENT INCOME

   3,015,511   3,418,874   9,411,011   8,561,204 
  

 

 

  

 

 

  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

     

Net realized gain (loss) from investments

     

Non-control/Non-affiliate investments

   20,770   260,244   (5,722,049  12,299,899 

Control investments

   166   —     63,720   —   
  

 

 

  

 

 

  

 

 

  

 

 

 

Net realized gain (loss) from investments

   20,936   260,244   (5,658,329  12,299,899 

Net change in unrealized appreciation (depreciation) on investments

     

Non-control/Non-affiliate investments

   1,624,685   (968,359  4,717,234   (11,019,005

Control investments

   (398,142  (1,136,983  3,677,020   290,883 
  

 

 

  

 

 

  

 

 

  

 

 

 

Net change in unrealized appreciation (depreciation) on investments

   1,226,543   (2,105,342  8,394,254   (10,728,122
  

 

 

  

 

 

  

 

 

  

 

 

 

Net gain (loss) on investments

   1,247,479   (1,845,098  2,735,925   1,571,777 
  

 

 

  

 

 

  

 

 

  

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $4,262,990  $1,573,776  $12,146,936  $10,132,981 
  

 

 

  

 

 

  

 

 

  

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $0.71  $0.27  $2.04  $1.77 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED

   6,040,311   5,727,933   5,952,086   5,735,443 
  For the three months ended  For the nine months ended 
  November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
INVESTMENT INCOME            
Interest from investments            
Interest income:            
Non-control/Non-affiliate investments $28,741,745  $19,549,044  $83,542,257  $49,597,660 
Affiliate investments  1,165,585   1,914,800   2,799,735   4,287,449 
Control investments  2,183,242   1,671,354   6,314,550   4,731,150 
Payment-in-kind interest income:                
Non-control/Non-affiliate investments  88,106   87,130   706,339   258,557 
Affiliate investments  221,348   191,860   644,484   221,027 
Control investments  258,729   102,720   542,581   260,161 
Total interest from investments  32,658,755   23,516,908   94,549,946   59,356,004 
Interest from cash and cash equivalents  521,574   200,258   1,864,956   235,410 
Management fee income  819,929   818,254   2,453,967   2,451,242 
Dividend Income  1,828,584   436,941   5,301,097   949,758 
Structuring and advisory fee income  312,135   553,497   1,786,357   2,813,311 
Other income  199,368   731,166   530,210   983,277 
Total investment income  36,340,345   26,257,024   106,486,533   66,789,002 
                 
OPERATING EXPENSES                
Interest and debt financing expenses  12,522,357   8,449,900   36,628,641   23,243,438 
Base management fees  4,857,059   4,258,821   14,262,147   12,164,989 
Incentive management fees expense  2,243,621   1,531,060   4,828,442   216,915 
Professional fees  434,552   558,531   1,407,275   1,344,021 
Administrator expenses  1,075,000   818,750   2,797,917   2,341,667 
Insurance  81,002   89,187   244,804   266,723 
Directors fees and expenses  80,729   80,000   280,797   300,000 
General and administrative  660,062   525,202   1,957,906   1,492,063 
Income tax expense (benefit)  219,900   68,136   (11,193)  (132,487)
Total operating expenses  22,174,282   16,379,587   62,396,736   41,237,329 
NET INVESTMENT INCOME  14,166,063   9,877,437   44,089,797   25,551,673 
                 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS                
Net realized gain (loss) from investments:                
Non-control/Non-affiliate investments  60,565   (740,434)  151,256   7,365,913 
Net realized gain (loss) from investments  60,565   (740,434)  151,256   7,365,913 
Income tax (provision) benefit from realized gain on investments  -   479,318   -   548,568 
Net change in unrealized appreciation (depreciation) on investments:                
Non-control/Non-affiliate investments  (1,948,502)  2,082,634   (15,334,087)  (12,430,125)
Affiliate investments  (1,084,259)  693,483   (1,289,895)  3,861,523 
Control investments  (14,833,592)  (5,952,325)  (23,302,249)  (17,199,511)
Net change in unrealized appreciation (depreciation) on investments  (17,866,353)  (3,176,208)  (39,926,231)  (25,768,113)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  (415,894)  (425,848)  (577,693)  (1,017,953)
Net realized and unrealized gain (loss) on investments  (18,221,682)  (3,863,172)  (40,352,668)  (18,871,585)
Realized losses on extinguishment of debt  -   -   (110,056)  (1,204,809)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $(4,055,619) $6,014,265  $3,627,073  $5,475,279 
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE $(0.31) $0.51  $0.29  $0.46 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED  13,052,896   11,893,173   12,355,815   11,989,811 

See accompanying notes to consolidated financial statements.


Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

  For the nine months ended 
  November 30,
2023
  November 30,
2022
 
INCREASE (DECREASE) FROM OPERATIONS:      
Net investment income $44,089,797  $25,551,673 
Net realized gain from investments  151,256   7,365,913 
Realized losses on extinguishment of debt  (110,056)  (1,204,809)
Income tax (provision) benefit from realized gain on investments  -   548,568 
Net change in unrealized appreciation (depreciation) on investments  (39,926,231)  (25,768,113)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  (577,693)  (1,017,953)
Net increase in net assets resulting from operations  3,627,073   5,475,279 
         
DECREASE FROM SHAREHOLDER DISTRIBUTIONS:        
Total distributions to shareholders  (25,832,379)  (19,232,096)
Net decrease in net assets from shareholder distributions  (25,832,379)  (19,232,096)
         
CAPITAL SHARE TRANSACTIONS:        
Proceeds from issuance of common stock(1)  31,510,617   - 
Capital contribution from manager  3,093,288   - 
Stock dividend distribution  2,667,152   3,347,802 
Repurchases of common stock  (2,157,605)  (9,600,116)
Repurchase fees  (1,772)  (7,792)
Offering costs  (305,667)  - 
Net increase (decrease) in net assets from capital share transactions  34,806,013   (6,260,106)
Total increase (decrease) in net assets  12,600,707   (20,016,923)
Net assets at beginning of period  346,958,042   355,780,523 
Net assets at end of period $359,558,749  $335,763,600 

(1)See Note 11 to the Consolidated Financial Statements contained herein for more information on share issuance.

See accompanying notes to consolidated financial statements.


Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

  For the nine months ended 
  November 30,
2023
  November 30,
2022
 
Operating activities      
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $3,627,073  $5,475,279 
ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING        
FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:        
Payment-in-kind and other adjustments to cost  4,054,128   1,374,899 
Net accretion of discount on investments  (1,641,652)  (1,245,358)
Amortization of deferred debt financing costs  3,909,127   2,567,903 
Realized losses on extinguishment of debt  110,056   1,204,809 
Income tax expense (benefit)  (11,193)  (681,055)
Net realized (gain) loss from investments  (151,256)  (7,365,913)
Net change in unrealized (appreciation) depreciation on investments  39,926,231   25,768,113 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  577,693   1,017,953 
Proceeds from sales and repayments of investments  19,247,834   162,090,516 
Purchases of investments  (202,883,641)  (345,088,953)
(Increase) decrease in operating assets:        
Interest receivable  (1,075,968)  (3,722,035)
Due from affiliate  -   90,968 
Management fee receivable  (223)  (1,266)
Other assets  (401,046)  18,119 
Current income tax receivable  336,875   - 
Increase (decrease) in operating liabilities:        
Base management and incentive fees payable  (3,975,165)  (3,390,134)
Accounts payable and accrued expenses  621,900   466,950 
Current tax payable  -   (2,793,200)
Interest and debt fees payable  956,499   2,145,104 
Directors fees payable  (14,932)  25,932 
Excise tax payable  -   (630,183)
Due to manager  239,065   (257,628)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES  (136,548,595)  (162,929,180)
         
Financing activities        
Borrowings on debt  62,500,000   105,500,000 
Paydowns on debt  (57,000,000)  (35,340,000)
Issuance of notes  77,500,000   163,500,000 
Repayments of notes  -   (43,125,000)
Payments of deferred debt financing costs  (4,474,813)  (7,400,318)
Discount on  debt issuance, 6.00% notes 2027  -   (176,000)
Discount on  debt issuance, 7.00% notes 2025  -   (360,000)
Proceeds from issuance of common stock  31,510,617   - 
Capital contribution from manager  3,093,288   - 
Payments of cash dividends  (23,165,227)  (15,884,294)
Repurchases of common stock  (2,157,605)  (9,600,116)
Repurchases fees  (1,772)  (7,792)
Payments of offering costs  (305,667)  - 
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES  87,498,821   157,106,480 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS  (49,049,774)  (5,822,700)
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD  96,076,273   52,870,342 
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD (See Note 2) $47,026,499  $47,047,642 
         
Supplemental information:        
Interest paid during the period $31,763,015  $18,374,593 
Cash paid for taxes  654,930   2,770,984 
Supplemental non-cash information:        
Payment-in-kind interest income and other adjustments to cost  (4,054,128)  1,374,899 
Net accretion of discount on investments  1,641,652   1,245,358 
Amortization of deferred debt financing costs  3,909,127   2,567,903 
Stock dividend distribution  2,667,152   3,347,802 

See accompanying notes to consolidated financial statements.


Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 20172023

(unaudited)

 

Company

 

Industry

 

Investment Interest Rate/

Maturity

 Principal/
Number of
Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments - 212.7% (b)

    

Tile Redi Holdings, LLC (d)

 Building Products First Lien Term Loan (L+10.00%), 11.49% Cash, 6/16/2022 $15,000,000  $14,860,121  $14,850,000   10.7
    

 

 

  

 

 

  

 

 

 
  Total Building Products   14,860,121   14,850,000   10.7
    

 

 

  

 

 

  

 

 

 

Apex Holdings Software Technologies, LLC

 Business Services First Lien Term Loan (L+8.00%), 9.49% Cash, 9/21/2021 $18,000,000   17,876,123   18,000,000   13.0

Avionte Holdings, LLC (g)

 Business Services Common Stock  100,000   100,000   418,000   0.3

BMC Software, Inc. (d)

 Business Services Syndicated Loan (L+4.00%), 5.49% Cash, 9/10/2022 $4,858,971   4,815,474   4,858,971   3.5

CLEO Communications Holding, LLC

 Business Services First Lien Term Loan (L+7.00%), 8.49% Cash/2.00% PIK, 3/31/2022 $13,155,248   13,031,619   13,155,248   9.5

CLEO Communications Holding, LLC (i)

 Business Services Delayed Draw Term Loan (L+7.00%), 8.49% Cash/2.00% PIK, 3/31/2022 $2,010,225   1,990,728   2,010,225   1.4

Courion Corporation

 Business Services Second Lien Term Loan (L+10.00%), 11.49% Cash, 6/1/2021 $15,000,000   14,896,990   14,827,500   10.7

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020 $3,300,000   3,298,364   3,317,160   2.4

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests Expires 12/28/2022  49,318   400,000   469,507   0.3

Erwin, Inc.

 Business Services Second Lien Term Loan (L+11.50%), 12.99% Cash/1.00% PIK, 8/28/2021 $13,211,246   13,114,439   13,161,043   9.5

FranConnect LLC (d)

 Business Services First Lien Term Loan (L+7.00%), 8.50% Cash, 5/26/2022 $14,500,000   14,432,349   14,438,428   10.4

GreyHeller LLC

 Business Services First Lien Term Loan (L+11.00%), 12.49% Cash, 11/16/2021 $7,000,000   6,941,430   7,000,000   5.0

GreyHeller LLC (j)

 Business Services Delayed Draw Term Loan B (L+11.00%), 12.49% Cash, 11/16/2021 $—     —     —     0.0

GreyHeller LLC (g)

 Business Services Common Stock  850,000   850,000   729,000   0.5

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services First Lien Term Loan (L+4.50%), 5.99% Cash, 10/8/2021 $5,390,651   5,302,560   5,404,127   3.9

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services Second Lien Term Loan (L+9.50%), 10.99% Cash, 10/8/2022 $3,000,000   2,930,542   2,937,510   2.1

Identity Automation Systems (g)

 Business Services Common Stock Class A Units  232,616   232,616   730,911   0.5

Identity Automation Systems

 Business Services First Lien Term Loan (L+9.50%), 10.99% Cash, 3/31/2021 $17,975,000   17,858,469   17,975,000   12.9

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan (L+8.75%), 10.24% Cash, 7/20/2021 $16,888,731   16,863,690   16,888,731   12.2

Microsystems Company

 Business Services Second Lien Term Loan (L+10.00%), 11.49% Cash, 7/1/2022 $8,000,000   7,935,313   8,000,000   5.8

National Waste Partners (d)

 Business Services Second Lien Term Loan 10.00% Cash, 2/13/2022 $9,000,000   8,922,021   9,000,000   6.5

Vector Controls Holding Co., LLC (d)

 Business Services First Lien Term Loan 13.75% (12.00% Cash/1.75% PIK), 3/6/2022 $11,571,437   11,528,660   11,571,437   8.3

Vector Controls Holding Co., LLC (g)

 Business Services Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027  343   —     879,567   0.6
    

 

 

  

 

 

  

 

 

 
  Total Business Services   163,321,387   165,772,365   119.3
    

 

 

  

 

 

  

 

 

 

Targus Holdings, Inc. (g)

 Consumer Products Common Stock  210,456   1,791,242   293,450   0.2
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   1,791,242   293,450   0.2
    

 

 

  

 

 

  

 

 

 

My Alarm Center, LLC

 Consumer Services Preferred Equity Class A Units 8.00% PIK  2,227   2,265,154   2,294,804   1.7

My Alarm Center, LLC (g)

 Consumer Services Preferred Equity Class B Units  1,797   1,796,880   1,442,069   1.0

My Alarm Center, LLC (g)

 Consumer Services Common Stock  96,224   —     —     0.0

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan (L+5.25%), 6.74% Cash, 7/1/2019 $2,480,695   2,471,520   2,486,153   1.8

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan (L+9.00%), 10.49% Cash, 7/1/2020 $11,000,000   10,972,589   11,003,300   7.9
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   17,506,143   17,226,326   12.4
    

 

 

  

 

 

  

 

 

 

C2 Educational Systems (d)

 Education First Lien Term Loan (L+8.50%), 10.00% Cash, 5/31/2020 $16,000,000   15,863,540   15,864,000   11.4

M/C Acquisition Corp., L.L.C. (g)

 Education Class A Common Stock  544,761   30,241   —     0.0

M/C Acquisition Corp., L.L.C. (g)

 Education First Lien Term Loan 1.00% Cash, 3/31/2018 $2,318,121   1,190,838   8,058   0.0

Texas Teachers of Tomorrow, LLC (g), (h)

 Education Common Stock  750,000   750,000   910,433   0.7

Texas Teachers of Tomorrow, LLC

 Education Second Lien Term Loan (L+9.75%), 11.24% Cash, 6/2/2021 $10,000,000   9,930,419   10,000,000   7.2
    

 

 

  

 

 

  

 

 

 
  Total Education   27,765,038   26,782,491   19.3
    

 

 

  

 

 

  

 

 

 

TM Restaurant Group L.L.C. (g)

 Food and Beverage First Lien Term Loan 14.50% PIK, 7/17/2017 $9,358,694   9,352,763   7,924,942   5.7

TM Restaurant Group L.L.C. (g)

 Food and Beverage Revolver 14.50% PIK, 7/17/2017 $413,954   413,954   350,536   0.3
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   9,766,717   8,275,478   6.0
    

 

 

  

 

 

  

 

 

 

Censis Technologies, Inc.

 Healthcare Services First Lien Term Loan B (L+10.00%), 11.49% Cash, 7/24/2019 $10,575,000   10,491,748   10,575,000   7.6

Censis Technologies, Inc. (g), (h)

 Healthcare Services Limited Partner Interests  999   999,000   1,129,234   0.8

ComForCare Health Care

 Healthcare Services First Lien Term Loan (L+8.50%), 9.99% Cash, 1/31/2022 $10,500,000   10,409,140   10,500,000   7.6

Ohio Medical, LLC (g)

 Healthcare Services Common Stock  5,000   500,000   267,202   0.2

Ohio Medical, LLC

 Healthcare Services Senior Subordinated Note 12.00% Cash, 7/15/2021 $7,300,000   7,247,321   6,601,686   4.7

Pathway Partners Vet Management Company LLC

 Healthcare Services Second Lien Term Loan (L+8.00%), 9.49% Cash, 10/10/2025 $2,083,333   2,062,715   2,062,500   1.5

Pathway Partners Vet Management Company LLC (j)

 Healthcare Services Delayed Draw Term Loan (L+8.00%), 9.49% Cash, 10/10/2025 $—     —     —     0.0

Roscoe Medical, Inc. (g)

 Healthcare Services Common Stock  5,081   508,077   507,987   0.4

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000   4,167,542   4,168,500   3.0

Zest Holdings, LLC (d)

 Healthcare Services Syndicated Loan (L+4.25%), 5.74% Cash, 8/16/2023 $4,116,226   4,040,574   4,141,953   3.0
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   40,426,117   39,954,062   28.8
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 12.00% Cash, 7/8/2021 $8,147,700   8,091,083   8,392,131   6.0

HMN Holdco, LLC

 Media Delayed Draw First Lien Term Loan 12.00% Cash, 7/8/2021 $4,800,000   4,761,382   4,950,240   3.6

HMN Holdco, LLC (g)

 Media Class A Series, Expires 1/16/2025  4,264   61,647   255,073   0.2

HMN Holdco, LLC (g)

 Media Class A Warrant, Expires 1/16/2025  30,320   438,353   1,434,136   1.0

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024  57,872   —     2,443,356   1.8

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Preferred), Expires 5/16/2024  8,139   —     400,602   0.3
    

 

 

  

 

 

  

 

 

 
  Total Media   13,352,465   17,875,538   12.9
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company, L.L.C. (g)

 Metals Common Stock  60,000   9,685,029   3,494,400   2.5

Elyria Foundry Company, L.L.C. (d)

 Metals Second Lien Term Loan 15.00% PIK, 8/10/2022 $847,100   847,100   847,100   0.6
    

 

 

  

 

 

  

 

 

 
  Total Metals   10,532,129   4,341,500   3.1
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

 

  299,321,359   295,371,210   212.7
    

 

 

  

 

 

  

 

 

 

Control investments - 31.3% (b)

      

Easy Ice, LLC (f)

 Business Services Preferred Equity 10.00% PIK  5,080,000   8,542,685   10,335,793   7.5

Easy Ice, LLC (d), (f)

 Business Services Second Lien Term Loan (L+11.00%), 5.44% Cash/7.56% PIK, 2/28/2023 $16,817,328   16,708,812   16,817,328   12.1
    

 

 

  

 

 

  

 

 

 
  Total Business Services   25,251,497   27,153,121   19.6
    

 

 

  

 

 

  

 

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (e), (f)

 

Structured Finance

Securities

 Other/Structured Finance Securities 29.48%, 10/20/2025 $30,000,000   9,191,696   11,814,256   8.5

Saratoga Investment Corp. Class F Note (a), (f)

 Structured Finance Securities Other/Structured Finance Securities (L+8.50%), 9.99%, 10/20/2025 $4,500,000   4,500,000   4,499,100   3.2
    

 

 

  

 

 

  

 

 

 
  Total Structured Finance Securities   13,691,696   16,313,356   11.7
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

   38,943,193   43,466,477   31.3
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 244.0% (b)

  $338,264,552  $338,837,687   244.0
    

 

 

  

 

 

  

 

 

 
      Principal  Cost  Fair Value  % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 6.3% (b)

    

U.S. Bank Money Market (k)

 $8,717,780  $8,717,780  $8,717,780   6.3
   

 

 

  

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

 $8,717,780  $8,717,780  $8,717,780   6.3
   

 

 

  

 

 

  

 

 

  

 

 

 
Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Non-control/Non-affiliate investments - 269.2% (b)                  
Altvia MidCo, LLC. Alternative Investment Management Software First Lien Term Loan
(3M USD TERM SOFR+8.50%), 13.87% Cash, 7/18/2027
 7/18/2022 $7,920,000  $7,856,836  $7,890,696   2.2%
Altvia MidCo, LLC. (h) Alternative Investment Management Software Series A-1 Preferred Shares 7/18/2022  2,000,000   2,000,000   2,919,054   0.8%
    Total Alternative Investment Management Software        9,856,836   10,809,750   3.0%
BQE Software, Inc. Architecture & Engineering Software First Lien Term Loan
(3M USD TERM SOFR+6.75%), 12.12% Cash, 4/13/2028
 4/13/2023 $24,500,000   24,273,149   24,291,750   6.8%
BQE Software, Inc. (j) Architecture & Engineering Software Delayed Draw Term Loan
(3M USD TERM SOFR+6.75%), 12.12% Cash, 4/13/2028
 4/13/2023 $750,000   743,020   743,625   0.2%
    Total Architecture & Engineering Software        25,016,169   25,035,375   7.0%
GrowthZone, LLC Association Management Software First Lien Term Loan
(3M USD TERM SOFR+8.25%), 13.62% Cash, 5/10/2028
 5/10/2023 $22,649,425   22,277,557   22,588,272   6.3%
Golden TopCo LP (h) Association Management Software Class A-2 Common Units 5/10/2023  1,072,394   1,072,394   1,108,099   0.3%
    Total Association Management Software        23,349,951   23,696,371   6.6%
Artemis Wax Corp. (d)(j) Consumer Services Delayed Draw Term Loan
(1M USD TERM SOFR+6.75%), 12.09% Cash, 5/20/2026
 5/20/2021 $57,500,000   57,182,306   57,747,250   16.1%
Artemis Wax Corp. (h) Consumer Services Series B-1 Preferred Stock 5/20/2021  934,463   1,500,000   4,556,457   1.3%
Artemis Wax Corp. (h) Consumer Services Series D Preferred Stock 12/22/2022  278,769   1,500,000   1,668,566   0.5%
    Total Consumer Services        60,182,306   63,972,273   17.9%
Schoox, Inc. (h), (i) Corporate Education Software Series 1 Membership Interest 12/8/2020  1,050   475,698   4,397,441   1.2%
    Total Corporate Education Software        475,698   4,397,441   1.2%
GreyHeller LLC (h) Cyber Security Common Stock 11/10/2021  7,857,689   1,906,275   2,715,526   0.8%
    Total Cyber Security        1,906,275   2,715,526   0.8%
Gen4 Dental Partners Holdings, LLC (j) Dental Practice Management Delayed Draw Term Loan
(3M USD TERM SOFR+10.33%), 15.70% Cash, 4/29/2026
 2/8/2023 $10,756,017   10,734,773   10,971,137   3.1%

 


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Gen4 Dental Partners Holdings, LLC (h)(i) Dental Practice Management Series A Preferred Units 2/8/2023  493,999   1,027,519   1,091,738   0.3%
New England Dental Partners Dental Practice Management First Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.52% Cash, 11/25/2025
 11/25/2020 $6,555,000   6,524,137   6,279,035   1.7%
New England Dental Partners Dental Practice Management Delayed Draw Term Loan
(3M USD TERM SOFR+8.00%), 13.52% Cash, 11/25/2025
 11/25/2020 $4,650,000   4,634,096   4,454,235   1.2%
    Total Dental Practice Management        22,920,525   22,796,145   6.3%
Exigo, LLC (d) Direct Selling Software First Lien Term Loan
(1M USD TERM SOFR+5.75%), 11.19% Cash, 3/16/2027
 3/16/2022 $24,375,000   24,220,792   23,953,313   6.7%
Exigo, LLC (j) Direct Selling Software Revolving Credit Facility
(1M USD TERM SOFR+5.75%), 11.19% Cash, 3/16/2027
 3/16/2022 $-   -   (18,021)  0.0%
Exigo, LLC (h), (i) Direct Selling Software Common Units 3/16/2022  1,041,667   1,041,667   1,188,396   0.3%
    Total Direct Selling Software        25,262,459   25,123,688   7.0%
C2 Educational Systems, Inc. (d) Education Services First Lien Term Loan
(3M USD TERM SOFR+8.50%), 13.87% Cash, 5/31/2025
 5/31/2017 $21,500,000   21,475,005   21,506,450   6.0%
C2 Educational Systems, Inc. (j) Education Services Delayed Draw Term Loan
(3M USD TERM SOFR+8.50%), 13.87% Cash, 5/31/2025
 4/28/2023 $-   -   -   0.0%
C2 Education Systems, Inc. (h) Education Services Series A-1 Preferred Stock 5/18/2021  3,127   499,904   569,082   0.2%
Zollege PBC (k) Education Services First Lien Term Loan
(3M USD TERM SOFR+7.00%), 14.37% Cash/2.00% PIK, 5/11/2026
 5/11/2021 $16,409,153   16,332,693   13,782,048   3.8%
Zollege PBC (j)(k) Education Services Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 14.37% Cash/2.00% PIK, 5/11/2026
 5/11/2021 $939,109   932,951   788,758   0.2%
Zollege PBC (h) Education Services Class A Units 5/11/2021  250,000   250,000   32,716   0.0%
    Total Education Services        39,490,553   36,679,054   10.2%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Destiny Solutions Inc. (h)(i) Education Software Limited Partner Interests 5/16/2018  3,068   3,969,291   9,633,415   2.7%
GoReact Education Software First Lien Term Loan
(3M USD TERM SOFR+7.50%), 14.07% Cash/1.00% PIK, 1/17/2025
 1/17/2020 $8,067,365   8,033,120   8,073,012   2.2%
GoReact (j) Education Software Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 14.07% Cash/1.00% PIK, 1/17/2025
 1/18/2022 $-   -   -   0.0%
Identity Automation Systems (h) Education Software Common Stock Class A-2 Units 8/25/2014  232,616   232,616   553,406   0.2%
Identity Automation Systems (h) Education Software Common Stock Class A-1 Units 3/6/2020  43,715   171,571   230,727   0.1%
Ready Education Education Software First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 8/5/2027
 8/5/2022 $27,000,000   26,783,146   26,454,600   7.4%
    Total Education Software        39,189,744   44,945,160   12.6%
TG Pressure Washing Holdings, LLC (h) Facilities Maintenance Preferred Equity 8/12/2019  488,148   488,148   274,272   0.1%
    Total Facilities Maintenance        488,148   274,272   0.1%
Davisware, LLC Field Service Management First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 7/31/2024
 9/6/2019 $6,000,000   5,985,947   5,976,600   1.7%
Davisware, LLC (j) Field Service Management Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 7/31/2024
 9/6/2019 $3,977,790   3,964,276   3,962,277   1.1%
    Total Field Service Management        9,950,223   9,938,877   2.8%
GDS Software Holdings, LLC Financial Services First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 12/30/2026
 12/30/2021 $22,713,926   22,616,511   22,389,117   6.2%
GDS Software Holdings, LLC Financial Services Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 12/30/2026
 12/30/2021 $3,286,074   3,260,914   3,239,083   0.9%
GDS Software Holdings, LLC  (h) Financial Services Common Stock Class A Units 8/23/2018  250,000   250,000   481,091   0.1%
    Total Financial Services        26,127,425   26,109,291   7.2%
Ascend Software, LLC Financial Services Software First Lien Term Loan
(3M USD TERM SOFR+7.50%), 13.13% Cash, 12/15/2026
 12/15/2021 $6,000,000   5,959,140   5,904,600   1.6%
Ascend Software, LLC (j) Financial Services Software Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 13.13% Cash, 12/15/2026
 12/15/2021 $4,050,000   4,018,101   3,961,755   1.1%
    Total Financial Services Software        9,977,241   9,866,355   2.7%
Inspect Point Holdings, LLC Fire Inspection Business Software First Lien Term Loan
(1M USD TERM SOFR+6.50%), 11.84% Cash, 07/19/2028
 7/19/2023 $10,000,000   9,904,135   9,900,000   2.8%
Inspect Point Holdings, LLC (j) Fire Inspection Business Software First Lien Term Loan
(1M USD TERM SOFR+6.50%), 11.84% Cash, 07/19/2028
 7/19/2023 $-   -   -   0.0%
    Total Fire Inspection Business Software        9,904,135   9,900,000   2.8%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Stretch Zone Franchising, LLC Health/Fitness Franchisor First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 3/31/2028
 3/31/2023 $30,000,000   29,725,038   29,925,000   8.3%
Stretch Zone Franchising, LLC (j) Health/Fitness Franchisor Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 3/31/2028
 3/31/2023 $-   -   -   0.0%
Stretch Zone Franchising, LLC (h) Health/Fitness Franchisor Class A Units 3/31/2023  20,000   2,000,000   2,076,541   0.6%
    Total Health/Fitness Franchisor        31,725,038   32,001,541   8.9%
                       
Axiom Medical Consulting, LLC Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.37% Cash, 9/11/2028
 9/11/2023 $10,000,000   9,914,732   9,913,000   2.8%
Axiom Medical Consulting, LLC (j) Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+6.00%), 11.37% Cash, 9/11/2028
 9/11/2023 $-   -   -   0.0%
Axiom Parent Holdings, LLC (h) Healthcare Services Class A Preferred Units 6/19/2018  400,000   258,389   657,124   0.2%
ComForCare Health Care (d) Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+6.25%), 11.62% Cash, 1/31/2025
 1/31/2017 $25,000,000   24,959,793   25,000,000   7.0%
    Total Healthcare Services        35,132,914   35,570,124   10.0%
HemaTerra Holding Company, LLC (d) Healthcare Software First Lien Term Loan
(1M USD TERM SOFR+8.25%), 13.59% Cash, 1/31/2027
 4/15/2019 $55,066,770   54,739,570   55,220,957   15.4%
HemaTerra Holding Company, LLC Healthcare Software Delayed Draw Term Loan
(1M USD TERM SOFR+8.25%), 13.59% Cash, 1/31/2027
 4/15/2019 $13,790,700   13,738,934   13,829,314   3.8%
TRC HemaTerra, LLC (h) Healthcare Software Class D Membership Interests 4/15/2019  2,487   2,816,693   5,188,325   1.4%
Procurement Partners, LLC Healthcare Software First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.87% Cash, 5/12/2026
 11/12/2020 $35,125,000   34,951,761   35,125,000   9.8%
Procurement Partners, LLC (j) Healthcare Software Delayed Draw Term Loan
(3M USD TERM SOFR+6.50%), 11.87% Cash, 5/12/2026
 11/12/2020 $10,300,000   10,223,547   10,300,000   2.9%
Procurement Partners Holdings LLC (h) Healthcare Software Class A Units 11/12/2020  571,219   571,219   825,014   0.2%
    Total Healthcare Software        117,041,724   120,488,610   33.5%
Roscoe Medical, Inc. (h) Healthcare Supply Common Stock 3/26/2014  5,081   508,077   -   0.0%
    Total Healthcare Supply        508,077   -   0.0%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Book4Time, Inc. (a)(d) Hospitality/Hotel First Lien Term Loan
(3M USD TERM SOFR+7.50%), 12.87%, 12/22/2025
 12/22/2020 $3,136,517   3,121,291   3,136,517   0.9%
Book4Time, Inc. (a) Hospitality/Hotel Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 12.87%, 12/22/2025
 12/22/2020 $2,000,000   1,988,440   2,000,000   0.6%
Book4Time, Inc. (a)(h)(i) Hospitality/Hotel Class A Preferred Shares 12/22/2020  200,000   156,826   363,008   0.1%
Knowland Group, LLC (k) Hospitality/Hotel Second Lien Term Loan
(3M USD TERM SOFR+8.00%), 16.52% Cash/3.00% PIK, 12/31/2024
 11/9/2018 $15,878,989   15,878,989   9,632,195   2.7%
Sceptre Hospitality Resources, LLC Hospitality/Hotel First Lien Term Loan
(3M USD TERM SOFR+7.25%), 12.62% Cash, 11/15/2027
 4/27/2020 $23,000,000   22,824,663   23,046,000   6.4%
Sceptre Hospitality Resources, LLC (j) Hospitality/Hotel Delayed Draw Term Loan
(3M USD TERM SOFR+7.25%), 12.62% Cash, 11/15/2027
 9/2/2021 $-   -   -   0.0%
    Total Hospitality/Hotel        43,970,209   38,177,720   10.7%
Granite Comfort, LP (d) HVAC Services and Sales First Lien Term Loan
(3M USD TERM SOFR+8.13%), 13.50% Cash, 11/16/2025
 11/16/2020 $43,000,000   42,768,427   43,017,200   12.0%
Granite Comfort, LP (j) HVAC Services and Sales Delayed Draw Term Loan
(3M USD TERM SOFR+8.13%), 13.50% Cash, 11/16/2025
 11/16/2020 $26,250,000   25,978,236   26,260,500   7.3%
    Total HVAC Services and Sales        68,746,663   69,277,700   19.3%
Vector Controls Holding Co., LLC (d) Industrial Products First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.75% Cash, 3/6/2025
 3/6/2013 $1,465,386   1,465,386   1,465,386   0.4%
Vector Controls Holding Co., LLC (h) Industrial Products Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027 5/31/2015  343   -   7,995,842   2.2%
    Total Industrial Products        1,465,386   9,461,228   2.6%
AgencyBloc, LLC Insurance Software First Lien Term Loan
(1M USD BSBY+8.00%), 13.37% Cash, 10/1/2026
 10/1/2021 $13,368,068   13,289,222   13,368,068   3.7%
Panther ParentCo LLC (h) Insurance Software Class A Units 10/1/2021  2,500,000   2,500,000   4,030,125   1.1%
    Total Insurance Software        15,789,222   17,398,193   4.8%
LogicMonitor, Inc. (d) IT Services First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.87% Cash, 5/17/2026
 3/20/2020 $43,000,000   42,967,165   43,000,000   12.0%
      Total IT Services        42,967,165   43,000,000   12.0%
ActiveProspect, Inc. (d) Lead Management Software First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.57% Cash, 8/8/2027
 8/8/2022 $12,000,000   11,915,633   12,120,000   3.4%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
ActiveProspect, Inc. (j) Lead Management Software Delayed Draw Term Loan
(3M USD TERM SOFR+6.00%), 11.57% Cash, 8/8/2027
 8/8/2022 $-   -   -   0.0%
    Total Lead Management Software        11,915,633   12,120,000   3.4%
Centerbase, LLC Legal Software First Lien Term Loan
(3M USD TERM SOFR+7.75%), 13.12% Cash, 1/18/2027
 1/18/2022 $21,086,880   20,925,530   20,776,903   5.8%
    Total Legal Software        20,925,530   20,776,903   5.8%
Madison Logic, Inc. (d) Marketing Orchestration Software First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.37% Cash, 12/30/2028
 12/30/2022 $18,905,000   18,577,980   18,630,878   5.2%
    Total Marketing Orchestration Software        18,577,980   18,630,878   5.2%
ARC Health OpCo LLC (d) Mental Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+8.47%), 13.84% Cash, 8/5/2027
 8/5/2022 $6,500,000   6,434,853   6,568,250   1.8%
ARC Health OpCo LLC (d)(j) Mental Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+8.47%), 13.84% Cash, 8/5/2027
 8/5/2022 $26,914,577   26,902,450   27,197,180   7.6%
ARC Health OpCo LLC (h) Mental Healthcare Services Class A Preferred Units 8/5/2022  3,818,400   4,169,599   4,314,792   1.2%
    Total Mental Healthcare Services        37,506,902   38,080,222   10.6%
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD TERM SOFR+5.25), 10.77% Cash, 8/26/2026
 8/26/2021 $15,000,000   14,905,503   14,715,000   4.1%
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD TERM SOFR+6.00), 11.52% Cash, 8/26/2026
 8/26/2021 $5,000,000   4,959,057   4,905,000   1.4%
Chronus LLC (h) Mentoring Software Series A Preferred Stock 8/26/2021  3,000   3,000,000   2,343,035   0.7%
    Total Mentoring Software        22,864,560   21,963,035   6.2%
Omatic Software, LLC Non-profit Services First Lien Term Loan
(3M USD TERM SOFR+8.00%), 14.63% Cash/1.00% PIK, 6/30/2024
 5/29/2018 $14,230,244   14,210,779   14,190,399   3.9%
    Total Non-profit Services        14,210,779   14,190,399   3.9%
Emily Street Enterprises, L.L.C. Office Supplies Senior Secured Note
(3M USD TERM SOFR+7.50%), 12.87% Cash, 12/31/2025
 12/28/2012 $6,000,000   5,991,114   6,028,200   1.7%
Emily Street Enterprises, L.L.C. (h) Office Supplies Warrant Membership Interests,                          
Expires 12/31/2025
 12/28/2012  49,318   400,000   995,001   0.3%
    Total Office Supplies        6,391,114   7,023,201   2.0%
Buildout, Inc. (d) Real Estate Services First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.47% Cash, 7/9/2025
 7/9/2020 $14,000,000   13,942,540   13,792,800   3.8%
Buildout, Inc. Real Estate Services Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.47% Cash, 7/9/2025
 2/12/2021 $38,500,000   38,318,136   37,930,200   10.5%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Buildout, Inc. (h)(i) Real Estate Services Limited Partner Interests 7/9/2020  1,250   1,372,557   1,404,599   0.4%
    Total Real Estate Services        53,633,233   53,127,599   14.7%
Wellspring Worldwide Inc. Research Software First Lien Term Loan
(1M USD BSBY+7.25%), 12.62% Cash, 6/27/2027
 6/27/2022 $9,576,000   9,493,397   9,524,290   2.6%
Archimedes Parent LLC (h) Research Software Class A Common Units 6/27/2022  1,125,160   1,125,160   1,107,618   0.3%
    Total Research Software        10,618,557   10,631,908   2.9%
LFR Chicken LLC Restaurant First Lien Term Loan
(1M USD TERM SOFR+7.00%), 12.34% Cash, 11/19/2026
 11/19/2021 $12,000,000   11,921,441   11,997,600   3.3%
LFR Chicken LLC Restaurant Delayed Draw Term Loan
(1M USD TERM SOFR+7.00%), 12.34% Cash, 11/19/2026
 11/19/2021 $9,000,000   8,932,176   8,998,200   2.5%
LFR Chicken LLC (h) Restaurant Series B Preferred Units 11/19/2021  497,183   1,000,000   1,408,936   0.4%
    Total Restaurant        21,853,617   22,404,736   6.2%
JobNimbus LLC Roofing Contractor Software First Lien Term Loan
(3M USD TERM SOFR+8.75%), 14.27% Cash, 9/20/2026
 3/28/2023 $9,950,000   9,865,212   10,001,740   2.8%
    Total Roofing Contractor Software        9,865,212   10,001,740   2.8%
Pepper Palace, Inc. (d)(k) Specialty Food Retailer First Lien Term Loan
(3M USD TERM SOFR+6.25%), 11.77% Cash, 6/30/2026
 6/30/2021 $33,320,000   33,129,970   4,821,774   1.3%
Pepper Palace, Inc. (j)(k) Specialty Food Retailer Delayed Draw Term Loan
(3M USD TERM SOFR+6.25%), 11.77% Cash, 6/30/2026
 6/30/2021 $1,101,600   1,091,442   159,414   0.0%
Pepper Palace, Inc. (j)(k) Specialty Food Retailer Revolving Credit Facility
(3M USD TERM SOFR+6.25%), 11.77% Cash, 6/30/2026
 6/30/2021 $-   -   -   0.0%
Pepper Palace, Inc. (h) Specialty Food Retailer Membership Interest (Series A) 6/30/2021  1,000,000   1,000,000   -   0.0%
Pepper Palace, Inc. (h) Specialty Food Retailer Membership Interest (Series B) 6/30/2021  197,035   197,035   -   0.0%
    Total Specialty Food Retailer        35,418,447   4,981,188   1.3%
ArbiterSports, LLC (d) Sports Management First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.37% Cash, 2/21/2025
 2/21/2020 $26,000,000   25,933,625   25,994,800   7.2%
ArbiterSports, LLC Sports Management Delayed Draw Term Loan
(3M USD TERM SOFR+6.00%), 11.37% Cash, 2/21/2025
 2/21/2020 $1,000,000   1,000,000   999,800   0.3%
    Total Sports Management        26,933,625   26,994,600   7.5%
Avionte Holdings, LLC (h) Staffing Services Class A Units 1/8/2014  100,000   100,000   2,089,107   0.6%
    Total Staffing Services        100,000   2,089,107   0.6%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
JDXpert Talent Acquisition Software First Lien Term Loan
(3M USD TERM SOFR+8.50%), 14.13% Cash, 5/2/2027
 5/2/2022 $6,000,000   5,952,909   6,120,000   1.7%
JDXpert (j) Talent Acquisition Software Delayed Draw Term Loan
(3M USD TERM SOFR+8.50%), 14.13% Cash, 5/2/2027
 5/2/2022 $1,000,000   991,053   1,020,000   0.3%
Jobvite, Inc. (d) Talent Acquisition Software First Lien Term Loan
(6M USD TERM SOFR+8.00%), 13.33% Cash, 8/5/2028
 8/5/2022 $20,000,000   19,872,540   19,960,000   5.8%
    Total Talent Acquisition Software        26,816,502   27,100,000   7.8%
VetnCare MSO, LLC (j) Veterinary Services Delayed Draw Term Loan
(3M USD TERM SOFR+5.75%), 11.12% Cash, 5/12/2028
 5/12/2023 $4,680,505   4,635,792   4,689,864   1.3%
    Total Veterinary Services        4,635,792   4,689,864   1.3%
Sub Total Non-control/Non-affiliate investments            983,711,569   976,440,074   272.2%
Affiliate investments - 16.2% (b)                      
ETU Holdings, Inc. (f) Corporate Education Software First Lien Term Loan
(3M USD TERM SOFR+9.00%), 14.52% Cash, 8/18/2027
 8/18/2022 $7,000,000   6,942,570   6,909,700   1.9%
ETU Holdings, Inc. (f) Corporate Education Software Second Lien Term Loan
15.00% PIK, 2/18/2028
 8/18/2022 $5,906,527   5,863,709   5,240,861   1.5%
ETU Holdings, Inc. (f)(h) Corporate Education Software Series A Preferred Units 8/18/2022  3,000,000   3,000,000   1,370,911   0.4%
    Total Corporate Education Software        15,806,279   13,521,472   3.8%
Modis Dental Partners OpCo, LLC (f) Dental Practice Management First Lien Term Loan
(1M USD TERM SOFR+9.48%), 14.82% Cash, 4/18/2028
 4/18/2023 $7,000,000   6,902,386   6,988,800   1.9%
Modis Dental Partners OpCo, LLC (j)(f) Dental Practice Management Delayed Draw Term Loan
(1M USD TERM SOFR+9.48%), 14.82% Cash, 4/18/2028
 4/18/2023 $-   -   -   0.0%
Modis Dental Partners OpCo, LLC (f)(h) Dental Practice Management Class A Preferred Units 4/18/2023  1,950,000   1,950,000   1,872,000   0.5%
    Total Dental Practice Management        8,852,386   8,860,800   2.4%
Axero Holdings, LLC (f) Employee Collaboration Software First Lien Term Loan
(3M USD TERM SOFR+10.00%), 15.52% Cash, 6/30/2026
 6/30/2021 $5,500,000   5,465,822   5,538,500   1.5%
Axero Holdings, LLC (f) Employee Collaboration Software Delayed Draw Term Loan
(3M USD TERM SOFR+10.00%), 15.52% Cash, 6/30/2026
 6/30/2021 $1,100,000   1,092,183   1,107,700   0.3%
Axero Holdings, LLC (f)(j) Employee Collaboration Software Revolving Credit Facility
(3M USD TERM SOFR+10.00%), 15.52% Cash, 6/30/2026
 2/3/2022 $-   -   -   0.0%


Company(1) Industry Investment Interest Rate/
Maturity
 Original
Acquisition
Date
 Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Axero Holdings, LLC (f)(h) Employee Collaboration Software Series A Preferred Units 6/30/2021  2,055,609   2,055,609   2,801,000   0.8%
Axero Holdings, LLC (f)(h) Employee Collaboration Software Series B Preferred Units 6/30/2021  2,055,609   2,055,609   4,446,367   1.2%
    Total Employee Collaboration Software        10,669,223   13,893,567   3.8%
Alpha Aesthetics Partners OpCo, LLC (f) Healthcare Services First Lien Term Loan
(1M USD TERM SOFR+9.98%), 15.32% Cash, 3/20/2028
 3/20/2023 $3,900,000   3,845,631   3,891,810   1.2%
Alpha Aesthetics Partners OpCo, LLC (f)(j) Healthcare Services Delayed Draw Term Loan
(1M USD TERM SOFR+9.98%), 15.32% Cash, 3/20/2028
 3/20/2023 $4,880,496   4,811,222   4,870,247   1.4%
Alpha Aesthetics Partners OpCo, LLC (f)(h) Healthcare Services Class A Preferred Units 3/20/2023  1,850,000   1,850,000   2,090,501   0.6%
    Total Healthcare Services        10,506,853   10,852,558   3.2%
Sub Total Affiliate investments            45,834,741   47,128,397   13.2%
Control investments - 25.2% (b)                      
Netreo Holdings, LLC (g) IT Services First Lien Term Loan
(3M USD TERM SOFR +6.50%), 15.52% Cash/3.50% PIK
12/31/2025
 7/3/2018 $5,643,670   5,632,944   5,515,558   1.5%
Netreo Holdings, LLC (d)(g) IT Services Delayed Draw Term Loan
(3M USD TERM SOFR +6.50%), 15.52% Cash/3.50% PIK,
12/31/2025
 5/26/2020 $25,048,948   24,957,841   24,480,337   6.8%
Netreo Holdings, LLC (g)(h) IT Services Common Stock Class A Units 7/3/2018  4,600,677   8,344,500   5,675,795   1.6%
    Total IT Services        38,935,285   35,671,690   9.9%
Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g) Structured Finance Securities Other/Structured Finance Securities
0.00%, 4/20/2033
 1/22/2008 $111,000,000   23,412,409   8,938,522   2.5%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+10.00%), 15.37%, 4/20/2033
 8/9/2021 $9,375,000   9,375,000   8,981,565   2.5%
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+8.55%), 13.92%, 10/20/2033
 10/28/2022 $12,250,000   11,392,500   11,467,384   3.2%
    Total Structured Finance Securities        44,179,909   29,387,471   8.2%
Saratoga Senior Loan Fund I JV, LLC (a)(g)(j) Investment Fund Unsecured Loan
10.00%, 10/20/2033
 2/17/2022 $17,618,954   17,618,954   17,618,954   4.9%
Saratoga Senior Loan Fund I JV, LLC (a)(g) Investment Fund Membership Interest 2/17/2022  17,583,486   17,583,486   7,792,023   2.2%
    Total Investment Fund        35,202,440   25,410,977   7.1%
Sub Total Control investments            118,317,634   90,470,138   25.2%
TOTAL INVESTMENTS - 310.6% (b)           $1,147,863,944  $1,114,038,609   310.6%


  Number of
Shares
  Cost  Fair Value  % of
Net Assets
 
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 13.1% (b)                
U.S. Bank Money Market (l)  47,026,499  $47,026,499  $47,026,499   13.1%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts  47,026,499  $47,026,499  $47,026,499   13.1%

(a)(1)Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities.
(a)Represents an investment that is not a non-qualifying investment as defined“qualifying asset” under Section 55 (a)55(a) of the Investment Company Act of 1940, as amended. Non-qualifyingamended (the 1940 Act”). As of November 30, 2023, non-qualifying assets represent 4.8%6.2% of the Company’s portfolio at fair value. As a BDC, the Company can onlygenerally has to invest 30%at least 70% of its portfoliototal assets in non-qualifyingqualifying assets.
(b)(b)Percentages are based on net assets of $138,846,223$359,558,749 as of November 30, 2017.2023.
(c)(c)Because there is no readily“readily available market valuequotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directorsdirectors.  These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).
(d)These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the nine months ended November 30, 2023 in which the issuer was an affiliate are as follows:

Company Purchases  Sales  Total Interest from Investments  Management Fee Income  Net Realized
Gain (Loss) from Investments
  Net Change in Unrealized Appreciation (Depreciation) 
Axero Holdings, LLC $-  $-  $691,807  $        -  $        -  $723,935 
ETU Holdings, Inc.  -   -   1,425,096   -   -   (2,367,949)
Modis Dental Partners OpCo, LLC  8,845,000   -   656,579   -   -   8,414 
Alpha Aesthetics Partners OpCo, LLC  10,498,789   -   424,543   -   -   345,705 
Total $19,343,789  $-  $3,198,025  $-  $-  $(1,289,895)


(g)As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the nine months ended November 30, 2023 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

Company Purchases  Sales  Total Interest
from
Investments
  Management
Fee Income
  Net Realized
Gain (Loss)
from Investments
  Net Change
in Unrealized
Appreciation
(Depreciation)
 
Netreo Holdings, LLC $2,475,000  $         -  $3,151,257  $-  $           -  $(11,543,808)
Saratoga Investment Corp. CLO 2013-1, Ltd.  -   -   -   2,453,967   -   (6,706,561)
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note  -   -   1,265,735   -   -   112,889 
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note  -   -   1,099,141   -   -   150,159 
Saratoga Senior Loan Fund I JV, LLC  -   -   1,340,998   -   -   - 
Saratoga Senior Loan Fund I JV, LLC  -   -   -   -   -   (5,314,928)
Total $2,475,000  $-  $6,857,131  $2,453,967  $-  $(23,302,249)

(h)Non-income producing at November 30, 2023.
(i)Includes securities issued by an affiliate of the company.
(j)All or a portion of this investment has an unfunded commitment as of November 30, 2023. (See Note 9 to the consolidated financial statements).
(k)As of November 30, 2023, the investment was on non-accrual status. The fair value of these investments was approximately $29.2 million, which represented 2.6% of the Company’s portfolio (see Note 2 to the consolidated financial statements).
(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of November 30, 2023.

BSBY - Bloomberg Short-Term Bank Yield

SOFR - Secured Overnight Financing Rate

1M USD BSBY - The 1 month USD BSBY rate as of November 30, 2023 was 5.37%.

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of November 30, 2023 was 5.34%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of November 30, 2023 was 5.37%.

6M USD TERM SOFR - The 6 month USD TERM SOFR rate as of November 30, 2023 was 5.33%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

See accompanying notes to consolidated financial statements.


Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Non-control/Non-affiliate investments - 238.6% (b)                      
Altvia MidCo, LLC. Alternative Investment Management Software First Lien Term Loan
(3M USD TERM SOFR+8.50%), 13.39% Cash, 7/18/2027
 7/18/2022 $7,980,000  $7,907,457  $7,911,372   2.3%
Altvia MidCo, LLC. (h) Alternative Investment Management Software Series A-1 Preferred Shares 7/18/2022  2,000,000   2,000,000   2,548,000   0.7%
    Total Alternative Investment Management Software        9,907,457   10,459,372   3.0%
Artemis Wax Corp. (d)(j) Consumer Services Delayed Draw Term Loan
(1M USD TERM SOFR+6.75%), 11.41% Cash, 5/20/2026
 5/20/2021 $57,500,000   57,059,057   57,500,000   16.6%
Artemis Wax Corp. (h) Consumer Services Series B-1 Preferred Stock 5/20/2021  934,463   1,500,000   4,642,322   1.3%
Artemis Wax Corp. (h) Consumer Services Series D Preferred Stock 12/22/2022  278,769   1,500,000   1,500,005   0.4%
    Total Consumer Services        60,059,057   63,642,327   18.3%
Schoox, Inc. (h), (i) Corporate Education Software Series 1 Membership Interest 12/8/2020  1,050   475,698   3,809,091   1.1%
    Total Corporate Education Software        475,698   3,809,091   1.1%
GreyHeller LLC (h) Cyber Security Common Stock 11/10/2021  7,857,689   1,906,275   2,509,210   0.7%
    Total Cyber Security        1,906,275   2,509,210   0.7%
New England Dental Partners Dental Practice Management First Lien Term Loan
(3M USD LIBOR+8.00%), 12.97% Cash, 11/25/2025
 11/25/2020 $6,555,000   6,514,437   6,523,536   1.9%
New England Dental Partners Dental Practice Management Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 12.97% Cash, 11/25/2025
 11/25/2020 $4,650,000   4,627,032   4,627,680   1.3%
Gen4 Dental Partners Holdings, LLC (j) Dental Practice Management Delayed Draw Term Loan
(3M USD TERM SOFR+10.35%), 15.24% Cash, 4/29/2026
 2/8/2023 $-   (94,504)  -   0.0%
Gen4 Dental Partners Holdings, LLC (i) Dental Practice Management Series A Preferred Units 2/8/2023  480,769   1,000,000   1,000,000   0.3%
    Total Dental Practice Management        12,046,965   12,151,216   3.5%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Exigo, LLC (d) Direct Selling Software First Lien Term Loan
(1M USD LIBOR+5.75%), 10.42% Cash, 3/16/2027
 3/16/2022 $24,812,500   24,632,494   24,504,825   7.1%
Exigo, LLC (j) Direct Selling Software Delayed Draw Term Loan
(1M USD LIBOR+5.75%), 10.42% Cash, 3/16/2027
 3/16/2022 $-   -   (51,667)  0.0%
Exigo, LLC (j) Direct Selling Software Revolving Credit Facility
(1M USD LIBOR+5.75%), 10.42% Cash, 3/16/2027
 3/16/2022 $208,334   208,333   195,417   0.1%
Exigo, LLC (h), (i) Direct Selling Software Common Units 3/16/2022  1,041,667   1,041,667   1,121,575   0.3%
    Total Direct Selling Software        25,882,494   25,770,150   7.5%
C2 Educational Systems (d) Education Services First Lien Term Loan
(3M USD LIBOR+8.50%), 13.47% Cash, 5/31/2023
 5/31/2017 $18,500,000   18,497,146   18,525,900   5.3%
C2 Education Systems, Inc. (h) Education Services Series A-1 Preferred Stock 5/18/2021  3,127   499,904   629,892   0.2%
Zollege PBC Education Services First Lien Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 5/11/2026
 5/11/2021 $16,000,000   15,905,830   14,827,200   4.3%
Zollege PBC (j) Education Services Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 5/11/2026
 5/11/2021 $500,000   496,809   390,050   0.1%
Zollege PBC (h) Education Services Class A Units 5/11/2021  250,000   250,000   115,676   0.0%
    Total Education Services        35,649,689   34,488,718   9.9%
Destiny Solutions Inc. (h), (i) Education Software Limited Partner Interests 5/16/2018  3,068   3,969,291   8,941,350   2.6%
GoReact Education Software First Lien Term Loan
(3M USD TERM SOFR+7.50%), 13.59% Cash, 1/17/2025
 1/17/2020 $8,006,000   7,952,042   7,982,783   2.3%
GoReact (j) Education Software Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 13.59% Cash, 1/17/2025
 1/18/2022 $1,000,750   1,000,750   997,848   0.3%
Identity Automation Systems (h) Education Software Common Stock Class A-2 Units 8/25/2014  232,616   232,616   218,168   0.1%
Identity Automation Systems (h) Education Software Common Stock Class A-1 Units 3/6/2020  43,715   171,571   217,370   0.1%
Ready Education Education Software First Lien Term Loan
(3M USD TERM SOFR+6.00%), 10.89% Cash, 8/5/2027
 8/5/2022 $27,000,000   26,751,573   26,597,700   7.7%
    Total Education Software        40,077,843   44,955,219   13.1%
TG Pressure Washing Holdings, LLC (h) Facilities Maintenance Preferred Equity 8/12/2019  488,148   488,148   407,760   0.1%
    Total Facilities Maintenance        488,148   407,760   0.1%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Davisware, LLC Field Service Management First Lien Term Loan
(3M USD TERM SOFR+7.00%), 11.89% Cash, 7/31/2024
 9/6/2019 $6,000,000   5,972,735   5,988,000   1.7%
Davisware, LLC Field Service Management Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 11.89% Cash, 7/31/2024
 9/6/2019 $3,977,790   3,950,992   3,969,834   1.1%
    Total Field Service Management        9,923,727   9,957,834   2.8%
B. Riley Financial, Inc. (a) Financial Services Senior Unsecured Loan
6.75% Cash, 5/31/2024
 10/18/2022 $165,301   165,301   160,077   0.0%
GDS Software Holdings, LLC Financial Services First Lien Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 12/30/2026
 12/30/2021 $22,713,926   22,603,970   22,311,890   6.4%
GDS Software Holdings, LLC Financial Services Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 12/30/2026
 12/30/2021 $3,286,074   3,257,297   3,227,910   0.9%
GDS Software Holdings, LLC  (h) Financial Services Common Stock Class A Units 8/23/2018  250,000   250,000   518,413   0.1%
    Total Financial Services        26,276,568   26,218,290   7.4%
Ascend Software, LLC Financial Services Software First Lien Term Loan
(3M USD LIBOR+7.50%), 12.47% Cash, 12/15/2026
 12/15/2021 $6,000,000   5,952,354   5,902,200   1.7%
Ascend Software, LLC (j) Financial Services Software Delayed Draw Term Loan
(3M USD LIBOR+7.50%), 12.47% Cash, 12/15/2026
 12/15/2021 $3,300,000   3,269,283   3,194,050   0.9%
    Total Financial Services Software        9,221,637   9,096,250   2.6%
Axiom Parent Holdings, LLC (h) Healthcare Services Common Stock Class A Units 6/19/2018 $400,000   400,000   1,286,156   0.4%
ComForCare Health Care (d) Healthcare Services First Lien Term Loan
(3M USD LIBOR+6.25%), 11.22% Cash, 1/31/2025
 1/31/2017 $25,000,000   24,938,666   25,000,000   7.2%
    Total Healthcare Services        25,338,666   26,286,156   7.6%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
HemaTerra Holding Company, LLC (d) Healthcare Software First Lien Term Loan
(1M USD TERM SOFR+8.25%), 12.91% Cash, 1/31/2027
 4/15/2019 $55,483,943   55,105,372   55,445,104   16.0%
HemaTerra Holding Company, LLC Healthcare Software Delayed Draw Term Loan
(1M USD TERM SOFR+8.25%), 12.91% Cash, 1/31/2027
 4/15/2019 $13,895,175   13,829,142   13,885,448   4.0%
TRC HemaTerra, LLC (h) Healthcare Software Class D Membership Interests 4/15/2019  2,487   2,816,693   4,606,741   1.3%
Procurement Partners, LLC Healthcare Software First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.39% Cash, 5/12/2026
 11/12/2020 $35,125,000   34,906,981   35,103,925   10.1%
Procurement Partners, LLC (j) Healthcare Software Delayed Draw Term Loan
(3M USD TERM SOFR+6.50%), 11.39% Cash, 5/12/2026
 11/12/2020 $9,300,000   9,219,412   9,294,420   2.7%
Procurement Partners Holdings LLC (h) Healthcare Software Class A Units 11/12/2020  571,219   571,219   788,283   0.2%
    Total Healthcare Software        116,448,819   119,123,921   34.3%
Roscoe Medical, Inc. (h) Healthcare Supply Common Stock 3/26/2014  5,081   508,077   -   0.0%
    Total Healthcare Supply        508,077   -   0.0%
Book4Time, Inc. (a), (d) Hospitality/Hotel First Lien Term Loan
(3M USD LIBOR+7.50%), 12.47%, 12/22/2025
 12/22/2020 $3,136,517   3,116,896   3,136,517   0.9%
Book4Time, Inc. (a) Hospitality/Hotel Delayed Draw Term Loan
(3M USD LIBOR+7.50%), 12.47%, 12/22/2025
 12/22/2020 $2,000,000   1,984,212   2,000,000   0.6%
Book4Time, Inc. (a), (h), (i) Hospitality/Hotel Class A Preferred Shares 12/22/2020  200,000   156,826   281,778   0.1%
Knowland Group, LLC (h), (k) Hospitality/Hotel Second Lien Term Loan
(3M USD LIBOR+8.00%), 13.97% Cash/1.00% PIK, 5/9/2024
 11/9/2018 $15,878,989   15,878,989   9,760,821   2.8%
Sceptre Hospitality Resources, LLC Hospitality/Hotel First Lien Term Loan
(3M USD TERM SOFR+7.25%), 12.14% Cash, 11/15/2027
 4/27/2020 $23,000,000   22,806,316   22,793,000   6.6%
Sceptre Hospitality Resources, LLC (j) Hospitality/Hotel Delayed Draw Term Loan
(3M USD TERM SOFR+7.25%), 12.14% Cash, 11/15/2027
 9/2/2021 $-   -   -   0.0%
    Total Hospitality/Hotel        43,943,239   37,972,116   11.0%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Granite Comfort, LP (d) HVAC Services and Sales First Lien Term Loan
(3M USD TERM SOFR+7.86%), 12.75% Cash, 11/16/2025
 11/16/2020 $43,000,000   42,694,831   42,570,000   12.3%
Granite Comfort, LP (j) HVAC Services and Sales Delayed Draw Term Loan
(3M USD TERM SOFR+7.86%), 12.75% Cash, 11/16/2025
 11/16/2020 $12,000,000   11,894,177   11,880,000   3.4%
    Total HVAC Services and Sales        54,589,008   54,450,000   15.7%
Vector Controls Holding Co., LLC (d) Industrial Products First Lien Term Loan
(3M USD LIBOR+6.50%), 11.47% Cash, 3/6/2025
 3/6/2013 $3,089,986   3,089,986   3,089,986   0.9%
Vector Controls Holding Co., LLC (h) Industrial Products Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027 5/31/2015  343   -   6,517,923   1.9%
    Total Industrial Products        3,089,986   9,607,909   2.8%
AgencyBloc, LLC Insurance Software First Lien Term Loan
(1M USD BSBY+8.00%), 12.58% Cash, 10/1/2026
 10/1/2021 $13,469,318   13,376,121   13,449,114   3.9%
Panther ParentCo LLC (h) Insurance Software Class A Units 10/1/2021  2,500,000   2,500,000   3,311,442   1.0%
    Total Insurance Software        15,876,121   16,760,556   4.9%
LogicMonitor, Inc. (d) IT Services First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.39% Cash, 5/17/2026
 3/20/2020 $43,000,000   42,953,087   43,000,000   12.4%
      Total IT Services        42,953,087   43,000,000   12.4%
ActiveProspect, Inc. (d) Lead Management Software First Lien Term Loan
(3M USD LIBOR+6.00%), 10.97% Cash, 8/8/2027
 8/8/2022 $12,000,000   11,906,362   12,090,000   3.5%
ActiveProspect, Inc. (j) Lead Management Software Delayed Draw Term Loan
(3M USD LIBOR+6.00%), 10.97% Cash, 8/8/2027
 8/8/2022 $-   -   -   0.0%
    Total Lead Management Software        11,906,362   12,090,000   3.5%
Centerbase, LLC Legal Software First Lien Term Loan
(1M USD TERM SOFR+7.75%), 12.41% Cash, 1/18/2027
 1/18/2022 $21,247,440   21,055,931   20,699,256   6.0%
    Total Legal Software        21,055,931   20,699,256   6.0%
Madison Logic, Inc. (d) Marketing Orchestration Software First Lien Term Loan
(3M USD TERM SOFR+7.00%), 11.89% Cash, 12/30/2028
 12/10/2021 $19,000,000   18,626,777   18,715,000   5.4%
    Total Marketing Orchestration Software        18,626,777   18,715,000   5.4%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
ARC Health OpCo LLC (d) Mental Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+8.48%), 13.37% Cash, 8/5/2027
 8/5/2022 $6,500,000   6,427,296   6,461,000   1.9%
ARC Health OpCo LLC (d), (j) Mental Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+8.48%), 13.37% Cash, 8/5/2027
 8/5/2022 $7,726,978   7,634,711   7,680,616   2.2%
ARC Health OpCo LLC (h) Mental Healthcare Services Class A Preferred Shares 8/5/2022  2,808,236   3,035,108   2,780,153   0.8%
    Total Mental Healthcare Services        17,097,115   16,921,769   4.9%
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD LIBOR+5.25), 10.22% Cash, 8/26/2026
 8/26/2021 $15,000,000   14,887,780   14,890,500   4.3%
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD LIBOR+6.00), 10.97% Cash, 8/26/2026
 8/26/2021 $3,000,000   2,973,634   2,978,100   0.9%
Chronus LLC (h) Mentoring Software Series A Preferred Stock 8/26/2021  3,000   3,000,000   3,490,403   1.0%
    Total Mentoring Software        20,861,414   21,359,003   6.2%
Omatic Software, LLC Non-profit Services First Lien Term Loan
(3M USD TERM SOFR+8.00%), 14.15% Cash/1.00% PIK, 1/31/2024
 5/29/2018 $13,122,781   13,091,197   13,095,223   3.8%
    Total Non-profit Services        13,091,197   13,095,223   3.8%
Emily Street Enterprises, L.L.C. Office Supplies Senior Secured Note
(3M USD TERM SOFR+7.50%), 12.39% Cash, 12/31/2025
 12/28/2012 $6,000,000   5,974,379   5,965,800   1.7%
Emily Street Enterprises, L.L.C. (h) Office Supplies Warrant Membership Interests,                          
Expires 12/31/2025
 12/28/2012  49,318   400,000   406,755   0.1%
    Total Office Supplies        6,374,379   6,372,555   1.8%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Buildout, Inc. Real Estate Services First Lien Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 7/9/2025
 7/9/2020 $14,000,000   13,924,435   13,855,800   4.0%
Buildout, Inc. Real Estate Services Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 7/9/2025
 2/12/2021 $38,500,000   38,257,589   38,103,450   11.0%
Buildout, Inc. (h), (i) Real Estate Services Limited Partner Interests 7/9/2020  1,250   1,372,557   1,447,219   0.4%
    Total Real Estate Services        53,554,581   53,406,469   15.4%
Archimedes Parent LLC (h) Research Software Class A Common Units 6/27/2022  1,125,160   1,125,160   1,136,503   0.3%
Wellspring Worldwide Inc. Research Software First Lien Term Loan
(1M USD BSBY+7.25%), 11.83% Cash, 6/27/2027
 6/27/2022 $9,600,000   9,503,123   9,540,480   2.7%
    Total Research Software        10,628,283   10,676,983   3.0%
LFR Chicken LLC Restaurant First Lien Term Loan
(1M USD LIBOR+7.00%), 11.67% Cash, 11/19/2026
 11/19/2021 $12,000,000   11,906,864   11,866,800   3.4%
LFR Chicken LLC (j) Restaurant Delayed Draw Term Loan
(1M USD LIBOR+7.00%), 11.67% Cash, 11/19/2026
 11/19/2021 $9,000,000   8,927,326   8,900,100   2.6%
LFR Chicken LLC (h) Restaurant Series B Preferred Units 11/19/2021  497,183   1,000,000   1,177,373   0.3%
TMAC Acquisition Co., LLC Restaurant Unsecured Term Loan
8.00% PIK, 3/1/2024
 3/1/2018 $3,217,657   3,217,657   2,881,888   0.8%
    Total Restaurant        25,051,847   24,826,161   7.1%
Pepper Palace, Inc. (d) Specialty Food Retailer First Lien Term Loan
(3M USD LIBOR+6.25%), 11.22% Cash, 6/30/2026
 6/30/2021 $33,490,000   33,255,863   24,410,861   7.0%
Pepper Palace, Inc. (j) Specialty Food Retailer Delayed Draw Term Loan
(3M USD LIBOR+6.25%), 11.22% Cash, 6/30/2026
 6/30/2021 $-   -   -   0.0%
Pepper Palace, Inc. (j) Specialty Food Retailer Revolving Credit Facility
(3M USD LIBOR+6.25%), 11.22% Cash, 6/30/2026
 6/30/2021 $-   -   -   0.0%
Pepper Palace, Inc. (h) Specialty Food Retailer Membership Interest 6/30/2021  1,000,000   1,000,000   -   0.0%
    Total Specialty Food Retailer        34,255,863   24,410,861   7.0%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
ArbiterSports, LLC (d) Sports Management First Lien Term Loan
(3M USD LIBOR+6.50%), 11.47% Cash, 2/21/2025
 2/21/2020 $26,000,000   25,894,505   25,721,800   7.4%
ArbiterSports, LLC Sports Management Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 11.47% Cash, 2/21/2025
 2/21/2020 $1,000,000   1,000,000   989,300   0.3%
    Total Sports Management        26,894,505   26,711,100   7.7%
Avionte Holdings, LLC (h) Staffing Services Class A Units 1/8/2014  100,000   100,000   2,079,325   0.6%
    Total Staffing Services        100,000   2,079,325   0.6%
JDXpert Talent Acquisition Software First Lien Term Loan
(3M USD LIBOR+8.50%), 13.47% Cash, 5/2/2027
 5/2/2022 $6,000,000   5,947,780   6,045,000   1.7%
JDXpert (j) Talent Acquisition Software Delayed Draw Term Loan
(3M USD LIBOR+8.50%), 13.47% Cash, 5/2/2027
 5/2/2022 $-   -   -   0.0%
Jobvite, Inc. (d) Talent Acquisition Software First Lien Term Loan
(3M USD TERM SOFR+8.00%), 12.89% Cash, 8/5/2028
 8/5/2022 $20,000,000   19,857,613   19,954,000   5.8%
    Total Talent Acquisition Software        25,805,393   25,999,000   7.5%
Sub Total Non-control/Non-affiliate investments            819,966,208   828,028,800   238.6%
Affiliate investments - 8.1% (b)                      
ETU Holdings, Inc. (f) Corporate Education Software First Lien Term Loan
(3M USD LIBOR+9.00%), 13.97% Cash, 8/18/2027
 8/18/2022 $7,000,000   6,935,556   7,006,300   2.0%
ETU Holdings, Inc. (f) Corporate Education Software Second Lien Term Loan
15.00% PIK, 2/18/2028
 8/18/2022 $5,282,563   5,235,433   5,175,327   1.5%
ETU Holdings, Inc. (f), (h) Corporate Education Software Series A-1 Preferred Stock 8/18/2022  3,000,000   3,000,000   3,072,504   0.9%
    Total Corporate Education Software        15,170,989   15,254,131   4.4%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Axero Holdings, LLC (f) Employee Collaboration Software First Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.04% Cash, 6/30/2026
 6/30/2021 $5,500,000   5,460,448   5,513,200   1.6%
Axero Holdings, LLC (f) Employee Collaboration Software Delayed Draw Term Loan
(3M USD TERM SOFR+8.00%), 13.04% Cash, 6/30/2026
 6/30/2021 $1,100,000   1,090,883   1,102,640   0.3%
Axero Holdings, LLC (f), (j) Employee Collaboration Software Revolving Credit Facility
(3M USD TERM SOFR+8.00%), 13.04% Cash, 6/30/2026
 2/3/2022 $-   -   -   0.0%
Axero Holdings, LLC (f), (h) Employee Collaboration Software Series A Preferred Units 6/30/2021  2,000,000   2,000,000   2,498,000   0.7%
Axero Holdings, LLC (f), (h) Employee Collaboration Software Series B Preferred Units 6/30/2021  2,000,000   2,000,000   3,937,900   1.1%
    Total Employee Collaboration Software        10,551,331   13,051,740   3.7%
Sub Total Affiliate investments            25,722,320   28,305,871   8.1%
Control investments - 33.6% (b)                      
Netreo Holdings, LLC (g) IT Services First Lien Term Loan
(3M USD LIBOR +6.50%), 13.47% Cash/2.00% PIK
12/31/2025
 7/3/2018 $5,539,029   5,522,608   5,443,757   1.6%
Netreo Holdings, LLC (d), (g) IT Services Delayed Draw Term Loan
(3M USD LIBOR +6.50%), 13.47% Cash/2.00% PIK,
12/31/2025
 5/26/2020 $22,111,008   22,019,877   21,730,699   6.3%
Netreo Holdings, LLC (g), (h) IT Services Common Stock Class A Unit 7/3/2018  4,600,677   8,344,500   16,992,742   4.9%
    Total IT Services        35,886,985   44,167,198   12.8%
Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (e), (g) Structured Finance Securities Other/Structured Finance Securities
0.00%, 4/20/2033
 1/22/2008 $111,000,000   28,943,904   21,176,578   6.1%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a), (g) Structured Finance Securities Other/Structured Finance Securities
(3M USD LIBOR+10.00%), 14.97%, 4/20/2033
 8/9/2021 $9,375,000   9,375,000   8,831,406   2.5%


Company(1) Industry Investment Interest Rate/
Maturity
 Original Acquisition Date Principal/
Number of Shares
  Cost  Fair Value (c)  % of
Net Assets
 
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a), (g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+8.55%), 13.44%, 10/20/2033
 10/28/2022 $12,250,000   11,392,500   11,354,495   3.3%
    Total Structured Finance Securities        49,711,404   41,362,479   11.9%
Saratoga Senior Loan Fund I JV, LLC (a), (g), (j) Investment Fund Unsecured Loan
10.00%, 6/15/2023
 2/17/2022 $17,618,954   17,618,954   17,618,954   5.1%
Saratoga Senior Loan Fund I JV, LLC (a), (g), (h) Investment Fund Membership Interest 2/17/2022  17,583,486   17,583,486   13,106,951   3.8%
    Total Investment Fund        35,202,440   30,725,905   8.9%
Sub Total Control investments            120,800,829   116,255,582   33.6%
TOTAL INVESTMENTS - 280.3% (b)           $966,489,357  $972,590,253   280.3%

  Number of
Shares
  Cost  Fair Value  % of
Net Assets
 
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 27.7% (b)                
U.S. Bank Money Market (l)  96,076,273  $96,076,273  $96,076,273   27.7%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts  96,076,273  $96,076,273  $96,076,273   27.7%

(1)Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities.
(a)Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 28, 2023, non-qualifying assets represent 8.6% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.
(b)Percentages are based on net assets of $346,958,042 as of February 28, 2023.
(c)Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).
(d)These securities are either fully or partially pledged as collateral under athe Company’s senior secured revolving credit facility (see Note 68 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 29.48%0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company1940 Act, we “Control” this portfolio company becauseis an “affiliate” as we own more than 25%between 5.0% and 25.0% of the portfolio company’s outstanding voting securities. Artemis Wax Corp. is no longer an affiliate as of February 28, 2023. Transactions during the nine monthsmonthsyear ended November 30, 2017February 28, 2023 in which the issuer was both an Affiliate and a portfolio company that we Controlaffiliate are as follows:

 

Company

  Purchases   Redemptions   Sales  Interest
Income
   Management
and Incentive
Fee Income
   Net Realized
Gains
   Net Change in
Unrealized
Appreciation
(Depreciation)
 

Easy Ice, LLC

  $—     $—     $(11,307,678 $2,814,092   $—     $63,720   $1,685,785 

Saratoga Investment Corp. CLO 2013-1, Ltd.

  $—     $—     $—    $1,719,744   $1,605,171   $—     $1,991,685 

Saratoga Investment Corp. Class F Note

  $—     $—     $—    $320,215   $—     $—     $(450
Company Purchases  Sales  Total Interest
from Investments
  Management
Fee Income
  Net Realized
Gain (Loss)
from Investments
  Net Change
in Unrealized
Appreciation
(Depreciation)
 
Artemis Wax Corp $27,440,000  $6,162,526  $3,418,378  $                -  $                 -  $(1,460,287)
Axero Holdings, LLC  1,089,000   -   848,422   -   -   1,951,499 
ETU Holdings, Inc.  14,880,000   -   923,437   -   -   83,142 
Total $43,409,000  $6,162,526  $5,190,237  $-  $-  $574,354 

 


(g)Non-income producing at November 30, 2017.
(h)(g)Includes securities issued by an affiliate of the company.
(i)The investment has an unfunded commitment as of November 30, 2017 (see Note 7 to the consolidated financial statements).
(j)The entire commitment was unfunded at November 30, 2017. As such, no interest is being earned on this investment.
(k)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of November 30, 2017.

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2017

Company

  

Industry

  

Investment Interest Rate/

Maturity

  Principal/
Number of
Shares
   Cost   Fair Value (c)   % of
Net Assets
 

Non-control/Non-affiliated investments - 190.5% (b)

        

Apex Holdings Software Technologies, LLC

  Business Services  First Lien Term Loan (L+8.00%), 9.05% Cash, 9/21/2021  $18,000,000   $17,857,818   $17,843,400    14.0

Avionte Holdings, LLC (g)

  Business Services  Common Stock   100,000    100,000    251,000    0.2

BMC Software, Inc. (d)

  Business Services  Syndicated Loan (L+4.00%), 5.05% Cash, 9/10/2020  $5,611,666    5,582,551    5,639,163    4.4

Courion Corporation

  Business Services  Second Lien Term Loan (L+10.00%), 11.05% Cash, 6/1/2021  $15,000,000    14,879,353    14,230,500    11.2

Emily Street Enterprises, L.L.C.

  Business Services  Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020  $3,300,000    3,282,213    3,316,500    2.6

Emily Street Enterprises, L.L.C. (g)

  Business Services  Warrant Membership Interests Expires 12/28/2022   49,318    400,000    394,544    0.3

Erwin, Inc.

  Business Services  Second Lien Term Loan (L+11.50%), 12.55% (11.50% Cash/1.00% PIK), 8/28/2021  $13,111,929    13,000,581    13,111,929    10.2

GreyHeller LLC

  Business Services  First Lien Term Loan (L+11.00%), 12.05% Cash, 11/16/2021  $7,000,000    6,933,141    6,930,000    5.4

GreyHeller LLC (i), (j)

  Business Services  Delayed Draw Term Loan B (L+11.00%), 12.05% Cash, 11/16/2021  $—      —      —      0.0

GreyHeller LLC (g)

  Business Services  Common Stock   850,000    850,000    850,000    0.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

  Business Services  First Lien Term Loan (L+5.25%), 6.30% Cash, 10/8/2021  $5,947,481    5,857,960    5,947,481    4.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

  Business Services  Second Lien Term Loan (L+9.50%), 10.55% Cash, 10/8/2022  $3,000,000    2,922,606    2,926,800    2.3

Identity Automation Systems

  Business Services  Convertible Promissory Note 13.50% (6.75% Cash/6.75% PIK), 8/18/2018   611,517    611,517    611,517    0.5

Identity Automation Systems (g)

  Business Services  Common Stock Class A Units   232,616    232,616    386,143    0.3

Identity Automation Systems

  Business Services  Second Lien Term Loan (L+9.25%), 10.30% (9.25% Cash/1.75% PIK) 12/18/2020  $10,293,791    10,223,741    10,293,791    8.1

Knowland Technology Holdings, L.L.C.

  Business Services  First Lien Term Loan (L+8.75%), 9.80% Cash, 7/20/2021  $17,777,730    17,692,307    17,777,730    14.0

Microsystems Company

  Business Services  Second Lien Term Loan (L+10.00%), 11.05% Cash, 7/1/2022  $8,000,000    7,927,489    7,964,800    6.3

National Waste Partners

  Business Services  First Lien Term Loan 10.00% Cash, 2/13/2022  $9,000,000    8,910,000    8,910,000    7.0

Vector Controls Holding Co., LLC (d)

  Business Services  First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018  $8,819,270    8,778,186    8,819,270    6.9

Vector Controls Holding Co., LLC (d), (g)

  Business Services  Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025   343    —      327,200    0.3
        

 

 

   

 

 

   

 

 

 
    Total Business Services     126,042,079    126,531,768    99.4
        

 

 

   

 

 

   

 

 

 

Targus Holdings, Inc. (d), (g)

  Consumer Products  Common Stock   210,456    1,791,242    29,241    0.0

Targus Holdings, Inc. (d)

  Consumer Products  Second Lien Term Loan A-2 15.00% PIK, 12/31/2019  $234,630    234,630    234,630    0.2

Targus Holdings, Inc. (d)

  Consumer Products  Second Lien Term Loan B 15.00% PIK, 12/31/2019  $703,889    703,889    703,889    0.6
        

 

 

   

 

 

   

 

 

 
    Total Consumer Products     2,729,761    967,760    0.8
        

 

 

   

 

 

   

 

 

 

My Alarm Center, LLC

  Consumer Services  Second Lien Term Loan (L+11.00%), 12.05% Cash, 7/9/2019  $9,375,000    9,359,492    7,061,250    5.6

PrePaid Legal Services, Inc. (d)

  Consumer Services  First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019  $2,687,143    2,672,435    2,687,143    2.1

PrePaid Legal Services, Inc. (d)

  Consumer Services  Second Lien Term Loan (L+9.00%), 10.25% Cash, 7/1/2020  $11,000,000    10,966,188    11,000,000    8.6
        

 

 

   

 

 

   

 

 

 
    Total Consumer Services     22,998,115    20,748,393    16.3
        

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

  Education  Class A Common Stock   544,761    30,241    —      0.0

M/C Acquisition Corp., L.L.C. (d)

  Education  First Lien Term Loan 1.00% Cash, 3/31/2018  $2,321,073    1,193,790    8,087    0.0

Texas Teachers of Tomorrow, LLC (g), (h)

  Education  Common Stock   750    750,000    919,680    0.7

Texas Teachers of Tomorrow, LLC

  Education  Second Lien Term Loan (L+9.75%), 10.80% Cash, 6/2/2021  $10,000,000    9,918,572    10,000,000    7.9
        

 

 

   

 

 

   

 

 

 
    Total Education     11,892,603    10,927,767    8.6
        

 

 

   

 

 

   

 

 

 

TM Restaurant Group L.L.C. (g)

  Food and Beverage  First Lien Term Loan (L+8.50%), 9.75% Cash, 7/17/2017  $9,358,694    9,331,446    8,422,825    6.6
        

 

 

   

 

 

   

 

 

 
    Total Food and Beverage     9,331,446    8,422,825    6.6
        

 

 

   

 

 

   

 

 

 

Censis Technologies, Inc.

  Healthcare Services  First Lien Term Loan B (L+10.00%), 11.05% Cash, 7/24/2019  $11,100,000    10,977,689    10,940,160    8.6

Censis Technologies, Inc. (g), (h)

  Healthcare Services  Limited Partner Interests   999    999,000    886,772    0.7

ComForCare Health Care

  Healthcare Services  First Lien Term Loan (L+8.50%), 9.55% Cash, 1/31/2022  $10,500,000    10,398,957    10,395,000    8.2

Roscoe Medical, Inc. (d), (g)

  Healthcare Services  Common Stock   5,081    508,077    680,823    0.5

Roscoe Medical, Inc.

  Healthcare Services  Second Lien Term Loan 11.25% Cash, 9/26/2019  $4,200,000    4,155,827    4,179,000    3.3

Ohio Medical, LLC (g)

  Healthcare Services  Common Stock   5,000    500,000    288,800    0.2

Ohio Medical, LLC

  Healthcare Services  Senior Subordinated Note 12.00%, 7/15/2021  $7,300,000    7,238,831    6,989,750    5.5

Zest Holdings, LLC (d)

  Healthcare Services  Syndicated Loan (L+4.75%), 5.80% Cash, 8/17/2020  $4,136,911    4,085,888    4,183,658    3.3
        

 

 

   

 

 

   

 

 

 
    Total Healthcare Services     38,864,269    38,543,963    30.3
        

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media  First Lien Term Loan 12.00% Cash, 7/8/2021  $8,462,482    8,376,876    8,462,482    6.6

HMN Holdco, LLC

  Media  Delayed Draw First Lien Term Loan 12.00% Cash, 7/8/2021  $4,800,000    4,751,258    4,800,000    3.8

HMN Holdco, LLC (g)

  Media  Class A Series, Expires 1/16/2025   4,264    61,647    294,770    0.2

HMN Holdco, LLC (g)

  Media  Class A Warrant, Expires 1/16/2025   30,320    438,353    1,706,410    1.3

HMN Holdco, LLC (g)

  Media  Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024   57,872    —      2,961,310    2.3

HMN Holdco, LLC (g)

  Media  Warrants to Purchase Limited Liability Company Interests (Preferred), Expires 5/16/2024   8,139    —      473,690    0.4
        

 

 

   

 

 

   

 

 

 
    Total Media     13,628,134    18,698,662    14.6
        

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

  Metals  Common Stock   35,000    9,217,564    413,350    0.3

Elyria Foundry Company, L.L.C. (d)

  Metals  Second Lien Term Loan 15.00% PIK, 8/10/2022  $437,500    437,500    437,500    0.4
        

 

 

   

 

 

   

 

 

 
    Total Metals     9,655,064    850,850    0.7
        

 

 

   

 

 

   

 

 

 

Mercury Network, LLC

  Real Estate  First Lien Term Loan (L+9.50%), 10.55% Cash, 8/24/2021  $15,773,875    15,644,382    15,773,875    12.4

Mercury Network, LLC (g)

  Real Estate  Common Stock   413,043    413,043    1,065,651    0.8
        

 

 

   

 

 

   

 

 

 
    Total Real Estate     16,057,425    16,839,526    13.2
        

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

     251,198,896    242,531,514    190.5
        

 

 

   

 

 

   

 

 

 

Control investments - 39.4% (b)

            

Easy Ice, LLC (g)

  Business Services  Preferred Equity   5,080,000    8,000,000    8,000,000    6.3

Easy Ice, LLC (d) (f)

  Business Services  First Lien Term Loan (L+10.25%) 11.02% Cash, 1/15/2020  $26,680,000    26,464,162    26,680,000    20.9
        

 

 

   

 

 

   

 

 

 
    Total Business Services     34,464,162    34,680,000    27.2
        

 

 

   

 

 

   

 

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

  Structured Finance Securities  Other/Structured Finance Securities 14.87%, 10/20/2025  $30,000,000    10,319,374    10,950,249    8.7

Saratoga Investment Corp. Class F Note (a), (d), (f)

  Structured Finance Securities  Other/Structured Finance Securities (L+8.50%), 9.55%, 10/20/2025  $4,500,000    4,500,000    4,499,550    3.5
        

 

 

   

 

 

   

 

 

 
    Total Structured Finance Securities     14,819,374    15,449,799    12.2
        

 

 

   

 

 

   

 

 

 

Sub Total Control investments

       49,283,536    50,129,799    39.4
        

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS - 229.9% (b)

    $300,482,432   $292,661,313    229.9
        

 

 

   

 

 

   

 

 

 
         Principal   Cost   Fair Value   % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 17.4% (b)

        

U.S. Bank Money Market (k)

      $22,087,968   $22,087,968   $22,087,968    17.4
      

 

 

   

 

 

   

 

 

   

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

  $22,087,968   $22,087,968   $22,087,968    17.4
      

 

 

   

 

 

   

 

 

   

 

 

 

(a)Represents a non-qualifying investment as defined under Section 55(a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 5.3% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $127,294,777 as of February 28, 2017.
(c)Because there is no readily available market value for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d)These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 14.87% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company1940 Act, we “Control”“control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 28, 20172023 in which the issuer was both an Affiliateaffiliate and a portfolio company that we Controlcontrol are as follows:

 

Company

 Purchases  Redemptions  Sales  Interest
Income
  Management
Fee Income
  Net Realized
Gains
(Losses)
  Net Change in
Unrealized
Appreciation
(Depreciation)
 

Easy Ice, LLC

 $20,553,200  $—    $—    $217,362  $—    $—    $283,226 

Saratoga Investment Corp. CLO 2013-1, Ltd.

 $—    $—    $—    $1,941,914  $1,499,001  $—    $833,646 

Saratoga Investment Corp. Class F Note

 $4,500,000  $—    $—    $122,121  $—    $—    $(450
Company Purchases  Sales  Total Interest
from Investments
  Management
Fee Income
  Net Realized
Gain (Loss)
from Investments
  Net Change
in Unrealized
Appreciation
(Depreciation)
 
Netreo Holdings, LLC $8,290,000  $          -  $2,529,483  $-  $            -  $(2,363,302)
Saratoga Investment Corp. CLO 2013-1, Ltd.  -   -   1,228,486   3,269,820   -   (4,149,106)
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note  11,392,500   -   552,330   -   -   (38,005)
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note  -   -   1,195,662   -   -   (543,594)
Saratoga Senior Loan Fund I JV, LLC  4,493,954   -   1,483,522   -   -   - 
Saratoga Senior Loan Fund I JV, LLC  4,458,486   -   -   -   -   (3,367,599)
Total $28,634,940  $-  $6,989,483  $3,269,820  $-  $(10,461,606)

 

(g)(h)Non-income producing at February 28, 2017.2023.
(h)(i)Includes securities issued by an affiliate of the company.
(i)(j)TheAll or a portion of this investment has an unfunded commitment as of February 28, 2017 (see2023. (See Note 79 to the consolidated financial statements).
(j)(k)The entire commitment was unfunded atAs of February 28, 2017. As such, no interest is being earned2023, the investment was on this investment.non-accrual status. The fair value of these investments was approximately $9.8 million, which represented 2.8% of the Company’s portfolio (see Note 2 to the consolidated financial statements).
(k)(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of February 28, 2017.2023.

BSBY - Bloomberg Short-Term Bank Yield

Saratoga Investment Corp.LIBOR - London Interbank Offered Rate

Consolidated StatementsSOFR - Secured Overnight Financing Rate

1M USD BSBY - The 1 month USD BSBY rate as of Changes in Net AssetsFebruary 28, 2023 was 4.58%.

(unaudited)3M USD BSBY - The 3 month USD BSBY rate as of February 28, 2023 was 4.87%.

1M USD LIBOR - The 1 month USD LIBOR rate as of February 28, 2023 was 4.67%.

3M USD LIBOR - The 3 month USD LIBOR rate as of February 28, 2023 was 4.97%.

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of February 28, 2023 was 4.66%

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of February 28, 2023 was 4.89%

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

 

   For the nine months ended
November 30, 2017
  For the nine months ended 
November 30, 2016
 

INCREASE FROM OPERATIONS:

   

Net investment income

  $9,411,011  $8,561,204 

Net realized gain (loss) from investments

   (5,658,329  12,299,899 

Net change in unrealized appreciation (depreciation) on investments

   8,394,254   (10,728,122
  

 

 

  

 

 

 

Net increase in net assets from operations

   12,146,936   10,132,981 
  

 

 

  

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

   

Distributions declared

   (8,323,545  (8,472,209
  

 

 

  

 

 

 

Net decrease in net assets from shareholder distributions

   (8,323,545  (8,472,209
  

 

 

  

 

 

 

CAPITAL SHARE TRANSACTIONS:

   

Proceeds from issuance of common stock

   5,985,282   —   

Stock dividend distribution

   1,825,036   4,125,696 

Repurchases of common stock

   —     (3,256,613

Offering costs

   (82,263  —   
  

 

 

  

 

 

 

Net increase in net assets from capital share transactions

   7,728,055   869,083 
  

 

 

  

 

 

 

Total increase in net assets

   11,551,446   2,529,855 

Net assets at beginning of period

   127,294,777   125,149,875 
  

 

 

  

 

 

 

Net assets at end of period

  $138,846,223  $127,679,730 
  

 

 

  

 

 

 

Net asset value per common share

  $22.58  $22.21 
   

Common shares outstanding at end of period

   6,149,582   5,748,247 

Distribution in excess of net investment income

  $(26,649,881 $(26,128,907

See accompanying notes to consolidated financial statements.

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

   For the nine months ended 
November 30, 2017
  For the nine months ended 
November 30, 2016
 

Operating activities

   

NET INCREASE IN NET ASSETS FROM OPERATIONS

  $12,146,936  $10,132,981 

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:

   

Payment-in-kind interest income

   (1,637,083  (433,609

Net accretion of discount on investments

   (481,356  (408,557

Amortization of deferred debt financing costs

   741,195   775,707 

Net realized (gain) loss from investments

   5,658,329   (12,299,899

Net change in unrealized (appreciation) depreciation on investments

   (8,394,254  10,728,122 

Proceeds from sales and repayments of investments

   45,554,971   94,691,232 

Purchase of investments

   (86,876,981  (85,850,895

(Increase) decrease in operating assets:

   

Interest receivable

   5,490   (788,833

Due from affiliate

   —     (46,078

Management and incentive fee receivable

   (94,899  (959

Other assets

   (389,811  106,195 

Receivable from unsettled trades

   156,000   15,097 

Increase (decrease) in operating liabilities:

   

Base management and incentive fees payable

   (619,847  338,491 

Accounts payable and accrued expenses

   491,660   (183,082

Interest and debt fees payable

   (781,890  (453,760

Payable for repurchases of common stock

   —     (20,957

Directors fees payable

   (51,500  19,500 

Due to manager

   (16,735  59,603 
  

 

 

  

 

 

 

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

   (34,589,775  16,380,299 
  

 

 

  

 

 

 

Financing activities

   

Borrowings on debt

   46,500,000   9,000,000 

Paydowns on debt

   (23,500,000  —   

Payments of deferred debt financing costs

   (1,204,517  (644,845

Proceeds from issuance of common stock

   5,985,282   —   

Payments of offering costs

   (62,669  —   

Repurchases of common stock

   —     (3,256,613

Payments of cash dividends

   (6,498,509  (5,222,112
  

 

 

  

 

 

 

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

   21,219,587   (123,570
  

 

 

  

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS

   (13,370,188  16,256,729 

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD

   22,087,968   7,034,783 
  

 

 

  

 

 

 

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD

  $8,717,780  $23,291,512 
  

 

 

  

 

 

 

Supplemental information:

   

Interest paid during the period

  $8,286,045  $6,784,922 

Cash paid for taxes

  $69,502  $158,294 

Supplemental non-cash information:

   

Payment-in-kind interest income

  $1,637,083  $433,609 

Net accretion of discount on investments

  $481,356  $408,557 

Amortization of deferred debt financing costs

  $741,195  $775,707 

Stock dividend distribution

  $1,825,036  $4,125,696 

See accompanying notes to consolidated financial statements.

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

November 30, 20172023

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under subchapterSubchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company expects to continue to qualify and to elect to be treated, for tax purposes, as a RIC. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager” or “Saratoga Investment Advisors”), pursuant to aan investment advisory and management agreement (the “Management Agreement”). Prior to July 30, 2010, the Company was managed and advised by GSCP (NJ), L.P.

The Company has established wholly-ownedwholly owned subsidiaries, SIA Avionte,SIA-AAP, Inc., SIA Easy Ice, LLC, SIA GH,SIA-ARC, Inc., SIA MAC,SIA-Avionte, Inc., SIA Mercury,SIA-AX, Inc., SIA TT,SIA-G4, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc. and SIA Vector,SIA-VR, Inc., which are structured as Delaware entities orthat are treated as corporations for U.S. federal income tax blockers,purposes and are intended to holdfacilitate its compliance with the requirements to be treated as a RIC under the Code by holding equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). Tax blockersThese entities are consolidated for accounting purposes, but are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expenseexpenses as a result of their ownership of portfolio companies. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. received an approved plan of liquidation following the sale of equity held by each of the portfolio companies.

On March 28, 2012, our wholly-owned subsidiary,

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC LP (“SBIC LP”), Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC LP and SBIC II LP, the “SBIC Subsidiaries”), received a Small Business Investment Company (“SBIC”) licenseSBIC licenses from the Small Business Administration (“SBA”).

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain aon March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBIC LP’s license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us has expired. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issueprovided up to $150.0 million in additional long-term capital in the form of additional SBA-guaranteedSBA debentures, while SBIC II LP’s and SBIC III LP’s SBIC licenses each provide up to $175.0 million. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in additioncombined regulatory capital. With all debentures repaid to the $150.0 million already approvedSBA, SBIC LP’s license was surrendered on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP.


The Company has formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC (“SIF II”), a Delaware limited liability company, for the purpose of entering into the senior secured revolving credit facility with Encina Lender Finance, LLC (the “Lender”), supported by loans held by SIF II and pledged to the Lender under the credit facility (the “Encina Credit Facility”).

On October 26, 2021, the Company and TJHA JV I LLC (“TJHA”) entered into a Limited Liability Company Agreement to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is under joint control and is not consolidated. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1 Ltd. (“SLF 2022”), which is a wholly owned subsidiary of SLF JV. SLF 2022 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first license.lien and second lien term loans or bonds in the primary and secondary markets. On October 28, 2022, SLF 2022 issued $402.1 million of debt (the “2022 JV CLO Notes”) through a collateralized loan obligation trust (the “JV CLO trust”). The 2022 JV CLO Notes were issued pursuant to an indenture, dated October 28, 2022 (the “JV Indenture”), with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the “Trustee”) servicing as the trustee.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its wholly owned special purpose financing subsidiary,subsidiaries, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC), SIF II, SBIC LP, SIA Avionte,SBIC II LP, SBIC III LP, SIA-AAP, Inc., SIA Easy Ice, LLC, SIA GH,SIA-ARC, Inc., SIA MAC,SIA-Avionte, Inc., SIA Mercury,SIA-AX, Inc., SIA TT,SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-MAC, Inc., SIA-PP, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., SIA-Vector, Inc. and SIA Vector,SIA-VR, Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

The Company, SBIC LP, SBIC II LP, and SBIC III LP are bothall considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946,Financial Services — Investment Companies (“ASC 946”). There have been no changes to the Company, SBIC LP, SBIC II LP, or SBIC III LP’s status as investment companies during the nine months ended November 30, 2017.2023.

Principles of Consolidation

Under the investment company rules and regulations pursuant to ASC 946, the Company is precluded from consolidating any entity other than another investment company or controlled operating company whose business consists of providing services to the Company.  As a result, the consolidated financial statements of the Company include only the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate its investment in SLF JV.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.


Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. The Company places its cash in financial institutions and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits. Cash and cash equivalents are carried at cost which approximates fair value. Per sectionPursuant to Section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company, such as a money market fund, if such investment would cause the Company to exceed any of the following limitations:to:

 

we were to own more than 3.0% of the total outstanding voting stock of the money market fund;
own more than 3.0% of the investment company’s total outstanding voting stock;

 

we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets, except as allowed pursuant to Rule 12d1-1 of Section 12(d)(1) of the 1940 Act which is designed to permit “cash sweep” arrangements rather than investments directly in short-term instruments; or
hold securities in the investment company having an aggregate value in excess of 5.0% of the value of the Company’s total assets; or

 

we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.
hold securities in investment companies having an aggregate value in excess of 10.0% of the value of the Company’s total assets.

As of November 30, 2017,2023, the Company did not exceed any of these limitations.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits, representing payments received on secured investments or other reserved amounts associated with the Encina Credit Facility held by the Company’s $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC.wholly owned subsidiary, SIF II. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.Encina Credit Facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within our wholly-owned subsidiary,the Company’s wholly owned subsidiaries, SBIC LP, SBIC II LP and SBIC III LP.

In November 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-18, Statement of Cash Flows (Topic 230):Restricted Cash(“ASU 2016-18”). ASU 2016-18 requires that the

The statements of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statements of cash flows. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and early adoption is permitted and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2016-18 as of November 30, 2016. The adoption of the provisions of ASU 2016-18 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.amounts.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

  November 30,
2017
   November 30,
2016
  November 30,
2023
  February 28,
2023
 

Cash and cash equivalents

  $680,065   $5,770,230  $21,386,880  $65,746,494 

Cash and cash equivalents, reserve accounts

   8,037,715    17,521,282   25,639,619   30,329,779 
  

 

   

 

 

Total cash and cash equivalents, and cash and cash equivalents, reserve accounts

  $8,717,780   $23,291,512 
  

 

   

 

 
Total cash and cash equivalents and cash and cash equivalents, reserve accounts $47,026,499  $96,076,273 

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments”“control investments” are defined as investments in companies in which we ownthe Company owns more than 25.0% of the voting securities or maintainmaintains greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments”“affiliated investments” are defined as those non-control investments in companies in which we ownthe Company owns between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments”“non-affiliated investments” are defined as investments that are neither Control Investmentscontrol investments nor Affiliated Investments.affiliated investments.


Investment Valuation

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820,Fair Value Measurements and DisclosuresMeasurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheetmeasurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third partythird-party pricing services and market makers subject to any decision by ourthe Company’s board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We valueThe Company values investments for which market quotations are not readily available at fair value as approved, in good faith, by ourthe Company’s board of directors based on input from ourthe Manager, the audit committee of ourthe board of directors and a third partythird-party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and
Each investment is initially valued by the responsible investment professionals of the Manager and preliminary valuation conclusions are documented, reviewed and discussed with our senior management; and

 

An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.
An independent valuation firm engaged by the Company’s board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. The Company uses a third-party independent valuation firm to value its investment in the subordinated notes of Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), the Class F-2-R-3 Notes of the Saratoga CLO, and the Class E Notes of the SLF 2022 every quarter.

In addition, all our investments are subject to the following valuation process:

 

The audit committee of our board of directors reviews and approves each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and
The audit committee of the Company’s board of directors reviews and approves each preliminary valuation and the Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

Our
The Company’s board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of the Manager, independent valuation firm (to the extent applicable) and the audit committee of the board of directors.

The Company uses multiple techniques for determining fair value based on the inputnature of our Manager, independentthe investment and experience with those types of investments and specific portfolio companies. The selections of the valuation firm (to the extent applicable)techniques and the audit committeeinputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of our boardvalues from which the Company determines a single best estimate. The types of directors.inputs and assumptions that may be considered in determining the range of values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.


The Company’s investmentinvestments in the subordinated notes of Saratoga Investment Corp. CLO, 2013-1, Ltd. (“Class F-2-R-3 Notes of the Saratoga CLO”) isCLO and the Class E Notes of SLF 2022 are carried at fair value, which is based on a discounted cash flow modelvaluation technique that utilizes prepayment, re-investment and loss assumptionsinputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds, similar to Saratoga CLO, when available, as determined by ourthe Manager and recommended to ourthe Company’s board of directors. Specifically, we usethe Company uses Intex cash flow models,flows, or an appropriate substitute, to form the basis for the valuation of ourits investment in the subordinated notes of Saratoga CLO.CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The assumptionsinputs are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine athe valuation for our investment in Saratoga CLO.

The Company’s equity investment in SLF JV is measured using the proportionate share of the net asset value (“NAV”), or equivalent, of SLF JV as a practical expedient for fair value, provided by ASC 820.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company’s net asset valueNAV could be materially affected if the determinations regarding the fair value of ourits investments were materially higher or lower than the values that wethe Company ultimately realizerealizes upon the disposal of such investments.

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards of directors, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides for certain recordkeeping requirements associated with fair value determinations. Finally, the Securities and Exchange Commission (the “SEC”) rescinded previously issued guidance on related issues, including the role of the board in determining fair value and the accounting and auditing of fund investments. While the Company’s board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815,Derivatives and Hedging(“ (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments.investments up to the earliest call date.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At November 30, 2023, our investment in three portfolio companies were on non-accrual status with a fair value of approximately $29.2 million, or 2.6% of the fair value of our portfolio. At February 28, 2023, our investment in one portfolio company was on non-accrual status with a fair value of approximately $9.8 million, or 1.0% of the fair value of our portfolio.


Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40,Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in the consolidated statements of operations when earned.

Payment-in-Kind Interest

The Company holds debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on thean accrual basis to the extent such amounts are expected to be collected. We stopThe Company stops accruing PIK interest if we do not expectit is expected that the issuer towill not be able to pay all principal and interest when due. At November 30, 2017,The Company restores to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Dividend Income

Dividend income is recorded in the consolidated statements of operations when earned.

Structuring and Advisory Fee Income

Structuring and advisory fee income represents various fee income earned and received for performing certain investmentsinvestment structuring and advisory activities during the closing of new investments.

Other Income

Other income includes prepayment income fees, and monitoring, administration, redemption and amendment fees and is recorded in two portfolio companies were on non-accrual status with a combined fair valuethe consolidated statements of approximately $8.3 million, or 2.4% of the total fair value of our portfolio.operations when earned.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight linestraight-line method over the life of the respective facility and debt securities. Financing costs incurred in connection with ourthe SBA debentures of SBIC LP, SBIC II LP, and SBIC III LP are deferred and amortized using the effective yieldstraight-line method over the life of the debentures. Any discount or premium on the issuance of any debt is accreted and amortized using the effective interest method over the life of the respective debt security.

ASU 2015-03,Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs(“ASU 2015-03”) requires that

The Company presents deferred debt issuancefinancing costs related to a recognized debt liability be presented inon the balance sheet as a contra-liability, which is a direct deduction

from the carrying amount of that debt liability, consistent with debt discounts. The Company has adopted

Realized Loss on Extinguishment of Debt 

Upon the provisionsrepayment of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financingobligations that are deemed to be extinguishments, the difference between the principal amount due at maturity adjusted for any unamortized debt issuance costs from within total assets to within total liabilitiesis recognized as a contra-liability. Prior period amounts were reclassified to conform toloss (i.e., the current period presentation.unamortized debt issuance costs are recognized as a loss upon extinguishment of the underlying debt obligation).


Contingencies

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feelsreasonably believes that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieveCode. By meeting these requirements, the Company fromwill not be subject to U.S. federal income taxes.tax on ordinary income or capital gains timely distributed to stockholders. Therefore, no provision has been recorded for federal income taxes.taxes, except as related to the Taxable Blockers (as defined below) and long-term capital gains, when applicable.

In order to qualify as a RIC, among other requirements, the Company generally is required to timely distribute to its stockholders at least 90.0%90% of its investment“investment company taxable income,income”, as defined by the Code, for each fiscal tax year. The Company will be subject to U.S. federal income tax at corporate rates on its investment company taxable income and net capital gains that it does not timely distribute to shareholders. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0%4% on undistributed income if it does not distribute at least 98.0%(1) 98% of its net ordinary income in any calendar year, and(2) 98.2% of its capital gain net income for each one-year period ending on October 31.31and (3) any net ordinary income and capital gain net income that it recognized for preceding years, but were not distributed during such year, and on which the Company paid no U.S federal income tax.

Depending on the level of investment company taxable income earned in a tax year and the amount of net capital gains recognized in such tax year, the Company may choose to carry forward investment company taxable income and net capital gains in excess of current year dividend distributions into the next tax year and pay aU.S. federal income tax, and possibly the 4.0% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual investment company taxable income will be in excess of estimated current year dividend distributions for U.S. federal excise tax purposes, the Company accrues the U.S. federal excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable U.S. Treasury regulations and private letter rulingspublished guidance issued by the Internal Revenue Service (“IRS”), a publicly offered RIC may treat a distribution of its own stock as fulfillingcounting toward its RIC distribution requirements if each stockholder may elect to receive his, her, or herits entire distribution in either cash or stock of the RIC subject to a limitation onRIC. This published guidance indicates that the rule will apply where the aggregate amount of cash to be distributed to all stockholders which limitation must beis not at least 20.0% of the aggregate declared distribution. IfUnder the published guidance, if too many stockholders elect to receive cash, each stockholderthe cash available for distribution must be allocated among the stockholders electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.SU.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

The Company may utilize wholly owned holding companies taxed under Subchapter C of the Code or tax blockers, when making equity investments in portfolio companies taxed as pass-through entities to meet its source-of-income requirements as a RIC (“Taxable Blockers”). Taxable Blockers are consolidated in the Company’s U.S. GAAP financial statements and may result in current and deferred federal and state income tax expense with respect to income derived from those investments. Such income, net of applicable income taxes, is not included in the Company’s tax-basis net investment income until distributed by the Taxable Blocker, which may result in timing and character differences between the Company’s U.S. GAAP and tax-basis net investment income and realized gains and losses. Income tax expense or benefit from Taxable Blockers related to net investment income are included in total operating expenses, while any expense or benefit related to federal or state income tax originated for capital gains and losses are included together with the applicable net realized or unrealized gain or loss line item. Deferred tax assets of the Taxable Blockers are reduced by a valuation allowance when, in the opinion of management, it is more-likely than-not that some portion or all of the deferred tax assets will not be realized.


FASB ASC Topic 740,Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 28, 2017,2023, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2014, 20152020, 2021, 2022 and 20162023 federal tax years for the Company remain subject to examination by the IRS. As ofAt November 30, 20172023, and February 28, 2017,2023, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain suchsome or all of our net capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends

automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations relating to the capital gains incentive fee payable to the Manager, as recorded on the consolidated statements of assets and liabilities by the Company to its investment adviser when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments, given the fact thatas a capital gains incentive fee would be owed to the investment adviserManager if the Company were to liquidate its investment portfolio at such time.

The actual incentive fee payable to the Company’s investment adviserManager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only reflect those realized capital gains net of realized and unrealized losses for the period.

New

Recent Accounting Pronouncements

In March 2017,June 2022, the FASB issued ASU 2017-08,2022-03, Receivables — Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable DebtFair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820) (“ASU 2017-08”2022-03”), which amendsclarifies that a contractual sale restriction prohibiting the amortization period for certain purchased callable debt securities held atsale of an equity security is a premium, shortening such period tocharacteristic of the earliest call date.reporting entity holding the equity security and is not included in the equity security’s unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. In addition, ASU 2017-08 does not require any accounting change for debt securities held at2022-03 prohibits an entity from recognizing a discount; the discount continues to be amortized to maturity.contractual sale restriction as a separate unit of account. ASU 2017-08 is2022-03 amendments are effective for fiscal years, and interim periods within those fiscal years beginning after December 15, 2018. Management2023, with early adoption permitted. The Company is currently evaluating the impact these changes will haveof the adoption of ASU 2022-03 on the Company’sits consolidated financial statements and disclosures..


In August 2016,March 2020, the FASB issued ASU 2016-15,2020-04, StatementReference Rate Reform (Topic 848): Facilitation of Cash Flows (Topic 230), Classificationthe Effects of Certain Cash ReceiptsReference Rate Reform on Financial Reporting (“ASU 2020-04”) to provide optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. ASU 2020-04 established Topic 848 to provide relief during the temporary transition period and Cash Payments(“ASU 2016-15”), which is intended to reduceincludes a sunset provision based on expectations of when the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02,Amendments to the Leases(“ASU Topic 842”London Interbank Offered Rate (“LIBOR”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01,Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities(“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management is currently evaluating the impact would cease being published. With the adoption of this standard has onASU 2020-04, there was no significant impact to the Company’s consolidated financial statements and disclosures.position.

In May 2014, the FASB issued ASU 2014-09,Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period for annual periods beginning after December 15, 2017. Management has concluded that the majority of its revenues associated with financial instruments are scoped out of ASC 606. Management is evaluating the impact of the standard on certain other income earned by the Company.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between independent market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments that are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

Level 3—Pricing inputs are unobservable for the investment and includes situations where there is little, if any, market activity for the investment. The inputs may be based on the Company’s own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation technique. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.


 

Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by a disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our valuation policy, we evaluatethe Company evaluates the source of inputs, including any markets in which ourits investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of November 30, 20172023 (dollars in thousands), according to the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—    $—    $9,001   $9,001 

First lien term loans

   —     —     185,661    185,661 

Second lien term loans

   —     —     99,427    99,427 

Structured finance securities

   —     —     16,313    16,313 

Equity interests

   —     —     28,436    28,436 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—    $—    $338,838   $338,838 
  

 

 

   

 

 

   

 

 

   

 

 

 

  Fair Value Measurements  Valued Using
Net Asset
    
  Level 1  Level 2  Level 3  Value*  Total 
First lien term loans $              -  $         -  $959,892  $      -  $959,892 
Second lien term loans  -   -   14,873   -   14,873 
Unsecured term loans  -   -   17,619   -   17,619 
Structured finance securities  -   -   29,387   -   29,387 
Equity interests  -   -   84,476   7,792   92,268 
Total $-  $-  $1,106,247  $7,792  $1,114,039 

*The Company's equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy.

The following table presents fair value measurements of investments, by major class, as of February 28, 20172023 (dollars in thousands), according to the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—    $—    $9,823   $9,823 

First lien term loans

   —     —     159,097    159,097 

Second lien term loans

   —     —     87,750    87,750 

Structured finance securities

   —     —     15,450    15,450 

Equity interests

   —     —     20,541    20,541 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—    $—    $292,661   $292,661 
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2017 (dollars in thousands):

  Fair Value Measurements  Valued Using
Net Asset
    
  Level 1  Level 2  Level 3  Value*  Total 
First lien term loans $         -  $          -  $798,534  $-  $798,534 
Second lien term loans  -   -   14,936   -   14,936 
Unsecured term loans  -   -   20,661   -   20,661 
Structured finance securities  -   -   41,362   -   41,362 
Equity interests  -   -   83,990   13,107   97,097 
Total $-  $-  $959,483  $13,107  $972,590 

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Structured
finance
securities
  Equity
interests
  Total 

Balance as of February 28, 2017

  $9,823  $159,097  $87,750  $15,450  $20,541  $292,661 

Net change in unrealized appreciation (depreciation) on investments

   (9  315   2,250   1,991   3,847   8,394 

Purchases and other adjustments to cost

   14   81,918   4,143   —    2,921   88,996 

Sales and repayments

   (773  (13,228  (27,023  (1,128  (3,403  (45,555

Net realized gain (loss) from investments

   (54  13   (7,530  —    1,913   (5,658

Restructures in

   —    —    39,837   —    2,617   42,454 

Restructures out

   —    (42,454  —    —    —    (42,454
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance as of November 30, 2017

  $9,001  $185,661  $99,427  $16,313  $28,436  $338,838 
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

  $(9 $452  $81  $1,991  $4,500  $7,015 
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
*The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy.

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 20162023 (dollars in thousands):

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Structured
finance
securities
  Equity
interests
  Total 

Balance as of February 29, 2016

  $11,868  $144,643  $88,178  $12,828  $26,479  $283,996 

Net change in unrealized appreciation (depreciation) on investments

   2,221   (174  290   20   (13,085  (10,728

Purchases and other adjustments to cost

   56   69,671   10,996   4,500   1,470   86,693 

Sales and redemptions

   (4,571  (54,033  (19,500  (2,082  (14,505  (94,691

Net realized gain from investments

   53   353   231   —    11,663   12,300 
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance as of November 30, 2016

  $9,627  $160,460  $80,195  $15,266  $12,022  $277,570 
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

  $1,075  $204  $(500 $20  $(1,981 $(1,182
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

  First lien
term loans
  Second lien
term loans
  Unsecured
term loans
  Structured
finance
securities
  Equity
interests
  Total 
Balance as of February 28, 2023 $798,534  $14,936  $20,661  $41,362  $83,990  $959,483 
Payment-in-kind and other adjustments to cost  1,147   624   -   (5,531)  (293)  (4,053)
Net accretion of discount on investments  1,637   4   -   -   -   1,641 
Net change in unrealized appreciation (depreciation) on investments  (20,102)  (691)  341   (6,444)  (7,715)  (34,611)
Purchases  194,541   -   -   -   8,343   202,884 
Sales and repayments  (15,865)  -   (3,383)  -   -   (19,248)
Net realized gain (loss) from investments  -   -   -   -   151   151 
Balance as of November 30, 2023 $959,892  $14,873  $17,619  $29,387  $84,476  $1,106,247 
Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period $(20,033) $(691) $(5) $(6,444) $(7,792) $(34,965)


Purchases, PIK and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

PIK interests.

Sales and repayments represent net proceeds received from investments sold and principal paydowns received during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2 or 3 during the nine months ended November 30, 2023.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2022 (dollars in thousands):

  First lien
term loans
  Second lien
term loans
  Unsecured
term loans
  Structured
finance
securities
  Equity
interests
  Total 
Balance as of February 28, 2022 $631,572  $44,386  $15,931  $38,030  $75,632  $805,551 
Payment-in-kind and other adjustments to cost  244   90   -   (2,159)  451   (1,374)
Net accretion of discount on investments  1,262   (17)  -   -   -   1,245 
Net change in unrealized appreciation (depreciation) on investments  (12,049)  (663)  10   (8,219)  2,467   (18,454)
Purchases  309,022   4,950   4,494   11,393   10,606   340,465 
Sales and repayments  (125,972)  (24,966)  -   (145)  (11,009)  (162,092)
Net realized gain (loss) from investments  163   -   -   -   7,203   7,366 
Balance as of November 30, 2022 $804,242  $23,780  $20,435  $38,900  $85,350  $972,707 
Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that were still held by the Company at the end of the period $(12,318) $(705) $10  $(8,219) $15,042  $(6,190)

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2 or 3 during the nine months ended November 30, 2022.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 20172023 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range

Syndicated loans

  $9,001   Market Comparables  Third-Party Bid (%)  94.0% - 100.6%

First lien term loans

   185,661   Market Comparables  Market Yield (%)  5.9% - 13.4%
      EBITDA Multiples (x)  3.0x - 5.5x
      Third-Party Bid (%)  100.1% - 100.3%

Second lien term loans

   99,427   Market Comparables  Market Yield (%)  9.2% - 15.5%
      Third-Party Bid (%)  97.9% - 99.9%
      EBITDA Multiples (x)  5.0x

Structured finance securities

   16,313   Discounted Cash Flow  Discount Rate (%)  8.5% - 14.0%

Equity interests

   28,436   Market Comparables  EBITDA Multiples (x)  3.7x - 14.0x

  Fair Value  Valuation Technique Unobservable Input Range Weighted Average* 
First lien term loans $959,892  Market Comparables Market Yield (%) 11.1% - 23.1%  13.2%
        Revenue Multiples (x) 0.3x - 5.2x  3.8x
        EBITDA Multiples (x) 5.0x – 15.0x  13.7x
Second lien term loans  14,873  Market Comparables Market Yield (%) 18.9% - 71.8%  53.2%
        Revenue Multiples (x) 14.8x - 14.8x  14.8x
Unsecured term loans  17,619  Collateral Value Coverage Net Asset Value 100.0%  100.0%
Structured finance securities  29,387  Discounted Cash Flow Discount Rate (%) 12.0% - 22.0%  15.8%
        Recovery Rate (%) 35.0% - 70.0%  70.0%
        Prepayment Rate (%) 20.0%  20.0%
Equity interests  84,476  Enterprise Value Waterfall Revenue Multiples (x) 1.3x - 10.9x  6.4x
        EBITDA Multiples (x) 0.3x - 28.6x  11.7x
Total $1,106,247           

*The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.


The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 20172023 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range

Syndicated loans

  $9,823   Market Comparables  Third-Party Bid (%)  100.5% - 101.1%

First lien term loans

   159,097   Market Comparables  Market Yield (%)  6.3% - 39.0%
      EBITDA Multiples (x)  3.0x - 10.3x
      Third-Party Bid (%)  100.0% - 100.2%

Second lien term loans

   87,750   Market Comparables  Market Yield (%)  10.1% - 26.4%
      Third-Party Bid (%)  97.6% - 99.9%

Structured finance securities

   15,450   Discounted Cash Flow  Discount Rate (%)  8.5% - 13.0%

Equity interests

   20,541   Market Comparables  EBITDA Multiples (x)  3.7x - 12.0x

  Fair Value  Valuation Technique Unobservable Input Range Weighted Average* 
First lien term loans $798,534  Market Comparables Market Yield (%) 10.5%  - 23.1%  12.8%
        Revenue Multiples (x) 4.1x  4.1x
        EBITDA Multiples (x) 8.0x  8.0x
Second lien term loans  14,936  Market Comparables Market Yield (%) 15.6% - 61.8%  45.8%
Unsecured term loans  20,661  Market Comparables Market Yield (%) 10.0% - 28.8%  12.6%
      Market Comparables Market Quote (%) 100.0%  100.0%
      Collateral Valuae Coverage Net Asset Value (%) 100.0%  100.0%
Structured finance securities  41,362  Discounted Cash Flow Discount Rate (%) 12.0% - 22.0%  17.6%
        Recovery Rate (%) 35.0% - 70.0%  70.0%
        Prepayment Rate (%) 20.0%  20.0%
Equity interests  83,990  Enterprise Value Waterfall EBITDA Multiples (x) 5.5x - 28.6x  11.0x
        Revenue Multiples (x) 1.3x - 11.2x  6.4x
Total $959,483           

*The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDAearnings before interest, tax, depreciation and amortization (“EBITDA”) or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, and prepayment rate, in isolation, would result in a significantly lower (higher) fair value measurement while a significant increase (decrease) in recovery rate, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a market quote, third party bid or net asset value in deriving a value, a significant increase (decrease) in the market quote, bid or net asset value in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of November 30, 2017,2023 at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $8,856    2.6 $9,001    2.7

First lien term loans

   187,030    55.3   185,661    54.8 

Second lien term loans

   99,736    29.5   99,427    29.3 

Structured finance securities

   13,692    4.0   16,313    4.8 

Equity interests

   28,951    8.6   28,436    8.4 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $338,265    100.0 $338,838    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

  Investments at
Amortized Cost
  Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
  Fair Value
Percentage of
Total Portfolio
 
First lien term loans $989,922   86.3% $959,892   86.2%
Second lien term loans  21,743   1.9   14,873   1.3 
Unsecured term loans  17,619   1.5   17,619   1.6 
Structured finance securities  44,180   3.8   29,387   2.6 
Equity interests  74,400   6.5   92,268   8.3 
Total $1,147,864   100.0% $1,114,039   100.0%

The composition of our investments as of February 28, 2017,2023 at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $9,669    3.2 $9,823    3.4

First lien term loans

   160,436    53.4   159,097    54.3 

Second lien term loans

   90,655    30.2   87,750    30.0 

Structured finance securities

   14,819    4.9   15,450    5.3 

Equity interests

   24,903    8.3   20,541    7.0 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $300,482    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

  Investments at
Amortized
Cost
  Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
  Fair Value
Percentage of
Total Portfolio
 
First lien term loans $808,464   83.7% $798,534   82.1%
Second lien term loans  21,114   2.2   14,936   1.5 
Unsecured term loans  21,001   2.2   20,661   2.1 
Structured finance securities  49,711   5.1   41,362   4.3 
Equity interests  66,199   6.8   97,097   10.0 
Total $966,489   100.0% $972,590   100.0%


For loans and debt securities for which market quotations are not readily available, we determinethe Company determines their fair value based on third party indicative broker quotes, where available, or the assumptionsinputs that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yieldcomparables valuation methodology.technique. In applying the market yieldcomparables valuation methodology, we determinetechnique, the Company determines the fair value based on such factors as market participant assumptionsinputs including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in ourthe Company’s judgment, the market yield methodologycomparables technique is not sufficient or appropriate, wethe Company may use additional methodologiestechniques such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determinethe Company determines the fair value based on the market approach with value then attributed to equity or equity like securities using thean enterprise value waterfall valuation methodology.technique. Under the enterprise value waterfall valuation methodology, we determinetechnique, the Company determines the enterprise fair value of the portfolio company and then waterfallwaterfalls the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weighthe Company weighs some or all of the traditional market valuation methodstechniques and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologiestechniques for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, wethe Company may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. WeThe Company also taketakes into account historical and anticipated financial results.

Our investment

The Company’s investments in Saratoga CLO isand SLF 2022 are carried at fair value, which is based on a discounted cash flow modelvaluation technique that utilizes prepayment, re-investment and loss assumptionsinputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO and SLF 2022, when available, as determined by ourthe Manager and recommended to ourthe Company’s board of directors. Specifically, we usethe Company uses Intex cash flow models,flows, or an appropriate substitute, to form the basis for the valuation of ourthe investment in Saratoga CLO.CLO and SLF 2022. The modelscash flows use a set of assumptionsinputs including projected default rates, recovery rates, reinvestment raterates and prepayment rates in order to arrive at estimated valuations. The assumptionsinputs are based on available market data and projections provided by third parties as well as management estimates. In connection with the refinancing of the Saratoga CLO liabilities, weThe Company ran Intex models based on assumptionsinputs about the refinanced Saratoga CLO’s structure and the SLF 2022 structure, including capital structure, cost of liabilities and reinvestment period. We useThe Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investmentinvestments in Saratoga CLO and SLF 2022 at November 30, 2017.2023. The significant inputs at November 30, 20172023 for the valuation model include:

 

Default rate: 2.0%

Recovery rate: 35%-70%

Discount rate: 12.0%-22.0%

Prepayment rate: 20.0%

Reinvestment rate / price: $98.00 for six months; then L+365bps / $99.00

Default rates: 2.0%


 

Recovery rates: 35-70%

The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV of SLF JV, or equivalent, as practical expedient.

Investment Concentration

Set forth is a brief description of each portfolio company in which the fair value of the Company’s investment represents greater than 5% of the Company’s total assets as of November 30, 2023, excluding Saratoga CLO, SLF JV and SLF 2022 (see Note 4 and Note 5 for more information on Saratoga CLO, SLF JV and SLF 2022, respectively).

HemaTerra Holdings Company, LLC

HemaTerra Holding Company, LLC (“HemaTerra”) provides SaaS-based software solutions addressing complex supply chain issues across a variety of medical environments, including blood, plasma, tissue, implants and DNA sample management, to customers in blood centers, hospitals, pharmaceuticals, and law enforcement settings.

Artemis Wax Corp.

Artemis Wax Corporation is a U.S. based retail aggregator of European Wax Center (“EWC”) franchise locations with a concentration in the northeast. Founded in 2004, EWC is the largest U.S. body waxing national chain with more than 800 locations across the country.

Granite Comfort, LP

Granite Comfort, LP is a U.S. based heating, ventilation and air conditioning (“HVAC”) company. The company provides traditional service and replacement of HVAC / plumbing systems, as well as a rental model that is in the early stages of implementation.

 

Discount rate: 14.0%

Prepayment rate: 20.0%

Reinvestment rate / price: L+350bps / $99.75

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, the Company invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by the Company that invests primarily in senior secured loans. Additionally, the Company entered into a collateral management agreement with GSC Investment Corp.Saratoga CLO, 2007, Ltd. pursuant to which we actthe Company acts as its collateral manager to it.manager. The Saratoga CLO was initially refinanced in October 2013 andwith its reinvestment period ended inextended to October 2016. On November 15, 2016, the Company completed thea second refinancing of the Saratoga CLO.CLO with its reinvestment period extended to October 2018.

On December 14, 2018, the Company completed a third refinancing and upsize of the Saratoga CLO (the “2013-1 Reset CLO Notes”). The third Saratoga CLO refinancing, among other things, extended its reinvestment period to October 2018,January 2021, and extended its legal maturity date to October 2025.January 2030. Following thethis refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure ofincreased its aggregate principal amount from approximately $300.0 million in aggregate principal amountto approximately $500.0 million of predominantly senior secured first lien term loans.

On February 11, 2020, the Company entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd. was repaid in full.

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing its liabilities, we alsoand upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $4.5$17.9 million in aggregate principal amount of the Class F notesF-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.


On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Note for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par, withpar. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a couponrealized loss of LIBOR plus 8.5%.$0.1 million.

The Saratoga CLO remains effectively 100.0% owned and managed by Saratoga Investment Corp. Following the refinancing, theCompany. The Company receives a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the fee basisoutstanding principal amount at the beginning of the collection period,Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. TheFollowing the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is alsono longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

For the three months ended November 30, 20172023 and November 30, 2016, we2022, the Company accrued $0.4 million and $0.4 million in management fee income of $0.8 million and $0.8 million, respectively, and $0.7interest income of $0.0 million and $0.5$0.2 million, in interest income, respectively, from the subordinated notes of Saratoga CLO.

For the nine months ended November 30, 20172023 and November 30, 2016, we2022, the Company accrued $1.1 million and $1.1 million in management fee income of $2.5 million and $2.5 million, respectively, and $1.7interest income of $0.0 million and $1.6$1.2 million, in interest income, respectively, from the subordinated notes of Saratoga CLO. For the three and nine months ended November 30, 2017, we accrued $0.2 million and $0.5 million, respectively, related to the incentive management fee from Saratoga CLO. For the three and nine months ended November 30, 2016, we did not accrue any amounts related to the incentive management fee from Saratoga CLO as the 12.0% hurdle rate had not yet been achieved.

As of November 30, 2017,2023, the Company determined thataggregate principal amounts of the fair value of its investmentCompany’s investments in the subordinated notes and Class F-2-R-3 Notes of the Saratoga CLO was $11.8 million.$111.0 million and $9.4 million, respectively, which had a corresponding fair value of $8.9 million and $9.0 million, respectively. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of November 30, 2017,2023, Saratoga CLO had investments with a principal balance of $308.6$643.5 million and a weighted average spread over LIBOR of 4.0%,3.8% and had debt with a principal balance of $282.4$611.0 million with a weighted average spread over LIBOR of 2.4%2.2%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. AtAs of November 30, 2017,2023, the present value of the projected future cash flows of the subordinated notes was approximately $12.1$8.9 million, using a 14.0%22.0% discount rate. The Company’s total investment in the subordinate notes of Saratoga Investment Corp. invested $32.8CLO is $57.8 million, into the CLO sincewhich consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021; to date, the Company has since received distributions of $52.2$83.2 million, management fees of $17.6$34.3 million and incentive fees of $0.5$1.2 million.

As of February 28, 2023, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $21.2 million. As of February 28, 2023, the fair value of its investment in the Class F-R-3 Notes of Saratoga CLO was $8.8 million. As of February 28, 2023, Saratoga CLO had investments with a principal balance of $645.6 million and a weighted average spread over LIBOR of 3.8% and had debt with a principal balance of $611.0 million with a weighted average spread over LIBOR of 2.2%. As of February 28, 2023, the present value of the projected future cash flows of the subordinated notes, was approximately $21.2 million, using a 22.0% discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 million, which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021. As of February 28, 2023, the Company has received distributions of $77.7 million, management fees of $31.9 million and incentive fees of $1.2 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of November 30, 20172023 (unaudited) and February 28, 20172023 and for the three and nine months ended November 30, 20172023 (unaudited) and November 30, 20162022 (unaudited).


Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

   As of 
   November 30, 2017  February 28, 2017 
   (unaudited)    

ASSETS

   

Investments

   

Fair Value Loans (amortized cost of $306,065,537 and $294,270,284, respectively)

  $302,689,881  $292,437,930 

Fair Value Other/Structured finance securities (cost of $3,531,218 and $3,531,218, respectively)

   4,316   22,718 
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $309,596,755 and $297,801,502 respectively)

   302,694,197   292,460,648 

Cash and cash equivalents

   4,971,935   13,046,555 

Receivable from open trades

   5,502,706   1,505,000 

Interest receivable

   1,372,574   1,443,865 

Other assets

   —     6,049 
  

 

 

  

 

 

 

Total assets

  $314,541,412  $308,462,117 
  

 

 

  

 

 

 

LIABILITIES

   

Interest payable

  $1,180,464  $1,031,457 

Payable from open trades

   15,409,509   9,431,552 

Accrued base management fee

   34,329   34,221 

Accrued subordinated management fee

   137,315   136,885 

Accrued incentive fee

   94,361   —   

Class A-1 Notes - SIC CLO 2013-1, Ltd.

   170,000,000   170,000,000 

Class A-2 Notes - SIC CLO 2013-1, Ltd.

   20,000,000   20,000,000 

Class B Notes - SIC CLO 2013-1, Ltd.

   44,800,000   44,800,000 

Class C Notes - SIC CLO 2013-1, Ltd.

   16,000,000   16,000,000 

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

   (70,593  (77,383

Class D Notes - SIC CLO 2013-1, Ltd.

   14,000,000   14,000,000 

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

   (327,726  (359,249

Class E Notes - SIC CLO 2013-1, Ltd.

   13,100,000   13,100,000 

Class F Notes - SIC CLO 2013-1, Ltd.

   4,500,000   4,500,000 

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

   (1,045,630  (1,161,590

Subordinated Notes

   30,000,000   30,000,000 
  

 

 

  

 

 

 

Total liabilities

  $327,812,029  $321,435,893 
  

 

 

  

 

 

 

Commitments and contingencies

   

NET ASSETS

   

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

  $250  $250 

Accumulated loss

   (12,974,026  (21,557,618

Net gain (loss)

   (296,841  8,583,592 
  

 

 

  

 

 

 

Total net assets

   (13,270,617  (12,973,776
  

 

 

  

 

 

 

Total liabilities and net assets

  $  314,541,412  $  308,462,117 
  

 

 

  

 

 

 
  November 30,
2023
  February 28,
2023
 
  (unaudited)    
ASSETS      
Investments at fair value      
Loans at fair value (amortized cost of $631,773,703 and $645,599,001, respectively) $594,703,611  $605,954,468 
Equities at fair value  (amortized cost of $615,405 and $0, respectively)  743,239   - 
Total investments at fair value (amortized cost of $632,389,108 and $645,599,001, respectively)  595,446,850   605,954,468 
Cash and cash equivalents  13,681,256   23,776,950 
Receivable from open trades  6,147,032   1,827,460 
Interest receivable (net of reserve of $791,292 and $234,690, respectively)  3,566,370   3,026,720 
Due from affiliate (See Note 7)  15,528   119,150 
Prepaid expenses and other assets  72,050   152,760 
Total assets $618,929,086  $634,857,508 
         
LIABILITIES        
Interest payable $5,495,223  $4,662,695 
Payable from open trades  8,413,799   23,184,337 
Accrued base management fee  72,806   72,762 
Accrued subordinated management fee  291,226   291,047 
Accounts payable and accrued expenses  79,241   82,565 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:        
Class A-1-R-3 Senior Secured Floating Rate Notes  357,500,000   357,500,000 
Class A-2-R-3 Senior Secured Floating Rate Notes  65,000,000   65,000,000 
Class B-FL-R-3 Senior Secured Floating Rate Notes  60,500,000   60,500,000 
Class B-FXD-R-3 Senior Secured Fixed Rate Notes  11,000,000   11,000,000 
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes  26,000,000   26,000,000 
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes  6,500,000   6,500,000 
Class D-R-3 Deferrable Mezzanine Floating Rate Notes  39,000,000   39,000,000 
Discount on Class D-R-3 Notes  (226,101)  (244,234)
Class E-R-3 Deferrable Mezzanine Floating Rate Notes  27,625,000   27,625,000 
Discount on Class E-R-3 Notes  (2,348,935)  (2,537,315)
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes  8,500,000   8,500,000 
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes  9,375,000   9,375,000 
Deferred debt financing costs  (1,754,687)  (1,897,076)
Subordinated Notes  111,000,000   111,000,000 
Discount on Subordinated Notes  (37,150,912)  (40,130,353)
Total liabilities  694,871,660   705,484,428 
NET ASSETS        
Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 common shares issued and outstanding, respectively  250   250 
Total distributable earnings (loss)  (75,942,824)  (70,627,170)
Total net deficit  (75,942,574)  (70,626,920)
Total liabilities and net assets $618,929,086  $634,857,508 

See accompanying notes to financial statements.


Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

   For the three months ended
November 30
  For the nine months ended
November 30
 
   2017  2016  2017  2016 

INVESTMENT INCOME

     

Interest from investments

  $4,178,651  $4,006,052  $12,307,120  $11,823,053 

Interest from cash and cash equivalents

   3,113   3,095   12,539   5,804 

Other income

   117,791   82,239   362,961   515,376 
  

 

 

  

 

 

  

 

 

  

 

 

 

Total investment income

   4,299,555   4,091,386   12,682,620   12,344,233 
  

 

 

  

 

 

  

 

 

  

 

 

 

EXPENSES

     

Interest expense

   3,461,049   2,457,705   10,396,665   9,347,508 

Professional fees

   78,048   39,694   131,155   79,120 

Miscellaneous fee expense

   36,350   25,974   66,309   48,365 

Base management fee

   75,289   167,592   225,617   541,763 

Subordinated management fee

   301,158   207,625   902,468   581,796 

Incentive fees

   209,434   —     477,087   —   

Trustee expenses

   41,025   30,871   115,740   95,398 

Amortization expense

   44,218   302,635   132,932   782,561 

Loss on extinguishment of debt

   —     6,641,915   —     6,641,915 
  

 

 

  

 

 

  

 

 

  

 

 

 

Total expenses

   4,246,571   9,874,011   12,447,973   18,118,426 
  

 

 

  

 

 

  

 

 

  

 

 

 

NET INVESTMENT INCOME (LOSS)

   52,984   (5,782,625  234,647   (5,774,193
  

 

 

  

 

 

  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

     

Net realized gain on investments

   260,872   130,337   1,030,216   351,753 

Net change in unrealized appreciation (depreciation) on investments

   (202,856  926,507   (1,561,704  10,714,904 
  

 

 

  

 

 

  

 

 

  

 

 

 

Net gain (loss) on investments

   58,016   1,056,844   (531,488  11,066,657 
  

 

 

  

 

 

  

 

 

  

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $111,000  $(4,725,781 $(296,841 $5,292,464 
  

 

 

  

 

 

  

 

 

  

 

 

 
  For the three months ended  For the nine months ended 
  November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
INVESTMENT INCOME            
Total interest from investments $15,599,943  $11,753,670  $46,240,246  $29,075,284 
Interest from cash and cash equivalents  139,759   13,215   480,995   19,320 
Other income  286,607   26,224   756,831   141,828 
Total investment income  16,026,309   11,793,109   47,478,072   29,236,432 
                 
EXPENSES                
Interest and debt financing expenses  14,644,320   10,177,731   43,349,057   26,287,544 
Base management fee  163,985   163,651   490,793   490,249 
Subordinated management fee  655,943   654,604   1,963,174   1,960,994 
Professional fees  87,540   53,254   260,431   263,647 
Trustee expenses  64,554   64,579   193,588   197,407 
Other expense  50,330   93,097   190,215   244,402 
Total expenses  15,666,672   11,206,916   46,447,258   29,444,243 
NET INVESTMENT INCOME (LOSS)  359,637   586,193   1,030,814   (207,811)
                 
REALIZED AND UNREALIZED LOSS ON INVESTMENTS                
Net realized loss from investments  (6,298,909)  (532,640)  (9,048,743)  (1,599,841)
Net change in unrealized depreciation on investments  (313,230)  (10,640,315)  2,702,275   (36,866,766)
Net realized and unrealized gain (loss) on investments  (6,612,139)  (11,172,955)  (6,346,468)  (38,466,607)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $(6,252,502) $(10,586,762) $(5,315,654) $(38,674,418)

See accompanying notes to financial statements.


Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 20172023

(unaudited)

Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Altisource Solutions S.a r.l. Banking, Finance, Insurance & Real Estate Common Stock  Equity                     15,981  $-  $68,239 
Envision Parent Inc Healthcare & Pharmaceuticals Common Stock  Equity                     4,410   175,000   175,000 
Envision Parent Inc Healthcare & Pharmaceuticals Warrants  Equity                     92,837   -   - 
Isagenix International, LLC Beverage, Food & Tobacco Common Stock  Equity                     86,398   -   - 
URS TOPCO LLC Transportation: Cargo Common Stock  Equity                     25,330   440,405   500,000 
19TH HOLDINGS GOLF, LLC Consumer goods: Durable Term Loan  Loan   1M USD SOFR+ 3.25%  0.50%  8.68%  2/7/2029  $2,479,925   2,386,376   2,349,729 
888 Acquisitions Limited Hotel, Gaming & Leisure Term Loan B  Loan   6M USD SOFR+ 5.25%  0.00%  10.82%  7/8/2028   2,478,261   2,165,072   2,378,684 
Adtalem Global Education Inc. Services: Business Term Loan B (02/21)  Loan   1M USD SOFR+ 4.00%  0.75%  9.46%  8/11/2028   691,846   686,981   691,127 
Aegis Sciences Corporation Healthcare & Pharmaceuticals Term Loan  Loan   3M USD SOFR+ 5.50%  1.00%  11.13%  5/9/2025   2,318,678   2,313,318   2,188,252 
Agiliti Health Inc. Healthcare & Pharmaceuticals Term Loan B (03/23)  Loan   3M USD SOFR+ 3.00%  0.00%  8.39%  5/1/2030   1,678,901   1,666,684   1,665,268 
AHEAD DB Holdings, LLC Services: Business Term Loan (04/21)  Loan   3M USD SOFR+ 3.75%  0.75%  9.24%  10/18/2027   2,932,500   2,860,328   2,896,899 
Air Canada Transportation: Consumer Term Loan B (07/21)  Loan   3M USD SOFR+ 3.50%  0.75%  9.14%  8/11/2028   1,975,000   1,852,793   1,971,129 
AIS HoldCo, LLC Services: Business Term Loan  Loan   3M USD SOFR+ 5.00%  0.00%  10.64%  8/15/2025   4,621,420   4,559,512   4,436,563 
AIT Worldwide Logistics Holdings, Inc. Transportation: Cargo Term Loan (04/21)  Loan   1M USD SOFR+ 4.75%  0.75%  10.17%  4/6/2028   2,481,013   2,334,057   2,415,266 
Alchemy US Holdco 1, LLC Metals & Mining Term Loan  Loan   1M USD LIBOR+ 7.32%  0.00%  7.42%  10/10/2025   1,654,803   1,646,697   1,638,255 
AlixPartners, LLP Banking, Finance, Insurance & Real Estate Term Loan B (01/21)  Loan   1M USD SOFR+ 2.75%  0.50%  8.21%  2/4/2028   243,750   243,463   243,947 
Alkermes, Inc. Healthcare & Pharmaceuticals Term Loan B (3/21)  Loan   1M USD SOFR+ 2.50%  0.50%  7.95%  3/12/2026   2,109,987   2,099,641   2,096,800 
Allen Media, LLC Media: Diversified & Production Term Loan (7/21)  Loan   3M USD SOFR+ 5.50%  0.00%  11.04%  2/10/2027   4,360,367   4,338,867   3,804,420 
Alliant Holdings Intermediate, LLC Banking, Finance, Insurance & Real Estate Term Loan B4  Loan   1M USD LIBOR+ 3.50%  0.50%  8.96%  11/5/2027   980,000   979,568   980,372 
Allied Universal Holdco LLC Services: Business Term Loan 4/21  Loan   1M USD SOFR+ 3.75%  0.50%  9.20%  5/12/2028   1,960,000   1,953,189   1,907,727 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Altisource Solutions S.a r.l. Banking, Finance, Insurance & Real Estate Term Loan B (03/18)  Loan    3M USD SOFR+ 5.00%  1.00%  10.49%  4/30/2025   1,100,390   1,099,813   870,409 
Altium Packaging LLC Containers, Packaging & Glass Term Loan (01/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  1/29/2028   487,500   485,997   484,521 
American Axle & Manufacturing Inc. Automotive Term Loan (12/22)  Loan    1M USD SOFR+ 3.50%  0.50%  8.92%  12/13/2029   490,000   476,804   488,927 
American Greetings Corporation Media: Advertising, Printing & Publishing Term Loan (01/23)  Loan    1M USD SOFR+ 6.00%  1.00%  11.35%  4/5/2028   2,990,265   2,988,626   2,985,271 
American Trailer World Corp Automotive Term Loan  Loan    1M USD SOFR+ 3.75%  0.75%  9.17%  3/3/2028   1,357,439   1,355,326   1,282,020 
AmWINS Group, LLC Banking, Finance, Insurance & Real Estate Term Loan 2/21  Loan    1M USD SOFR+ 2.25%  0.75%  7.71%  2/17/2028   1,945,026   1,928,224   1,941,661 
Anastasia Parent LLC Consumer goods: Non-durable Term Loan  Loan    3M USD SOFR+ 3.75%  0.00%  9.40%  8/11/2025   950,000   948,542   626,525 
Anchor Glass Container Corporation Containers, Packaging & Glass Term Loan (07/17)  Loan    6M USD LIBOR+ 2.75%  1.00%  8.04%  12/7/2023   466,406   466,399   377,789 
Anchor Packaging, LLC Containers, Packaging & Glass Term Loan B  Loan    1M USD SOFR+ 3.50%  0.00%  8.95%  7/18/2026   1,964,425   1,942,201   1,934,468 
ANI Pharmaceuticals, Inc. Healthcare & Pharmaceuticals Term Loan B  Loan    1M USD SOFR+ 6.00%  0.75%  11.46%  11/19/2027   2,947,500   2,906,490   2,936,447 
AP Core Holdings II LLC High Tech Industries Term Loan B1  Loan    1M USD SOFR+ 5.50%  0.75%  10.96%  9/1/2027   1,800,000   1,781,280   1,760,994 
AP Core Holdings II LLC High Tech Industries Term Loan B2  Loan    1M USD SOFR+ 5.50%  0.75%  10.96%  9/1/2027   500,000   494,807   487,915 
APEX GROUP TREASURY LLC Banking, Finance, Insurance & Real Estate Term Loan  Loan    3M USD SOFR+ 5.00%  0.50%  10.40%  7/26/2028   496,250   468,286   495,630 
APLP Holdings Limited Partnership Energy: Electricity Term Loan B (3/21)  Loan    3M USD SOFR+ 3.75%  1.00%  9.24%  5/14/2027   278,378   276,619   279,539 
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B  Loan    1M USD SOFR+ 2.75%  0.00%  8.21%  5/15/2026   2,916,244   2,896,013   2,821,466 
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 (2/21)  Loan    1M USD SOFR+ 3.50%  0.50%  8.94%  3/6/2028   975,000   968,360   936,000 
AppLovin Corporation High Tech Industries Term Loan (10/21)  Loan    1M USD SOFR+ 3.10%  0.50%  8.45%  10/21/2028   1,477,500   1,474,732   1,476,673 
AppLovin Corporation High Tech Industries Term Loan (08/23)  Loan    1M USD SOFR+ 3.00%  0.50%  8.45%  8/15/2030   972,054   972,054   971,898 
Aramark Services, Inc. Services: Consumer Term Loan B (4/21)  Loan    1M USD SOFR+ 2.50%  0.00%  7.96%  4/1/2028   1,753,715   1,748,034   1,751,523 
Aramark Services, Inc. Services: Consumer Term Loan  Loan    1M USD SOFR+ 1.75%  0.00%  7.21%  1/15/2027   2,331,250   2,289,490   2,323,977 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
ARC FALCON I INC. Chemicals, Plastics, & Rubber Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.95%  9/23/2028   983,774   980,943   950,926 
Arches Buyer Inc. Services: Consumer Term Loan B  Loan    1M USD SOFR+ 3.25%  0.50%  8.70%  12/6/2027   1,469,697   1,462,751   1,443,977 
ARCIS GOLF LLC Services: Consumer Term Loan B  Loan    1M USD SOFR+ 4.25%  0.50%  9.71%  11/19/2028   497,980   493,142   498,189 
Aretec Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan B  Loan    1M USD SOFR+ 4.50%  0.00%  9.95%  8/9/2030   2,649,358   2,633,197   2,605,829 
Asplundh Tree Expert, LLC Services: Business Term Loan 2/21  Loan    1M USD SOFR+ 1.75%  0.00%  7.20%  9/7/2027   970,000   967,259   971,620 
AssuredPartners Capital, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (2/20)  Loan    1M USD SOFR+ 3.50%  0.00%  8.96%  2/12/2027   982,143   979,630   980,915 
Assuredpartners Inc. Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.85%  2/12/2027   492,500   491,781   492,195 
Assuredpartners Inc. Banking, Finance, Insurance & Real Estate Incremental Term Loan (7/21)  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  2/12/2027   977,500   977,500   976,689 
ASTRO ONE ACQUISITION CORPORATION Consumer goods: Durable Term Loan  Loan    3M USD LIBOR+ 5.50%  0.75%  11.23%  9/15/2028   2,947,500   2,925,937   1,277,240 
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B10  Loan    1M USD SOFR+ 4.00%  0.00%  9.45%  8/19/2028   1,980,000   1,896,782   1,939,568 
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B8  Loan    1M USD SOFR+ 3.25%  0.00%  8.71%  12/18/2026   2,942,168   2,935,901   2,899,153 
ATHENAHEALTH GROUP INC. Healthcare & Pharmaceuticals Term Loan B (2/22)  Loan    1M USD SOFR+ 3.25%  0.50%  8.60%  2/15/2029   1,320,514   1,316,061   1,294,843 
Avolon TLB Borrower 1 (US) LLC Capital Equipment Term Loan B6  Loan    1M USD SOFR+ 2.50%  0.00%  7.83%  6/8/2028   997,500   944,250   998,637 
Avolon TLB Borrower 1 (US) LLC Capital Equipment Term Loan B5 (7/21)  Loan    1M USD SOFR+ 2.25%  0.50%  7.68%  12/1/2027   486,250   483,209   486,362 
Axalta Coating Systems US Holdings Chemicals, Plastics, & Rubber Term Loan B (08/23)  Loan    3M USD SOFR+ 2.50%  0.50%  7.89%  12/20/2029   920,194   912,118   921,629 
AZURITY PHARMACEUTICALS, INC. Healthcare & Pharmaceuticals Term Loan B  Loan    1M USD SOFR+ 6.62%  0.75%  12.08%  9/20/2027   456,250   446,528   438,000 
B&G Foods, Inc. Beverage, Food & Tobacco Term Loan  Loan    1M USD SOFR+ 2.50%  0.00%  7.85%  10/10/2026   556,042   553,602   544,921 
B.C. Unlimited Liability Co (Burger King) Beverage, Food & Tobacco Term Loan B (09/23)  Loan    1M USD SOFR+ 2.25%  0.00%  7.60%  9/12/2030   1,447,500   1,426,632   1,440,943 
BAKELITE UK INTERMEDIATE LTD. Chemicals, Plastics, & Rubber Term Loan  Loan    3M USD SOFR+ 4.00%  0.50%  9.54%  5/29/2029   987,500   983,531   955,406 
Baldwin Risk Partners, LLC Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  10/14/2027   1,965,074   1,950,504   1,956,880 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Barnes Group Inc. Aerospace & Defense Term Loan B  Loan    1M USD SOFR+ 3.00%  0.00%  8.45%  8/9/2030   250,000   248,176   249,438 
Bausch Health Companies Inc. Healthcare & Pharmaceuticals Term Loan B (1/22)  Loan    1M USD SOFR+ 5.25%  0.50%  10.69%  2/1/2027   1,875,000   1,724,183   1,414,069 
Belfor Holdings Inc. Services: Consumer Term Loan B-1 (11/23)  Loan    1M USD SOFR+ 3.75%  0.50%  9.10%  10/25/2030   1,600,000   1,584,111   1,598,000 
Belron Finance US LLC Automotive Term Loan B (3/21)  Loan    3M USD SOFR+ 2.43%  0.50%  8.07%  4/13/2028   1,950,000   1,937,133   1,949,025 
Belron Finance US LLC Automotive Term Loan (04/23)  Loan    3M USD SOFR+ 2.75%  0.50%  8.25%  4/17/2029   249,375   248,202   249,624 
Bengal Debt Merger Sub LLC Beverage, Food & Tobacco Term Loan  Loan    3M USD SOFR+ 3.25%  0.50%  8.74%  1/24/2029   1,975,000   1,974,221   1,846,941 
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan (6/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  4/23/2026   1,453,957   1,447,944   1,421,242 
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan B  Loan    1M USD SOFR+ 2.25%  0.00%  7.71%  4/23/2026   972,152   968,404   944,202 
Blue Tree Holdings, Inc. Chemicals, Plastics, & Rubber Term Loan (2/21)  Loan    3M USD SOFR+ 2.50%  0.00%  8.15%  3/4/2028   975,000   973,497   960,785 
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan B3  Loan    1M USD SOFR+ 2.75%  0.50%  8.10%  12/13/2029   495,009   483,825   492,411 
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan (1/20)  Loan    1M USD SOFR+ 2.00%  0.00%  7.45%  5/24/2027   1,443,799   1,439,363   1,423,051 
Boost Newco Borrower, LLC (Worldpay) Banking, Finance, Insurance & Real Estate Term Loan B  Loan    1M USD SOFR+ 3.00%  0.50%  8.32%  9/20/2030   500,000   497,500   499,375 
Boxer Parent Company, Inc. High Tech Industries Term Loan (2/21)  Loan    1M USD SOFR+ 3.75%  0.00%  9.21%  10/2/2025   512,255   512,255   512,070 
BrightSpring Health Services (Phoenix Guarantor) Healthcare & Pharmaceuticals Term Loan B-3  Loan    1M USD SOFR+ 3.50%  0.00%  8.96%  3/5/2026   975,000   975,000   973,840 
BroadStreet Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B3  Loan    1M USD SOFR+ 3.00%  0.00%  8.46%  1/22/2027   2,926,045   2,922,815   2,918,729 
Brookfield WEC Holdings Inc. Energy: Electricity Term Loan (1/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  8/1/2025   1,451,420   1,452,327   1,452,261 
BROWN GROUP HOLDING, LLC Aerospace & Defense Term Loan B-2  Loan    3M USD SOFR+ 3.75%  0.00%  9.14%  7/1/2029   495,000   484,548   495,040 
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan B2  Loan    1M USD SOFR+ 2.50%  0.00%  7.83%  11/15/2030   333,333   332,721   333,250 
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan (1/21)  Loan    1M USD SOFR+ 2.25%  0.00%  7.67%  11/1/2026   1,601,929   1,595,092   1,602,058 
BW Gas & Convenience Holdings LLC Beverage, Food & Tobacco Term Loan B  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  3/31/2028   2,443,750   2,427,104   2,419,313 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Callaway Golf Company Retail Term Loan B  Loan    1M USD SOFR+ 3.50%  0.00%  8.95%  3/9/2030   497,500   492,717   495,948 
Camping World, Inc. Retail Term Loan B (5/21)  Loan    1M USD SOFR+ 2.50%  0.75%  7.96%  6/5/2028   2,468,354   2,275,387   2,352,268 
CAPSTONE BORROWER INC Services: Business Term Loan (06/23)  Loan    3M USD SOFR+ 3.75%  0.00%  9.14%  6/15/2030   1,000,000   985,743   993,130 
CareerBuilder, LLC Services: Business Term Loan B3  Loan    3M USD SOFR+ 6.75%  0.00%  12.40%  7/31/2026   4,035,492   4,015,117   706,211 
Castle US Holding Corporation Media: Advertising, Printing & Publishing Term Loan B (USD)  Loan    1M USD SOFR+ 3.75%  0.00%  9.21%  1/27/2027   1,950,825   1,943,262   1,362,730 
CASTLELAKE AVIATION LLC Aerospace & Defense Term Loan B  Loan    3M USD SOFR+ 2.75%  0.50%  8.42%  10/21/2027   992,500   985,896   991,259 
CBI BUYER, INC. Consumer goods: Durable Term Loan  Loan    1M USD SOFR+ 3.25%  0.50%  8.71%  1/6/2028   2,947,273   2,811,619   1,224,769 
CBL & Associates Limited Partnership Retail Term Loan 11/21  Loan    1M USD SOFR+ 2.75%  1.00%  8.18%  11/1/2025   2,473,146   2,136,126   2,164,893 
CCC Intelligent Solutions Inc. Services: Business Term Loan B  Loan    1M USD SOFR+ 2.25%  0.50%  7.71%  9/16/2028   245,625   245,216   245,522 
CCI Buyer, Inc Telecommunications Term Loan  Loan    3M USD SOFR+ 4.00%  0.75%  9.39%  12/17/2027   243,750   242,208   241,878 
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan  Loan    1M USD SOFR+ 4.25%  0.50%  9.67%  3/5/2028   992,500   949,779   930,469 
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan B  Loan    1M USD SOFR+ 3.75%  0.75%  9.21%  3/5/2028   975,000   971,749   917,309 
CCS-CMGC Holdings, Inc. Healthcare & Pharmaceuticals Term Loan  Loan    6M USD SOFR+ 5.50%  0.00%  11.32%  9/25/2025   2,381,250   2,373,889   1,998,393 
CDK GLOBAL, INC. High Tech Industries Term Loan B (10/23)  Loan    3M USD SOFR+ 4.00%  0.00%  9.41%  7/6/2029   992,500   966,595   992,679 
Cengage Learning, Inc. Media: Advertising, Printing & Publishing Term Loan B (6/21)  Loan    3M USD SOFR+ 4.75%  1.00%  10.41%  7/14/2026   2,940,000   2,923,619   2,935,237 
CENTURI GROUP, INC. Construction & Building Term Loan B  Loan    1M USD SOFR+ 2.50%  0.50%  7.96%  8/27/2028   870,830   864,602   869,523 
CenturyLink, Inc. Telecommunications Term Loan B (1/20)  Loan    1M USD SOFR+ 2.25%  0.00%  7.71%  3/15/2027   3,850,497   3,847,375   2,302,058 
Charlotte Buyer, Inc. Services: Business Term Loan B  Loan    1M USD SOFR+ 5.25%  0.50%  10.57%  2/11/2028   1,488,750   1,403,657   1,486,472 
Chemours Company, (The) Chemicals, Plastics, & Rubber Term Loan B2  Loan    1M USD SOFR+ 3.50%  0.50%  8.85%  8/10/2028   2,399,716   2,359,528   2,368,232 
Churchill Downs Incorporated Hotel, Gaming & Leisure Term Loan B1 (3/21)  Loan    1M USD SOFR+ 2.00%  0.00%  7.45%  3/17/2028   487,500   486,756   486,077 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
CIMPRESS PUBLIC LIMITED COMPANY Media: Advertising, Printing & Publishing USD Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  5/17/2028   1,964,874   1,887,057   1,937,857 
CITADEL SECURITIES LP Banking, Finance, Insurance & Real Estate Term Loan B (07/23)  Loan    1M USD SOFR+ 2.50%  0.00%  7.96%  7/29/2030   4,875,281   4,874,298   4,872,649 
Citco Funding LLC Banking, Finance, Insurance & Real Estate Term Loa 1st Lien Incremental  Loan    3M USD SOFR+ 3.25%  0.50%  8.64%  4/27/2028   1,000,000   995,042   1,001,250 
Clarios Global LP Automotive Incremental Term Loan (04/23)  Loan    1M USD SOFR+ 3.75%  0.00%  9.10%  5/5/2030   1,200,000   1,194,227   1,200,900 
Claros Mortgage Trust, Inc Banking, Finance, Insurance & Real Estate Term Loan B-1 (11/21)  Loan    1M USD SOFR+ 4.50%  0.50%  9.94%  8/9/2026   3,413,379   3,398,299   3,217,109 
CLYDESDALE ACQUISITION HOLDINGS, INC. Containers, Packaging & Glass Term Loan B  Loan    1M USD SOFR+ 4.18%  0.50%  9.62%  4/13/2029   1,481,250   1,450,627   1,468,748 
Columbus McKinnon Corporation Capital Equipment Term Loan (4/21)  Loan    3M USD SOFR+ 2.75%  0.50%  8.42%  5/14/2028   419,219   418,529   418,695 
Conduent, Inc. Services: Business Term Loan B  Loan    1M USD SOFR+ 4.25%  0.50%  9.71%  10/16/2028   2,769,376   2,705,272   2,702,440 
Connect Finco SARL Telecommunications Term Loan (1/21)  Loan    1M USD SOFR+ 3.50%  1.00%  8.85%  12/11/2026   2,895,000   2,811,282   2,887,299 
Consolidated Communications, Inc. Telecommunications Term Loan B  Loan    1M USD SOFR+ 3.50%  0.75%  8.96%  10/2/2027   2,714,005   2,544,699   2,492,352 
CORAL-US CO-BORROWER LLC Telecommunications Term Loan B-5  Loan    1M USD SOFR+ 2.25%  0.00%  7.79%  1/31/2028   4,000,000   3,990,261   3,941,520 
Corelogic, Inc. Services: Business Term Loan (4/21)  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  6/2/2028   2,450,000   2,441,541   2,295,356 
Cortes NP Acquisition Corp (Vertiv) Capital Equipment Term Loan 2/21  Loan    1M USD SOFR+ 2.75%  0.00%  8.18%  3/2/2027   1,945,000   1,945,000   1,946,712 
Creative Artists Agency, LLC Media: Diversified & Production Term Loan B (02/23)  Loan    1M USD SOFR+ 3.50%  0.00%  8.85%  11/27/2028   1,592,002   1,581,259   1,594,884 
CROCS INC Consumer goods: Durable Term Loan B  Loan    3M USD SOFR+ 3.00%  0.00%  8.54%  2/19/2029   1,500,000   1,450,389   1,503,195 
Cross Financial Corp Banking, Finance, Insurance & Real Estate Term Loan B (3/21)  Loan    1M USD SOFR+ 4.00%  0.75%  9.46%  9/15/2027   488,750   488,517   488,139 
Crown Subsea Communications Holding, Inc. Construction & Building Term Loan (4/21)  Loan    1M USD SOFR+ 5.00%  0.75%  10.43%  4/27/2027   3,404,110   3,381,709   3,421,130 
CSC Holdings LLC (Neptune Finco Corp.) Media: Broadcasting & Subscription Term Loan B-5  Loan    1M USD LIBOR+ 2.50%  0.00%  7.94%  4/15/2027   481,250   481,250   449,743 
CSC Holdings LLC (Neptune Finco Corp.) Media: Broadcasting & Subscription Term Loan 12/22  Loan    1M USD SOFR+ 4.50%  0.00%  9.82%  4/15/2027   2,382,032   2,373,479   2,291,229 
CTC Holdings, LP Banking, Finance, Insurance & Real Estate Term Loan B  Loan    3M USD SOFR+ 5.00%  0.50%  10.52%  2/15/2029   2,216,250   2,169,883   2,177,466 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
CTS Midco, LLC High Tech Industries Term Loan B  Loan    3M USD SOFR+ 6.00%  1.00%  11.64%  11/2/2027   1,941,421   1,905,431   1,727,864 
Daseke Inc Transportation: Cargo Term Loan 2/21  Loan    1M USD SOFR+ 4.00%  0.75%  9.46%  3/5/2028   1,200,000   1,196,089   1,186,128 
Dave & Buster’s Inc. Hotel, Gaming & Leisure Term Loan (6/23)  Loan    1M USD SOFR+ 3.75%  0.50%  9.19%  6/29/2029   990,019   947,653   989,860 
DCert Buyer, Inc. High Tech Industries Term Loan  Loan    1M USD SOFR+ 4.00%  0.00%  9.35%  10/16/2026   1,458,438   1,458,438   1,439,712 
Delek US Holdings, Inc. Utilities: Oil & Gas Term Loan B (11/22)  Loan    1M USD SOFR+ 3.50%  0.50%  8.95%  11/16/2029   5,359,500   5,254,511   5,347,334 
Delos Aircraft DAC Transportation: Consumer Term Loan B  Loan    3M USD SOFR+ 2.00%  0.00%  7.39%  10/14/2027   250,000   250,000   250,548 
Delta 2 Lux Sarl Hotel, Gaming & Leisure Term Loan B  Loan    1M USD SOFR+ 2.25%  0.50%  7.60%  1/15/2030   2,000,000   1,991,065   2,000,620 
Derby Buyer LLC Chemicals, Plastics, & Rubber Term Loan (09/23)  Loan    1M USD SOFR+ 4.25%  0.50%  9.57%  11/1/2030   625,000   615,729   622,394 
DexKo Global, Inc. (Dragon Merger) Automotive Term Loan (9/21)  Loan    3M USD SOFR+ 3.75%  0.50%  9.40%  10/4/2028   985,000   982,036   965,073 
DG Investment Intermediate Holdings 2, Inc. Aerospace & Defense Incremental Term Loan (3/22)  Loan    1M USD SOFR+ 4.75%  0.75%  10.10%  3/31/2028   495,000   478,051   491,287 
Diamond Sports Group, LLC (a) Media: Broadcasting & Subscription Second Lien Term Loan  Loan    1M USD SOFR+ 5.25%  0.00%  10.67%  8/24/2026   3,374,880   3,089,287   71,716 
Diamond Sports Group, LLC (a) Media: Broadcasting & Subscription 1st Priority Term Loan  Loan    1M USD SOFR+ 10.00%  1.00%  15.42%  5/25/2026   342,343   335,566   246,977 
DIRECTV FINANCING, LLC Media: Broadcasting & Subscription Term Loan  Loan    1M USD SOFR+ 5.00%  0.75%  10.46%  8/2/2027   3,280,000   3,258,124   3,222,862 
DISCOVERY PURCHASER CORPORATION Chemicals, Plastics, & Rubber Term Loan  Loan    3M USD SOFR+ 4.38%  0.50%  9.77%  10/4/2029   1,488,750   1,383,919   1,417,662 
Dispatch Acquisition Holdings, LLC Environmental Industries Term Loan B (3/21)  Loan    3M USD SOFR+ 4.25%  0.75%  9.79%  3/25/2028   488,750   485,513   458,203 
DOMTAR CORPORATION Forest Products & Paper Term Loan 9/21  Loan    1M USD SOFR+ 5.50%  0.75%  10.96%  11/30/2028   1,260,510   1,227,610   1,241,602 
DOTDASH MEREDITH, INC. Media: Advertising, Printing & Publishing Term Loan B  Loan    1M USD SOFR+ 4.00%  0.50%  9.42%  11/30/2028   1,979,798   1,807,707   1,950,101 
DRI HOLDING INC. Media: Advertising, Printing & Publishing Term Loan (12/21)  Loan    1M USD SOFR+ 5.25%  0.50%  10.70%  12/15/2028   3,942,469   3,813,846   3,587,646 
DRW Holdings, LLC Banking, Finance, Insurance & Real Estate Term Loan (2/21)  Loan    1M USD SOFR+ 3.75%  0.00%  9.21%  3/1/2028   6,370,000   6,336,957   6,351,400 
DTZ U.S. Borrower, LLC Construction & Building Term Loan  Loan    1M USD SOFR+ 2.75%  0.00%  8.21%  8/21/2025   198,929   198,647   198,432 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
DTZ U.S. Borrower, LLC Construction & Building Term Loan (01/23)  Loan    1M USD SOFR+ 3.25%  0.50%  8.70%  1/31/2030   2,029,327   2,026,514   1,963,374 
DTZ U.S. Borrower, LLC Construction & Building Term Loan (08/23)  Loan    1M USD SOFR+ 4.00%  0.50%  9.35%  1/31/2030   1,100,000   1,073,252   1,075,250 
EAB Global, Inc. Services: Business Term Loan (08/21)  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  8/16/2028   982,500   979,067   976,566 
Echo Global Logistics, Inc. Services: Business Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.95%  11/23/2028   1,970,000   1,966,879   1,851,091 
Edelman Financial Group Inc., The Banking, Finance, Insurance & Real Estate Term Loan B (3/21)  Loan    1M USD SOFR+ 3.50%  0.75%  8.96%  4/7/2028   2,171,883   2,166,634   2,147,949 
Electrical Components Inter., Inc. Capital Equipment Term Loan (6/18)  Loan    3M USD SOFR+ 4.25%  0.00%  9.74%  6/26/2025   1,873,417   1,873,417   1,844,154 
ELECTRON BIDCO INC. Healthcare & Pharmaceuticals Term Loan  Loan    1M USD SOFR+ 3.00%  0.50%  8.46%  11/1/2028   492,500   490,840   491,953 
ELO Touch Solutions, Inc. Media: Diversified & Production Term Loan (12/18)  Loan    1M USD SOFR+ 6.50%  0.00%  11.96%  12/14/2025   1,966,935   1,929,446   1,911,625 
Embecta Corp Healthcare & Pharmaceuticals Term Loan B  Loan    6M USD SOFR+ 3.00%  0.50%  8.34%  3/30/2029   2,605,208   2,587,637   2,547,685 
Emerson Climate Technologies Inc Services: Business Term Loan B (04/23)  Loan    1M USD SOFR+ 3.00%  0.00%  8.35%  5/31/2030   626,147   620,209   626,422 
Endo Luxembourg Finance Company I S.a.r.l. Healthcare & Pharmaceuticals Term Loan (3/21)  Loan    Prime 6.00%  0.75%  14.50%  3/27/2028   2,335,285   2,329,778   1,500,421 
Endure Digital, Inc. High Tech Industries Term Loan B  Loan    6M USD SOFR+ 3.50%  0.75%  9.42%  2/10/2028   2,443,750   2,435,835   2,351,670 
Entain Holdings (Gibraltar) Limited Hotel, Gaming & Leisure Term Loan B (10/22)  Loan    3M USD SOFR+ 3.50%  0.50%  8.99%  10/30/2029   1,491,248   1,475,263   1,492,486 
EOS U.S. FINCO LLC Transportation: Cargo Term Loan  Loan    3M USD SOFR+ 5.75%  0.50%  11.16%  10/6/2029   981,250   911,874   899,482 
Equiniti Group PLC Services: Business Term Loan B  Loan    6M USD SOFR+ 4.50%  0.50%  10.09%  12/11/2028   982,500   975,049   983,119 
Evertec Group LLC Banking, Finance, Insurance & Real Estate Term Loan B (09/23)  Loan    1M USD SOFR+ 3.50%  0.50%  8.85%  10/12/2030   1,250,000   1,231,250   1,246,875 
EyeCare Partners, LLC Healthcare & Pharmaceuticals Term Loan  Loan    3M USD SOFR+ 3.75%  0.00%  9.39%  2/18/2027   1,933,172   1,933,172   999,972 
Finco I LLC Banking, Finance, Insurance & Real Estate Term Loan B (08/23)  Loan    3M USD SOFR+ 3.00%  0.00%  8.38%  6/27/2029   2,823,872   2,820,834   2,826,216 
First Brands Group, LLC Automotive 1st Lien Term Loan (3/21)  Loan    6M USD SOFR+ 5.00%  1.00%  10.88%  3/30/2027   4,875,000   4,825,909   4,788,469 
First Eagle Investment Management Banking, Finance, Insurance & Real Estate Refinancing Term Loan  Loan    3M USD SOFR+ 2.50%  0.00%  7.99%  2/1/2027   5,105,275   5,095,245   5,061,268 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  

Current Rate

(All In)

  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
First Student Bidco Inc. Transportation: Consumer Term Loan B  Loan    3M USD SOFR+ 3.00%  0.50%  8.65%  7/21/2028   717,321   713,586   705,069 
First Student Bidco Inc. Transportation: Consumer Term Loan C  Loan    3M USD SOFR+ 3.00%  0.50%  8.65%  7/21/2028   269,608   268,194   265,003 
Fitness International, LLC (LA Fitness) Services: Consumer Term Loan B (4/18)  Loan    1M USD SOFR+ 3.25%  1.00%  8.70%  4/18/2025   1,330,058   1,327,769   1,319,844 
Flutter Financing B.V. Hotel, Gaming & Leisure Term Loan B (11/23)  Loan    1M USD SOFR+ 2.25%  0.50%  7.57%  11/10/2030   3,000,000   2,992,500   2,985,000 
Flutter Financing B.V. Hotel, Gaming & Leisure Third Amendment 2028-B Term Loan  Loan    3M USD SOFR+ 3.25%  0.50%  8.90%  7/21/2028   311,641   305,724   311,747 
FOCUS FINANCIAL PARTNERS, LLC Banking, Finance, Insurance & Real Estate Term Loan B  Loan    1M USD SOFR+ 3.25%  0.50%  8.60%  6/30/2028   1,476,115   1,461,210   1,475,008 
Franchise Group, Inc. Services: Consumer First Out Term Loan  Loan    3M USD SOFR+ 4.75%  0.75%  10.44%  3/10/2026   799,104   794,937   594,533 
Franchise Group, Inc. Services: Consumer Term Loan B  Loan    3M USD SOFR+ 4.75%  0.75%  10.39%  3/10/2026   2,985,000   2,870,120   2,238,750 
Franklin Square Holdings, L.P. Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 2.25%  0.00%  7.70%  8/1/2025   4,274,975   4,265,372   4,274,975 
Froneri International (R&R Ice Cream) Beverage, Food & Tobacco Term Loan B-2  Loan    1M USD SOFR+ 2.25%  0.00%  7.70%  1/29/2027   1,935,000   1,933,409   1,934,013 
Garrett LX III S.a r.l. Automotive Dollar Term Loan  Loan    3M USD SOFR+ 3.25%  0.50%  8.89%  4/30/2028   1,470,000   1,465,230   1,468,163 
Gemini HDPE LLC Chemicals, Plastics, & Rubber Term Loan B (12/20)  Loan    3M USD SOFR+ 3.00%  0.50%  8.64%  12/31/2027   2,210,434   2,199,038   2,198,918 
Genesee & Wyoming, Inc. Transportation: Cargo Term Loan (11/19)  Loan    3M USD SOFR+ 2.00%  0.00%  7.49%  12/30/2026   1,447,500   1,444,152   1,447,876 
GGP Inc. Banking, Finance, Insurance & Real Estate Term Loan B  Loan    1M USD SOFR+ 2.50%  0.00%  7.95%  8/27/2025   2,813,716   2,599,873   2,793,120 
GIP Pilot Acquisition Partners, L.P. Energy: Oil & Gas Term Loan  Loan    3M USD SOFR+ 3.00%  0.00%  8.39%  10/4/2030   500,000   497,500   498,750 
Global Tel*Link Corporation Telecommunications Term Loan B  Loan    3M USD SOFR+ 4.25%  0.00%  9.78%  11/29/2025   4,859,368   4,750,849   4,666,353 
Go Daddy Operating Company, LLC High Tech Industries Term Loan 2/21  Loan    1M USD SOFR+ 2.00%  0.00%  7.46%  8/10/2027   949,865   949,865   949,865 
GOLDEN WEST PACKAGING GROUP LLC Forest Products & Paper Term Loan (11/21)  Loan    1M USD SOFR+ 5.25%  0.75%  10.71%  12/1/2027   1,900,000   1,886,250   1,691,000 
Graham Packaging Co Inc Containers, Packaging & Glass Term Loan (2/21)  Loan    1M USD SOFR+ 3.00%  0.75%  8.46%  8/7/2027   945,831   941,791   943,012 
Great Outdoors Group, LLC Retail Term Loan B2  Loan    3M USD SOFR+ 3.75%  0.75%  9.40%  3/6/2028   972,650   969,503   963,449 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Griffon Corporation Consumer goods: Durable Term Loan B  Loan    3M USD SOFR+ 2.25%  0.50%  7.79%  1/24/2029   144,688   144,458   144,507 
Grosvenor Capital Management Holdings, LLLP Banking, Finance, Insurance & Real Estate Amendment 5 Term Loan  Loan    1M USD SOFR+ 2.50%  0.50%  7.96%  2/24/2028   2,815,150   2,813,659   2,817,796 
Groupe Solmax Inc. Environmental Industries Term Loan (6/21)  Loan    3M USD SOFR+ 4.75%  0.75%  10.40%  5/27/2028   2,479,747   2,115,899   2,289,773 
GYP HOLDINGS III CORP. Construction & Building 2023 Refinancing Term Loans  Loan    1M USD SOFR+ 3.00%  0.00%  8.35%  4/25/2030   250,000   248,786   250,625 
Harbor Freight Tools USA, Inc. Retail Term Loan B (06/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  10/19/2027   3,344,665   3,329,534   3,317,941 
Helix Gen Funding, LLc Energy: Electricity Term Loan  Loan    1M USD SOFR+ 4.75%  1.00%  10.10%  12/31/2027   991,574   972,966   992,447 
Hertz Corporation (The) Transportation: Consumer Term Loan B  Loan    1M USD SOFR+ 3.75%  0.00%  9.08%  6/30/2028   500,000   490,016   493,750 
Hillman Group Inc. (The) (New) Consumer goods: Durable Term Loan B-1 (2/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  7/14/2028   3,181,350   3,177,383   3,176,865 
Hilton Domestic Operating Company Inc. Hotel, Gaming & Leisure Term Loan B 4  Loan    1M USD SOFR+ 2.00%  0.00%  7.44%  11/8/2030   1,500,000   1,496,277   1,500,810 
Hilton Grand Vacations Borrower LLC Hotel, Gaming & Leisure Term Loan (3/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  8/2/2028   498,728   498,728   498,104 
Hilton Grand Vacations Borrower LLC Hotel, Gaming & Leisure Term Loan B  Loan    1M USD SOFR+ 2.75%  0.00%  8.18%  8/2/2028   500,000   500,000   499,375 
HLF Financing SARL (Herbalife) Consumer goods: Non-durable Term Loan B (08/18)  Loan    1M USD SOFR+ 2.50%  0.00%  7.96%  8/18/2025   3,480,000   3,475,798   3,455,849 
Holley Purchaser, Inc Automotive Term Loan (11/21)  Loan    3M USD SOFR+ 3.75%  0.75%  9.40%  11/17/2028   2,260,252   2,253,200   2,136,888 
Howden Group Holdings Banking, Finance, Insurance & Real Estate Term Loan (1/21)  Loan    1M USD LIBOR+ 3.25%  0.75%  8.75%  11/12/2027   2,135,720   2,128,773   2,131,812 
Hudson River Trading LLC Banking, Finance, Insurance & Real Estate Term Loan (3/21)  Loan    1M USD SOFR+ 3.00%  0.00%  8.46%  3/17/2028   5,850,000   5,811,835   5,801,796 
Hunter Douglas Inc Consumer goods: Durable Term Loan B-1  Loan    3M USD SOFR+ 3.50%  0.50%  8.88%  2/26/2029   1,979,950   1,737,158   1,909,582 
Idera, Inc. High Tech Industries Term Loan (02/21)  Loan    3M USD SOFR+ 3.75%  0.75%  9.28%  3/2/2028   4,774,385   4,767,842   4,714,705 
IMA Financial Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan (11/23)  Loan    1M USD SOFR+ 3.75%  0.50%  9.19%  11/1/2028   500,000   497,500   498,750 
IMA Financial Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/21)  Loan    1M USD SOFR+ 3.75%  0.50%  9.21%  11/1/2028   1,965,000   1,957,998   1,960,088 
INDY US BIDCO, LLC Services: Business Term Loan (11/21)  Loan    1M USD SOFR+ 3.75%  0.00%  9.10%  3/6/2028   2,198,875   2,198,096   2,112,305 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
INEOS 226 Ltd. Chemicals, Plastics, & Rubber Term Loan 3/23  Loan    1M USD SOFR+ 3.75%  0.00%  9.20%  3/13/2030   498,750   493,951   481,917 
Ineos US Finance LLC Chemicals, Plastics, & Rubber Term Loan C  Loan    1M USD SOFR+ 3.50%  0.00%  8.95%  2/9/2030   997,500   987,946   987,994 
INEOS US PETROCHEM LLC Chemicals, Plastics, & Rubber Term Loan B  Loan    1M USD SOFR+ 4.25%  0.00%  9.70%  4/3/2029   2,464,874   2,410,868   2,394,009 
Informatica Inc. High Tech Industries Term Loan B (10/21)  Loan    1M USD SOFR+ 2.75%  0.00%  8.21%  10/27/2028   492,500   492,222   490,776 
Ingram Micro Inc. Wholesale Term Loan (09/23)  Loan    3M USD SOFR+ 3.00%  0.50%  8.65%  6/30/2028   1,095,000   1,087,159   1,092,263 
Inmar, Inc. Services: Business Term Loan (06/23)  Loan    1M USD SOFR+ 5.50%  1.00%  10.85%  5/1/2026   3,341,625   3,239,173   3,249,730 
Innophos, Inc. Chemicals, Plastics, & Rubber Term Loan B  Loan    1M USD SOFR+ 3.25%  0.00%  8.71%  2/4/2027   482,500   481,433   472,729 
INSTANT BRANDS HOLDINGS INC. (a) Consumer goods: Durable Term Loan 4/21  Loan    Prime 4.00%  0.75%  14.50%  4/7/2028   3,942,576   3,928,417   285,009 
INSTANT BRANDS HOLDINGS INC. (a) Consumer goods: Durable PIK DIP Term Loan  Loan    1M USD SOFR+ 10.00%  1.00%  15.46%  12/12/2023   1,505,449   1,447,846   1,543,085 
IRB Holding Corporation Beverage, Food & Tobacco Term Loan B (1/22)  Loan    1M USD SOFR+ 3.00%  0.75%  8.45%  12/15/2027   496,221   491,846   495,219 
Isagenix International, LLC Beverage, Food & Tobacco Term Loan  Loan    6M USD SOFR+ 2.50%  0.00%  8.04%  4/13/2028   1,231,904   797,368   1,047,119 
Isolved Inc. Services: Business Term Loan  Loan    6M USD SOFR+ 4.00%  0.50%  9.48%  10/5/2030   625,000   618,832   624,219 
Jane Street Group Banking, Finance, Insurance & Real Estate Term Loan (1/21)  Loan    1M USD SOFR+ 2.75%  0.00%  8.21%  1/31/2028   3,890,000   3,888,510   3,890,739 
Journey Personal Care Corp. Consumer goods: Non-durable Term Loan B  Loan    6M USD LIBOR+ 4.25%  0.75%  9.98%  3/1/2028   977,500   974,155   941,333 
JP Intermediate B, LLC Consumer goods: Non-durable Term Loan 7/23  Loan    3M USD SOFR+ 5.50%  1.00%  11.14%  11/20/2027   3,456,884   3,441,879   622,239 
Kleopatra Finco S.a r.l. Containers, Packaging & Glass Term Loan (1/21) (USD)  Loan    6M USD SOFR+ 4.73%  0.50%  10.48%  2/12/2026   1,462,500   1,459,970   1,346,421 
Kodiak BP, LLC Construction & Building Term Loan  Loan    3M USD SOFR+ 3.25%  0.75%  8.90%  3/13/2028   487,430   486,463   484,788 
Koppers Inc Chemicals, Plastics, & Rubber Term Loan B  Loan    1M USD SOFR+ 3.50%  0.50%  8.93%  4/10/2030   997,500   969,191   999,994 
KREF Holdings X LLC Banking, Finance, Insurance & Real Estate Term Loan (11/21)  Loan    1M USD SOFR+ 3.50%  0.50%  8.94%  9/1/2027   487,566   480,274   477,814 
Lakeland Tours, LLC Hotel, Gaming & Leisure Holdco Fixed Term Loan  Loan   - 0.00%  0.00%  8.00%  9/27/2027   1,127,568   554,262   834,400 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Lealand Finance Company B.V. Energy: Oil & Gas Exit Term Loan  Loan    1M USD SOFR+ 1.00%  0.00%  6.46%  6/30/2025   353,067   353,067   156,673 
LHS BORROWER, LLC Construction & Building Term Loan (02/22)  Loan    1M USD SOFR+ 4.75%  0.50%  10.20%  2/16/2029   2,482,172   2,076,065   2,181,209 
Lifetime Brands, Inc Consumer goods: Non-durable Term Loan  Loan    1M USD SOFR+ 5.50%  1.00%  10.94%  8/26/2027   1,659,313   1,652,811   1,568,051 
Liquid Tech Solutions Holdings, LLC Services: Business Term Loan  Loan    3M USD SOFR+ 4.75%  0.75%  10.40%  3/17/2028   977,500   975,116   959,582 
LogMeIn, Inc. High Tech Industries Term Loan (8/20)  Loan    3M USD SOFR+ 4.75%  0.00%  10.28%  8/31/2027   3,890,000   3,845,562   2,547,950 
LOYALTY VENTURES INC. (a) Services: Business Term Loan B  Loan    Prime 5.50%  0.50%  14.00%  11/3/2027   2,913,525   2,901,389   26,717 
LPL Holdings, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1  Loan    1M USD SOFR+ 1.75%  0.00%  7.17%  11/11/2026   1,198,517   1,197,542   1,197,271 
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan (01/23)  Loan    1M USD SOFR+ 4.25%  0.50%  9.70%  10/14/2028   1,496,250   1,476,730   1,479,103 
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.96%  10/16/2028   246,250   245,423   242,125 
LSF11 TRINITY BIDCO INC Aerospace & Defense Term Loan  Loan    1M USD SOFR+ 4.25%  0.00%  9.57%  6/14/2030   997,500   983,188   997,500 
LSF9 Atlantis Holdings, LLC (A Wireless) Retail Term Loan B  Loan    3M USD SOFR+ 7.25%  0.75%  12.64%  3/29/2029   2,812,500   2,734,432   2,635,847 
MAGNITE, INC. Services: Business Term Loan  Loan    1M USD SOFR+ 5.00%  0.75%  10.46%  4/28/2028   2,942,374   2,884,940   2,946,581 
Marriott Ownership Resorts, Inc. Hotel, Gaming & Leisure Term Loan (11/19)  Loan    1M USD SOFR+ 1.75%  0.00%  7.20%  8/29/2025   1,317,074   1,317,074   1,312,793 
Match Group, Inc, The Services: Consumer Term Loan (1/20)  Loan    3M USD SOFR+ 1.75%  0.00%  7.30%  2/15/2027   250,000   249,714   248,673 
Mayfield Agency Borrower Inc. (FeeCo) Banking, Finance, Insurance & Real Estate Term Loan B (02/23)  Loan    1M USD SOFR+ 5.00%  0.00%  10.45%  2/27/2028   3,441,375   3,350,332   3,446,399 
McGraw-Hill Education, Inc. Media: Advertising, Printing & Publishing Term Loan (07/21)  Loan    1M USD SOFR+ 4.75%  0.50%  10.21%  7/28/2028   1,960,000   1,944,688   1,922,544 
MedAssets Software Inter Hldg, Inc. High Tech Industries Term Loan (11/21) (USD)  Loan    1M USD SOFR+ 4.00%  0.50%  9.46%  12/18/2028   492,500   489,926   388,051 
Mermaid Bidco Inc. High Tech Industries Term Loan B2  Loan    3M USD SOFR+ 4.50%  0.75%  9.90%  12/22/2027   1,971,366   1,951,214   1,970,143 
Michaels Companies Inc Retail Term Loan B (Magic Mergeco)  Loan    3M USD SOFR+ 4.25%  0.75%  9.90%  4/8/2028   2,448,662   2,434,987   1,857,922 
MKS Instruments, Inc. High Tech Industries Term Loan B  Loan    1M USD SOFR+ 2.50%  0.50%  7.82%  8/17/2029   1,500,000   1,496,324   1,495,620 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Momentive Performance Materials Inc. Chemicals, Plastics, & Rubber Term Loan (03/23)  Loan    1M USD SOFR+ 4.50%  0.00%  9.85%  3/28/2028   497,500   479,421   475,610 
Moneygram International, Inc. Services: Business Term Loan  Loan    3M USD SOFR+ 5.50%  0.50%  10.91%  5/31/2030   2,500,000   2,120,669   2,381,250 
Mosel Bidco SE High Tech Industries Term Loan B  Loan    3M USD SOFR+ 4.75%  0.50%  10.14%  9/16/2030   500,000   495,100   499,375 
MPH Acquisition Holdings LLC (Multiplan) Services: Business Term Loan B (08/21)  Loan    3M USD SOFR+ 4.25%  0.50%  9.90%  9/1/2028   2,969,697   2,732,570   2,812,303 
NAB Holdings, LLC (North American Bancard) Banking, Finance, Insurance & Real Estate Term Loan (11/21)  Loan    3M USD SOFR+ 3.00%  0.50%  8.54%  11/23/2028   2,947,500   2,942,337   2,943,816 
Napa Management Services Corp Healthcare & Pharmaceuticals Term Loan B (02/22)  Loan    1M USD SOFR+ 5.25%  0.75%  10.70%  2/22/2029   2,977,330   2,436,226   2,476,781 
Natgasoline LLC Chemicals, Plastics, & Rubber Term Loan  Loan    1M USD SOFR+ 3.50%  0.00%  8.96%  11/14/2025   3,314,598   3,302,114   3,289,738 
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan 2/21  Loan    1M USD SOFR+ 3.75%  0.75%  9.20%  3/2/2028   2,715,157   2,707,940   2,458,928 
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan C 2/21  Loan    3M USD SOFR+ 3.75%  0.75%  9.24%  3/2/2028   87,464   87,202   79,210 
Nexstar Broadcasting, Inc. (Mission Broadcasting) Media: Broadcasting & Subscription Term Loan  Loan    1M USD SOFR+ 2.50%  0.00%  7.96%  9/18/2026   657,625   653,653   657,007 
Next Level Apparel, Inc. Retail Term Loan  Loan    3M USD SOFR+ 7.50%  1.00%  13.00%  8/9/2024   2,627,584   2,586,255   1,970,688 
NortonLifeLock Inc. High Tech Industries Term Loan B  Loan    1M USD SOFR+ 2.00%  0.50%  7.45%  9/12/2029   1,244,848   1,239,968   1,241,026 
Nouryon Finance B.V. Chemicals, Plastics, & Rubber Term Loan B  Loan    1M USD SOFR+ 4.00%  0.00%  9.42%  4/3/2028   498,750   493,763   494,800 
Nouryon Finance B.V. Chemicals, Plastics, & Rubber Term Loan (05/23)  Loan    3M USD SOFR+ 4.00%  0.00%  9.47%  4/3/2028   500,000   495,075   495,780 
Novae LLC Automotive Term Loan B  Loan    1M USD SOFR+ 5.00%  0.75%  10.43%  12/22/2028   1,970,000   1,958,410   1,883,813 
Nuvei Technologies Corp. High Tech Industries US Term Loan  Loan    1M USD SOFR+ 2.50%  0.50%  7.96%  9/29/2025   2,199,375   2,197,567   2,196,978 
Olaplex, Inc. Consumer goods: Non-durable Term Loan (2/22)  Loan    1M USD SOFR+ 3.50%  0.50%  8.95%  2/23/2029   2,473,665   2,379,080   2,261,647 
Open Text Corporation High Tech Industries Term Loan B (08/23)  Loan    1M USD SOFR+ 2.75%  0.50%  8.20%  1/31/2030   1,457,369   1,416,604   1,458,827 
Organon & Co. Healthcare & Pharmaceuticals Term Loan USD  Loan    1M USD SOFR+ 3.00%  0.50%  8.44%  6/2/2028   2,118,750   2,112,032   2,113,453 
Oxbow Carbon, LLC Metals & Mining Term Loan B (04/23)  Loan    3M USD SOFR+ 4.00%  0.50%  9.49%  5/2/2030   498,750   489,222   497,817 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
PACIFIC DENTAL SERVICES, LLC Healthcare & Pharmaceuticals Term Loan  Loan    1M USD SOFR+ 3.50%  0.75%  8.96%  4/21/2028   897,704   896,605   896,304 
Pacific Gas & Electric Utilities: Electric Term Loan  Loan    1M USD SOFR+ 3.00%  0.50%  8.46%  6/18/2025   1,453,675   1,450,940   1,452,992 
PACTIV EVERGREEN GROUP HOLDINGS INC. Containers, Packaging & Glass Term Loan B  Loan    1M USD SOFR+ 3.25%  0.50%  8.71%  9/20/2028   975,000   971,601   974,961 
Padagis LLC Healthcare & Pharmaceuticals Term Loan  Loan    3M USD SOFR+ 4.75%  0.50%  10.43%  7/6/2028   941,176   934,257   880,000 
PAR PETROLEUM LLC Energy: Oil & Gas Term Loan 2/23  Loan    3M USD SOFR+ 4.25%  0.50%  9.74%  2/27/2030   2,489,994   2,465,456   2,482,723 
PATAGONIA HOLDCO LLC Telecommunications Term Loan B  Loan    3M USD SOFR+ 5.75%  0.50%  11.12%  8/1/2029   1,980,000   1,667,115   1,732,500 
Pathway Partners Vet Management Company LLC Services: Business Term Loan  Loan    1M USD SOFR+ 3.75%  0.00%  9.21%  3/30/2027   482,785   476,627   424,450 
PCI Gaming Authority Hotel, Gaming & Leisure Term Loan  Loan    1M USD SOFR+ 2.50%  0.00%  7.96%  5/29/2026   809,038   807,346   808,488 
PEARLS (Netherlands) Bidco B.V. Chemicals, Plastics, & Rubber USD Term Loan (02/22)  Loan    3M USD SOFR+ 3.75%  0.50%  9.13%  2/28/2029   985,000   983,406   973,919 
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC Healthcare & Pharmaceuticals Term Loan (12/22)  Loan    1M USD SOFR+ 3.25%  0.50%  8.71%  12/29/2028   1,478,391   1,473,623   1,399,549 
Penn National Gaming, Inc Hotel, Gaming & Leisure Term Loan B  Loan    1M USD SOFR+ 2.75%  0.50%  8.20%  5/3/2029   987,500   983,469   986,937 
Peraton Corp. Aerospace & Defense Term Loan B  Loan    1M USD SOFR+ 3.75%  0.75%  9.20%  2/1/2028   5,250,093   5,236,942   5,213,553 
PHYSICIAN PARTNERS, LLC Healthcare & Pharmaceuticals Term Loan  Loan    3M USD SOFR+ 4.00%  0.50%  9.53%  12/23/2028   2,966,209   2,904,698   2,794,406 
Pike Corporation Construction & Building Term Loan (8/22)  Loan    1M USD SOFR+ 3.50%  0.00%  8.85%  1/21/2028   495,000   484,990   494,941 
Pitney Bowes Inc Services: Business Term Loan B  Loan    1M USD SOFR+ 4.00%  0.00%  9.46%  3/17/2028   3,909,849   3,886,929   3,795,016 
Plastipak Holdings Inc. Containers, Packaging & Glass Term Loan B (11/21)  Loan    1M USD SOFR+ 2.50%  0.50%  7.95%  12/1/2028   1,906,176   1,899,212   1,902,612 
Playtika Holding Corp. High Tech Industries Term Loan B (3/21)  Loan    1M USD SOFR+ 2.75%  0.00%  8.21%  3/13/2028   4,387,500   4,381,054   4,355,691 
PMHC II, INC. Chemicals, Plastics, & Rubber Term Loan (02/22)  Loan    3M USD SOFR+ 4.25%  0.50%  9.81%  4/21/2029   1,980,000   1,972,003   1,769,011 
PointClickCare Technologies, Inc. High Tech Industries Term Loan B  Loan    6M USD SOFR+ 3.00%  0.75%  8.76%  12/29/2027   487,500   485,978   486,281 
Polymer Process Holdings, Inc. Containers, Packaging & Glass Term Loan  Loan    1M USD SOFR+ 4.75%  0.75%  10.21%  2/12/2028   5,362,500   5,324,344   4,985,463 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Pre-Paid Legal Services, Inc. Services: Consumer Term Loan (12/21)  Loan    1M USD SOFR+ 3.75%  0.50%  9.21%  12/15/2028   2,955,000   2,935,606   2,923,854 
Presidio, Inc. Services: Business Term Loan B (1/20)  Loan    3M USD SOFR+ 3.50%  0.00%  8.98%  1/22/2027   483,750   483,344   483,508 
Prime Security Services Borrower, LLC (ADT) Services: Consumer Term Loan B (10/23)  Loan    1M USD SOFR+ 2.50%  0.00%  7.83%  10/11/2030   2,000,000   1,980,233   2,000,140 
PRIORITY HOLDINGS, LLC Services: Consumer Term Loan  Loan    1M USD SOFR+ 5.75%  1.00%  11.21%  4/27/2027   2,932,500   2,913,181   2,921,503 
PriSo Acquisition Corporation Construction & Building Term Loan (01/21)  Loan    3M USD SOFR+ 3.25%  0.75%  8.91%  12/28/2027   487,493   485,875   469,324 
Project Leopard Holdings, Inc. (NEW) High Tech Industries Term Loan B (06/22)  Loan    3M USD SOFR+ 5.25%  0.50%  10.73%  7/20/2029   992,500   932,308   861,619 
Propulsion (BC) Finco Aerospace & Defense Term Loan  Loan    3M USD SOFR+ 3.75%  0.50%  9.14%  9/14/2029   750,000   742,500   747,855 
PUG LLC Services: Consumer Term Loan B (02/20)  Loan    1M USD SOFR+ 3.50%  0.00%  8.96%  2/12/2027   476,413   475,263   460,634 
Quartz AcquireCo, LLC High Tech Industries Term Loan B  Loan    1M USD SOFR+ 3.50%  0.00%  8.85%  6/28/2030   1,000,000   990,335   1,000,000 
QUEST BORROWER LIMITED High Tech Industries Term Loan (1/22)  Loan    3M USD SOFR+ 4.25%  0.50%  9.78%  2/1/2029   1,975,000   1,959,333   1,438,788 
Rackspace Technology Global, Inc. High Tech Industries Term Loan (1/21)  Loan    1M USD SOFR+ 2.75%  0.75%  8.19%  2/15/2028   2,952,114   2,872,658   1,203,902 
RAND PARENT LLC Transportation: Cargo Term Loan B  Loan    3M USD SOFR+ 4.25%  0.00%  9.64%  3/16/2030   2,487,500   2,404,220   2,436,506 
RealPage, Inc. High Tech Industries Term Loan (04/21)  Loan    1M USD SOFR+ 3.00%  0.50%  8.46%  4/24/2028   980,000   978,635   954,892 
Recess Holdings, Inc. Consumer goods: Durable Term Loan B  Loan    3M USD SOFR+ 4.00%  1.00%  9.39%  3/17/2027   1,000,000   990,639   998,130 
Rent-A-Center, Inc. Retail Term Loan B2 (9/21)  Loan    6M USD SOFR+ 3.25%  0.50%  9.12%  2/17/2028   1,865,209   1,831,318   1,858,215 
Research Now Group, Inc Media: Advertising, Printing & Publishing Term Loan  Loan    3M USD SOFR+ 5.50%  1.00%  11.14%  12/20/2024   4,264,202   4,235,793   3,156,832 
Resideo Funding Inc. Services: Consumer Term Loan (1/21)  Loan    1M USD SOFR+ 2.25%  0.50%  7.69%  2/11/2028   1,462,500   1,461,040   1,463,231 
Resolute Investment Managers (American Beacon), Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/20)  Loan    3M USD SOFR+ 4.25%  1.00%  9.79%  4/30/2024   3,004,051   3,002,736   1,903,817 
Restoration Hardware, Inc. Retail Term Loan (9/21)  Loan    1M USD SOFR+ 2.50%  0.50%  7.96%  10/20/2028   3,436,140   3,431,061   3,242,857 
Reynolds Consumer Products LLC Containers, Packaging & Glass Term Loan  Loan    1M USD SOFR+ 1.75%  0.00%  7.17%  1/29/2027   1,148,220   1,148,220   1,147,347 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
Reynolds Group Holdings Inc. Containers, Packaging & Glass Term Loan B2  Loan    1M USD SOFR+ 3.25%  0.00%  8.71%  2/5/2026   1,933,578   1,928,916   1,935,918 
Russell Investments US Inst’l Holdco, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/20)  Loan    1M USD SOFR+ 3.50%  1.00%  8.92%  6/2/2025   5,503,217   5,484,868   5,146,884 
RV Retailer LLC Automotive Term Loan  Loan    1M USD SOFR+ 3.75%  0.75%  9.19%  2/8/2028   2,935,225   2,896,162   2,348,180 
Ryan Specialty Group LLC Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 3.00%  0.75%  8.45%  9/1/2027   1,467,278   1,457,466   1,467,278 
S&S HOLDINGS LLC Services: Business Term Loan  Loan    3M USD SOFR+ 5.00%  0.50%  10.50%  3/10/2028   2,439,950   2,397,129   2,353,332 
Sally Holdings LLC Retail Term Loan B  Loan    1M USD SOFR+ 2.25%  0.00%  7.60%  2/28/2030   497,500   494,003   497,500 
Schweitzer-Mauduit International, Inc. High Tech Industries Term Loan B  Loan    1M USD SOFR+ 3.75%  0.75%  9.21%  4/20/2028   2,932,500   2,921,724   2,888,513 
Scientific Games Holdings LP Hotel, Gaming & Leisure Term Loan B  Loan    3M USD SOFR+ 3.50%  0.50%  8.91%  4/4/2029   495,000   494,105   492,129 
Sedgwick Claims Management Services, Inc. Services: Business Term Loan B 2/23  Loan    1M USD SOFR+ 3.75%  0.00%  9.10%  2/17/2028   995,000   986,084   995,746 
SETANTA AIRCRAFT LEASING DAC Aerospace & Defense Term Loan  Loan    3M USD SOFR+ 2.00%  0.00%  7.65%  11/2/2028   1,000,000   998,223   999,690 
Sitel Worldwide Corporation Services: Business USD Term Loan (7/21)  Loan    1M USD SOFR+ 3.75%  0.50%  9.21%  8/28/2028   1,960,000   1,953,329   1,868,860 
SiteOne Landscape Supply, LLC Services: Business Term Loan (3/21)  Loan    1M USD SOFR+ 2.00%  0.50%  7.46%  3/18/2028   1,270,636   1,264,813   1,270,636 
SMG US Midco 2, Inc. Services: Business Term Loan (01/20)  Loan    3M USD SOFR+ 2.50%  0.00%  8.14%  1/23/2025   481,250   481,250   481,009 
Smyrna Ready Mix Concrete, LLC Construction & Building Term Loan B  Loan    1M USD SOFR+ 3.50%  0.00%  8.83%  4/1/2029   514,217   510,649   514,217 
Sotheby’s Services: Business Term Loan (7/21)  Loan    3M USD SOFR+ 4.50%  0.50%  10.16%  1/15/2027   3,199,197   3,165,699   3,108,212 
Sparta U.S. HoldCo LLC Chemicals, Plastics, & Rubber Term Loan (04/21)  Loan    1M USD SOFR+ 3.25%  0.75%  8.68%  8/2/2028   1,965,000   1,958,268   1,943,955 
Specialty Pharma III Inc. Services: Business Term Loan  Loan    1M USD SOFR+ 4.25%  0.75%  9.70%  3/31/2028   1,960,000   1,946,802   1,901,200 
Spin Holdco, Inc. Services: Consumer Term Loan 3/21  Loan    3M USD SOFR+ 4.00%  0.75%  9.66%  3/4/2028   2,925,000   2,914,050   2,530,652 
Spirit Aerosystems Inc. Aerospace & Defense Term Loan  Loan    3M USD SOFR+ 4.25%  0.50%  9.62%  1/14/2027   -   3,010   - 
SRAM, LLC Consumer goods: Durable Term Loan (05/21)  Loan    1M USD LIBOR+ 2.75%  0.50%  7.94%  5/12/2028   2,654,545   2,651,633   2,637,955 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair Value 
STANDARD INDUSTRIES INC. Construction & Building Term Loan B  Loan    1M USD SOFR+ 2.25%  0.50%  7.70%  9/22/2028   622,750   618,411   622,750 
Staples, Inc. Wholesale Term Loan (03/19)  Loan    1M USD SOFR+ 5.00%  0.00%  10.43%  4/16/2026   4,307,528   4,232,220   3,927,647 
Star Parent, Inc. Services: Business Term Loan B (09/23)  Loan    3M USD SOFR+ 4.00%  0.00%  9.39%  9/19/2030   1,250,000   1,231,694   1,220,663 
Storable, Inc High Tech Industries Term Loan B  Loan    1M USD SOFR+ 3.50%  0.50%  8.85%  4/17/2028   491,250   490,647   486,686 
Summit Materials, LLC Metals & Mining Term Loan B (12/22)  Loan    6M USD SOFR+ 3.00%  0.00%  8.57%  12/13/2027   248,125   246,032   248,311 
Superannuation & Investments US LLC Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 3.75%  0.50%  9.21%  12/1/2028   982,500   975,039   980,348 
Sweetwater Borrower, LLC Retail Term Loan (8/21)  Loan    1M USD SOFR+ 4.25%  0.75%  9.71%  8/2/2028   1,897,331   1,817,038   1,864,128 
Syncsort Incorporated High Tech Industries Term Loan B (10/21)  Loan    3M USD SOFR+ 4.00%  0.75%  9.64%  4/24/2028   2,451,228   2,450,470   2,389,947 
Ta TT Buyer LLC Media: Broadcasting & Subscription Term Loan 3/22  Loan    3M USD SOFR+ 5.00%  0.50%  10.39%  4/2/2029   990,000   981,723   987,525 
Tenable Holdings, Inc. Services: Business Term Loan B (6/21)  Loan    1M USD SOFR+ 2.75%  0.50%  8.21%  7/7/2028   982,500   980,870   980,044 
Teneo Holdings LLC Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 5.25%  1.00%  10.70%  7/15/2025   4,349,239   4,311,114   4,335,669 
Ten-X, LLC Banking, Finance, Insurance & Real Estate Term Loan 5/23  Loan    1M USD SOFR+ 6.00%  0.00%  11.35%  5/25/2028   1,885,000   1,884,599   1,791,334 
The Dun & Bradstreet Corporation Services: Business Term Loan B  Loan    1M USD SOFR+ 3.00%  0.00%  8.34%  1/18/2029   246,250   244,835   246,250 
The Dun & Bradstreet Corporation Services: Business Term Loan B (7/23)  Loan    1M USD SOFR+ 2.75%  0.00%  8.19%  2/6/2026   905,556   905,108   905,701 
Thor Industries, Inc. Automotive Term Loan B2  Loan    1M USD SOFR+ 2.75%  0.00%  8.07%  11/15/2030   847,276   838,835   849,394 
Torrid LLC Wholesale Term Loan 5/21  Loan    6M USD SOFR+ 5.50%  0.75%  11.26%  6/14/2028   3,339,681   2,907,402   2,237,586 
TORY BURCH LLC Retail Term Loan  Loan    1M USD SOFR+ 3.25%  0.50%  8.71%  4/15/2028   2,314,001   2,172,572   2,287,321 
Tosca Services, LLC Containers, Packaging & Glass Term Loan (2/21)  Loan    3M USD SOFR+ 3.50%  0.75%  9.14%  8/18/2027   486,250   482,017   399,941 
Trans Union LLC Banking, Finance, Insurance & Real Estate Term Loan  Loan    1M USD SOFR+ 2.25%  0.50%  7.71%  12/1/2028   619,597   618,540   619,386 
Transdigm, Inc. Aerospace & Defense Term Loan H  Loan    3M USD SOFR+ 3.25%  0.00%  8.64%  2/21/2027   1,978,420   1,975,263   1,979,349 


Issuer Name Industry Asset Name Asset
Type
  Reference
Rate/Spread
  SOFR/LIBOR Floor  Current Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
TRITON WATER HOLDINGS, INC. Beverage, Food & Tobacco Term Loan (03/21)  Loan    3M USD SOFR+ 3.25%  0.50%  8.90%  3/31/2028   1,466,253   1,461,285   1,440,594 
Tronox Finance LLC Chemicals, Plastics, & Rubber Term Loan  Loan    1M USD SOFR+ 2.50%  0.00%  7.96%  3/10/2028   346,923   346,508   342,285 
Tronox Finance LLC Chemicals, Plastics, & Rubber Incremental Term Loan  Loan    1M USD SOFR+ 3.50%  0.50%  8.85%  8/11/2028   2,000,000   1,980,723   1,989,380 
TruGreen Limited Partnership Services: Consumer Term Loan  Loan    1M USD SOFR+ 4.00%  0.75%  9.45%  10/29/2027   947,196   942,620   887,324 
Uber Technologies, Inc. Transportation: Consumer Term Loan 2/23  Loan    3M USD SOFR+ 2.75%  0.00%  8.16%  2/27/2030   396,688   395,747   397,434 
Ultra Clean Holdings, Inc. High Tech Industries Incremental Term Loan 3/21  Loan    1M USD SOFR+ 3.75%  0.00%  9.21%  8/27/2025   769,730   768,007   769,968 
Unimin Corporation Metals & Mining Term Loan (12/20)  Loan    3M USD SOFR+ 4.00%  1.00%  9.68%  7/31/2026   496,815   480,224   491,936 
United Natural Foods, Inc Beverage, Food & Tobacco Term Loan B  Loan    1M USD SOFR+ 3.25%  0.00%  8.71%  10/22/2025   1,270,714   1,243,594   1,265,263 
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/21)  Loan    1M USD SOFR+ 3.25%  0.75%  8.71%  3/15/2026   2,428,019   2,423,974   2,423,770 
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/22)  Loan    3M USD SOFR+ 4.25%  0.50%  9.64%  6/25/2029   246,875   240,628   246,413 
USI T/L (09/23)   Term Loan (09/23)  Loan                     -   2   - 
Utz Quality Foods, LLC Beverage, Food & Tobacco Term Loan B  Loan    3M USD SOFR+ 3.00%  0.00%  8.64%  1/20/2028   1,814,474   1,813,602   1,811,643 
Vaco Holdings, LLC Services: Business Term Loan (01/22)  Loan    6M USD SOFR+ 5.00%  0.75%  10.59%  1/19/2029   2,324,466   2,264,168   2,243,110 
Vericast Corp. Media: Advertising, Printing & Publishing Term Loan  Loan    3M USD SOFR+ 7.75%  1.00%  13.40%  6/15/2026   1,201,006   1,200,103   1,138,950 
Verifone Systems, Inc. Banking, Finance, Insurance & Real Estate Term Loan (7/18)  Loan    3M USD SOFR+ 4.00%  0.00%  9.64%  8/20/2025   1,357,316   1,354,603   1,284,197 
Vertex Aerospace Services Corp Aerospace & Defense Term Loan (10/21)  Loan    1M USD SOFR+ 3.25%  0.75%  8.70%  12/6/2028   985,000   981,666   983,926 
VFH Parent LLC Banking, Finance, Insurance & Real Estate Term Loan (01/22)  Loan    1M USD SOFR+ 3.00%  0.50%  8.45%  1/12/2029   3,069,879   3,064,493   3,059,135 
Viasat Inc Telecommunications Term Loan (2/22)  Loan    1M USD SOFR+ 4.50%  0.50%  9.85%  3/2/2029   2,974,912   2,913,288   2,859,218 
Virtus Investment Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (9/21)  Loan    1M USD SOFR+ 2.25%  0.00%  7.71%  9/28/2028   2,830,909   2,824,386   2,823,832 
Vistra Energy Corp Utilities: Electric 2018 Incremental Term Loan  Loan    1M USD SOFR+ 1.75%  0.00%  7.21%  12/31/2025   889,393   889,296   889,508 
Vizient, Inc Healthcare & Pharmaceuticals Term Loan 4/22  Loan    1M USD SOFR+ 2.25%  0.50%  7.70%  5/16/2029   493,750   489,630   494,367 
VM Consolidated, Inc. Construction & Building Term Loan B (3/21)  Loan    1M USD SOFR+ 3.25%  0.00%  8.71%  3/24/2028   1,847,267   1,845,878   1,851,497 
Vouvray US Finance LLC High Tech Industries Term Loan  Loan    1M USD SOFR+ 6.00%  1.00%  11.35%  9/30/2025   467,500   467,500   461,268 
Walker & Dunlop, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (12/22)  Loan    1M USD SOFR+ 3.00%  0.50%  8.45%  12/15/2028   497,500   488,708   495,013 
Warner Music Group Corp. (WMG Acquisition Corp.) Hotel, Gaming & Leisure Term Loan G  Loan    1M USD SOFR+ 2.13%  0.00%  7.59%  1/20/2028   1,250,000   1,249,887   1,249,225 
Watlow Electric Manufacturing Company High Tech Industries Term Loan B  Loan    3M USD SOFR+ 3.75%  0.50%  9.40%  3/2/2028   2,893,795   2,883,133   2,861,848 
WeddingWire, Inc. Services: Consumer Term Loan (09/23)  Loan    1M USD SOFR+ 4.50%  0.00%  9.85%  1/29/2028   4,808,923   4,805,746   4,742,801 
WEX Inc. Services: Business Term Loan B (3/21)  Loan    1M USD SOFR+ 2.25%  0.00%  7.71%  3/31/2028   2,932,368   2,925,031   2,934,890 
WildBrain Ltd. Media: Diversified & Production Term Loan  Loan    1M USD SOFR+ 4.25%  0.75%  9.71%  3/27/2028   1,950,000   1,923,431   1,890,291 
Wyndham Hotels & Resorts, Inc. Hotel, Gaming & Leisure Term Loan  5/23  Loan    1M USD SOFR+ 2.25%  0.00%  7.70%  5/24/2030   997,500   992,657   998,468 
Xerox 10/23 T/L B Services: Business Term Loan  Loan    1M USD SOFR+ 4.25%  0.50%  9.68%  10/16/2028   -   263   - 
Xperi Corporation High Tech Industries Term Loan  Loan    1M USD SOFR+ 3.50%  0.00%  8.97%  6/8/2028   2,188,346   2,183,612   2,180,819 
Zayo Group, LLC Telecommunications Term Loan 4/22  Loan    1M USD SOFR+ 4.25%  0.50%  9.67%  3/9/2027   985,000   966,759   838,068 
ZEBRA BUYER (Allspring) LLC Banking, Finance, Insurance & Real Estate Term Loan 4/21  Loan    3M USD SOFR+ 3.25%  0.50%  8.95%  11/1/2028   1,871,259   1,862,197   1,841,524 
Zekelman Industries, Inc. Metals & Mining Term Loan (01/20)  Loan    1M USD SOFR+ 2.00%  0.00%  7.44%  1/25/2027   955,889   955,889   952,964 
Zest Acquisition Corp. Healthcare & Pharmaceuticals Term Loan (1/23)  Loan    1M USD SOFR+ 5.50%  0.00%  10.85%  2/8/2028   1,985,000   1,898,214   1,935,375 
Zodiac Pool Solutions High Tech Industries Term Loan (1/22)  Loan    1M USD SOFR+ 4.25%  0.00%  9.70%  11/28/2025   491,250   490,406   489,161 
 TOTAL INVESTMENTS                               $

632,389,108

  $

595,446,850

 


  Number of Shares  Cost  Fair Value 
Cash and cash equivalents         
U.S. Bank Money Market (b)  13,681,256  $13,681,256  $13,681,256 
Total cash and cash equivalents  13,681,256  $13,681,256  $13,681,256 

(a)As of November 30, 2023, the investment was in default and on non-accrual status.
(b)Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of November 30, 2023.
(c)Investments include Payment-in-Kind Interest.

(unaudited)LIBOR—London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

 

Issuer Name

  

Industry

  

Asset Name

  

Asset
Type

  Spread  LIBOR
Floor
  PIK  Current
Rate
(All In)
  Maturity
Date
   Principal/
Number of
Shares
   Cost   Fair Value 

Education Management II, LLC

  Leisure Goods/Activities/Movies  A-1 Preferred Shares  Equity   0.00  0.00  0.00  0.00    6,692   $669,214   $40 

Education Management II, LLC

  Leisure Goods/Activities/Movies  A-2 Preferred Shares  Equity   0.00  0.00  0.00  0.00    18,975    1,897,538    114 

New Millennium Holdco, Inc.

  Healthcare & Pharmaceuticals  Common Stock  Equity   0.00  0.00  0.00  0.00    14,813    964,466    4,162 

24 Hour Holdings III, LLC

  Leisure Goods/Activities/Movies  Term Loan  Loan   3.75  1.00  1.34  5.09  5/28/2021   $1,979,884    1,979,013    1,978,241 

ABB Con-Cise Optical Group, LLC

  Healthcare & Pharmaceuticals  Term Loan B  Loan   5.00  1.00  1.32  6.32  6/15/2023    1,980,000    1,960,509    1,975,050 

Acosta Holdco, Inc.

  Media  Term Loan B1  Loan   3.25  1.00  1.35  4.60  9/26/2021    1,940,025    1,930,926    1,693,215 

Advantage Sales & Marketing, Inc.

  Services: Business  Delayed Draw Term Loan  Loan   3.25  1.00  1.38  4.63  7/25/2021    2,427,437    2,425,364    2,357,648 

Aegis Toxicology Science Corporation

  Healthcare & Pharmaceuticals  Term B Loan  Loan   4.50  1.00  1.33  5.83  2/24/2021    2,444,599    2,339,103    2,383,484 

Agrofresh, Inc.

  Food Services  Term Loan  Loan   4.75  1.00  1.34  6.09  7/30/2021    1,955,000    1,948,414    1,937,894 

AI MISTRAL T/L (V. GROUP)

  Utilities  Term Loan  Loan   3.00  1.00  1.35  4.35  3/11/2024    497,500    497,500    495,326 

Akorn, Inc.

  Healthcare & Pharmaceuticals  Term Loan B  Loan   4.25  1.00  1.38  5.63  4/16/2021    398,056    397,150    399,051 

Albertson’s LLC

  Retailers (Except Food and Drugs)  Term LoanB-4  Loan   2.75  0.75  1.35  4.10  8/25/2021    2,660,984    2,646,180    2,584,161 

Alion Science and Technology Corporation

  High Tech Industries  Term Loan B (First Lien)  Loan   4.50  1.00  1.35  5.85  8/19/2021    2,878,259    2,868,884    2,874,661 

Almonde, Inc. (Misys)

  High Tech Industries  Term Loan B  Loan   3.50  1.00  1.48  4.98  4/26/2024    997,500    992,816    996,522 

ALPHA 3 T/L B1 (ATOTECH)

  Chemicals/Plastics  Term Loan B 1  Loan   3.00  1.00  1.33  4.33  1/31/2024    249,375    248,786    250,934 

Anchor Glass T/L (11/16)

  Containers/Glass Products  Term Loan  Loan   2.75  1.00  1.25  4.00  12/7/2023    496,250    493,924    495,982 

APCO Holdings, Inc.

  Automotive  Term Loan  Loan   6.00  1.00  1.35  7.35  1/31/2022    1,844,054    1,804,819    1,797,953 

Aramark Corporation

  Food Products  U.S. Term F Loan  Loan   2.00  0.00  1.35  3.35  3/28/2024    1,612,143    1,612,143    1,618,688 

Arctic Glacier U.S.A., Inc.

  Beverage, Food & Tobacco  Term Loan B  Loan   4.25  1.00  1.24  5.49  3/20/2024    497,500    495,187    502,475 

Argon Medical Devices, Inc.

  Healthcare & Pharmaceuticals  Term Loan  Loan   3.75  1.00  1.34  5.09  10/28/2024    1,000,000    997,500    1,004,380 

ASG Technologies Group, Inc.

  High Tech Industries  Term Loan  Loan   4.75  1.00  1.35  6.10  7/31/2024    500,000    497,550    505,000 

Aspen Dental Management, Inc.

  Healthcare & Pharmaceuticals  Term Loan Initial  Loan   3.75  1.00  1.48  5.23  4/29/2022    1,969,830    1,965,966    1,989,528 

Astoria Energy T/L B

  Utilities  Term Loan  Loan   4.00  1.00  1.35  5.35  12/24/2021    1,458,457    1,445,778    1,463,022 

Asurion, LLC (fka Asurion Corporation)

  Insurance  Term Loan B4 (First Lien)  Loan   2.75  0.00  1.35  4.10  8/4/2022    2,379,723    2,368,448    2,389,647 

Asurion, LLC (fka Asurion Corporation)

  Insurance  Term Loan B5  Loan   3.00  1.00  1.35  4.35  11/3/2023    519,512    515,048    521,377 

Avantor, Inc.

  Chemicals/Plastics  Term Loan  Loan   4.00  1.00  1.29  5.29  11/21/2024    2,000,000    1,970,000    2,002,920 

Avaya, Inc.

  Services: Business  Exit Term Loan  Loan   4.75  1.00  1.34  6.09  11/8/2024    1,000,000    990,000    985,540 

AVOLON TLB BORROWER 1 LUXEMBOURG S.A.R.L.

  Capital Equipment  Term LoanB-2  Loan   2.25  0.75  1.28  3.53  3/21/2022    997,500    993,011    997,350 

Blackboard T/L B4

  High Tech Industries  Term Loan B4  Loan   5.00  1.00  1.35  6.35  6/30/2021    2,970,000    2,950,694    2,894,265 

Blount International, Inc.

  Forest Products & Paper  Term Loan B  Loan   4.25  1.00  1.24  5.49  4/12/2023    500,000    498,780    504,585 

Blucora, Inc.

  High Tech Industries  Term Loan B  Loan   3.00  1.00  1.41  4.41  5/22/2024    933,333    928,675    936,255 

BMC Software

  Technology  Term Loan  Loan   4.00  1.00  1.33  5.33  9/12/2022    1,936,437    1,883,437    1,941,278 

BMC Software T/L US

  Technology  Term Loan  Loan   3.75  1.00  1.35  5.10  9/12/2022    585,494    576,235    585,828 

Brickman Group Holdings, Inc.

  Brokers/Dealers/Investment Houses  Initial Term Loan (First Lien)  Loan   3.00  1.00  1.28  4.28  12/18/2020    1,424,189    1,415,112    1,430,242 

Broadstreet Partners, Inc.

  Banking, Finance, Insurance & Real Estate  Term LoanB-1  Loan   3.75  1.00  1.35  5.10  11/8/2023    1,000,000    997,500    1,004,380 

Cable One, Inc.

  Telecommunications  Term Loan B  Loan   2.25  0.00  1.32  3.57  5/1/2024    498,750    498,187    498,750 

California Resources Corporation

  Oil & Gas  Term Loan  Loan   4.75  1.00  1.27  6.02  12/30/2022    1,000,000    980,000    982,760 

Candy Intermediate Holdings, Inc.

  Beverage, Food & Tobacco  Term Loan  Loan   4.50  1.00  1.35  5.85  6/15/2023    493,750    491,811    492,669 

Canyon Valor Companies, Inc.

  High Tech Industries  Term Loan B  Loan   4.25  0.00  1.33  5.58  6/16/2023    1,000,000    997,500    1,011,880 

Capital Automotive L.P.

  Conglomerate  TrancheB-1 Term Loan Facility  Loan   2.50  1.00  1.35  3.85  3/25/2024    484,168    481,881    485,137 

Caraustar Industries Inc.

  Forest Products & Paper  Term Loan B  Loan   5.50  1.00  1.33  6.83  3/14/2022    497,500    496,321    496,570 

CareerBuilder, LLC

  Services: Business  Term Loan  Loan   6.75  1.00  1.33  8.08  7/31/2023    2,500,000    2,429,964    2,418,750 

CASA SYSTEMS T/L

  Telecommunications  Term Loan  Loan   4.00  1.00  1.33  5.33  12/20/2023    1,488,750    1,475,555    1,498,055 

Catalent Pharma Solutions, Inc

  Drugs  Initial Term B Loan  Loan   2.25  1.00  1.35  3.60  5/20/2021    421,036    419,907    423,142 

Cengage Learning Acquisitions, Inc.

  Publishing  Term Loan  Loan   4.25  1.00  1.24  5.49  6/7/2023    1,464,371    1,449,727    1,392,441 

CenturyLink, Inc.

  Telecommunications  Term Loan B  Loan   2.75  0.00  1.35  4.10  1/31/2025    3,000,000    2,992,778    2,872,500 

CH HOLD (CALIBER COLLISION) T/L

  Automotive  Term Loan  Loan   3.00  0.00  1.35  4.35  2/1/2024    247,348    246,862    249,359 

Charter Communications Operating, LLC

  Cable and Satellite Television  Term F Loan  Loan   2.00  0.00  1.35  3.35  1/3/2021    1,597,024    1,592,194    1,601,624 

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals  Term G Loan  Loan   2.75  1.00  1.48  4.23  12/31/2019    612,172    602,823    595,448 

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals  Term H Loan  Loan   3.00  1.00  1.48  4.48  1/27/2021    1,133,925    1,102,761    1,085,880 

CITGO Petroleum Corporation

  Oil & Gas  Term Loan B  Loan   3.50  1.00  1.34  4.84  7/29/2021    1,949,798    1,934,085    1,919,576 

Communications Sales & Leasing, Inc.

  Telecommunications  Term Loan B (First Lien)  Loan   3.00  1.00  1.35  4.35  10/24/2022    1,955,287    1,945,009    1,879,520 

Concordia Healthcare Corporation

  Healthcare & Pharmaceuticals  Term Loan B  Loan   4.25  1.00  1.35  5.60  10/21/2021    1,942,500    1,868,083    1,555,224 

Consolidated Aerospace Manufacturing, LLC

  Aerospace and Defense  Term Loan (First Lien)  Loan   3.75  1.00  1.35  5.10  8/11/2022    1,418,750    1,413,585    1,404,563 

Consolidated Communications, Inc.

  Telecommunications  Term LoanB-2  Loan   3.00  1.00  1.35  4.35  10/5/2023    499,385    496,966    490,541 

CPI Acquisition Inc.

  Technology  Term Loan B (First Lien)  Loan   4.50  1.00  1.46  5.96  8/17/2022    1,436,782    1,420,943    1,020,115 

CT Technologies Intermediate Hldgs, Inc

  Healthcare & Pharmaceuticals  Term Loan  Loan   4.25  1.00  1.35  5.60  12/1/2021    1,458,919    1,449,392    1,457,708 

Culligan InternationalCompany-T/L

  Conglomerate  Term Loan  Loan   3.50  1.00  1.35  4.85  12/13/2023    2,034,625    2,034,536    2,048,623 

Culligan InternationalCompany-T/L

  Utilities  Incremental Term Loan B  Loan   3.50  1.00  1.35  4.85  12/13/2023    500,000    499,395    503,440 

Cumulus Media Holdings Inc.

  Broadcast Radio and Television  Term Loan  Loan   3.25  1.00  1.35  4.60  12/23/2020    448,889    446,756    387,248 

Cypress Intermediate Holdings III, Inc.

  Services: Business  Term Loan B  Loan   3.00  1.00  1.35  4.35  4/29/2024    498,750    497,567    499,373 

Daseke Companies, Inc.

  Transportation  Term Loan  Loan   5.00  1.00  1.41  6.41  2/27/2024    1,995,607    1,982,837    1,994,768 

Dell International L.L.C.

  High Tech Industries  Term Loan (01/17)  Loan   2.00  0.75  1.35  3.35  9/7/2023    1,500,000    1,498,865    1,500,105 

Delta 2 (Lux) S.a.r.l.

  Lodging & Casinos  Term LoanB-3  Loan   3.00  1.00  1.35  4.35  2/1/2024    1,500,000    1,497,143    1,507,185 

DEX MEDIA, INC.

  Media  Term Loan (07/16)  Loan   10.00  1.00  1.35  11.35  7/29/2021    33,047    33,047    33,874 

DHX Media Ltd.

  Media  Term Loan  Loan   3.75  1.00  1.35  5.10  12/29/2023    498,750    496,395    499,064 

DJO Finance, LLC

  Healthcare & Pharmaceuticals  Term Loan  Loan   3.25  1.00  1.35  4.60  6/8/2020    488,750    487,541    484,068 

Dole Food Company, Inc.

  Beverage, Food & Tobacco  Term Loan B  Loan   2.75  1.00  1.31  4.06  4/8/2024    496,875    494,564    498,326 

Drew Marine Group, Inc.

  Chemicals/Plastics  Term Loan (First Lien)  Loan   3.25  1.00  1.35  4.60  11/19/2020    2,863,470    2,842,651    2,854,535 

DTZ U.S. Borrower, LLC

  Construction & Building  Term Loan BAdd-on  Loan   3.25  1.00  1.48  4.73  11/4/2021    1,947,613    1,939,606    1,912,556 

DUKE FINANCE (OM GROUP/VECTRA) T/L

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   4.25  1.00  1.33  5.58  2/21/2024    1,481,288    1,381,599    1,492,397 

Eagletree-Carbide Acquisition Corp.

  High Tech Industries  Term Loan  Loan   4.75  1.00  1.33  6.08  8/28/2024    2,000,000    1,980,464    2,005,000 

Education Management II, LLC

  Leisure Goods/Activities/Movies  Term Loan A  Loan   4.50  1.00  1.35  5.85  7/2/2020    423,861    415,001    175,110 

Education Management II, LLC

  Leisure Goods/Activities/Movies  Term Loan B (2.00% Cash/6.50% PIK)  Loan   1.00  1.00  6.50  7.50  7/2/2020    954,307    938,252    13,837 

EIG Investors Corp.

  High Tech Industries  Term Loan  Loan   4.00  1.00  1.46  5.46  2/9/2023    492,054    490,824    495,129 

Emerald 2 Limited

  Chemicals/Plastics  Term Loan B1A  Loan   4.00  1.00  1.33  5.33  5/14/2021    991,628    985,743    987,494 

Emerald Performance Materials, LLC

  Chemicals/Plastics  Term Loan (First Lien)  Loan   3.50  1.00  1.35  4.85  8/1/2021    480,295    478,943    482,696 

Endo International plc

  Healthcare & Pharmaceuticals  Term Loan B  Loan   4.25  0.75  1.38  5.63  4/29/2024    997,500    992,740    1,003,375 

Engility Corporation

  Aerospace and Defense  Term LoanB-1  Loan   2.75  0.00  1.35  4.10  8/12/2020    225,000    224,206    226,246 

Equian, LLC

  Services: Business  Term Loan B  Loan   3.75  1.00  1.29  5.04  5/20/2024    1,995,000    1,982,980    2,007,469 

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)  New Term Loan  Loan   3.75  1.25  1.36  5.11  7/9/2019    947,625    944,801    858,387 

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment  Term Loan (First Lien)  Loan   3.75  1.00  1.33  5.08  1/15/2021    2,845,207    2,834,102    2,864,782 

Extreme Reach, Inc.

  Media  Term Loan B  Loan   6.25  1.00  1.34  7.59  2/7/2020    2,718,750    2,699,558    2,702,900 

Federal-Mogul Corporation

  Automotive  Tranche C Term Loan  Loan   3.75  1.00  1.35  5.10  4/15/2021    2,296,974    2,290,349    2,311,697 

FinCo I LLC

  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   2.75  0.00  0.00  2.75  6/14/2022    500,000    498,848    505,250 

First Data Corporation

  Financial Intermediaries  First Data T/L Ext (2021)  Loan   2.25  0.00  1.31  3.56  4/26/2024    1,741,492    1,659,279    1,741,805 

First Eagle Holdings, Inc.

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   3.00  0.75  1.36  4.36  12/1/2022    1,475,047    1,465,760    1,486,110 

Fitness International, LLC

  Leisure Goods/Activities/Movies  Term Loan B  Loan   3.50  1.00  1.35  4.85  7/1/2020    1,409,751    1,393,394    1,429,135 

Frontier Communications Corporation

  Telecommunications  Term Loan B  Loan   3.75  0.75  1.34  5.09  6/17/2024    1,995,000    1,904,428    1,899,001 

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)  Amended Tranche B Term Loan  Loan   4.25  0.75  1.50  5.75  3/4/2019    2,047,169    2,044,907    1,897,050 

Global Tel*Link Corporation

  Services: Business  Term Loan (First Lien)  Loan   4.00  1.25  1.33  5.33  5/26/2020    3,125,063    3,119,213    3,128,001 

GLOBALLOGIC HOLDINGS INC TERM LOAN B

  Services: Business  Term Loan B  Loan   4.50  1.00  1.33  5.83  6/20/2022    497,500    493,267    497,500 

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics  Loan (Second Lien)  Loan   2.00  0.00  1.27  3.27  4/30/2019    1,833,333    1,824,919    1,837,147 

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/Investment Houses  Initial Term Loan  Loan   3.00  1.00  1.35  4.35  8/18/2023    994,962    990,319    995,380 

Hargray Communications Group, Inc.

  Media  Term Loan B  Loan   3.00  1.00  1.35  4.35  2/9/2022    997,500    995,040    997,191 

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing  TrancheB-4 Term Loan  Loan   4.75  1.00  1.32  6.07  11/3/2023    1,961,082    1,948,503    1,966,592 

HD Supply Waterworks, Ltd.

  Construction & Building  Term Loan  Loan   3.00  1.00  1.46  4.46  8/1/2024    500,000    498,803    502,815 

Heartland Dental, LLC

  Services: Consumer  Term Loan  Loan   4.75  1.00  1.34  6.09  7/31/2023    3,000,000    2,985,324    3,039,390 

Helix Gen Funding, LLC

  Utilities  Term Loan B  Loan   3.75  1.00  1.33  5.08  6/3/2024    475,821    473,827    478,557 

Helix Acquisition Holdings, Inc.

  Utilities  Term Loan B  Loan   4.00  1.00  1.33  5.33  9/30/2024    1,000,000    995,075    1,009,380 

Help/Systems Holdings, Inc.

  High Tech Industries  Term Loan  Loan   4.50  1.00  1.33  5.83  10/8/2021    1,345,968    1,297,550    1,349,332 

Hemisphere Media Holdings, LLC

  Media  Term Loan B  Loan   3.50  0.00  1.35  4.85  2/14/2024    2,481,250    2,492,514    2,360,289 

Herbalife T/L B (HLF Financing)

  Drugs  Term Loan B  Loan   5.50  0.75  1.24  6.74  2/15/2023    1,925,000    1,912,772    1,918,590 

Hercules Achievement Holdings, Inc.

  Retailers (Except Food and Drugs)  Term Loan B  Loan   3.50  1.00  1.24  4.74  12/10/2021    244,962    243,231    246,493 

Highline Aftermarket Acquisition, LLC

  Automotive  Term Loan B  Loan   4.25  1.00  1.38  5.63  3/15/2024    957,198    952,412    961,984 

Hoffmaster Group, Inc.

  Containers/Glass Products  Term Loan  Loan   4.50  1.00  1.33  5.83  11/21/2023    992,500    995,827    998,703 

Hostess Brands, LLC

  Beverage, Food & Tobacco  Term Loan B (First Lien)  Loan   2.25  0.75  1.35  3.60  8/3/2022    1,482,559    1,478,894    1,484,101 

HUB International Limited

  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   3.00  1.00  1.41  4.41  10/2/2022    216    216    217 

Husky Injection Molding Systems Ltd.

  Services: Business  Term Loan B  Loan   3.25  1.00  1.35  4.60  6/30/2021    418,923    417,231    421,253 

Hyland Software, Inc.

  High Tech Industries  Term Loan B  Loan   3.25  0.75  1.35  4.60  7/1/2022    997,494    995,010    1,006,222 

Hyperion Refinance T/L

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   4.00  1.00  1.38  5.38  4/29/2022    1,872,588    1,852,507    1,888,186 

ICSH Parent, Inc.

  Containers/Glass Products  Term Loan  Loan   3.50  1.00  1.38  4.88  4/29/2024    847,059    843,042    850,235 

ICSH Parent, Inc.

  Containers/Glass Products  Delayed Draw Term Loan  Loan   3.50  1.00  1.48  4.98  4/29/2024    59,245    59,245    59,467 

Idera, Inc.

  High Tech Industries  Term Loan B  Loan   5.00  1.00  1.35  6.35  6/28/2024    1,686,682    1,669,815    1,686,682 

IG Investments Holdings, LLC

  Services: Business  Term Loan  Loan   3.50  1.00  1.39  4.89  10/29/2021    3,423,936    3,404,509    3,445,336 

Infor US (Lawson) T/LB-6

  Services: Business  Term LoanB-6  Loan   2.75  1.00  1.33  4.08  2/1/2022    1,601,753    1,589,416    1,599,750 

Informatica Corporation

  High Tech Industries  Term Loan B  Loan   3.50  1.00  1.33  4.83  8/5/2022    483,195    482,323    484,176 

Inmar, Inc.

  Services: Business  Term Loan B  Loan   3.50  1.00  1.42  4.92  5/1/2024    498,750    493,978    499,583 

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)  TermB-1 Loan Retired 03/05/2014  Loan   3.22  1.00  1.35  4.57  3/5/2021    832,627    832,627    479,802 

J.Jill Group, Inc.

  Retailers (Except Food and Drugs)  Term Loan (First Lien)  Loan   5.00  1.00  1.38  6.38  5/9/2022    874,524    871,494    807,841 

Kinetic Concepts, Inc.

  Healthcare & Pharmaceuticals  Term LoanF-1  Loan   3.25  1.00  1.33  4.58  2/2/2024    2,394,000    2,383,432    2,385,525 

Koosharem, LLC

  Services: Business  Term Loan  Loan   6.50  1.00  1.33  7.83  5/15/2020    2,912,638    2,899,212    2,798,549 

Lannett Company, Inc.

  Healthcare & Pharmaceuticals  Term Loan B  Loan   5.38  1.00  1.35  6.72  11/25/2022    2,811,486    2,762,882    2,811,486 

LEARFIELD COMMUNICATIONS INITIAL T/L(A-L PARENT)

  Healthcare & Pharmaceuticals  Initial Term Loan(A-L Parent)  Loan   3.25  1.00  1.35  4.60  12/1/2023    496,250    494,144    498,111 

Legalzoom.com, Inc.

  Services: Consumer  Term Loan B  Loan   4.50  1.00  1.44  5.94  11/21/2024    1,000,000    990,000    997,500 

Lighthouse Network

  Utilities  Term Loan C  Loan   4.50  1.00  1.35  5.85  1/30/2024    1,000,000    995,000    995,000 

Lightstone Generation T/L C

  Utilities  Term Loan B Refinancing  Loan   4.50  1.00  1.35  5.85  1/30/2024    930,362    913,161    932,781 

Lightstone Generation T/L B

  Utilities  Term Loan C  Loan   4.50  1.00  1.35  5.85  1/30/2024    57,971    56,898    58,122 

Limetree Bay Terminals T/L (01/17)

  Oil & Gas  Term Loan  Loan   4.00  1.00  1.28  5.28  2/15/2024    497,500    492,585    490,660 

Liquidnet Holdings, Inc.

  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   4.25  1.00  1.35  5.60  7/15/2024    493,750    488,964    494,984 

LPL Holdings, Inc.

  Banking, Finance, Insurance & Real Estate  Term Loan B (2022)  Loan   2.25  0.00  1.33  3.58  9/23/2024    1,745,625    1,741,435    1,749,256 

McAfee, LLC

  Services: Business  Term Loan B  Loan   4.50  1.00  1.33  5.83  9/30/2024    2,000,000    1,980,354    2,008,760 

McGraw-Hill Global Education Holdings, LLC

  Publishing  Term Loan  Loan   4.00  1.00  1.35  5.35  5/4/2022    987,500    983,908    988,033 

MHVC Acquisition Corp.

  Aerospace and Defense  Term Loan  Loan   5.25  1.00  1.35  6.60  4/29/2024    1,995,000    1,985,319    2,013,713 

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)  Term Loan B1  Loan   2.75  1.00  1.35  4.10  1/30/2023    2,665,882    2,653,444    2,643,675 

Micro Holding Corporation

  High Tech Industries  Term Loan  Loan   3.75  1.00  1.32  5.07  9/13/2024    1,475,684    1,469,848    1,468,305 

Midas Intermediate Holdco II, LLC

  Automotive  Term Loan (Initial)  Loan   2.75  1.00  1.33  4.08  8/18/2021    242,542    241,810    242,695 

Midwest Physician Administrative Services LLC

  Healthcare & Pharmaceuticals  Term Loan  Loan   3.00  0.75  1.42  4.42  8/15/2024    1,000,000    995,768    1,001,250 

Milacron T/L B

  Capital Equipment  Term Loan B  Loan   2.75  0.00  1.35  4.10  9/28/2023    1,985,000    1,981,704    1,986,251 

Milk Specialties Company

  Beverage, Food & Tobacco  Term Loan  Loan   4.00  1.00  1.33  5.33  8/16/2023    990,000    981,217    993,713 

Mister Car Wash T/L

  Automotive  Term Loan  Loan   3.75  1.00  1.38  5.13  8/20/2021    1,487,628    1,482,563    1,491,347 

MRC Global (US) Inc.

  Metals & Mining  Term Loan B  Loan   3.50  1.00  1.35  4.85  9/20/2024    500,000    498,768    502,500 

Navistar, Inc.

  Automotive  Term Loan B  Loan   3.50  1.00  1.25  4.75  11/6/2024    2,000,000    1,990,063    2,005,840 

New Media Holdings II T/L (NEW)

  Retailers (Except Food and Drugs)  Term Loan  Loan   6.25  1.00  1.35  7.60  6/4/2020    4,141,573    4,121,968    4,144,182 

New Millennium Holdco, Inc.

  Healthcare & Pharmaceuticals  Term Loan  Loan   6.50  1.00  1.35  7.85  12/21/2020    1,915,053    1,798,718    749,264 

Novetta Solutions

  Aerospace and Defense  Term Loan (200MM)  Loan   5.00  1.00  1.34  6.34  10/16/2022    1,965,000    1,950,402    1,886,400 

Novetta Solutions

  Aerospace and Defense  Term Loan (2nd Lien)  Loan   8.50  1.00  1.34  9.84  10/16/2023    1,000,000    991,987    940,000 

NPC International, Inc.

  Food Services  Term Loan (2013)  Loan   3.50  1.00  1.34  4.84  4/19/2024    498,750    498,138    501,244 

NVA Holdings (National Veterinary) T/L B2

  Services: Consumer  Term Loan B2  Loan   3.50  1.00  1.33  4.83  8/14/2021    1,754,162    1,749,377    1,765,125 

NXT Capital T/L (11/16)

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   3.50  1.00  1.35  4.85  11/23/2022    1,241,247    1,236,607    1,252,108 

Office Depot, Inc.

  Retailers (Except Food and Drugs)  Term Loan B  Loan   7.00  1.00  1.24  8.24  11/8/2022    2,500,000    2,425,581    2,487,500 

Onex Carestream Finance LP

  Healthcare & Pharmaceuticals  Term Loan (First Lien 2013)  Loan   4.00  1.00  1.33  5.33  6/7/2019    3,037,274    3,032,894    3,040,129 

OpenLink International, LLC

  Services: Business  Term B Loan  Loan   6.50  1.25  1.31  7.81  7/29/2019    2,890,820    2,889,135    2,901,661 

P.F. Chang’s China Bistro, Inc.

  Food/Drug Retailers  Term B Loan  Loan   5.00  1.00  1.51  6.51  9/1/2022    2,000,000    1,983,021    1,860,000 

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Services: Business  Term Loan (First Lien)  Loan   4.00  1.00  1.40  5.40  10/30/2020    962,500    960,014    940,045 

Petsmart, Inc. (Argos Merger Sub, Inc.)

  Retailers (Except Food and Drugs)  Term Loan B1  Loan   3.00  1.00  1.34  4.34  3/11/2022    975,000    971,086    838,013 

PGX Holdings, Inc.

  Financial Intermediaries  Term Loan  Loan   5.25  1.00  1.35  6.60  9/29/2020    2,774,194    2,762,490    2,762,070 

Pike Corporation

  Construction & Building  Term Loan B  Loan   3.50  1.00  1.35  4.85  9/20/2024    498,750    496,320    505,398 

Planet Fitness Holdings LLC

  Leisure Goods/Activities/Movies  Term Loan  Loan   3.00  0.75  1.35  4.35  3/31/2021    2,374,353    2,368,360    2,386,225 

Plastipak Packaging, Inc

  Containers/Glass Products  Term Loan B  Loan   2.75  1.00  1.27  4.02  10/14/2024    1,000,000    995,063    1,004,750 

Polycom Term Loan (9/16)

  Telecommunications  Term Loan  Loan   5.25  1.00  1.35  6.60  9/27/2023    1,587,333    1,568,052    1,599,238 

PrePaid Legal Services, Inc.

  Services: Business  Term Loan B  Loan   5.25  1.25  1.35  6.60  7/1/2019    3,072,812    3,074,884    3,074,748 

Presidio, Inc.

  Services: Business  Term Loan  Loan   3.25  1.00  1.35  4.60  2/2/2022    1,964,615    1,912,468    1,977,503 

Prestige Brands T/L B4

  Drugs  Term Loan B4  Loan   2.75  0.75  1.35  4.10  1/26/2024    440,434    439,472    442,566 

Prime Security Services (Protection One)

  Services: Business  Term Loan  Loan   2.75  1.00  1.35  4.10  5/2/2022    1,975,112    1,966,007    1,988,484 

Project Leopard Holdings, Inc.

  High Tech Industries  Term Loan  Loan   5.50  1.00  1.33  6.83  7/7/2023    500,000    498,773    503,125 

Rackspace Hosting, Inc.

  High Tech Industries  Term Loan B  Loan   3.00  1.00  1.38  4.38  11/3/2023    500,000    498,755    499,220 

Radio Systems Corporation

  Leisure Goods/Activities/Movies  Term Loan  Loan   3.50  1.00  1.35  4.85  5/2/2024    1,496,250    1,496,250    1,501,861 

Ranpak Holdings, Inc.

  Services: Business  Term Loan  Loan   3.25  1.00  1.35  4.60  10/1/2021    909,054    906,782    913,600 

Red Ventures, LLC

  High Tech Industries  Term Loan  Loan   4.00  0.00  1.33  5.33  11/8/2024    1,000,000    990,038    994,690 

Research Now Group, Inc

  Media  Term Loan B  Loan   4.50  1.00  1.33  5.83  3/18/2021    2,004,470    1,997,772    1,994,448 

Resolute Investment Managers, Inc.

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   3.25  1.00  1.33  4.58  4/29/2022    724,665    724,665    732,817 

Reynolds Group Holdings Inc.

  Industrial Equipment  Incremental U.S. Term Loan  Loan   3.00  0.00  1.35  4.35  2/3/2023    1,747,926    1,747,926    1,755,424 

RGIS Services, LLC

  Services: Business  Term Loan  Loan   7.50  1.00  1.33  8.83  3/31/2023    497,500    490,583    463,546 

Robertshaw US Holding Corp.

  Consumer Goods: Durable  Term Loan  Loan   4.50  1.00  1.25  5.75  8/12/2024    500,000    496,355    503,125 

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric  TrancheB-3 Term Loan  Loan   2.50  0.75  1.35  3.85  7/2/2021    1,451,250    1,447,313    1,455,792 

Russell Investment Management T/L B

  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   4.25  1.00  1.35  5.60  6/1/2023    2,223,116    2,122,032    2,243,968 

Sable International Finance Ltd

  Telecommunications  Term Loan B2  Loan   3.50  0.00  1.35  4.85  1/31/2025    2,500,000    2,487,907    2,501,950 

Sally Holdings, LLC

  Retail  Term Loan B1  Loan   2.50  0.00  1.38  3.88  7/5/2024    1,000,000    995,155    997,500 

Sally Holdings, LLC

  Retail  Term Loan (Fixed)  Loan   4.50  0.00  1.38  5.88  7/5/2024    1,000,000    995,164    997,500 

SBP Holdings LP

  Industrial Equipment  Term Loan (First Lien)  Loan   4.00  1.00  1.35  5.35  3/27/2021    965,000    962,482    911,124 

SCS Holdings (Sirius Computer)

  High Tech Industries  Term Loan (First Lien)  Loan   4.25  1.00  1.35  5.60  10/31/2022    2,352,332    2,319,885    2,360,166 

Seadrill Operating LP

  Oil & Gas  Term Loan B  Loan   3.00  1.00  1.33  4.33  2/21/2021    969,773    924,735    749,838 

SG Acquisition, Inc. (Safe Guard)

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   5.00  1.00  1.33  6.33  3/29/2024    1,975,000    1,956,875    1,960,187 

Shearers Foods LLC

  Food Services  Term Loan (First Lien)  Loan   3.94  1.00  1.33  5.27  6/30/2021    970,000    968,536    963,938 

Sitel Worldwide

  Telecommunications  Term Loan  Loan   5.50  1.00  1.38  6.88  9/18/2021    1,960,000    1,946,630    1,956,727 

SMB Shipping Logistics T/L B (REP WWEX Acquisition)

  Transportation  Term Loan B  Loan   4.00  1.00  1.48  5.48  2/2/2024    1,995,000    1,993,026    1,990,850 

Sonneborn, LLC

  Chemicals/Plastics  Term Loan (First Lien)  Loan   3.75  1.00  1.35  5.10  12/10/2020    206,389    206,111    207,163 

Sonneborn, LLC

  Chemicals/Plastics  Initial US Term Loan  Loan   3.75  1.00  1.35  5.10  12/10/2020    1,169,537    1,167,961    1,173,923 

Sophia, L.P.

  Electronics/Electric  Term Loan (Closing Date)  Loan   3.25  1.00  1.33  4.58  9/30/2022    1,935,910    1,927,542    1,935,097 

SRAM, LLC

  Industrial Equipment  Term Loan (First Lien)  Loan   3.25  1.00  1.44  4.69  3/15/2024    2,517,804    2,497,084    2,536,687 

Staples, Inc.

  Retail  Term Loan B  Loan   4.00  1.00  1.31  5.31  8/15/2024    2,000,000    1,995,041    1,913,580 

Steak ‘n Shake Operations, Inc.

  Food Services  Term Loan  Loan   3.75  1.00  1.35  5.10  3/19/2021    847,491    843,134    771,217 

Survey Sampling International

  Services: Business  Term Loan B  Loan   4.00  1.00  4.25  8.25  12/16/2020    2,700,965    2,689,404    2,700,965 

Sybil Software LLC

  High Tech Industries  Term Loan B  Loan   2.75  1.00  1.31  4.06  9/29/2023    962,813    958,108    968,676 

Syncsort Incorporated

  High Tech Industries  Term Loan B  Loan   5.00  1.00  1.36  6.36  8/16/2024    2,000,000    1,980,439    1,948,340 

Ten-X, LLC

  Banking, Finance, Insurance & Real Estate  Term Loan  Loan   4.00  1.00  1.35  5.35  9/30/2024    2,000,000    1,997,570    2,002,500 

Townsquare Media, Inc.

  Media  Term Loan B  Loan   3.00  1.00  1.42  4.42  4/1/2022    911,712    907,766    911,429 

TransDigm, Inc.

  Aerospace and Defense  Tranche C Term Loan  Loan   3.00  0.75  1.35  4.35  2/28/2020    4,200,623    4,207,721    4,219,273 

Travel Leaders Group, LLC

  Hotel, Gaming and Leisure  Term Loan B  Loan   4.50  0.00  1.42  5.92  1/25/2024    1,990,013    1,981,185    2,019,863 

TRC Companies, Inc.

  Services: Business  Term Loan  Loan   4.00  1.00  1.28  5.28  6/21/2024    3,000,000    2,985,656    3,001,890 

Truck Hero, Inc. (Tectum Holdings)

  Transportation  Term Loan B  Loan   4.00  1.00  1.33  5.33  4/22/2024    2,995,000    2,970,996    2,991,256 

Trugreen Limited Partnership

  Services: Business  Term Loan B  Loan   4.00  1.00  1.25  5.25  4/13/2023    495,000    487,926    501,806 

Twin River Management Group, Inc.

  Lodging & Casinos  Term Loan B  Loan   3.50  1.00  1.33  4.83  7/10/2020    787,846    788,759    796,378 

Univar Inc.

  Chemicals/Plastics  Term B Loan  Loan   2.50  0.00  1.34  3.84  7/1/2022    2,940,281    2,925,589    2,947,632 

Univision Communications Inc.

  Telecommunications  Replacement First-Lien Term Loan  Loan   2.75  1.00  1.35  4.10  3/15/2024    2,862,450    2,845,791    2,841,382 

UOS, LLC (Utility One Source)

  Capital Equipment  Term Loan B  Loan   5.50  1.00  1.35  6.85  4/18/2023    598,750    596,590    611,473 

UPC Broadband Holding B.V.

  Media, Broadcasting & Subscription  Term Loan  Loan   2.50  0.00  1.25  3.75  1/15/2026    1,000,000    998,760    1,000,830 

Valeant Pharmaceuticals International, Inc.

  Drugs  Series D2 Term Loan B  Loan   3.50  0.75  1.25  4.75  4/1/2022    976,339    976,339    989,275 

Virtus Investment Partners, Inc.

  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan   3.50  0.75  1.32  4.82  6/3/2024    498,750    496,430    503,738 

Vizient Inc.

  Healthcare & Pharmaceuticals  Term Loan  Loan   3.50  1.00  1.35  4.85  2/13/2023    860,245    840,130    862,396 

Washington Inventory Service

  High Tech Industries  U.S. Term Loan (First Lien)  Loan   6.00  0.00  1.32  7.32  6/8/2020    1,111,056    1,123,172    980,507 

Weight Watchers International, Inc.

  Services: Consumer  Term Loan B  Loan   4.75  0.75  1.48  6.23  11/29/2024    2,000,000    1,960,000    1,966,880 

Western Dental Services, Inc.

  Retail  Term Loan B  Loan   5.25  1.00  1.35  6.60  6/30/2023    2,495,000    2,477,137    2,505,928 

Western Digital Corporation

  High Tech Industries  Term Loan B (USD)  Loan   2.00  0.75  1.31  3.31  4/28/2023    1,580,060    1,533,109    1,583,836 

Windstream Services, LLC

  Telecommunications  Term Loan B6  Loan   4.00  0.75  1.27  5.27  3/29/2021    888,561    881,085    835,247 

Wirepath LLC

  Consumer Goods:Non-durable  Term Loan  Loan   5.25  1.00  1.33  6.58  8/5/2024    1,000,000    998,418    1,005,000 

Xerox Business Services T/L B (Conduent)

  Services: Business  Term Loan  Loan   3.00  0.00  1.35  4.35  12/7/2023    744,375    733,437    748,566 

ZEP, Inc.

  Chemicals/Plastics  Term Loan B  Loan   4.00  1.00  1.38  5.38  6/27/2022    2,500,000    2,487,810    2,512,500 

Zest Holdings 1st Lien T/L (2014 Replacement)

  Healthcare & Pharmaceuticals  Term Loan  Loan   4.25  1.00  1.35  5.60  8/16/2023    995,000    990,405    1,001,219 
                

 

 

   

 

 

 
                $309,596,755   $302,694,197 
                

 

 

   

 

 

 
                            Principal   Cost   Fair Value 

Cash and cash equivalents

                

U.S. Bank Money Market (a)

            $4,971,935   $4,971,935   $4,971,935 
              

 

 

   

 

 

   

 

 

 

Total cash and cash equivalents

            $4,971,935   $4,971,935   $4,971,935 
              

 

 

   

 

 

   

 

 

 

(a) Included within cash and cash equivalents in Saratoga CLO’s statements of assets and liabilities1M USD LIBOR—The 1 month USD LIBOR rate as of November 30, 2017.    

2023 was 5.46%.

3M USD LIBOR—The 3 month USD LIBOR rate as of November 30, 2023 was 5.63%.

6M USD LIBOR—The 6 month USD LIBOR rate as of November 30, 2023 was 5.76%.

1M SOFR - The 1 month SOFR rate as of November 30, 2023 was 5.34%.

3M SOFR - The 3 month SOFR rate as of November 30, 2023 was 5.37%.

6M SOFR - The 6 month SOFR rate as of November 30, 2023 was 5.33%.

Prime—The Prime Rate as of November 30, 2023 was 8.50%.

See accompanying notes to financial statements.


Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 20172023

Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
19TH HOLDINGS GOLF, LLC Consumer goods: Durable Term Loan Loan  1M USD SOFR+ 3.00%  0.50%  7.67%  2/7/2029  $1,997,500  $1,924,905  $1,901,380 
888 Acquisitions Limited Hotel, Gaming & Leisure Term Loan B Loan  3M USD SOFR+ 5.25%  0.00%  9.93%  7/8/2028   2,494,565   2,143,085   2,126,617 
ADMI Corp. Healthcare & Pharmaceuticals Term Loan B Loan  1M USD LIBOR+ 3.00%  0.00%  7.63%  4/30/2025   1,910,276   1,907,516   1,825,517 
Adtalem Global Education Inc. Services: Business Term Loan B (02/21) Loan  1M USD LIBOR+ 4.00%  0.75%  8.63%  8/11/2028   691,846   686,475   689,992 
Aegis Sciences Corporation Healthcare & Pharmaceuticals Term Loan Loan  3M USD LIBOR+ 5.50%  1.00%  10.36%  5/9/2025   2,349,601   2,341,307   2,268,540 
Agiliti Health Inc. Healthcare & Pharmaceuticals Term Loan (09/20) Loan  1M USD LIBOR+ 2.75%  0.75%  7.38%  1/4/2026   214,286   213,103   212,946 
Agiliti Health Inc. Healthcare & Pharmaceuticals Term Loan (1/19) Loan  1M USD LIBOR+ 2.75%  0.00%  7.38%  1/4/2026   1,468,430   1,463,378   1,457,416 
AHEAD DB Holdings, LLC Services: Business Term Loan (04/21) Loan  3M USD LIBOR+ 3.75%  0.75%  8.48%  10/18/2027   2,955,000   2,871,299   2,915,285 
AI Convoy (Luxembourg) S.a.r.l. Aerospace & Defense Term Loan B (USD) Loan  6M USD LIBOR+ 3.50%  1.00%  8.17%  1/18/2027   -   -   - 
Air Canada Transportation: Consumer Term Loan B (07/21) Loan  3M USD LIBOR+ 3.50%  0.75%  8.37%  8/11/2028   1,990,000   1,851,613   1,984,408 
AIS HoldCo, LLC Services: Business Term Loan Loan  3M USD LIBOR+ 5.00%  0.00%  9.83%  8/15/2025   4,789,642   4,700,517   4,622,004 
AIT Worldwide Logistics Holdings, Inc. Transportation: Cargo Term Loan (04/21) Loan  1M USD LIBOR+ 4.75%  0.75%  9.33%  4/6/2028   2,500,000   2,333,827   2,407,300 
AL GCX Holdings (Arclight) T/L B Energy: Oil & Gas Term Loan B Loan  3M USD SOFR+ 3.50%  0.50%  8.28%  5/17/2029   976,802   971,918   975,581 
Alchemy US Holdco 1, LLC Metals & Mining Term Loan Loan  1M USD LIBOR+ 5.50%  0.00%  5.60%  10/10/2025   1,654,803   1,644,633   1,551,378 
AlixPartners, LLP Banking, Finance, Insurance & Real Estate Term Loan B (01/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  2/4/2028   245,625   245,275   245,050 
Alkermes, Inc. Healthcare & Pharmaceuticals Term Loan B (3/21) Loan  1M USD LIBOR+ 2.50%  0.50%  7.11%  3/12/2026   2,126,218   2,112,914   2,062,432 
Allen Media, LLC Media: Diversified & Production Term Loan (7/21) Loan  3M USD SOFR+ 5.50%  0.00%  10.23%  2/10/2027   4,394,261   4,368,566   3,649,434 
Alliant Holdings Intermediate, LLC Banking, Finance, Insurance & Real Estate Term Loan B4 Loan  1M USD LIBOR+ 3.50%  0.50%  8.09%  11/5/2027   987,500   986,800   974,781 
Allied Universal Holdco LLC Services: Business Term Loan 4/21 Loan  1M USD SOFR+ 3.75%  0.50%  8.47%  5/12/2028   1,975,000   1,967,474   1,900,404 
Altisource Solutions S.a r.l. Banking, Finance, Insurance & Real Estate Term Loan B (03/18) Loan  3M USD LIBOR+ 4.00%  1.00%  8.73%  4/3/2024   1,126,283   1,124,635   893,142 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Altium Packaging LLC Containers, Packaging & Glass Term Loan (01/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  1/29/2028   491,250   489,554   480,506 
American Airlines T/L (2/23) Transportation: Consumer Term Loan Loan  N/A N/A   N/A   N/A   N/A   -   27   - 
American Axle & Manufacturing Inc. Automotive Term Loan (12/22) Loan  1M USD SOFR+ 3.50%  0.50%  8.16%  12/5/2029   500,000   485,367   499,000 
American Greetings Corporation Media: Advertising, Printing & Publishing Term Loan Loan  1M USD LIBOR+ 4.50%  1.00%  9.07%  4/6/2024   3,012,861   3,011,462   3,011,596 
American Trailer World Corp Automotive Term Loan Loan  1M USD SOFR+ 3.75%  0.75%  8.47%  3/3/2028   1,357,439   1,354,762   1,194,967 
AmWINS Group, LLC Banking, Finance, Insurance & Real Estate Term Loan 2/21 Loan  1M USD LIBOR+ 2.25%  0.75%  6.88%  2/17/2028   1,960,017   1,940,778   1,926,462 
Anastasia Parent LLC Consumer goods: Non-durable Term Loan Loan  3M USD LIBOR+ 3.75%  0.00%  8.48%  8/11/2025   957,500   955,643   791,134 
Anchor Glass Container Corporation Containers, Packaging & Glass Term Loan (07/17) Loan  3M USD LIBOR+ 2.75%  1.00%  7.48%  12/7/2023   470,138   469,901   333,915 
Anchor Packaging, LLC Containers, Packaging & Glass Term Loan B Loan  1M USD LIBOR+ 4.00%  0.00%  8.63%  7/18/2026   977,215   971,052   952,785 
ANI Pharmaceuticals, Inc. Healthcare & Pharmaceuticals Term Loan B Loan  1M USD LIBOR+ 6.00%  0.75%  10.63%  11/19/2027   2,970,000   2,922,446   2,866,050 
AP Core Holdings II LLC High Tech Industries Term Loan B1 Loan  1M USD LIBOR+ 5.50%  0.75%  10.13%  9/1/2027   1,875,000   1,852,824   1,802,344 
AP Core Holdings II LLC High Tech Industries Term Loan B2 Loan  1M USD LIBOR+ 5.50%  0.75%  10.13%  9/1/2027   500,000   494,095   480,415 
APEX GROUP TREASURY LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  3M USD SOFR+ 5.00%  0.50%  9.66%  7/26/2028   500,000   468,464   497,500 
APi Group DE, Inc. (J2 Acquisition) Services: Business Term Loan B Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  10/1/2026   1,757,184   1,751,429   1,754,548 
APLP Holdings Limited Partnership Energy: Electricity Term Loan B (3/21) Loan  3M USD LIBOR+ 3.75%  1.00%  8.48%  5/14/2027   440,541   437,327   440,726 
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan  1M USD LIBOR+ 2.75%  0.00%  7.38%  5/15/2026   2,939,086   2,914,348   2,850,914 
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 (2/21) Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  3/6/2028   982,500   975,109   928,463 
AppLovin Corporation High Tech Industries Term Loan (10/21) Loan  3M USD SOFR+ 3.10%  0.50%  7.70%  10/21/2028   1,488,750   1,485,729   1,472,002 
AppLovin Corporation High Tech Industries Term Loan B Loan  3M USD SOFR+ 3.35%  0.00%  7.94%  8/15/2025   979,592   979,592   972,245 
Aramark Corporation Services: Consumer Term Loan B (4/21) Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  4/1/2028   1,753,715   1,747,448   1,747,139 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Aramark Corporation Services: Consumer Term Loan Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  1/15/2027   2,331,250   2,280,733   2,305,023 
ARC FALCON I INC. Chemicals, Plastics, & Rubber Term Loan Loan  1M USD LIBOR+ 3.75%  0.50%  8.38%  9/23/2028   863,885   860,682   811,836 
ARC FALCON I INC. (a) Chemicals, Plastics, & Rubber Delayed Draw Term Loan Loan  3M USD LIBOR+ 1.00%  0.50%  1.00%  9/29/2028   -   (512)  (7,675)
Arches Buyer Inc. Services: Consumer Term Loan B Loan  1M USD SOFR+ 3.25%  0.50%  7.97%  12/6/2027   1,484,848   1,477,106   1,395,758 
Aretec Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/18) Loan  1M USD SOFR+ 4.25%  0.00%  8.97%  10/1/2025   1,916,203   1,913,228   1,887,460 
ASP BLADE HOLDINGS, INC. Capital Equipment Term Loan Loan  3M USD LIBOR+ 4.00%  0.50%  8.73%  10/7/2028   99,059   98,658   82,491 
Asplundh Tree Expert, LLC Services: Business Term Loan 2/21 Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  9/7/2027   977,500   974,396   974,010 
AssuredPartners Capital, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (2/20) Loan  1M USD LIBOR+ 3.50%  0.00%  8.13%  2/12/2027   989,796   986,847   967,773 
AssuredPartners Inc. Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD SOFR+ 3.50%  0.50%  8.12%  2/12/2027   496,250   495,400   485,084 
AssuredPartners Inc. Banking, Finance, Insurance & Real Estate Incremental Term Loan (7/21) Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  2/12/2027   985,000   985,000   962,838 
ASTRO ONE ACQUISITION CORPORATION Consumer goods: Durable Term Loan Loan  3M USD LIBOR+ 5.50%  0.75%  10.23%  9/15/2028   2,970,000   2,946,187   1,767,150 
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B10 Loan  3M USD SOFR+ 4.00%  0.00%  8.68%  8/19/2028   1,995,000   1,901,937   1,866,741 
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B8 Loan  1M USD LIBOR+ 3.25%  0.00%  7.88%  12/18/2026   2,964,858   2,956,667   2,817,683 
ATHENAHEALTH GROUP INC. Healthcare & Pharmaceuticals Term Loan B (2/22) Loan  1M USD SOFR+ 3.50%  0.50%  8.06%  2/15/2029   1,330,543   1,325,206   1,227,426 
ATHENAHEALTH GROUP INC. (a) Healthcare & Pharmaceuticals Delayed Draw Term Loan (02/22) Loan  3M USD LIBOR+ 3.50%  0.50%  3.50%  2/15/2029   -   -   (12,636)
Avison Young (Canada) Inc Services: Business Term Loan (08/22) Loan  1M USD SOFR+ 7.00%  0.00%  11.73%  1/31/2026   748,125   708,918   635,906 
Avison Young (Canada) Inc Services: Business Term Loan Loan  1M USD SOFR+ 5.75%  0.00%  10.48%  1/31/2026   3,370,882   3,344,831   2,646,142 
Avolon TLB Borrower 1 (US) LLC Capital Equipment Term Loan B5 (7/21) Loan  1M USD LIBOR+ 2.25%  0.50%  6.85%  12/1/2027   490,000   486,530   489,539 
Avolon TLB Borrower 1 (US) LLC Capital Equipment Term Loan B3 Loan  1M USD LIBOR+ 1.75%  0.75%  6.35%  1/15/2025   1,000,000   932,184   998,440 
Axalta Coating Systems Dutch Holding B B.V. Chemicals, Plastics, & Rubber Term Loan B-4 Dollar Loan  3M USD SOFR+ 3.00%  0.50%  7.51%  12/7/2029   1,000,000   990,447   1,003,570 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
AZURITY PHARMACEUTICALS, INC. Healthcare & Pharmaceuticals Term Loan B Loan  3M USD LIBOR+ 6.00%  0.75%  10.75%  9/20/2027   475,000   463,094   457,188 
B&G Foods, Inc. Beverage, Food & Tobacco Term Loan Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  10/10/2026   642,295   638,890   613,391 
B.C. Unlimited Liability Co (Burger King) Beverage, Food & Tobacco Term Loan B4 Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  11/19/2026   1,455,000   1,430,342   1,440,712 
BAKELITE UK INTERMEDIATE LTD. Chemicals, Plastics, & Rubber Term Loan Loan  3M USD SOFR+ 4.00%  0.50%  8.73%  5/29/2029   995,000   990,609   940,275 
Baldwin Risk Partners, LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD LIBOR+ 3.50%  0.50%  8.10%  10/14/2027   1,226,325   1,215,617   1,205,637 
Bausch Health Companies Inc. Healthcare & Pharmaceuticals Term Loan B (1/22) Loan  1M USD SOFR+ 5.25%  0.50%  9.91%  2/1/2027   1,950,000   1,764,574   1,534,299 
Belfor Holdings Inc. Services: Consumer Term Loan B-2 (3/22) Loan  1M USD SOFR+ 4.25%  0.50%  8.87%  4/6/2026   994,911   971,026   992,424 
Belfor Holdings Inc. Services: Consumer Term Loan Loan  1M USD LIBOR+ 4.00%  0.00%  8.63%  4/6/2026   245,547   245,547   244,995 
Belron Finance US LLC Automotive Term Loan B (3/21) Loan  3M USD LIBOR+ 2.50%  0.50%  7.38%  4/13/2028   1,965,000   1,950,181   1,960,913 
Bengal Debt Merger Sub LLC Beverage, Food & Tobacco Term Loan Loan  3M USD SOFR+ 3.25%  0.50%  7.93%  1/24/2029   1,990,000   1,988,811   1,804,273 
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan (6/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  4/23/2026   1,465,141   1,457,842   1,441,332 
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan  1M USD LIBOR+ 2.25%  0.00%  6.88%  4/23/2026   979,747   975,006   952,804 
Blue Tree Holdings, Inc. Chemicals, Plastics, & Rubber Term Loan (2/21) Loan  3M USD LIBOR+ 2.50%  0.00%  7.23%  3/4/2028   982,500   980,692   967,763 
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan  12/22 Loan  1M USD SOFR+ 3.50%  0.50%  8.12%  12/12/2029   498,750   486,572   496,007 
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan (1/20) Loan  1M USD LIBOR+ 2.00%  0.00%  6.63%  5/24/2027   1,455,049   1,449,140   1,416,854 
Boxer Parent Company, Inc. High Tech Industries Term Loan (2/21) Loan  1M USD LIBOR+ 3.75%  0.00%  8.38%  10/2/2025   516,794   516,794   509,827 
Bracket Intermediate Holding Corp Healthcare & Pharmaceuticals Term Loan Loan  3M USD LIBOR+ 4.25%  0.00%  9.04%  9/5/2025   957,500   955,597   929,378 
BrightSpring Health Services (Phoenix Guarantor) Healthcare & Pharmaceuticals Term Loan B-3 Loan  1M USD LIBOR+ 3.50%  0.00%  8.13%  3/5/2026   982,500   982,500   967,556 
BroadStreet Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B3 Loan  1M USD LIBOR+ 3.00%  0.00%  7.63%  1/22/2027   2,948,786   2,944,577   2,906,412 
Brookfield WEC Holdings Inc. Energy: Electricity Term Loan (1/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  8/1/2025   1,462,613   1,464,152   1,456,090 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
BROWN GROUP HOLDING, LLC Aerospace & Defense Term Loan B-2 Loan  1M USD SOFR+ 3.75%  0.00%  8.37%  6/8/2029   498,750   487,209   498,336 
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan (1/21) Loan  1M USD LIBOR+ 2.25%  0.00%  6.82%  11/1/2026   1,950,188   1,941,198   1,946,931 
BW Gas & Convenience Holdings LLC Beverage, Food & Tobacco Term Loan B Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  3/31/2028   2,462,500   2,443,814   2,437,875 
Callaway Golf Company Retail Term Loan B Loan  1M USD LIBOR+ 4.50%  0.00%  9.13%  1/4/2026   675,000   668,575   674,582 
Camping World, Inc. Retail Term Loan B (5/21) Loan  1M USD LIBOR+ 2.50%  0.75%  7.09%  6/5/2028   2,487,342   2,268,038   2,208,560 
CareerBuilder, LLC Services: Business Term Loan Loan  3M USD LIBOR+ 6.75%  1.00%  11.48%  7/31/2023   5,393,388   5,347,671   3,513,792 
Castle US Holding Corporation Media: Advertising, Printing & Publishing Term Loan B (USD) Loan  1M USD LIBOR+ 3.75%  0.00%  8.38%  1/27/2027   1,963,384   1,954,023   1,375,469 
CASTLELAKE AVIATION LLC Aerospace & Defense Term Loan B Loan  1M USD SOFR+ 2.75%  0.50%  7.31%  10/21/2027   1,000,000   992,500   987,080 
CBI BUYER, INC. Consumer goods: Durable Term Loan Loan  1M USD LIBOR+ 3.25%  0.50%  7.88%  1/6/2028   2,969,887   2,814,181   2,026,948 
CCC Intelligent Solutions Inc. Services: Business Term Loan B Loan  1M USD LIBOR+ 2.25%  0.50%  6.88%  9/16/2028   247,500   247,017   244,612 
CCI Buyer, Inc Telecommunications Term Loan Loan  3M USD SOFR+ 4.00%  0.75%  8.58%  12/17/2027   245,625   243,880   241,223 
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan Loan  1M USD SOFR+ 4.25%  0.50%  8.97%  3/5/2028   1,000,000   951,484   975,000 
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan B Loan  1M USD LIBOR+ 3.75%  0.75%  8.39%  3/5/2028   982,500   978,899   957,938 
CCS-CMGC Holdings, Inc. Healthcare & Pharmaceuticals Term Loan Loan  1M USD LIBOR+ 5.50%  0.00%  10.13%  9/25/2025   2,400,000   2,390,330   1,605,504 
CDK GLOBAL, INC. High Tech Industries Term Loan B Loan  3M USD SOFR+ 4.50%  0.50%  9.08%  7/6/2029   1,000,000   971,508   996,150 
Cengage Learning, Inc. Media: Advertising, Printing & Publishing Term Loan B (6/21) Loan  6M USD LIBOR+ 4.75%  1.00%  9.88%  7/14/2026   2,962,500   2,942,124   2,794,171 
CENTURI GROUP, INC. Construction & Building Term Loan B Loan  3M USD LIBOR+ 2.50%  0.50%  7.45%  8/27/2028   878,330   871,190   870,100 
CenturyLink, Inc. Telecommunications Term Loan B (1/20) Loan  1M USD LIBOR+ 2.25%  0.00%  6.88%  3/15/2027   3,887,492   3,883,600   3,208,269 
Charlotte Buyer, Inc. Services: Business Term Loan B Loan  1M USD SOFR+ 5.25%  0.00%  9.81%  2/11/2028   1,500,000   1,403,100   1,455,945 
Chemours Company, (The) Chemicals, Plastics, & Rubber Term Loan Loan  1M USD LIBOR+ 1.75%  0.00%  6.39%  4/3/2025   905,031   880,859   898,406 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Churchill Downs Incorporated Hotel, Gaming & Leisure Term Loan B1 (3/21) Loan  1M USD LIBOR+ 2.00%  0.00%  6.64%  3/17/2028   491,250   490,382   486,952 
CIMPRESS PUBLIC LIMITED COMPANY Media: Advertising, Printing & Publishing USD Term Loan Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  5/17/2028   1,979,950   1,892,607   1,785,419 
CITADEL SECURITIES LP Banking, Finance, Insurance & Real Estate Term Loan B (01/21) Loan  1M USD SOFR+ 2.50%  0.00%  7.23%  2/2/2028   4,912,500   4,910,914   4,865,684 
Clarios Global LP Automotive Term Loan B1 Loan  1M USD LIBOR+ 3.25%  0.00%  7.88%  4/30/2026   1,267,812   1,261,524   1,260,091 
Claros Mortgage Trust, Inc Banking, Finance, Insurance & Real Estate Term Loan B-1 (11/21) Loan  1M USD SOFR+ 4.50%  0.50%  9.16%  8/9/2026   3,439,962   3,421,651   3,401,262 
CLYDESDALE ACQUISITION HOLDINGS, INC. Containers, Packaging & Glass Term Loan B Loan  1M USD SOFR+ 4.18%  0.50%  8.89%  4/13/2029   1,492,500   1,458,949   1,469,993 
Cole Haan Consumer goods: Non-durable Term Loan B Loan  3M USD LIBOR+ 5.50%  0.00%  10.23%  2/7/2025   875,000   871,486   841,461 
Columbus McKinnon Corporation Capital Equipment Term Loan (4/21) Loan  3M USD LIBOR+ 2.75%  0.50%  7.50%  5/14/2028   449,172   448,339   446,926 
Conduent, Inc. Services: Business Term Loan B Loan  1M USD LIBOR+ 4.25%  0.50%  8.88%  10/16/2028   1,787,985   1,755,247   1,742,177 
Connect Finco SARL Telecommunications Term Loan (1/21) Loan  1M USD SOFR+ 3.50%  1.00%  8.14%  12/11/2026   2,917,500   2,816,917   2,863,526 
Consolidated Communications, Inc. Telecommunications Term Loan B Loan  1M USD LIBOR+ 3.50%  0.75%  8.19%  10/2/2027   2,714,005   2,520,099   2,435,819 
CORAL-US CO-BORROWER LLC Telecommunications Term Loan B-5 Loan  1M USD LIBOR+ 2.25%  0.00%  6.84%  1/31/2028   4,000,000   3,988,733   3,867,160 
Corelogic, Inc. Services: Business Term Loan (4/21) Loan  1M USD LIBOR+ 3.50%  0.50%  8.19%  6/2/2028   2,468,750   2,459,383   2,110,164 
Cortes NP Acquisition Corp (Vertiv) Capital Equipment Term Loan 2/21 Loan  1M USD LIBOR+ 2.75%  0.00%  7.32%  3/2/2027   1,960,000   1,960,000   1,934,579 
COWEN INC. Banking, Finance, Insurance & Real Estate Term Loan Loan  6M USD LIBOR+ 3.25%  0.00%  7.43%  3/24/2028   3,927,406   3,907,308   3,922,496 
Creative Artists Agency, LLC Media: Diversified & Production Term Loan B (02/23) Loan  1M USD SOFR+ 3.50%  0.00%  8.06%  11/1/2028   1,600,000   1,588,000   1,595,008 
CROCS INC Consumer goods: Durable Term Loan Loan  6M USD SOFR+ 3.50%  0.50%  7.73%  2/20/2029   2,512,500   2,421,039   2,504,133 
Cross Financial Corp Banking, Finance, Insurance & Real Estate Term Loan B (3/21) Loan  1M USD LIBOR+ 4.00%  0.75%  8.69%  9/15/2027   492,500   492,174   489,422 
Crown Subsea Communications Holding, Inc. Construction & Building Term Loan (4/21) Loan  1M USD LIBOR+ 4.75%  0.75%  9.32%  4/27/2027   3,404,110   3,377,740   3,340,283 
CSC Holdings LLC (Neptune Finco Corp.) Media: Broadcasting & Subscription Term Loan B-5 Loan  1M USD LIBOR+ 2.50%  0.00%  7.09%  4/15/2027   485,000   485,000   435,894 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
CSC Holdings LLC (Neptune Finco Corp.) Media: Broadcasting & Subscription Term Loan 12/22 Loan  1M USD SOFR+ 4.50%  0.00%  9.06%  4/15/2027   2,400,032   2,389,363   2,244,030 
CTS Midco, LLC High Tech Industries Term Loan B Loan  3M USD LIBOR+ 6.00%  1.00%  10.83%  11/2/2027   1,960,000   1,917,602   1,666,000 
Daseke Inc Transportation: Cargo Term Loan 2/21 Loan  1M USD LIBOR+ 4.00%  0.75%  8.64%  3/5/2028   1,473,750   1,468,500   1,468,223 
Dave & Buster’s Inc. Hotel, Gaming & Leisure Term Loan B (04/22) Loan  1M USD SOFR+ 5.00%  0.50%  9.75%  6/29/2029   995,000   948,574   997,736 
DCert Buyer, Inc. High Tech Industries Term Loan Loan  6M USD SOFR+ 4.00%  0.00%  8.70%  10/16/2026   1,469,773   1,469,773   1,446,257 
Delek US Holdings, Inc. Utilities: Oil & Gas Term Loan B (11/22) Loan  1M USD SOFR+ 3.50%  0.50%  8.22%  11/16/2029   5,400,000   5,285,256   5,298,750 
Delta 2 Lux Sarl Hotel, Gaming & Leisure Term Loan B Loan  1M USD SOFR+ 3.25%  0.50%  7.87%  1/15/2030   1,000,000   990,424   1,001,750 
DexKo Global, Inc. (Dragon Merger) Automotive Term Loan (9/21) Loan  3M USD LIBOR+ 3.75%  0.50%  8.48%  10/4/2028   992,500   989,236   928,980 
DG Investment Intermediate Holdings 2, Inc. Aerospace & Defense Incremental Term Loan (3/22) Loan  1M USD SOFR+ 4.75%  0.75%  9.37%  3/31/2028   498,750   479,659   488,152 
Diamond Sports Group, LLC (b) Media: Broadcasting & Subscription Second Lien Term Loan Loan  3M USD SOFR+ 3.40%  0.00%  8.03%  8/24/2026   3,374,880   3,017,273   382,306 
Diamond Sports Group, LLC (b) Media: Broadcasting & Subscription 1st Priority Term Loan Loan  6M USD SOFR+ 8.00%  1.00%  13.06%  5/25/2026   342,343   333,975   318,951 
DIRECTV FINANCING, LLC Media: Broadcasting & Subscription Term Loan Loan  1M USD LIBOR+ 5.00%  0.75%  9.63%  8/2/2027   3,550,000   3,523,794   3,448,754 
DISCOVERY PURCHASER CORPORATION Chemicals, Plastics, & Rubber Term Loan Loan  3M USD SOFR+ 4.38%  0.50%  8.96%  10/4/2029   1,500,000   1,385,334   1,433,310 
Dispatch Acquisition Holdings, LLC Environmental Industries Term Loan B (3/21) Loan  3M USD LIBOR+ 4.25%  0.75%  8.98%  3/25/2028   492,500   488,806   434,631 
DOMTAR CORPORATION Forest Products & Paper Term Loan 9/21 Loan  1M USD LIBOR+ 5.50%  0.75%  10.10%  11/30/2028   1,310,136   1,272,492   1,286,121 
DOTDASH MEREDITH, INC. Media: Advertising, Printing & Publishing Term Loan B Loan  1M USD SOFR+ 4.00%  0.50%  8.67%  11/30/2028   1,994,949   1,803,027   1,755,556 
DRI HOLDING INC. Media: Advertising, Printing & Publishing Term Loan (12/21) Loan  1M USD LIBOR+ 5.25%  0.50%  9.88%  12/15/2028   3,972,487   3,830,439   3,552,913 
DRW Holdings, LLC Banking, Finance, Insurance & Real Estate Term Loan (2/21) Loan  1M USD LIBOR+ 3.75%  0.00%  8.38%  3/1/2028   6,435,000   6,396,896   6,284,164 
DTZ U.S. Borrower, LLC Construction & Building Term Loan Loan  1M USD LIBOR+ 2.75%  0.00%  7.38%  8/21/2025   1,612,878   1,609,665   1,602,798 
DTZ U.S. Borrower, LLC Construction & Building Term Loan (01/23) Loan  1M USD SOFR+ 3.25%  0.00%  7.97%  1/31/2030   2,034,413   2,031,025   2,021,698 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
EAB Global, Inc. Services: Business Term Loan (08/21) Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  8/16/2028   990,000   985,965   969,586 
Echo Global Logistics, Inc. Services: Business Term Loan Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  11/23/2028   1,985,000   1,981,077   1,916,776 
Edelman Financial Group Inc., The Banking, Finance, Insurance & Real Estate Term Loan B (3/21) Loan  1M USD LIBOR+ 3.50%  0.75%  8.13%  4/7/2028   2,188,547   2,182,686   2,129,281 
Electrical Components Inter., Inc. Capital Equipment Term Loan (6/18) Loan  1M USD LIBOR+ 4.25%  0.00%  8.88%  6/26/2025   1,888,404   1,888,404   1,719,638 
ELECTRON BIDCO INC. Healthcare & Pharmaceuticals Term Loan Loan  1M USD LIBOR+ 3.00%  0.50%  7.63%  11/1/2028   496,250   494,396   491,208 
ELO Touch Solutions, Inc. Media: Diversified & Production Term Loan (12/18) Loan  1M USD LIBOR+ 6.50%  0.00%  11.13%  12/14/2025   2,175,269   2,121,627   2,169,831 
Embecta Corp Healthcare & Pharmaceuticals Term Loan B Loan  6M USD SOFR+ 3.00%  0.50%  7.79%  3/30/2029   614,918   611,634   604,735 
Endo Luxembourg Finance Company I S.a.r.l. Healthcare & Pharmaceuticals Term Loan (3/21) Loan  Prime 6.00%  0.75%  13.75%  3/27/2028   2,335,285   2,328,380   1,839,037 
Endure Digital, Inc. High Tech Industries Term Loan B Loan  1M USD LIBOR+ 3.50%  0.75%  8.07%  2/10/2028   2,462,500   2,453,593   2,276,581 
Entain Holdings (Gibraltar) Limited Hotel, Gaming & Leisure Term Loan B (10/22) Loan  3M USD SOFR+ 3.50%  0.50%  8.18%  10/30/2029   1,000,000   987,635   999,060 
Envision Healthcare Corporation Healthcare & Pharmaceuticals Term Loan B (06/18) Loan  3M USD LIBOR+ 3.75%  0.00%  8.48%  10/10/2025   4,784,383   4,782,311   1,202,076 
EOS U.S. FINCO LLC Transportation: Cargo Term Loan Loan  3M USD SOFR+ 6.00%  0.50%  10.60%  8/3/2029   1,000,000   923,495   986,250 
Equiniti Group PLC Services: Business Term Loan B Loan  6M USD SOFR+ 4.50%  0.50%  9.54%  12/11/2028   990,000   981,797   990,624 
EyeCare Partners, LLC Healthcare & Pharmaceuticals Term Loan Loan  3M USD LIBOR+ 3.75%  0.00%  8.48%  2/18/2027   1,948,081   1,948,081   1,621,174 
Finco I LLC Banking, Finance, Insurance & Real Estate Term Loan B (9/20) Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  6/27/2025   2,830,950   2,826,805   2,830,950 
First Brands Group, LLC Automotive 1st Lien Term Loan (3/21) Loan  6M USD SOFR+ 5.00%  1.00%  10.25%  3/30/2027   4,912,500   4,854,265   4,754,367 
First Eagle Investment Management Banking, Finance, Insurance & Real Estate Refinancing Term Loan Loan  3M USD LIBOR+ 2.50%  0.00%  7.23%  2/1/2027   5,146,145   5,133,892   5,055,007 
First Student Bidco Inc. Transportation: Consumer Term Loan B Loan  3M USD LIBOR+ 3.00%  0.50%  7.73%  7/21/2028   723,088   718,928   689,255 
First Student Bidco Inc. Transportation: Consumer Term Loan C Loan  3M USD LIBOR+ 3.00%  0.50%  7.73%  7/21/2028   269,608   268,052   256,993 
Fitness International, LLC (LA Fitness) Services: Consumer Term Loan B (4/18) Loan  3M USD SOFR+ 3.25%  1.00%  8.08%  4/18/2025   1,330,058   1,326,810   1,268,211 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Flutter Financing B.V. Hotel, Gaming & Leisure Term Loan Loan  3M USD LIBOR+ 2.25%  0.00%  6.98%  7/21/2026   1,975,000   1,972,044   1,971,643 
Flutter Financing B.V. Hotel, Gaming & Leisure Third Amendment 2028-B Term Loan Loan  3M USD SOFR+ 3.25%  0.50%  8.09%  7/21/2028   748,125   732,248   747,848 
FOCUS FINANCIAL PARTNERS, LLC Banking, Finance, Insurance & Real Estate Term Loan B Loan  1M USD SOFR+ 3.25%  0.50%  7.87%  6/30/2028   1,487,298   1,470,684   1,477,765 
Franchise Group, Inc. Services: Consumer First Out Term Loan Loan  3M USD LIBOR+ 4.75%  0.75%  9.56%  3/10/2026   799,104   793,938   760,148 
Franchise Group, Inc. Services: Consumer Term Loan B Loan  3M USD SOFR+ 4.75%  0.75%  9.70%  3/10/2026   3,000,000   2,852,614   2,857,500 
Franklin Square Holdings, L.P. Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD LIBOR+ 2.25%  0.00%  6.94%  8/1/2025   4,308,730   4,296,025   4,303,344 
Froneri International (R&R Ice Cream) Beverage, Food & Tobacco Term Loan B-2 Loan  1M USD LIBOR+ 2.25%  0.00%  6.88%  1/29/2027   1,950,000   1,948,124   1,915,524 
Garrett LX III S.a r.l. Automotive Dollar Term Loan Loan  3M USD LIBOR+ 3.25%  0.50%  8.08%  4/30/2028   1,481,250   1,475,822   1,460,261 
Gates Global LLC Automotive Term Loan (11/22) Loan  1M USD SOFR+ 3.50%  0.50%  8.12%  11/15/2029   249,375   242,119   249,121 
Gemini HDPE LLC Chemicals, Plastics, & Rubber Term Loan B (12/20) Loan  3M USD LIBOR+ 3.00%  0.50%  7.83%  12/31/2027   2,289,884   2,276,592   2,281,297 
Genesee & Wyoming, Inc. Transportation: Cargo Term Loan (11/19) Loan  3M USD LIBOR+ 2.00%  0.00%  6.73%  12/30/2026   1,458,750   1,454,820   1,453,892 
GGP Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan  1M USD LIBOR+ 2.50%  0.00%  2.96%  8/27/2025   3,072,992   2,734,560   3,053,141 
Global Tel*Link Corporation Telecommunications Term Loan B Loan  3M USD SOFR+ 4.25%  0.00%  9.08%  11/29/2025   4,897,634   4,753,219   4,342,830 
Go Daddy Operating Company, LLC High Tech Industries Term Loan 2/21 Loan  1M USD LIBOR+ 2.00%  0.00%  6.63%  8/10/2027   1,959,799   1,959,799   1,950,255 
GOLDEN WEST PACKAGING GROUP LLC Forest Products & Paper Term Loan (11/21) Loan  1M USD LIBOR+ 5.25%  0.75%  9.88%  12/1/2027   1,962,500   1,946,411   1,903,625 
Graham Packaging Co Inc Containers, Packaging & Glass Term Loan (2/21) Loan  1M USD LIBOR+ 3.00%  0.75%  7.63%  8/7/2027   962,517   957,931   956,501 
Great Outdoors Group, LLC Retail Term Loan B2 Loan  1M USD LIBOR+ 3.75%  0.75%  8.38%  3/6/2028   980,094   976,551   964,471 
Greenhill & Co., Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan  3M USD LIBOR+ 3.25%  0.00%  8.20%  4/12/2024   2,844,231   2,836,329   2,789,707 
Griffon Corporation Consumer goods: Durable Term Loan B Loan  1M USD SOFR+ 2.50%  0.50%  7.20%  1/24/2029   154,375   154,051   152,959 
Grosvenor Capital Management Holdings, LLLP Banking, Finance, Insurance & Real Estate Amendment 5 Term Loan Loan  1M USD LIBOR+ 2.50%  0.50%  7.13%  2/24/2028   2,836,805   2,834,453   2,808,437 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Groupe Solmax Inc. Environmental Industries Term Loan (6/21) Loan  3M USD LIBOR+ 4.75%  0.75%  9.48%  5/27/2028   1,994,937   1,625,873   1,720,633 
Harbor Freight Tools USA, Inc. Retail Term Loan B (06/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  10/19/2027   3,438,442   3,420,645   3,324,355 
Helix Gen Funding, LLc Energy: Electricity Term Loan B (02/17) Loan  1M USD LIBOR+ 3.75%  1.00%  8.38%  6/3/2024   209,702   209,702   208,332 
Hillman Group Inc. (The) (New) Consumer goods: Durable Term Loan B-1 (2/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  7/14/2028   3,479,167   3,473,274   3,441,105 
Hillman Group Inc. (The) (New) (a) Consumer goods: Durable Delayed Draw Term Loan (2/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  7/14/2028   66,667   66,667   57,444 
HLF Financing SARL (Herbalife) Consumer goods: Non-durable Term Loan B (08/18) Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  8/18/2025   3,510,000   3,504,423   3,452,225 
Holley Purchaser, Inc Automotive Term Loan (11/21) Loan  3M USD LIBOR+ 3.75%  0.75%  8.48%  11/17/2028   2,317,577   2,309,047   1,888,825 
Howden Group Holdings Banking, Finance, Insurance & Real Estate Term Loan (1/21) Loan  1M USD LIBOR+ 3.25%  0.75%  7.94%  11/12/2027   2,152,191   2,144,311   2,117,218 
Hudson River Trading LLC Banking, Finance, Insurance & Real Estate Term Loan (3/21) Loan  1M USD SOFR+ 3.00%  0.00%  7.73%  3/17/2028   5,895,000   5,850,826   5,619,173 
Idera, Inc. High Tech Industries Term Loan (02/21) Loan  3M USD LIBOR+ 3.75%  0.75%  8.51%  3/2/2028   4,811,111   4,802,585   4,635,698 
IMA Financial Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/21) Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  11/1/2028   1,980,000   1,972,160   1,947,825 
INDY US BIDCO, LLC Services: Business Term Loan (11/21) Loan  1M USD LIBOR+ 3.75%  0.00%  8.38%  3/6/2028   2,215,703   2,215,226   1,888,200 
Ineos US Finance LLC Chemicals, Plastics, & Rubber Term Loan C Loan  1M USD SOFR+ 3.75%  0.00%  8.42%  2/9/2030   1,000,000   990,000   991,560 
INEOS US PETROCHEM LLC Chemicals, Plastics, & Rubber Term Loan (1/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  1/29/2026   1,979,950   1,929,143   1,967,080 
Informatica Inc. High Tech Industries Term Loan B (10/21) Loan  1M USD LIBOR+ 2.75%  0.00%  7.44%  10/27/2028   496,250   495,896   494,761 
Ingram Micro Inc. Wholesale Term Loan Loan  3M USD LIBOR+ 3.50%  0.50%  8.23%  6/30/2028   1,477,500   1,465,872   1,468,266 
Inmar Acquisition Sub, Inc. Services: Business Term Loan B Loan  1M USD LIBOR+ 4.00%  1.00%  8.63%  5/1/2024   3,350,673   3,327,770   3,270,055 
Innophos, Inc. Chemicals, Plastics, & Rubber Term Loan B Loan  1M USD LIBOR+ 3.25%  0.00%  7.88%  2/4/2027   486,250   484,966   483,007 
INSTANT BRANDS HOLDINGS INC. Consumer goods: Durable Term Loan 4/21 Loan  3M USD LIBOR+ 5.00%  0.75%  9.95%  4/7/2028   4,027,667   4,010,741   2,154,802 
IRB Holding Corporation Beverage, Food & Tobacco Term Loan B3 Loan  1M USD SOFR+ 3.00%  0.75%  7.57%  12/14/2027   500,000   495,150   493,125 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
IRB Holding T/L B (1/22) Beverage, Food & Tobacco Term Loan B Loan  1M USD SOFR+ 3.00%  0.75%  7.69%  12/15/2027   500,000   495,150   493,125 
Isagenix International, LLC (b) Beverage, Food & Tobacco Term Loan Loan  3M USD LIBOR+ 7.75%  1.00%  11.35%  6/14/2025   2,330,036   2,311,947   814,068 
J Jill Group, Inc Retail Priming Term Loan Loan  3M USD LIBOR+ 5.00%  1.00%  9.83%  5/8/2024   1,553,698   1,553,299   1,464,361 
Jane Street Group Banking, Finance, Insurance & Real Estate Term Loan (1/21) Loan  1M USD LIBOR+ 2.75%  0.00%  7.38%  1/31/2028   3,920,000   3,917,671   3,897,970 
Journey Personal Care Corp. Consumer goods: Non-durable Term Loan B Loan  3M USD LIBOR+ 4.25%  0.75%  8.98%  3/1/2028   985,000   981,310   731,569 
JP Intermediate B, LLC Consumer goods: Non-durable Term Loan Loan  3M USD LIBOR+ 5.50%  1.00%  10.33%  11/15/2025   3,884,160   3,863,896   2,469,199 
Klockner-Pentaplast of America, Inc. Containers, Packaging & Glass Term Loan (1/21) (USD) Loan  6M USD SOFR+ 4.75%  0.50%  10.13%  2/12/2026   1,473,750   1,469,605   1,354,936 
Kodiak BP, LLC Construction & Building Term Loan Loan  3M USD LIBOR+ 3.25%  0.75%  7.98%  3/13/2028   491,242   490,111   472,083 
KREF Holdings X LLC Banking, Finance, Insurance & Real Estate Term Loan (11/21) Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  9/1/2027   491,288   482,835   482,690 
Lakeland Tours, LLC Hotel, Gaming & Leisure Holdco Fixed Term Loan Loan  Fixed 0.00%  0.00%  13.25%  9/27/2027   990,775   383,373   644,004 
Lealand Finance Company B.V. Energy: Oil & Gas Exit Term Loan Loan  1M USD LIBOR+ 1.00%  0.00%  5.63%  6/30/2025   345,078   345,078   221,426 
LHS BORROWER, LLC Construction & Building Term Loan (02/22) Loan  1M USD SOFR+ 4.75%  0.50%  9.47%  2/16/2029   997,487   815,989   817,940 
Lifetime Brands, Inc Consumer goods: Non-durable Term Loan B Loan  1M USD SOFR+ 3.50%  1.00%  8.23%  2/28/2025   2,616,496   2,602,628   2,295,975 
Liquid Tech Solutions Holdings, LLC Services: Business Term Loan Loan  6M USD LIBOR+ 4.75%  0.00%  8.92%  3/17/2028   985,000   982,312   940,675 
LogMeIn, Inc. High Tech Industries Term Loan (8/20) Loan  1M USD LIBOR+ 4.75%  0.00%  9.38%  8/31/2027   3,920,000   3,868,809   2,137,145 
LOYALTY VENTURES INC. (b) Services: Business Term Loan B Loan  Prime 3.50%  0.50%  11.25%  11/3/2027   3,089,630   3,074,278   926,889 
LPL Holdings, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 Loan  1M USD LIBOR+ 1.75%  0.00%  6.32%  11/11/2026   1,207,856   1,206,501   1,203,701 
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan (01/23) Loan  1M USD SOFR+ 4.25%  0.50%  8.97%  10/14/2028   500,000   486,534   489,165 
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan Loan  1M USD SOFR+ 3.50%  0.50%  8.23%  10/16/2028   248,125   247,170   241,508 
LSF9 Atlantis Holdings, LLC (A Wireless) Retail Term Loan B Loan  3M USD SOFR+ 7.25%  0.75%  11.83%  3/29/2029   2,962,500   2,872,908   2,888,438 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
MAGNITE, INC. Services: Business Term Loan Loan  1M USD LIBOR+ 5.00%  0.75%  9.63%  4/28/2028   2,964,950   2,901,156   2,826,575 
Marriott Ownership Resorts, Inc. Hotel, Gaming & Leisure Term Loan (11/19) Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  8/29/2025   1,317,074   1,317,074   1,308,842 
Match Group, Inc, The Services: Consumer Term Loan (1/20) Loan  3M USD LIBOR+ 1.75%  0.00%  6.49%  2/15/2027   250,000   249,658   247,500 
Maxar Technologies Inc Aerospace & Defense Term Loan (6/22) Loan  1M USD SOFR+ 4.25%  0.50%  8.97%  6/14/2029   1,994,987   1,926,722   1,997,641 
Mayfield Agency Borrower Inc. (FeeCo) Banking, Finance, Insurance & Real Estate Term Loan B (02/23) Loan  3M USD SOFR+ 5.00%  0.00%  8.81%  2/27/2028   3,450,000   3,346,500   3,363,750 
McGraw-Hill Education, Inc. Media: Advertising, Printing & Publishing Term Loan (07/21) Loan  3M USD LIBOR+ 4.75%  0.50%  9.70%  7/28/2028   1,975,000   1,957,770   1,894,025 
MedAssets Software Inter Hldg, Inc. High Tech Industries Term Loan (11/21) (USD) Loan  1M USD LIBOR+ 4.00%  0.50%  8.63%  12/18/2028   496,250   493,413   462,753 
Mermaid Bidco Inc. High Tech Industries Term Loan B2 Loan  3M USD LIBOR+ 3.50%  0.75%  8.30%  12/22/2027   983,769   981,224   964,093 
Messer Industries, LLC Chemicals, Plastics, & Rubber Term Loan B Loan  3M USD LIBOR+ 2.50%  0.00%  7.23%  3/1/2026   2,980,405   2,970,477   2,968,871 
Michaels Companies Inc Retail Term Loan B (Magic Mergeco) Loan  3M USD LIBOR+ 4.25%  0.75%  8.98%  4/8/2028   2,467,450   2,452,022   2,254,632 
MPH Acquisition Holdings LLC (Multiplan) Services: Business Term Loan B (08/21) Loan  3M USD LIBOR+ 4.25%  0.50%  9.20%  9/1/2028   2,992,424   2,725,679   2,509,148 
MW Industries, Inc. (Helix Acquisition Holdings) Capital Equipment Term Loan (2019 Incremental) Loan  3M USD LIBOR+ 3.75%  0.00%  8.48%  9/30/2024   2,842,097   2,823,791   2,778,150 
NAB Holdings, LLC (North American Bancard) Banking, Finance, Insurance & Real Estate Term Loan (11/21) Loan  3M USD SOFR+ 3.00%  0.50%  7.73%  11/23/2028   2,970,000   2,963,897   2,927,678 
Napa Management Services Corp Healthcare & Pharmaceuticals Term Loan B (02/22) Loan  1M USD SOFR+ 5.25%  0.75%  9.95%  2/22/2029   3,000,000   2,407,500   2,285,640 
Natgasoline LLC Chemicals, Plastics, & Rubber Term Loan Loan  1M USD LIBOR+ 3.50%  0.00%  8.19%  11/14/2025   3,436,481   3,419,311   3,395,690 
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan 2/21 Loan  1M USD SOFR+ 3.75%  0.75%  8.47%  3/2/2028   2,736,043   2,727,702   2,108,477 
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan C 2/21 Loan  3M USD LIBOR+ 3.75%  0.75%  8.48%  3/2/2028   87,464   87,137   67,402 
NEW ERA CAP, LLC Consumer goods: Durable Term Loan (01/22) Loan  3M USD LIBOR+ 6.00%  0.75%  10.82%  7/13/2027   3,628,164   3,627,422   3,483,037 
Nexstar Broadcasting, Inc. (Mission Broadcasting) Media: Broadcasting & Subscription Term Loan Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  9/18/2026   657,625   652,850   655,745 
Next Level Apparel, Inc. Retail Term Loan Loan  3M USD LIBOR+ 5.50%  1.00%  10.33%  8/9/2024   1,675,340   1,670,519   1,373,779 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
NortonLifeLock Inc. High Tech Industries Term Loan B Loan  1M USD SOFR+ 2.00%  0.50%  6.72%  9/12/2029   1,398,374   1,392,077   1,382,391 
Novae LLC Automotive Term Loan B Loan  3M USD SOFR+ 5.00%  0.75%  9.82%  12/22/2028   1,985,000   1,972,048   1,692,213 
Nuvei Technologies Corp. High Tech Industries US Term Loan Loan  1M USD LIBOR+ 2.50%  0.50%  7.13%  9/29/2025   2,216,250   2,213,211   2,210,709 
Olaplex, Inc. Consumer goods: Non-durable Term Loan (2/22) Loan  1M USD SOFR+ 3.50%  0.50%  8.20%  2/23/2029   2,492,500   2,386,817   2,224,556 
Open Text Corporation High Tech Industries Term Loan B Loan  1M USD SOFR+ 3.50%  0.50%  8.22%  8/24/2029   1,500,000   1,455,000   1,496,955 
Organon & Co. Healthcare & Pharmaceuticals Term Loan USD Loan  3M USD LIBOR+ 3.00%  0.50%  7.75%  6/2/2028   2,327,083   2,318,310   2,297,995 
Pacific Gas & Electric Utilities: Electric Term Loan Loan  1M USD LIBOR+ 3.00%  0.50%  7.69%  6/18/2025   1,464,944   1,460,891   1,457,619 
PACTIV EVERGREEN GROUP HOLDINGS INC. Containers, Packaging & Glass Term Loan B Loan  1M USD LIBOR+ 3.25%  0.50%  7.88%  9/20/2028   987,500   983,571   981,950 
Padagis LLC Healthcare & Pharmaceuticals Term Loan Loan  3M USD LIBOR+ 4.75%  0.50%  9.54%  7/6/2028   941,176   933,570   864,122 
Panther Guarantor II, L.P. (Forcepoint) High Tech Industries Term Loan 1/21 Loan  3M USD LIBOR+ 4.25%  0.50%  9.08%  1/7/2028   492,500   489,882   461,719 
PAR PETROLEUM LLC Energy: Oil & Gas Term Loan 2/23 Loan  1M USD SOFR+ 4.25%  0.50%  8.92%  2/13/2030   1,500,000   1,477,500   1,479,375 
PATAGONIA HOLDCO LLC Telecommunications Term Loan B Loan  3M USD SOFR+ 5.75%  0.50%  10.47%  8/1/2029   1,995,000   1,653,635   1,700,738 
Pathway Partners Vet Management Company LLC Services: Business Term Loan Loan  1M USD LIBOR+ 3.75%  0.00%  8.38%  3/30/2027   486,509   479,333   424,630 
PCI Gaming Authority Hotel, Gaming & Leisure Term Loan Loan  1M USD LIBOR+ 2.50%  0.00%  7.13%  5/29/2026   809,038   806,994   807,396 
PEARLS (Netherlands) Bidco B.V. Chemicals, Plastics, & Rubber USD Term Loan (02/22) Loan  3M USD SOFR+ 3.75%  0.50%  8.43%  2/28/2029   992,500   990,539   975,131 
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC Healthcare & Pharmaceuticals Term Loan (12/22) Loan  1M USD LIBOR+ 3.25%  0.50%  7.88%  12/29/2028   1,292,862   1,287,663   1,272,396 
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC (a) Healthcare & Pharmaceuticals Delayed Draw Term Loan (12/21) Loan  1M USD LIBOR+ 3.25%  0.50%  7.88%  12/29/2028   147,287   147,287   144,174 
Penn National Gaming, Inc Hotel, Gaming & Leisure Term Loan B Loan  1M USD SOFR+ 2.75%  0.50%  7.47%  5/3/2029   995,000   990,530   990,851 
Peraton Corp. Aerospace & Defense Term Loan B Loan  1M USD LIBOR+ 3.75%  0.75%  8.38%  2/1/2028   5,306,577   5,291,284   5,249,372 
PHYSICIAN PARTNERS, LLC Healthcare & Pharmaceuticals Term Loan Loan  1M USD SOFR+ 4.00%  0.50%  8.72%  12/23/2028   1,985,000   1,967,896   1,900,638 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Pike Corporation Construction & Building Term Loan (8/22) Loan  1M USD SOFR+ 3.50%  0.00%  8.12%  1/21/2028   498,750   487,274   497,294 
Pitney Bowes Inc Services: Business Term Loan B Loan  1M USD SOFR+ 4.00%  0.00%  8.73%  3/17/2028   3,939,924   3,914,651   3,789,734 
Plastipak Holdings Inc. Containers, Packaging & Glass Term Loan B (11/21) Loan  1M USD LIBOR+ 2.50%  0.50%  7.13%  12/1/2028   1,921,176   1,913,386   1,911,974 
Playtika Holding Corp. High Tech Industries Term Loan B (3/21) Loan  1M USD LIBOR+ 2.75%  0.00%  7.38%  3/13/2028   4,421,250   4,414,119   4,370,804 
PMHC II, INC. Chemicals, Plastics, & Rubber Term Loan (02/22) Loan  3M USD SOFR+ 4.25%  0.50%  9.08%  4/21/2029   1,995,000   1,986,056   1,710,912 
PointClickCare Technologies, Inc. High Tech Industries Term Loan B Loan  3M USD LIBOR+ 3.00%  0.75%  7.75%  12/29/2027   491,250   489,531   487,566 
Polymer Process Holdings, Inc. Containers, Packaging & Glass Term Loan Loan  1M USD LIBOR+ 4.75%  0.75%  9.38%  2/12/2028   5,403,750   5,359,857   5,025,488 
Pre-Paid Legal Services, Inc. Services: Consumer Term Loan (12/21) Loan  1M USD LIBOR+ 3.75%  0.50%  8.38%  12/15/2028   2,977,500   2,956,393   2,929,116 
Presidio, Inc. Services: Business Term Loan B (1/20) Loan  3M USD SOFR+ 3.50%  0.00%  8.28%  1/22/2027   487,500   486,909   485,267 
Prime Security Services Borrower, LLC (ADT) Services: Consumer Term Loan (1/21) Loan  3M USD LIBOR+ 2.75%  0.75%  7.52%  9/23/2026   3,520,468   3,520,468   3,511,667 
PRIORITY HOLDINGS, LLC Services: Consumer Term Loan Loan  3M USD LIBOR+ 5.75%  1.00%  10.70%  4/27/2027   2,955,000   2,932,371   2,936,531 
PriSo Acquisition Corporation Construction & Building Term Loan (01/21) Loan  3M USD LIBOR+ 3.25%  0.75%  8.00%  12/28/2027   491,245   489,458   450,310 
Project Leopard Holdings, Inc. (NEW) High Tech Industries Term Loan B (06/22) Loan  6M USD SOFR+ 5.25%  0.50%  9.80%  7/20/2029   1,000,000   933,902   924,690 
Prometric Inc. (Sarbacane Bidco) Services: Consumer Term Loan Loan  1M USD LIBOR+ 3.00%  1.00%  7.64%  1/29/2025   476,438   475,777   444,278 
PUG LLC Services: Consumer Term Loan B (02/20) Loan  1M USD LIBOR+ 3.50%  0.00%  8.13%  2/12/2027   480,126   478,777   378,099 
QUEST BORROWER LIMITED High Tech Industries Term Loan (1/22) Loan  3M USD SOFR+ 4.25%  0.50%  9.08%  2/1/2029   1,990,000   1,972,710   1,707,539 
Rackspace Technology Global, Inc. High Tech Industries Term Loan (1/21) Loan  3M USD LIBOR+ 2.75%  0.75%  7.60%  2/15/2028   2,974,823   2,882,889   1,863,310 
RAND PARENT LLC Transportation: Cargo Term Loan B Loan  1M USD SOFR+ 4.25%  0.00%  8.80%  2/7/2030   1,500,000   1,462,500   1,455,000 
RealPage, Inc. High Tech Industries Term Loan (04/21) Loan  1M USD LIBOR+ 3.00%  0.50%  7.63%  4/24/2028   987,500   985,860   955,159 
Renaissance Learning, Inc. Services: Consumer Term Loan (5/18) Loan  1M USD LIBOR+ 3.25%  0.00%  7.88%  5/30/2025   2,938,373   2,922,432   2,871,025 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Rent-A-Center, Inc. Retail Term Loan B2 (9/21) Loan  3M USD LIBOR+ 3.25%  0.50%  8.13%  2/17/2028   1,976,155   1,934,422   1,927,997 
Research Now Group, Inc Media: Advertising, Printing & Publishing Term Loan Loan  3M USD LIBOR+ 5.50%  1.00%  10.31%  12/20/2024   4,298,135   4,249,328   3,200,305 
Resideo Funding Inc. Services: Consumer Term Loan (1/21) Loan  3M USD LIBOR+ 2.25%  0.50%  7.12%  2/11/2028   1,473,750   1,471,623   1,471,908 
Resolute Investment Managers (American Beacon), Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/20) Loan  3M USD LIBOR+ 4.25%  1.00%  8.98%  4/30/2024   3,038,616   3,035,050   2,385,313 
Restoration Hardware, Inc. Retail Term Loan (9/21) Loan  1M USD LIBOR+ 2.50%  0.50%  7.13%  10/20/2028   3,462,437   3,456,353   3,320,477 
Reynolds Consumer Products LLC Containers, Packaging & Glass Term Loan Loan  1M USD SOFR+ 1.75%  0.00%  6.47%  1/29/2027   1,276,932   1,276,737   1,273,880 
Reynolds Group Holdings Inc. Containers, Packaging & Glass Term Loan B2 Loan  1M USD LIBOR+ 3.25%  0.00%  7.88%  2/5/2026   3,124,551   3,114,804   3,114,302 
Rocket Software, Inc. High Tech Industries Term Loan (11/18) Loan  1M USD LIBOR+ 4.25%  0.00%  8.88%  11/28/2025   2,875,317   2,870,016   2,818,414 
Russell Investments US Inst’l Holdco, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/20) Loan  1M USD LIBOR+ 3.50%  1.00%  8.13%  6/2/2025   5,590,662   5,565,048   5,499,813 
RV Retailer LLC Automotive Term Loan Loan  3M USD SOFR+ 3.75%  0.75%  8.55%  2/8/2028   2,957,631   2,912,519   2,516,441 
Ryan Specialty Group LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD SOFR+ 3.00%  0.75%  7.72%  9/1/2027   1,478,623   1,467,543   1,474,010 
S&S HOLDINGS LLC Services: Business Term Loan Loan  3M USD LIBOR+ 5.00%  0.50%  9.83%  3/10/2028   2,458,719   2,409,819   2,349,625 
Sally Holdings LLC Retail Term Loan B Loan  1M USD SOFR+ 2.50%  0.00%  7.06%  3/24/2030   500,000   496,250   498,750 
Samsonite International S.A. Consumer goods: Non-durable Term Loan B2 Loan  1M USD LIBOR+ 3.00%  0.75%  7.63%  4/25/2025   927,537   914,134   927,537 
Schweitzer-Mauduit International, Inc. High Tech Industries Term Loan B Loan  1M USD LIBOR+ 3.75%  0.75%  8.44%  4/20/2028   2,955,000   2,942,014   2,895,900 
Scientific Games Holdings LP Hotel, Gaming & Leisure Term Loan B Loan  3M USD SOFR+ 3.50%  0.50%  8.10%  4/4/2029   498,750   497,703   489,942 
Sedgwick Claims Management Services, Inc. Services: Business Term Loan B 2/23 Loan  1M USD SOFR+ 3.75%  0.00%  8.32%  2/17/2028   1,000,000   990,000   987,500 
SETANTA AIRCRAFT LEASING DAC Aerospace & Defense Term Loan Loan  3M USD LIBOR+ 2.00%  0.00%  6.73%  11/2/2028   1,000,000   998,000   991,250 
Signify Health, LLC Healthcare & Pharmaceuticals Term Loan B (6/21) Loan  3M USD LIBOR+ 3.00%  0.50%  7.73%  6/16/2028   493,750   491,846   493,750 
Sitel Worldwide Corporation Services: Business USD Term Loan (7/21) Loan  1M USD LIBOR+ 3.75%  0.50%  8.39%  8/28/2028   1,975,000   1,967,031   1,966,982 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
SiteOne Landscape Supply, LLC Services: Business Term Loan (3/21) Loan  1M USD LIBOR+ 2.00%  0.50%  6.64%  3/18/2028   777,852   776,450   774,609 
SMG US Midco 2, Inc. Services: Business Term Loan (01/20) Loan  3M USD LIBOR+ 2.50%  0.00%  7.33%  1/23/2025   485,000   485,000   479,243 
Smyrna Ready Mix Concrete, LLC Construction & Building Term Loan Loan  1M USD SOFR+ 4.25%  0.50%  8.97%  4/2/2029   1,000,000   992,500   995,000 
Solis IV B.V. Consumer goods: Durable Term Loan B-1 Loan  3M USD SOFR+ 3.50%  0.50%  8.37%  2/26/2029   1,994,987   1,724,963   1,826,132 
Sotheby’s Services: Business Term Loan (7/21) Loan  3M USD LIBOR+ 4.50%  0.50%  9.33%  1/15/2027   3,223,744   3,183,482   3,209,237 
Sparta U.S. HoldCo LLC Chemicals, Plastics, & Rubber Term Loan (04/21) Loan  1M USD LIBOR+ 3.25%  0.75%  7.82%  8/2/2028   1,980,000   1,972,123   1,964,160 
Specialty Pharma III Inc. Services: Business Term Loan Loan  1M USD LIBOR+ 4.25%  0.75%  8.88%  3/31/2028   1,975,000   1,959,930   1,821,938 
Spectrum Brands, Inc. Consumer goods: Durable Term Loan (2/21) Loan  3M USD LIBOR+ 2.00%  0.50%  6.96%  3/3/2028   491,250   490,363   487,158 
Spin Holdco, Inc. Services: Consumer Term Loan 3/21 Loan  3M USD LIBOR+ 4.00%  0.75%  8.77%  3/4/2028   2,947,500   2,935,211   2,475,487 
Spirit Aerosystems Inc. Aerospace & Defense Term Loan (11/22) Loan  3M USD SOFR+ 4.50%  0.50%  9.18%  1/14/2027   498,750   484,414   498,541 
SRAM, LLC Consumer goods: Durable Term Loan (05/21) Loan  1M USD LIBOR+ 2.75%  0.50%  7.38%  5/12/2028   2,709,091   2,705,948   2,682,000 
SS&C Technologies, Inc. Services: Business Term Loan B3 Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  4/16/2025   167,061   166,987   166,678 
SS&C Technologies, Inc. Services: Business Term Loan B4 Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  4/16/2025   148,146   148,083   147,807 
SS&C Technologies, Inc. Services: Business Term Loan B-5 Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  4/16/2025   458,152   457,773   457,199 
STANDARD INDUSTRIES INC. Construction & Building Term Loan B Loan  6M USD LIBOR+ 2.25%  0.50%  6.43%  9/22/2028   630,250   625,240   628,032 
Staples, Inc. Wholesale Term Loan (03/19) Loan  3M USD LIBOR+ 5.00%  0.00%  9.81%  4/16/2026   4,341,357   4,246,081   4,013,802 
Storable, Inc High Tech Industries Term Loan B Loan  3M USD SOFR+ 3.50%  0.50%  8.08%  4/17/2028   495,000   494,153   482,318 
Summit Materials, LLC Metals & Mining Term Loan B (12/22) Loan  3M USD SOFR+ 3.00%  0.00%  7.61%  12/13/2027   250,000   247,640   249,583 
Superannuation & Investments US LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD LIBOR+ 3.75%  0.50%  8.38%  12/1/2028   990,000   981,648   984,515 
Sweetwater Borrower, LLC Retail Term Loan (8/21) Loan  1M USD LIBOR+ 4.25%  0.75%  8.94%  8/2/2028   2,000,000   1,905,968   1,880,000 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
Syncsort Incorporated High Tech Industries Term Loan B (10/21) Loan  3M USD LIBOR+ 4.00%  0.75%  8.82%  4/24/2028   2,469,987   2,468,993   2,243,984 
Ta TT Buyer LLC Media: Broadcasting & Subscription Term Loan 3/22 Loan  6M USD SOFR+ 5.00%  0.50%  8.98%  4/2/2029   997,500   988,507   982,538 
Tenable Holdings, Inc. Services: Business Term Loan B (6/21) Loan  3M USD LIBOR+ 2.75%  0.50%  7.58%  7/7/2028   990,000   988,026   980,922 
Teneo Holdings LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD SOFR+ 5.25%  1.00%  9.97%  7/15/2025   4,383,217   4,330,652   4,322,948 
Ten-X, LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD LIBOR+ 4.00%  1.00%  8.63%  9/27/2024   1,900,000   1,899,296   1,819,250 
The Dun & Bradstreet Corporation Services: Business Term Loan B Loan  1M USD SOFR+ 3.25%  0.00%  7.85%  1/18/2029   248,125   246,554   246,636 
The Dun & Bradstreet Corporation Services: Business Term Loan Loan  1M USD LIBOR+ 3.25%  0.00%  7.87%  2/6/2026   962,949   962,285   960,021 
THE KNOT WORLDWIDE INC. Services: Consumer Term Loan (1/22) Loan  1M USD SOFR+ 4.50%  0.00%  9.22%  12/19/2025   4,845,447   4,840,970   4,833,333 
Thor Industries, Inc. Automotive USD Term Loan (3/21) Loan  1M USD LIBOR+ 3.00%  0.00%  7.69%  2/1/2026   2,015,823   1,990,264   2,004,494 
Torrid LLC Wholesale Term Loan 5/21 Loan  3M USD LIBOR+ 5.50%  0.75%  10.31%  6/14/2028   2,978,835   2,540,024   2,529,031 
TORY BURCH LLC Retail Term Loan Loan  1M USD LIBOR+ 3.50%  0.50%  8.13%  4/15/2028   1,329,211   1,232,469   1,268,147 
Tosca Services, LLC Containers, Packaging & Glass Term Loan (2/21) Loan  1M USD SOFR+ 3.50%  0.75%  8.23%  8/18/2027   490,000   485,078   383,180 
Trans Union LLC Banking, Finance, Insurance & Real Estate Term Loan Loan  1M USD LIBOR+ 2.25%  0.50%  6.88%  12/1/2028   796,452   794,928   791,203 
Transdigm, Inc. Aerospace & Defense Term Loan H Loan  3M USD SOFR+ 3.25%  0.00%  7.83%  2/21/2027   1,993,370   1,990,666   1,989,941 
TRITON WATER HOLDINGS, INC. Beverage, Food & Tobacco Term Loan (03/21) Loan  3M USD LIBOR+ 3.50%  0.50%  8.23%  3/31/2028   1,477,502   1,471,933   1,372,422 
Tronox Finance LLC Chemicals, Plastics, & Rubber Term Loan Loan  1M USD LIBOR+ 2.25%  0.00%  6.88%  3/10/2028   346,923   346,338   340,907 
TruGreen Limited Partnership Services: Consumer Term Loan Loan  1M USD LIBOR+ 4.00%  0.75%  8.63%  10/29/2027   954,501   949,189   873,368 
Uber Technologies, Inc. Transportation: Consumer Term Loan B (2/21) Loan  3M USD LIBOR+ 3.50%  0.00%  8.45%  2/25/2027   3,906,277   3,874,854   3,913,620 
Ultra Clean Holdings, Inc. High Tech Industries Incremental Term Loan 3/21 Loan  1M USD LIBOR+ 3.75%  0.00%  8.38%  8/27/2025   820,338   817,776   819,928 
Unimin Corporation Metals & Mining Term Loan (12/20) Loan  3M USD LIBOR+ 4.00%  1.00%  8.78%  7/31/2026   496,815   476,431   489,984 


Issuer Name Industry Asset Name Asset
Type
 Reference
Rate/Spread
 SOFR/LIBOR Floor  Current
Rate
(All In)
  Maturity Date  Principal/
Number of Shares
  Cost  Fair
Value
 
United Natural Foods, Inc Beverage, Food & Tobacco Term Loan B Loan  1M USD SOFR+ 3.25%  0.00%  7.98%  10/22/2025   1,289,967   1,252,901   1,291,309 
United Road Services Inc. Transportation: Cargo Term Loan (10/17) Loan  3M USD LIBOR+ 5.75%  1.00%  10.70%  9/1/2024   889,180   886,242   465,335 
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/21) Loan  1M USD LIBOR+ 3.25%  0.75%  7.88%  3/15/2026   2,446,648   2,441,783   2,426,610 
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/22) Loan  3M USD SOFR+ 4.25%  0.50%  8.83%  6/25/2029   248,750   241,881   248,233 
Utz Quality Foods, LLC Beverage, Food & Tobacco Term Loan B Loan  1M USD SOFR+ 3.00%  0.00%  7.73%  1/20/2028   1,828,465   1,827,288   1,825,046 
Vaco Holdings, LLC Services: Business Term Loan (01/22) Loan  3M USD SOFR+ 5.00%  0.75%  9.73%  1/19/2029   2,342,210   2,275,198   2,310,989 
Vericast Corp. Media: Advertising, Printing & Publishing Term Loan Loan  3M USD SOFR+ 7.75%  1.00%  12.33%  6/15/2026   1,201,006   1,199,817   939,787 
Verifone Systems, Inc. Banking, Finance, Insurance & Real Estate Term Loan (7/18) Loan  3M USD LIBOR+ 4.00%  0.00%  8.96%  8/20/2025   1,368,031   1,364,137   1,269,875 
Vertex Aerospace Services Corp Aerospace & Defense Term Loan (10/21) Loan  1M USD LIBOR+ 3.50%  0.75%  8.13%  12/6/2028   992,500   988,789   987,895 
VFH Parent LLC Banking, Finance, Insurance & Real Estate Term Loan (01/22) Loan  1M USD SOFR+ 3.00%  0.50%  7.66%  1/12/2029   3,069,879   3,063,097   3,036,111 
Viasat Inc Telecommunications Term Loan (2/22) Loan  1M USD SOFR+ 4.50%  0.50%  9.23%  3/2/2029   1,994,987   1,948,951   1,967,137 
Virtus Investment Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (9/21) Loan  1M USD LIBOR+ 2.25%  0.00%  6.85%  9/28/2028   2,853,409   2,845,646   2,834,377 
Vistra Energy Corp Utilities: Electric 2018 Incremental Term Loan Loan  1M USD LIBOR+ 1.75%  0.00%  6.38%  12/31/2025   897,014   896,802   895,023 
Vizient, Inc Healthcare & Pharmaceuticals Term Loan 4/22 Loan  1M USD SOFR+ 2.25%  0.50%  6.91%  5/16/2029   497,500   492,868   496,525 
VM Consolidated, Inc. Construction & Building Term Loan B (3/21) Loan  1M USD LIBOR+ 3.25%  0.00%  7.88%  3/24/2028   2,185,087   2,183,095   2,180,170 
Vouvray US Finance LLC High Tech Industries Term Loan Loan  1M USD SOFR+ 6.00%  1.00%  10.62%  9/9/2025   471,250   471,250   442,386 
Walker & Dunlop, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (12/22) Loan  1M USD SOFR+ 3.00%  0.50%  7.72%  12/15/2028   500,000   490,249   496,250 
Warner Music Group Corp. (WMG Acquisition Corp.) Hotel, Gaming & Leisure Term Loan Incremental (11/22) Loan  1M USD SOFR+ 3.00%  0.50%  7.62%  1/19/2028   500,000   490,562   498,960 
Warner Music Group Corp. (WMG Acquisition Corp.) Hotel, Gaming & Leisure Term Loan G Loan  1M USD LIBOR+ 2.13%  0.00%  6.76%  1/20/2028   1,250,000   1,249,851   1,243,750 
Watlow Electric Manufacturing Company High Tech Industries Term Loan B Loan  3M USD SOFR+ 3.75%  0.50%  8.69%  3/2/2028   2,456,250   2,447,468   2,417,368 
West Corporation Telecommunications Term Loan B-3 Loan  3M USD SOFR+ 4.00%  1.00%  8.93%  4/9/2027   1,189,119   1,172,865   1,044,939 
WEX Inc. Services: Business Term Loan B (3/21) Loan  1M USD LIBOR+ 2.25%  0.00%  6.88%  3/31/2028   2,954,924   2,946,492   2,944,582 
WildBrain Ltd. Media: Diversified & Production Term Loan Loan  1M USD SOFR+ 4.25%  0.75%  8.98%  3/27/2028   1,965,000   1,935,307   1,864,903 
Xperi Corporation High Tech Industries Term Loan Loan  1M USD LIBOR+ 3.50%  0.00%  8.13%  6/8/2028   2,427,446   2,420,580   2,388,752 
Zayo Group, LLC Telecommunications Term Loan 4/22 Loan  1M USD SOFR+ 4.25%  0.50%  8.87%  3/9/2027   992,500   971,029   842,027 
ZEBRA BUYER (Allspring) LLC Banking, Finance, Insurance & Real Estate Term Loan 4/21 Loan  3M USD LIBOR+ 3.00%  0.50%  7.75%  11/1/2028   880,444   876,985   874,941 
Zekelman Industries, Inc. Metals & Mining Term Loan (01/20) Loan  3M USD LIBOR+ 2.00%  0.00%  6.73%  1/25/2027   961,471   961,471   948,251 
Zest Acquisition Corp. Healthcare & Pharmaceuticals Term Loan (1/23) Loan  1M USD SOFR+ 5.50%  0.00%  10.07%  1/31/2028   2,000,000   1,901,512   1,928,340 
Zodiac Pool Solutions Consumer goods: Durable Term Loan (1/22) Loan  1M USD SOFR+ 2.00%  0.50%  6.72%  1/29/2029   495,000   494,015   490,192 
 TOTAL INVESTMENTS                            $

645,599,001

  $

605,954,468

 


  Number of Shares  Cost  Fair Value 
Cash and cash equivalents         
U.S. Bank Money Market (c)  23,776,950  $23,776,950  $23,776,950 
Total cash and cash equivalents  23,776,950  $23,776,950  $23,776,950 

(a)All or a portion of this investment has an unfunded commitment as of February 28, 2023.
(b)As of February 28, 2023, the investment was in default and on non-accrual status.
(c)Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 28, 2023.
(d)Investments include Payment-in-Kind Interest.

LIBOR—London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
 Spread  LIBOR
Floor
  PIK  Current
Rate
(All In)
  Maturity
Date
  Principal/
Number of
Shares
  Cost  Fair Value 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares Equity  0.00  0.00  0.00  0.00   6,692  $669,214  $6,725 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares Equity  0.00  0.00  0.00  0.00   18,975   1,897,538   247 

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Common Stock Equity  0.00  0.00  0.00  0.00   14,813   964,466   15,746 

24 Hour Holdings III, LLC

 Leisure Goods/Activities/Movies Term Loan Loan  3.75  1.00  0.00  4.75  5/28/2021  $487,500   484,284   476,127 

ABBCon-Cise Optical Group, LLC

 Healthcare & Pharmaceuticals Term Loan B Loan  5.00  1.00  0.00  6.00  6/15/2023   1,995,000   1,975,193   2,009,963 

Acosta Holdco, Inc.

 Media Term Loan B1 Loan  3.25  1.00  0.00  4.29  9/26/2021   1,940,025   1,929,297   1,893,348 

Advantage Sales & Marketing, Inc.

 Services: Business Delayed Draw Term Loan Loan  3.25  1.00  0.00  4.25  7/25/2021   2,446,206   2,443,710   2,438,574 

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan Loan  4.50  1.00  0.00  5.50  2/24/2021   2,463,550   2,337,204   2,412,234 

Agrofresh, Inc.

 Food Services Term Loan Loan  4.75  1.00  0.00  5.75  7/30/2021   1,970,000   1,962,367   1,898,587 

AI MISTRAL T/L (V. GROUP)

 Utilities Term Loan Loan  3.00  1.00  0.00  4.00  3/11/2024   500,000   500,000   500,940 

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  1.00  0.00  5.25  4/16/2021   398,056   396,948   403,529 

Albertson’s LLC

 Retailers (Except Food and Drugs) Term LoanB-4 Loan  3.00  0.75  0.00  3.78  8/25/2021   2,896,193   2,879,009   2,931,179 

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Term Loan B Loan  3.25  1.00  0.00  4.25  6/20/2022   917,946   916,144   919,479 

Alion Science and Technology Corporation

 High Tech Industries Term Loan B (First Lien) Loan  4.50  1.00  0.00  5.50  8/19/2021   2,955,000   2,943,621   2,951,306 

Alliance Healthcare Services, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  3.25  1.00  0.00  4.29  6/3/2019   984,570   981,094   977,184 

ALPHA 3 T/L B1 (ATOTECH)

 Chemicals/Plastics Term Loan B 1 Loan  3.00  1.00  0.00  4.00  1/31/2024   250,000   249,377   252,500 

Anchor Glass T/L (11/16)

 Containers/Glass Products Term Loan Loan  3.25  1.00  0.00  4.25  12/7/2023   500,000   497,626   505,780 

APCO Holdings, Inc.

 Automotive Term Loan Loan  6.00  1.00  0.00  7.00  1/31/2022   1,933,919   1,887,037   1,885,571 

Aramark Corporation

 Food Products U.S. Term F Loan Loan  2.50  0.75  0.00  3.50  2/24/2021   3,118,358   3,118,358   3,147,327 

Aspen Dental Management, Inc.

 Healthcare & Pharmaceuticals Term Loan Initial Loan  4.25  1.00  0.00  5.25  4/29/2022   1,484,941   1,481,061   1,491,446 

Astoria Energy T/L B

 Utilities Term Loan Loan  4.00  1.00  0.00  5.00  12/24/2021   1,495,307   1,480,354   1,499,045 

Asurion, LLC (fka Asurion Corporation)

 Insurance Replacement Term LoanB-2 Loan  3.25  0.75  0.00  4.03  7/8/2020   531,422   526,976   537,024 

Asurion, LLC (fka Asurion Corporation)

 Insurance Term Loan B4 (First Lien) Loan  3.25  1.00  0.00  4.25  8/4/2022   2,434,375   2,422,950   2,463,661 

Auction.com, LLC

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.00  1.00  0.00  6.00  5/13/2019   2,718,634   2,718,434   2,739,024 

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan Loan  5.00  1.00  0.00  6.00  6/21/2022   2,784,429   2,760,689   2,819,234 

AVOLON TLB BORROWER 1 LUXEMBOURG S.A.R.L.

 Capital Equipment Term LoanB-2 Loan  2.75  0.75  0.00  3.50  3/20/2022   1,000,000   995,000   1,017,300 

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) Term Loan Loan  3.25  0.75  0.00  4.02  6/5/2020   1,473,750   1,471,637   1,411,116 

Belmond Interfin Ltd.

 Lodging & Casinos Term Loan Loan  3.00  1.00  0.00  4.00  3/19/2021   2,481,122   2,484,502   2,488,888 

BJ’s Wholesale Club, Inc.

 Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien) Loan  3.75  1.00  0.00  4.75  2/2/2024   1,500,000   1,496,335   1,487,385 

Blackboard T/L B4

 High Tech Industries Term Loan B4 Loan  5.00  1.00  0.00  6.02  6/30/2021   2,992,500   2,969,529   3,008,390 

BMC Software

 Technology Term Loan Loan  4.00  1.00  0.00  5.00  9/10/2020   1,959,596   1,917,256   1,965,729 

BMC Software T/L US

 Technology Term Loan Loan  4.00  1.00  0.00  5.00  9/10/2020   676,193   665,400   679,607 

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan  3.00  1.00  0.00  4.00  12/18/2020   1,461,186   1,451,382   1,467,952 

BWAY Holding Company

 Leisure Goods/Activities/Movies Term Loan B Loan  3.25  0.00  0.00  4.75  8/14/2023   1,189,327   1,179,242   1,189,826 

Candy Intermediate Holdings, Inc.

 Beverage, Food & Tobacco Term Loan Loan  4.50  1.00  0.00  5.50  6/15/2023   497,500   495,317   500,609 

Capital Automotive L.P.

 Conglomerate TrancheB-1 Term Loan Facility Loan  3.00  1.00  0.00  4.00  4/10/2019   1,487,353   1,489,058   1,500,829 

CASA SYSTEMS T/L

 Telecommunications Term Loan Loan  4.00  1.00  0.00  5.00  12/20/2023   1,500,000   1,485,318   1,500,000 

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan Loan  2.75  1.00  0.00  3.75  5/20/2021   424,821   423,456   429,953 

Cengage Learning Acquisitions, Inc.

 Publishing Term Loan Loan  4.25  1.00  0.00  5.25  6/7/2023   1,492,500   1,477,575   1,411,965 

CH HOLD (CALIBER COLLISION) T/L

 Automotive Term Loan Loan  3.00  0.00  0.00  4.00  2/1/2024   227,273   226,758   229,545 

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan Loan  2.00  0.00  0.00  2.79  1/3/2021   1,609,533   1,603,525   1,617,130 

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term G Loan Loan  2.75  1.00  0.00  3.80  12/31/2019   981,177   960,939   972,866 

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term H Loan Loan  3.00  1.00  0.00  4.05  1/27/2021   1,805,352   1,763,950   1,773,940 

CITGO Petroleum Corporation

 Oil & Gas Term Loan B Loan  3.50  1.00  0.00  4.50  7/29/2021   1,964,874   1,946,245   1,976,172 

Communications Sales & Leasing, Inc.

 Telecommunications Term Loan B (First Lien) Loan  3.00  1.00  0.00  4.00  10/24/2022   1,970,062   1,958,282   1,980,405 

Concordia Healthcare Corporation

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  1.00  0.00  5.25  10/21/2021   1,980,000   1,891,488   1,615,522 

Consolidated Aerospace Manufacturing, LLC

 Aerospace and Defense Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  8/11/2022   1,418,750   1,412,839   1,365,547 

Consolidated Communications, Inc.

 Telecommunications Term LoanB-2 Loan  3.00  1.00  0.00  4.00  10/5/2023   500,000   497,500   502,890 

CPI Acquisition Inc.

 Technology Term Loan B (First Lien) Loan  4.50  1.00  0.00  5.83  8/17/2022   1,436,782   1,418,783   1,289,511 

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan Loan  3.25  1.00  0.00  4.25  11/17/2017   2,462,342   2,461,490   2,457,934 

Crosby US Acquisition Corporation

 Industrial Equipment Initial Term Loan (First Lien) Loan  3.00  1.00  0.00  4.05  11/23/2020   727,500   726,911   667,329 

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan Loan  4.25  1.00  0.00  5.25  12/1/2021   1,470,113   1,458,924   1,389,256 

Culligan InternationalCompany-T/L

 Conglomerate Term Loan Loan  4.00  1.00  0.00  5.00  12/13/2023   2,050,000   2,049,738   2,083,313 

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan Loan  3.25  1.00  0.00  4.25  12/23/2020   470,093   467,345   342,580 

DAE Aviation (StandardAero)

 Aerospace and Defense Term Loan Loan  4.25  1.00  0.00  5.25  7/7/2022   1,975,000   1,967,190   1,987,838 

DASEKE T/L (HENNESSY CAPITAL)

 Transportation Term Loan Loan  5.50  1.00  0.00  6.50  2/27/2024   714,286   707,143   717,857 

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan Loan  7.25  1.50  0.00  8.75  3/19/2018   2,101,458   2,096,045   2,101,458 

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term LoanB-3 Loan  3.75  1.00  0.00  5.07  7/30/2021   1,000,000   996,568   1,002,920 

DELL INTERNATIONAL 1ST LIEN T/L

 High Tech Industries Term Loan (01/17) Loan  2.50  0.75  0.00  3.25  9/7/2023   1,000,000   998,850   1,006,480 

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (Incremental) Loan  6.00  1.00  0.00  7.04  2/28/2020   1,000,000   972,672   997,500 

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  5.50  1.00  0.00  6.54  2/28/2020   1,868,084   1,869,141   1,864,199 

DEX MEDIA, INC.

 Media Term Loan (07/16) Loan  10.00  1.00  0.00  11.00  7/29/2021   43,444   43,444   44,041 

Diebold, Inc.

 High Tech Industries Term Loan B Loan  4.50  0.75  0.00  5.31  11/6/2023   398,750   395,190   404,731 

DIGITALGLOBE T/L B (12/16)

 Aerospace and Defense Term Loan B Loan  2.75  0.75  0.00  3.53  1/15/2024   500,000   498,815   502,030 

DJO Finance, LLC

 Healthcare & Pharmaceuticals Term Loan Loan  3.25  1.00  0.00  4.25  6/8/2020   492,500   490,933   483,388 

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan 2015 Incr Dollar Loan  3.25  1.00  0.00  4.25  3/11/2021   2,925,000   2,919,916   2,937,431 

Drew Marine Group, Inc.

 Chemicals/Plastics Term Loan (First Lien) Loan  3.25  1.00  0.00  4.25  11/19/2020   2,950,591   2,923,591   2,928,461 

DTZ U.S. Borrower, LLC

 Construction & Building Term Loan BAdd-on Loan  3.25  1.00  0.00  4.30  11/4/2021   1,962,557   1,954,741   1,973,703 

DUKE FINANCE (OM GROUP/VECTRA) T/L

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.00  1.00  0.00  6.00  2/21/2024   1,500,000   1,395,987   1,511,250 

Edelman Financial Group, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.50  1.00  0.00  6.51  12/19/2022   1,485,000   1,459,535   1,487,317 

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan A Loan  4.50  1.00  0.00  5.51  7/2/2020   501,970   488,778   177,446 

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan B (2.00% Cash/6.50% PIK) Loan  1.00  1.00  6.50  8.51  7/2/2020   954,307   934,189   77,938 

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  3.50  1.00  0.00  4.50  8/1/2021   480,756   479,151   483,308 

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.75  1.00  0.00  8.75  8/1/2022   500,000   498,153   498,595 

Emerald 2 Limited

 Chemicals/Plastics Term Loan B1A Loan  4.00  1.00  0.00  5.00  5/14/2021   1,000,000   994,172   950,000 

Endo International plc

 Healthcare & Pharmaceuticals Term Loan B Loan  3.00  0.75  0.00  3.81  9/26/2022   990,000   987,999   994,247 

EnergySolutions, LLC

 Environmental Industries Term Loan B Loan  5.75  1.00  0.00  6.75  5/29/2020   795,000   785,654   799,969 

Engility Corporation

 Aerospace and Defense Term LoanB-1 Loan  4.25  0.70  0.00  4.03  8/12/2020   243,750   242,680   245,503 

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan Loan  3.75  1.25  0.00  5.00  7/9/2019   955,106   954,175   846,224 

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  1/15/2021   1,947,330   1,943,904   1,954,632 

EWT Holdings III Corp.

 Capital Equipment Term Loan Loan  4.50  1.00  0.00  5.50  1/15/2021   992,500   984,248   997,463 

Extreme Reach, Inc.

 Media Term Loan B Loan  6.25  1.00  0.00  7.25  2/7/2020   2,887,500   2,860,092   2,905,547 

Federal-Mogul Corporation

 Automotive Tranche C Term Loan Loan  3.75  1.00  0.00  4.75  4/15/2021   2,925,000   2,915,873   2,894,434 

First Data Corporation

 Financial Intermediaries First Data T/L Ext (2021) Loan  3.00  0.70  0.00  3.78  3/24/2021   1,886,914   1,804,119   1,904,010 

First Eagle Investment Management

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.00  0.75  0.00  5.00  12/1/2022   1,485,000   1,460,081   1,493,361 

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  5.00  1.00  0.00  6.00  7/1/2020   1,929,311   1,905,661   1,947,793 

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 Nonferrous Metals/Minerals Loan Loan  2.75  1.00  0.00  3.75  6/28/2019   801,502   802,865   806,279 

Garda World Security Corporation

 Services: Business Term B Delayed Draw Loan Loan  3.00  1.00  0.00  4.00  11/6/2020   197,083   196,509   197,822 

Garda World Security Corporation

 Services: Business Term B Loan Loan  3.00  1.00  0.00  4.00  11/6/2020   770,417   768,226   773,306 

Gardner Denver, Inc.

 High Tech Industries Initial Dollar Term Loan Loan  3.25  1.00  0.00  4.57  7/30/2020   2,426,061   2,421,316   2,420,263 

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  3.25  1.00  0.00  4.25  7/5/2021   481,656   476,839   481,478 

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan  2.50  0.75  0.00  3.29  3/4/2019   2,121,102   2,117,573   1,765,817 

GLOBALLOGIC HOLDINGS INC TERM LOAN B

 Services: Business Term Loan B Loan  4.50  1.00  0.00  5.50  6/20/2022   500,000   495,133   501,250 

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien) Loan  3.75  1.25  0.00  5.00  5/26/2020   2,667,633   2,661,035   2,654,962 

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien) Loan  3.00  0.75  0.00  3.78  4/30/2019   1,333,333   1,320,613   1,333,747 

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan Loan  2.75  1.00  0.00  3.75  1/4/2021   1,014,560   1,011,573   1,010,755 

GTCR Valor Companies, Inc.

 Services: Business Term Loan B Loan  6.00  1.00  0.00  7.00  6/16/2023   1,492,500   1,436,528   1,501,201 

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing TrancheB-4 Term Loan Loan  5.50  1.00  0.00  6.50  2/9/2022   2,176,889   2,117,378   2,190,495 

Headwaters Incorporated

 Building & Development Term Loan Loan  3.00  1.00  0.00  4.00  3/24/2022   242,058   241,141   242,784 

Help/Systems Holdings, Inc.

 High Tech Industries Term Loan Loan  5.25  1.00  0.00  6.25  10/8/2021   1,485,000   1,433,886   1,485,000 

Hemisphere Media Holdings, LLC

 Media Term Loan B Loan  3.50  0.00  0.00  4.27  2/14/2024   2,500,000   2,512,500   2,493,750 

Herbalife T/L B (HLF Financing)

 Drugs Term Loan B Loan  5.50  0.75  0.00  6.28  2/15/2023   2,000,000   1,985,000   2,001,660 

Hercules Achievement Holdings, Inc.

 Retailers (Except Food and Drugs) Term Loan B Loan  4.00  1.00  0.00  5.00  12/10/2021   246,851   244,820   250,431 

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan Loan  4.50  1.00  0.00  5.50  11/21/2023   1,000,000   1,003,734   1,013,750 

Hostess Brand, LLC

 Beverage, Food & Tobacco Term Loan B (First Lien) Loan  3.00  1.00  0.00  4.00  8/3/2022   1,490,000   1,486,482   1,507,508 

Huntsman International LLC

 Chemicals/Plastics Term Loan B (First Lien) Loan  3.00  0.70  0.00  3.78  4/19/2019   1,518,031   1,510,811   1,525,150 

Husky Injection Molding Systems Ltd.

 Services: Business Term Loan B Loan  3.25  1.00  0.00  4.25  6/30/2021   469,398   467,182   472,158 

Hyperion Refinance T/L

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.50  1.00  0.00  5.50  4/29/2022   1,994,924   1,971,849   1,998,675 

Imagine! Print Solutions, Inc.

 Media Term Loan B Loan  6.00  1.00  0.00  7.00  3/30/2022   496,250   489,837   499,972 

Infor US (Lawson) T/LB-6

 Services: Business Term LoanB-6 Loan  2.75  1.00  0.00  3.75  2/1/2022   1,609,802   1,595,316   1,610,945 

Informatica Corporation

 High Tech Industries Term Loan B Loan  3.50  1.00  0.00  4.50  8/5/2022   493,750   492,732   490,664 

Insight Global

 Services: Business Term Loan Loan  5.00  1.00  0.00  6.00  10/29/2021   3,450,126   3,434,977   3,471,690 

ION Media T/L B

 Media Term Loan B Loan  3.50  1.00  0.00  4.50  12/18/2020   500,000   497,615   506,875 

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) TermB-1 Loan Retired 03/05/2014 Loan  3.00  1.00  0.00  4.00  3/5/2021   945,756   945,756   540,660 

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14 Loan  3.50  1.00  0.00  4.50  6/19/2021   487,879   487,106   471,208 

J.Jill Group, Inc.

 Retailers (Except Food and Drugs) Term Loan (First Lien) Loan  5.00  1.00  0.00  6.04  5/9/2022   950,648   946,877   935,200 

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Term Loan F-1 Loan  4.00  1.00  0.00  4.28  2/2/2024   2,400,000   2,388,246   2,399,496 

Koosharem, LLC

 Services: Business Term Loan Loan  6.50  1.00  0.00  7.50  5/15/2020   2,935,100   2,917,778   2,730,259 

Kraton Polymers, LLC

 Chemicals/Plastics Term Loan (Initial) Loan  5.00  1.00  0.00  5.00  1/6/2022   2,500,000   2,286,776   2,533,825 

Lannett Company T/L A

 Healthcare & Pharmaceuticals Term Loan A Loan  4.75  1.00  0.00  5.75  11/25/2020   1,000,000   970,576   985,000 

Lannett Company, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  5.38  1.00  0.00  6.38  11/25/2022   1,900,000   1,842,852   1,885,750 

LEARFIELD COMMUNICATIONS INITIAL T/L(A-L PARENT)

 Healthcare & Pharmaceuticals Initial Term Loan(A-L Parent) Loan  3.25  1.00  0.00  4.25  12/1/2023   500,000   497,713   505,625 

Lightstone Generation T/L B

 Utilities Term Loan B Loan  5.50  1.00  0.00  6.54  1/30/2024   913,043   894,897   925,981 

Lightstone Generation T/L C

 Utilities Term Loan C Loan  5.50  1.00  0.00  6.54  1/30/2024   86,957   85,236   88,189 

Limetree Bay Terminals T/L (01/17)

 Oil & Gas Term Loan Loan  5.00  1.00  0.00  6.04  2/15/2024   500,000   495,000   503,125 

LPL Holdings

 Banking, Finance, Insurance & Real Estate Term Loan B (2022) Loan  4.00  0.75  0.00  4.78  11/21/2022   1,980,000   1,963,355   2,007,225 

Mauser Holdings, Inc.

 Containers/Glass Products Term Loan Loan  3.50  1.00  0.00  4.50  7/31/2021   488,750   487,123   488,647 

McGraw-Hill Global Education Holdings, LLC

 Publishing Term Loan Loan  4.00  1.00  0.00  5.00  5/4/2022   995,000   990,840   977,468 

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B1 Loan  2.75  1.00  0.00  3.75  1/30/2023   1,679,779   1,674,140   1,674,673 

Micro Holding Corporation

 High Tech Industries Term Loan Loan  3.75  1.00  0.00  4.75  7/8/2021   982,378   978,629   985,079 

Microsemi Corporation

 Electronics/Electric Term Loan B Loan  2.25  0.00  0.00  3.03  1/17/2023   868,445   845,882   874,593 

Midas Intermediate Holdco II, LLC

 Automotive Term Loan (Initial) Loan  3.50  1.00  0.00  3.75  8/18/2021   244,375   243,499   246,005 

Milacron T/L B

 Capital Equipment Term Loan B Loan  3.00  0.00  0.00  3.78  9/28/2023   1,000,000   996,250   1,004,380 

Milk Specialties Company

 Beverage, Food & Tobacco Term Loan Loan  5.00  1.00  0.00  5.00  8/16/2023   997,500   987,646   1,004,562 

Mister Car Wash T/L

 Automotive Term Loan Loan  4.25  1.00  0.00  5.25  8/20/2021   831,203   825,179   832,931 

MSC Software Corporation

 Services: Business Term Loan Loan  4.00  1.00  0.00  5.00  5/29/2020   1,969,898   1,931,995   1,972,360 

MWI Holdings, Inc.

 Capital Equipment Term Loan (First Lien) Loan  5.50  1.00  0.00  6.50  6/29/2020   2,985,000   2,956,823   3,007,388 

National Veterinary Associates, Inc

 Healthcare & Pharmaceuticals Term Loan B Loan  3.50  1.00  0.00  4.50  8/14/2021   977,543   974,893   982,430 

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien) Loan  5.75  1.00  0.00  6.75  3/11/2022   250,000   249,793   242,750 

New Media Holdings II T/L (NEW)

 Retailers (Except Food and Drugs) Term Loan Loan  6.25  1.00  0.00  7.25  6/4/2020   3,168,116   3,154,983   3,140,395 

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Term Loan Loan  6.50  1.00  0.00  7.50  12/21/2020   1,930,106   1,777,976   980,494 

Novetta Solutions

 Aerospace and Defense Term Loan (200MM) Loan  5.00  1.00  0.00  6.00  10/16/2022   1,980,000   1,963,361   1,890,900 

Novetta Solutions

 Aerospace and Defense Term Loan (2nd Lien) Loan  8.50  1.00  0.00  9.50  10/16/2023   1,000,000   991,237   930,000 

NPC International, Inc.

 Food Services Term Loan (2013) Loan  3.75  1.00  0.00  4.75  12/28/2018   476,250   476,250   477,241 

NVA Holdings (National Veterinary) T/L B2

 Services: Consumer Term Loan B2 Loan  3.50  1.00  0.00  4.50  8/14/2021   129,601   129,601   130,897 

NVA Holdings, Inc.

 Services: Consumer Term Loan B1 Loan  3.50  1.00  0.00  4.50  8/14/2021   157,443   157,108   158,034 

NXT Capital T/L (11/16)

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.50  1.00  0.00  5.50  11/23/2022   1,000,000   995,240   1,013,750 

ON Semiconductor Corporation

 High Tech Industries Term Loan B Loan  3.25  0.70  0.00  4.03  3/31/2023   498,750   491,370   503,204 

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013) Loan  4.00  1.00  0.00  5.00  6/7/2019   3,613,555   3,606,228   3,490,297 

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B Loan  3.75  1.00  0.00  4.75  10/1/2021   488,750   486,195   475,554 

OpenLink International, LLC

 Services: Business Term B Loan Loan  6.50  1.25  0.00  7.75  7/29/2019   2,913,824   2,913,362   2,938,096 

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing Loan  3.25  1.00  0.00  4.54  6/24/2019   1,417,598   1,413,680   1,389,245 

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien) Loan  4.00  1.00  0.00  5.25  10/30/2020   970,000   966,928   933,625 

Petsmart, Inc. (Argos Merger Sub, Inc.)

 Retailers (Except Food and Drugs) Term Loan B1 Loan  3.00  1.00  0.00  4.00  3/11/2022   982,500   977,998   967,183 

PGX Holdings, Inc.

 Financial Intermediaries Term Loan Loan  5.25  1.00  0.00  6.25  9/29/2020   2,891,464   2,876,188   2,889,671 

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan Loan  3.50  0.75  0.00  4.28  3/31/2021   2,392,341   2,385,223   2,407,293 

Polycom Term Loan (9/16)

 Telecommunications Term Loan Loan  5.25  1.00  0.00  6.25  9/27/2023   1,894,167   1,868,863   1,907,426 

PrePaid Legal Services, Inc.

 Services: Business Term Loan B Loan  5.25  1.25  0.00  6.50  7/1/2019   3,328,536   3,330,285   3,335,825 

Presidio, Inc.

 Services: Business Term Loan Loan  3.50  1.00  0.00  4.50  2/2/2022   2,297,698   2,248,964   2,314,930 

Prestige Brands T/L B4

 Drugs Term Loan B4 Loan  2.75  0.75  0.00  3.53  1/26/2024   500,000   498,779   506,040 

Prime Security Services (Protection One)

 Services: Business Term Loan Loan  3.25  1.00  0.00  4.25  5/2/2022   1,985,025   1,975,632   2,003,645 

Ranpak Holdings, Inc.

 Services: Business Term Loan Loan  3.25  1.00  0.00  4.25  10/1/2021   916,047   913,757   918,337 

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien) Loan  7.25  1.00  0.00  8.25  10/3/2022   500,000   498,149   475,000 

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien) Loan  3.50  1.00  0.00  4.54  12/3/2020   485,019   483,001   486,634 

Regal Cinemas Corporation

 Services: Consumer Term Loan Loan  2.50  0.75  0.00  3.28  4/1/2022   495,009   493,772   499,573 

Research Now Group, Inc

 Media Term Loan B Loan  4.50  1.00  0.00  5.50  3/18/2021   2,037,705   2,029,696   2,002,045 

Resolute Investment Managers, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.25  1.00  0.00  5.25  4/30/2022   240,815   239,883   241,518 

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan Loan  2.75  1.00  0.00  3.75  8/21/2023   732,374   732,374   736,497 

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan Loan  2.75  1.00  0.00  3.75  8/21/2023   641,402   641,402   645,013 

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan Loan  3.00  0.00  0.00  3.78  2/3/2023   1,761,134   1,761,134   1,773,603 

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric TrancheB-3 Term Loan Loan  2.50  0.75  0.00  3.29  7/2/2021   1,462,500   1,457,765   1,467,984 

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.50  1.00  0.00  8.50  6/19/2023   275,862   274,109   276,552 

Royal Holdings T/L (02/17)

 Chemicals/Plastics Term Loan (Second Lien) Loan  3.25  1.00  0.00  4.25  6/17/2022   541,607   539,167   544,992 

RPI Finance Trust

 Financial Intermediaries TermB-4 Term Loan Loan  2.50  0.00  0.00  3.50  10/14/2022   2,554,764   2,554,764   2,580,848 

Russell Investment Management T/L B

 Banking, Finance, Insurance & Real Estate Term Loan B Loan  5.75  1.00  0.00  6.75  6/1/2023   2,240,000   2,127,043   2,259,600 

Sable International Finance Ltd

 Telecommunications Term Loan B2 Loan  4.75  0.75  0.00  5.53  12/30/2022   1,500,000   1,470,825   1,521,570 

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien) Loan  4.00  1.00  0.00  5.00  3/27/2021   972,500   969,442   870,388 

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2 Loan  4.00  0.75  0.00  4.85  10/1/2021   769,549   762,102   781,416 

SCS Holdings (Sirius Computer)

 High Tech Industries Term Loan (First Lien) Loan  4.25  1.00  0.00  5.25  10/31/2022   1,972,528   1,934,960   1,991,030 

Seadrill Operating LP

 Oil & Gas Term Loan B Loan  3.00  1.00  0.00  4.00  2/21/2021   977,330   922,444   729,635 

Shearers Foods LLC

 Food Services Term Loan (First Lien) Loan  3.94  1.00  0.00  4.94  6/30/2021   977,500   975,832   979,944 

Sitel Worldwide

 Telecommunications Term Loan Loan  5.50  1.00  0.00  6.56  9/18/2021   1,975,000   1,959,274   1,961,432 

SMB Shipping Logistics T/L B (REP WWEX Acquisition)

 Transportation Term Loan B Loan  4.50  1.00  0.00  5.53  2/2/2024   1,000,000   995,095   1,008,330 

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  3.75  1.00  0.00  4.75  12/10/2020   207,981   207,633   208,501 

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan Loan  3.75  1.00  0.00  4.75  12/10/2020   1,178,561   1,176,588   1,181,508 

Sophia, L.P.

 Electronics/Electric Term Loan (Closing Date) Loan  3.25  1.00  0.00  4.25  9/30/2022   1,960,897   1,951,404   1,967,761 

SourceHOV LLC

 Services: Business Term Loan B (First Lien) Loan  6.75  1.00  0.00  7.75  10/31/2019   1,837,500   1,804,647   1,808,412 

SRAM, LLC

 Industrial Equipment Term Loan (First Lien) Loan  3.00  1.00  0.00  4.00  4/10/2020   2,725,103   2,719,454   2,718,289 

Steak ‘n Shake Operations, Inc.

 Food Services Term Loan Loan  3.75  1.00  0.00  4.75  3/19/2021   923,173   917,444   930,097 

Survey Sampling International

 Services: Business Term Loan B Loan  5.00  1.00  0.00  6.00  12/16/2020   2,721,749   2,707,531   2,721,749 

Sybil Finance BV

 High Tech Industries Term Loan B Loan  4.00  1.00  0.00  5.00  9/30/2022   987,500   982,957   1,002,006 

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan Loan  3.00  1.00  0.00  4.04  4/23/2019   468,977   466,972   427,473 

TaxACT, Inc.

 Services: Business Term Loan B Loan  6.00  1.00  0.00  7.00  1/3/2023   1,200,000   1,168,727   1,206,000 

Tectum Holdings, Inc.

 Transportation Delayed Draw Term Loan (Initial) Loan  4.75  1.00  0.00  5.80  8/24/2023   997,500   988,185   1,004,981 

Tennessee Merger T/L (Team Health)

 Healthcare & Pharmaceuticals Term Loan Loan  2.75  1.00  0.00  3.75  2/6/2024   1,000,000   997,518   996,880 

TGI Friday’s, Inc.

 Food Services Term Loan B Loan  4.25  1.00  0.00  5.25  7/15/2020   1,651,817   1,648,856   1,646,316 

Townsquare Media, Inc.

 Media Term Loan B Loan  3.00  1.00  0.00  4.00  4/1/2022   932,522   927,933   937,185 

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B Loan  4.00  1.00  0.00  5.00  10/2/2021   1,413,873   1,364,619   1,426,683 

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan Loan  3.00  0.75  0.00  3.78  2/28/2020   4,233,198   4,238,155   4,249,920 

Travel Leaders Group, LLC

 Hotel, Gaming and Leisure Term Loan B Loan  5.25  0.00  0.00  6.03  1/25/2024   2,000,000   1,990,095   2,025,000 

Trugreen Limited Partnership

 Services: Business Term Loan B Loan  5.50  1.00  0.00  6.50  4/13/2023   497,500   490,931   503,719 

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B Loan  3.50  1.00  0.00  4.50  7/10/2020   809,438   810,684   819,556 

Univar Inc.

 Chemicals/Plastics Term B Loan Loan  2.75  0.00  0.00  3.61  7/1/2022   2,962,500   2,948,361   2,971,565 

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan Loan  3.00  1.00  0.00  4.00  3/1/2020   2,885,666   2,876,319   2,896,949 

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B Loan  4.25  0.75  0.00  5.03  2/13/2019   2,445,056   2,437,788   2,456,890 

Verint Systems Inc.

 Services: Business Term Loan Loan  2.75  0.75  0.00  3.53  9/6/2019   1,006,278   1,003,396   1,010,554 

Vistra Operations Company T/L B (12/16)

 Utilities Term Loan B Loan  3.25  0.75  0.00  4.02  12/13/2023   500,000   498,784   502,970 

Vizient Inc.

 Healthcare & Pharmaceuticals Term Loan Loan  4.00  1.00  0.00  5.00  2/13/2023   879,853   856,884   891,405 

Vouvray US Finance

 Industrial Equipment Term Loan Loan  3.75  1.00  0.00  4.75  6/27/2021   487,500   485,889   486,891 

Washington Inventory Service

 Services: Business U.S. Term Loan (First Lien) Loan  0.00  0.00  5.75  5.75  12/20/2018   1,735,292   1,743,798   1,418,601 

Western Digital Corporation

 High Tech Industries Term Loan B (USD) Loan  3.75  0.75  0.00  4.53  5/1/2023   1,592,000   1,547,312   1,602,396 

Windstream Services, LLC

 Telecommunications Term Loan B6 Loan  4.00  0.75  0.00  4.78  3/29/2021   999,375   989,489   1,006,121 

Xerox Business Services T/L B (Conduent)

 Services: Business Term Loan Loan  5.50  0.75  0.00  6.28  12/7/2023   750,000   737,850   761,955 

Zekelman Industries (JMC Steel) T/L (01/17)

 Nonferrous Metals/Minerals Term Loan Loan  3.75  1.00  0.00  4.75  6/14/2021   500,000   501,250   506,040 

ZEP, Inc.

 Chemicals/Plastics Term Loan B Loan  4.00  1.00  0.00  5.00  6/27/2022   2,955,000   2,941,390   2,984,550 

Zest Holdings 1st Lien T/L (2014 Replacement)

 Healthcare & Pharmaceuticals Term Loan Loan  4.75  1.00  0.00  5.75  8/17/2020   1,000,000   995,523   1,012,500 
          

 

 

  

 

 

 
          $297,801,502  $292,460,648 
          

 

 

  

 

 

 
                       Principal  Cost  Fair Value 

Cash and cash equivalents

          

U.S. Bank Money Market (a)

        $13,046,555  $13,046,555  $13,046,555 
         

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents

        $13,046,555  $13,046,555  $13,046,555 
         

 

 

  

 

 

  

 

 

 

(a) Included within cash and cash equivalents in Saratoga CLO’s statements of assets and liabilities1M USD LIBOR—The 1 month USD LIBOR rate as of February 28, 2017.

2023 was 4.67%.

3M USD LIBOR—The 3 month USD LIBOR rate as of February 28, 2023 was 4.97%.

6M USD LIBOR—The 6 month USD LIBOR rate as of February 28, 2023 was 5.26%.

1M SOFR - The 1 month SOFR rate as of February 28, 2023 was 4.66%.

3M SOFR - The 3 month SOFR rate as of February 28, 2023 was 4.89%.

6M SOFR - The 6 month SOFR rate as of February 28, 2023 was 5.15%.

Prime—The Prime Rate as of February 28, 2023 was 7.75%.

See accompanying notes to financial statements.


Note 5. Investment in SLF JV

On October 26, 2021, the Company and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

The Company and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with the Company providing $43.75 million and TJHA providing $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note pays a fixed rate of 10.0% per annum and is due and payable in full on October 20, 2033. As of November 30, 2023, the Company and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of November 30, 2023 and February 28, 2023, the Company’s investment in the unsecured note of SLF JV had a fair value of $17.6 million and $17.6 million, respectively, and the Company’s investment in the membership interests of SLF JV had a fair value of $7.8 million and $13.1 million, respectively.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC 810, Consolidation, concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLF JV.

For the three months ended November 30, 2023 and November 30, 2022, the Company earned $0.4 million and $0.1 million, respectively, of interest income related to SLF JV, which is included in interest income. For the nine months ended November 30, 2023 and November 30, 2022, the Company earned $1.3 million and $1.1 million, respectively, of interest income related to SLF JV, which is included in interest income. As of November 30, 2023 and February 28, 2023, $0.2 million and $0.4 million, respectively, of interest income related to SLF JV was included in interest receivable.

For the three months ended November 30, 2023 and November 30, 2022, the Company earned $1.3 million and $0.0 million, respectively, of dividend income related to SLF JV, which is included in dividend income. For the nine months ended November 30, 2023 and November 30, 2022, the Company earned $4.7 million and $0.0 million, respectively, of dividend income related to SLF JV, which is included in dividend income.

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

On October 28, 2022, SLF 2022 issued $402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of November 30, 2023 and February 28, 2023, the fair value of these Class E Notes were $11.5 million and $11.4 million, respectively.


Note 6. Income Taxes

SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-MAC, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., SIA-Vector, Inc., and SIA-VR, Inc., each 100% owned by the Company, are each filing standalone C Corporation tax returns for U.S. federal and state tax purposes. As separately regarded entities for tax purposes, these entities are subject to U.S. federal income tax at normal corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company’s shareholders. Generally, such distributions of the entities’ income to the Company’s shareholders will be considered as qualified dividends for tax purposes. The entities’ taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences arising from net operating losses and unrealized appreciation and deprecation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the taxable blockers. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. received an approved plan of liquidation following the sale of equity held by each of the portfolio companies.

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay the 21% U.S. federal tax on the net capital gain, potentially in the form of a “deemed distribution” to its stockholders.  Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax (provision) benefit from realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations. 

Deferred tax assets and liabilities, and related valuation allowance as of November 30, 2023 and February 28, 2023 were as follows:

  November 30,
2023
  February 28,
2023
 
Total deferred tax assets $2,382,032  $2,542,373 
Total deferred tax liabilities  (3,586,522)  (3,008,829)
Valuation allowance on net deferred tax assets  (2,217,816)  (2,350,116)
Net deferred tax liability $(3,422,306) $(2,816,572)

As of November 30, 2023, the valuation allowance on deferred tax assets was $2.2 million, which represents the federal and state tax effect of net operating losses and unrealized losses that the Company does not believe will be realized through future taxable income. Any adjustments to the Company’s valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.


Net income tax expense for the three months ended November 30, 2023 includes $0.4 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and $0.2 million net change in total operating expense in the consolidated statement of operations, respectively. Net income tax expense for the three months ended November 30, 2022 includes $0.4 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and ($0.5) million income tax provision/benefit from realized gain/(loss) on investments and $0.1 million net change in total operating expense, in the consolidated statement of operations, respectively.

Net income tax expense for the nine months ended November 30, 2023 includes $0.6 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and ($0.0) million net change in total operating expense, in the consolidated statement of operations, respectively. Net income tax expense for the nine months ended November 30, 2022 includes $1.0 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, ($0.5) million income tax provision/(benefit) from realized gain/(loss) on investments and ($0.1) million net change in total operating expense, in the consolidated statement of operations, respectively.

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

Federal and state income tax (provisions) benefit on investments for three and nine months ended November 30, 2023 and November 30, 2022:

  For the three months ended  For the nine months ended 
  November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
Current            
Federal $-  $(255,959) $-  $(473,475)
State  -   (158,721)      (80,273)
Net current expense  -   (414,680)  -   (553,748)
Deferred                
Federal  699,986   460,531   661,245   844,727 
State  (64,192)  (29,901)  (55,512)  45,917 
Net deferred expense  635,794   430,629   605,733   890,645 
Net tax provision $635,794  $15,949  $605,733  $336,896 

Note 7. Agreements and Related Party Transactions

Investment Advisory and Management Agreement

On July 30, 2010, the Company entered into the Management Agreement with ourthe Manager. The initial term of the Management Agreement was two years from its effective date, with automatic, one-year renewals at the end of each year,thereafter subject to certain approvals by ourthe Company’s board of directors and/or the Company’s stockholders. OnMost recently, on July 11, 2017, our6, 2023, the Company’s board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, ourthe Manager implements ourthe Company’s business strategy on a day-to-day basis and performs certain services for us,the Company, subject to oversight by ourthe board of directors. OurThe Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay ourthe Company pays the Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

Base Management Fee and Incentive Management Fee

The base management fee of 1.75% per year is calculated based on the average value of ourthe Company’s gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent quarterly report on Form 10-Q.


The incentive management fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of ourthe Company’s pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, ourthe Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. OurThe Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of ourthe Company’s “incentive fee capital gains,” which equals ourthe Company’s realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and ourthe Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended November 30, 20172023 and November 30, 2016,2022, the Company incurred $1.5$4.9 million and $1.2$4.3 million in base management fees, respectively. For the three months ended November 30, 20172023 and November 30, 2016,2022, the Company incurred $0.8$3.3 million and $0.8$2.3 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended November 30, 2017,2023 and November 30, 2022, the Company accrued $0.3an expense (benefit) of ($1.0) million and ($0.8) million in incentive fees related to capital gains. For the three months ended November 30, 2016, there was a reduction of $0.4 million in incentive fees related to capital gains.

For the nine months ended November 30, 20172023 and November 30, 2016,2022, the Company incurred $4.4$14.3 million and $3.6$12.2 million in base management fees, respectively. For the nine months ended November 30, 20172023 and November 30, 2016,2022, the Company incurred $2.5$9.8 million and $2.2$3.9 million in incentive fees related to pre-incentive fee net investment income, respectively. For the nine months ended November 30, 20172023 and November 30, 2016,2022, the Company accrued $0.4an expense (benefit) of ($5.0) million and $0.1($3.7) million in incentive fees related to capital gains, respectively. gains.


The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2017,2023, the base management fees accrual was $1.5$4.9 million and the incentive fees accrual was $3.7$3.3 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2017,2023, the base management fees accrual was $1.2$4.3 million and the incentive fees accrual was $4.6$7.9 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

Administration Agreement

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with ourthe Manager, pursuant to which ourthe Manager, as ourthe Company’s administrator, has agreed to furnish usthe Company with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on ourthe Company’s behalf to those portfolio companies to which we arethe Company is required to provide such assistance. The initial term of the Administration Agreement was two years from its effective date, with automatic, one-year renewals at the end of each yearthereafter subject to certain approvals by ourthe Company’s board of directors and/or ourthe Company’s stockholders. The amount of

expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two yeartwo-year term of the Administration Agreement and subsequent renewals. OnMost recently, on July 8, 2015, our6, 2023, the Company’s board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not beensubsequently increased since the inception of the agreement, to $1.3 million. On October 5, 2016, our board of directors determined to increase the cap on the payment or reimbursement of expenses by the Company under the Administration Agreement, from $1.3 million to $1.5 million, effective November 1, 2016. On July 11, 2017, our board of directors approved the renewal of the Administration Agreement for an additional one-year term, and determined to increase the cap on the payment or reimbursement of expenses by the Company from $1.5$3.275 million to $1.75$4.3 million, effective August 1, 2017.2023.

For the three months ended November 30, 20172023 and November 30, 2016, we2022, the Company recognized $0.4$1.1 million and $0.3$0.8 million in administrator expenses, respectively, pertaining to bookkeeping, record keepingrecordkeeping and other administrative services provided to usthe Company in addition to ourthe Company’s allocable portion of rent and other overhead related expenses. For the nine months ended November 30, 20172023 and November 30, 2016, we2022, the Company recognized $1.2$2.8 million and $1.0$2.3 million in administrator expenses, respectively, pertaining to bookkeeping, record keepingrecordkeeping and other administrative services provided to usthe Company in addition to ourthe Company’s allocable portion of rent and other overhead related expenses. As of November 30, 2017,2023 and February 28, 2023, $0.4 million and $0.001 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

Saratoga CLO

On December 14, 2018, the Company completed the third refinancing and issuance of the 2013-1 Reset CLO Notes. This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $300 million in assets to approximately $500 million.

In conjunction with the third refinancing and issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to receive an incentive management fee from Saratoga CLO. See Note 4 for additional information.


On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and extended the non-call period to February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of February 28, 2017, $0.4this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of administrator expensesClass F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were accruedrepaid. The Company also paid $2.6 million of transaction costs related to the refinancing and includedupsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At November 30, 2021, the outstanding receivable of 2.6 million was repaid in duefull.

On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to managerthird parties, resulting in a realized loss of $0.1 million.

For the accompanying consolidated statementsthree months ended November 30, 2023 and November 30, 2022, the Company recognized management fee income of assets$0.8 million and liabilities. $0.8 million, respectively, related to the Saratoga CLO.

For the nine months ended November 30, 20172023 and November 30, 2016,2022, the Company recognized management fee income of $2.5 million and $2.5 million, respectively, related to the Saratoga CLO.

For the nine months ended November 30, 2023 and November 30, 2022, the Company neither bought nor sold any investments from the Saratoga CLO.

SLF JV

On October 26, 2021, the Company and TJHA entered into an LLC Agreement to co-manage the SLF JV. SLF JV is a joint venture that invests in the debt or equity interests of collateralized loan obligations, loan, notes and other debt instruments.

On October 28, 2022, SLF 2022 issued $402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee.

As of November 30, 2023, the Company’s investment in the SLF JV had a fair value of $25.4 million, consisting of an unsecured loan of $17.6 million and membership interest of $7.8 million. For the three and nine months ended November 30, 2023, the Company had $0.4 million and $1.3 million, respectively, of interest income related to SLF JV, of which $0.2 million was included in interest receivable as of November 30, 2023. For the three and nine months ended November 30, 2022, the Company had $0.1 million and $0.1 million, respectively, of interest income related to SLF JV, of which $0.0 million was included in interest receivable as of November 30, 2022. For the three and nine months ended November 30, 2023, the Company had $1.3 million and $4.7 million, respectively, of dividend income related to SLF JV. For the three and nine months ended November 30, 2022, the Company had $0.0 million and $0.0 million, respectively, of dividend income related to SLF JV.

As part of the JV CLO trust transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million.


Note 6.8. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0%200% after giving effect to such leverage.leverage, or 150% if certain requirements under the 1940 Act are met. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act”) of the Company (“independent directors”), approved a minimum asset coverage ratio of 150%. The 150% asset coverage ratio became effective on April 16, 2019. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was 284.0%159.3% as of November 30, 20172023 and 271.0%165.9% as of February 28, 2017.2023.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC (the “Madison Credit Facility”), in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have beenSBIC II LP and SBIC III LP, were pledged under the Madison Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended ourOctober 4, 2021, all outstanding amounts on the Madison Credit Facility were repaid and the Madison Credit Facility was terminated. The repayment and termination of the Madison Credit Facility resulted in a realized loss on the extinguishment of debt of $0.8 million.


Encina Credit Facility

On October 4, 2021, the Company entered into the Credit and Security Agreement (the “Credit Agreement”) relating to a $50.0 million senior secured revolving credit facility with Madison Capital Funding LLCthe Lender, supported by loans held by SIF II and pledged to the Encina Credit Facility. The terms of the Encina Credit Facility required a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increased to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. Advances under the Encina Credit Facility originally bore interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to the selection by the Lender and the Company of a replacement benchmark rate. 

On January 27, 2023, we entered into the first amendment to the Credit Agreement to, among other things:

 

expand the borrowing capacity under the Credit Facility from $40.0
increase the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

change the underlying benchmark used to compute interest under the Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

increase the applicable effective margin rate on borrowings from 4.00% to 4.25%;

extend the revolving period from October 4, 2024 to January 27, 2026;

extend the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

revise the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

amend the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

In addition to $45.0 million;

extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lendersany fees or automatically, be terminated. All borrowings and other amounts payable under the terms of the Encina Credit Facility, are due andan administrative agent fee per annum equal to $0.1 million is payable five years after the end of the Revolving Period; and

remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:in equal monthly installments in arrears.

 

extend the commitment termination date from February 24, 2015 to September 17, 2017;

extend the maturity date of the Credit Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

On May 18, 2017, we entered into a third amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

extend the commitment termination date from September 17, 2017 to September 17, 2020;

extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025 (unless terminated sooner upon certain events);

reduce the floor on base rate borrowings from 2.25% to 2.00%;

reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.

As of November 30, 20172023 and February 28, 2017,2023, there was $1.0were $35.0 million and $0.0, respectively, of$32.5 million outstanding borrowings under the Encina Credit Facility andFacility. During the applicable periods, the Company was in compliance with all of the limitations and requirements ofunder the Credit Facility.Agreement. Financing costs of $3.1$2.0 million related to the Encina Credit Facility have been capitalized and are being amortized over the term of the facility. facility, with all existing financing costs amortized through January 27, 2026 from the date of the amendment and extension.

For the three months ended November 30, 20172023 and November 30, 2016,2022, we recorded $0.2$0.9 million and $0.1$0.6 million of interest expense respectively. Forrelated to the nine months ended November 30, 2017Encina Credit Facility, respectively, which includes commitment and November 30, 2016, we recorded $0.7 million and $0.3 million of interest expense, respectively.administrative agent fees. For the three months ended November 30, 20172023 and November 30, 2016, we recorded $0.02 million and $0.02 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. For the nine months ended November 30, 2017 and November 30, 2016,2022, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and Revolving Facility, respectively. The weighted averageamortization of deferred financing costs are reported as interest rates duringand debt financing expense on the consolidated statements of operations. During the three and nine months ended November 30, 20172023, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility were 6.05%was 9.79%, and 5.97%, respectively. During the three and nine months ended November 30, 2017, the average dollar amount of outstanding borrowings under the Encina Credit Facility was $6.0 million and $9.3 million, respectively. During$35.0 million.


For the three and nine months ended November 30, 2016, there were no2023 and November 30, 2022, we recorded $3.0 million and $1.2 million of interest expense related to the Encina Credit Facility, respectively, which includes commitment and administrative agent fees. For the nine months ended November 30, 2023 and November 30, 2022, we recorded $0.3 million and $0.3 million of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility.Facility was 9.62%, and the average dollar amount of outstanding borrowings under the Encina Credit Facility was $38.9 million.

The Encina Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Encina Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Encina Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base.borrowing base. Funds may be borrowed at the greater of the prevailing LIBORone-month SOFR rate, and 1.00%, plus an applicable effective margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%4.25%. In addition, the Company will pay the lenderslender a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility for the duration of the Revolving Period.Facility.

Our borrowing base under the Encina Credit Facility was $31.8is $86.4 million subject to the Encina Credit Facility cap of $45.0$65.0 million at November 30, 2017.2023. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the November 30, 20172023 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended August 31, 2017, as filed with the SEC on October 11, 2017.2023. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

The Company’s wholly owned subsidiaries, SBIC LP, is able to borrow fundsSBIC II LP, and SBIC III LP, received SBIC licenses from the SBA against regulatoryon March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBIC LP’s license provides up to $150.0 million in additional long-term capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of November 30, 2017, we have funded SBIC LP with $75.0 million of equity capital, and have $134.7 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rateform of SBA debentures, is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount thatwhile SBIC LP may borrow to a maximum of $150.0 million, which isII LP’s and SBIC III LP’s SBIC licenses provide up to twice its potential regulatory capital.$175.0 million each. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. With all debentures repaid to the SBA, SBIC LP’s license was surrendered on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5$24.0 million and have average annual fully taxed net income not exceeding $6.5$8.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns“smaller enterprises” as defined by the SBA. A smaller concernenterprise is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

The Company’s wholly owned SBIC LP isSubsidiaries are able to borrow funds from the SBA against each SBIC’s regulatory capital (which generally approximates equity capital in the respective SBIC). The SBIC Subsidiaries are subject to regulation and oversightcustomary regulatory requirements including but not limited to, a periodic examination by the SBA includingand requirements with respect to maintainingmaintain certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that the SBIC LPSubsidiaries will receive SBA-guaranteed debenture funding, which is dependent upon the SBIC LP continuing to be in complianceSubsidiaries complying with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to each SBIC LP’sSubsidiaries’ assets over ourthe Company’s stockholders and debtholders in the event we liquidatethat the Company liquidates such SBIC LPSubsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by the SBIC LPSubsidiary upon an event of default.


The Company received exemptive relief from the SEC to permit it to exclude the debt of the SBIC LPsubsidiaries guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage testrequirement by permitting it to borrow up to $150.0$350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of November 30, 20172023, SBIC LP, SBIC II LP and February 28, 2017,SBIC III LP had an aggregate total of equity capital of $75.0 million, $87.5 million and $66.7 million, respectively, and had $205.0 million in SBA-guaranteed debentures collectively outstanding, with $0.0 million held in SBIC LP, $175.0 million held in SBIC II LP and $30.0 million held in SBIC III LP.

As noted above, as of November 30, 2023, there was $134.7$205.0 million and $112.7 million outstanding of SBA debentures respectively.outstanding and as of February 28, 2023, there was $202.0 million of SBA debentures outstanding. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage $4.6and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $5.0 million, of financing costs$6.0 million, and $0.4 million related to the SBA debentures issued by SBIC LP, SBIC II LP and SBIC III LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown. During the nine months ended November 30, 2023, the Company repaid $27.0 million of SBA debentures in SBIC LP, resulting in a realized loss on extinguishment of $0.1 million related to the acceleration of deferred debt financing costs.

For the three months ended November 30, 20172023 and November 30, 2016, we2022, the Company recorded $1.1$1.6 million and $0.9$1.7 million of interest expense related to the SBA debentures, respectively. For the three months ended November 30, 20172023 and November 30, 2016, we2022, the Company recorded $0.1$0.3 million and $0.1$0.2 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the three months ended November 30, 20172023 and November 30, 20162022 on the outstanding borrowings of the SBA debentures was 3.14%3.25% and 3.08%2.86%, respectively. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of SBA debentures outstanding was $200.4 million and $242.7 million, respectively.

For the nine months ended November 30, 20172023 and November 30, 2016, we2022, the Company recorded $3.0$4.6 million and $2.5$4.6 million of interest expense related to the SBA debentures, respectively. For the nine months ended November 30, 20172023 and November 30, 2016, we2022, the Company recorded $0.4$0.7 million and $0.4$0.7 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the nine months ended November 30, 20172023 and November 30, 20162022 on the outstanding borrowings of the SBA debentures was 3.12%3.01% and 3.12%2.74%, respectively. During the three and nine months ended November 30, 2017,2023 and November 30, 2022, the average dollar amount of SBA debentures outstanding was $134.7$201.7 million and $127.8 million, respectively. During the three and nine months ended November 30, 2016, the average dollar amount of SBA debentures outstanding was $110.7 million and $106.0$226.5 million, respectively.

In December 2015, the 2016 omnibus spending bill approved by Congress and signed into law by the President increased the amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding from $225.0 million to $350.0 million, subject to SBA approval. SBA regulations currently limit the amount of SBA-guaranteed debentures that an SBIC may issue to $150.0 million when it has at least $75.0 million in regulatory capital. Affiliated SBICs are permitted to issue up to a combined maximum amount of $350.0 million in SBA-guaranteed debentures when they have at least $175.0 million in combined regulatory capital.

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in

the process of complying, the existing “green light” letter that the SBA issued to us has expired. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Notes

6.25% 2025 Notes

On May 10, 2013,August 28, 2018, the Company issued $42.0$40.0 million in aggregate principal amount of 7.50%6.25% fixed-rate notes due 2025 (the “6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million in aggregate principal amount of 6.25% 2025 Notes within 30 days. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and were amortized over the term of the 6.25% 2025 Notes.


On February 5, 2019, the Company issued an additional $20.0 million in aggregate principal amount of the 6.25% 2025 Notes for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million in aggregate principal amount of 6.25% 2025 Notes within 30 days. The additional 6.25% 2025 Notes were treated as a single series with the existing 6.25% 2025 Notes under the indenture and have the same terms as the existing 6.25% 2025 Notes. The net proceeds from this offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and were amortized over the term of the 6.25% 2025 Notes.

On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of issued and outstanding 6.25% 2025 Notes. The 6.25% 2025 Notes were listed on the NYSE under the trading symbol of “SAF” and have been delisted following the full redemption on August 31, 2021. As such, it was not fair valued with market quotes and is not fair value leveled. The repayment of the 6.25% 2025 Notes resulted in a realized loss on the extinguishment of debt of $1.5 million. 

7.25% 2025 Notes

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of 7.25% fixed-rate notes due 2025 (the “2020“7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% 2025 Notes. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and were amortized over the term of the 7.25% 2025 Notes.

On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes. The 7.25% 2025 Notes were listed on the NYSE under the trading symbol of “SAK” and have been delisted following the full redemption on July 14, 2022. As such, it was not fair valued with market quotes and is not fair value leveled. The repayment of the 7.25% 2025 Notes resulted in a realized loss on the extinguishment of debt of $1.0 million.

 For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.0 million and $0.0 million, respectively, of interest expense and $0.0 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 7.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of the 7.25% 2025 Notes outstanding was $0.0 million and $0.0 million respectively. 

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $0.0 million and $1.2 million, respectively, of interest expense and $0.0 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 7.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022, the average dollar amount of the 7.25% 2025 Notes outstanding was $0.0 million and $18.0 million respectively. 

7.75% 2025 Notes

On July 9, 2020, the Company issued $5.0 million in aggregate principal amount of 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company’s option subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the 7.75% 2025 Notes.


As of November 30, 2023, the total 7.75% 2025 Notes outstanding was $5.0 million. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the amount outstanding of 7.75% 2025 Notes had a fair value of $4.9 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 7.75% 2025 Notes was $5.0 million and $4.9 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.1 million and $0.1 million, respectively, of interest expense and $0.01 million and $0.01 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of 7.75% 2025 Notes outstanding was $5.0 million and $5.0 million respectively.

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $0.3 million and $0.3 million, respectively, of interest expense and $0.04 million and $0.04 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022, the average dollar amount of 7.75% 2025 Notes outstanding was $5.0 million and $5.0 million respectively.

6.25% 2027 Notes

On December 29, 2020, the Company issued $5.0 million in aggregate principal amount of 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 20206.25% 2027 Notes will mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company’s option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, the Company issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the “Additional 6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, 2020,August 31 and since May 31, 2016,November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

As of November 30, 2023, the total 6.25% 2027 Notes outstanding was $15.0 million. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the amount outstanding of 6.25% 2027 Notes had a fair value of $14.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 6.25% 2027 Notes was $15.0 million and $13.7 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.2 million and $0.2 million, respectively, of interest expense and $0.02 million and $0.02 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest will be payable quarterly beginning August 15, 2013.expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022 the average dollar amount of 6.25% 2027 Notes outstanding was $15.0 million and $15.0 million respectively.


For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $0.7 million and $0.7 million, respectively, of interest expense and $0.05 million and $0.05 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022 the average dollar amount of 6.25% 2027 Notes outstanding was $15.0 million and $15.0 million respectively.

4.375% 2026 Notes

On May 17, 2013,March 10, 2021, the Company closedissued $50.0 million in aggregate principal amount of 4.375% fixed-rate notes due in 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

On July 15, 2021, the Company issued an additional $6.3$125.0 million in aggregate principal amount of the 20204.375% 2026 Notes pursuant(the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.8 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting commissions of $2.5 million. Offering costs incurred were approximately $0.2 million. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes. The net proceeds from the offering were used to redeem all of the outstanding 6.25% fixed-rate note due 2025, and for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $2.7 million have been capitalized and are being amortized over the term of the additional 4.375% 2026 Notes.

As of November 30, 2023, the total 4.375% 2026 Notes outstanding was $175.0 million. The 4.375% 2026 Notes are not listed and are issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. The carrying amount of the amount outstanding of 4.375% 2026 Notes had a fair value of $160.4 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 4.375% 2026 Notes was $175.0 million and $156.1 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $1.9 million and $1.9 million, respectively, of interest expense, $0.1 million and $0.2 million, respectively, of amortization of deferred financing costs and $0.08 million and $0.07 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of 4.375% 2026 Notes outstanding was $175.0 million and $175.0 million, respectively.

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $5.7 million and $5.7 million, respectively, of interest expense, $0.4 million and $0.6 million, respectively, of amortization of deferred financing costs and $0.2 million and $0.2 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022, the average dollar amount of 4.375% 2026 Notes outstanding was $175.0 million and $175.0 million, respectively.


4.35% 2027 Notes

On January 19, 2022, the Company issued $75.0 million in aggregate principal amount of 4.35% fixed-rate notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at the Company’s option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.8 million related to the full exercise4.35% 2027 Notes have been capitalized and are being amortized over the term of the underwriters’4.35% 2027 Notes.

As of November 30, 2023, the total 4.35% 2027 Notes outstanding was $75.0 million. The 4.35% 2027 Notes are not listed. The carrying amount of the amount outstanding of 4.35% 2027 Notes had a fair value of $66.2 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 4.35% 2027 Notes was $75.0 million and $64.5 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.8 million and $0.8 million, respectively, of interest expense, $0.1 million and $0.1 million, respectively, of amortization of deferred financial costs and $0.02 million and $0.02 million, respectively, of amortization of discount related to the 4.35% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of 4.35% 2027 Notes outstanding was $75.0 million and $75.0 million, respectively.

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $2.4 million and $2.4 million, respectively, of interest expense, $0.3 million and $0.3 million, respectively, of amortization of deferred financial costs and $0.08 million and $0.07 million, respectively, of amortization of discount related to the 4.35% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022, the average dollar amount of 4.35% 2027 Notes outstanding was $75.0 million and $75.0 million, respectively.

6.00% 2027 Notes

On April 27, 2022, the Company issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional 2020 Notes. On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0$10.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. As of November 30, 2017,6.00% 2027 Notes. Net proceeds to the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, the Company issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $71.7were $9.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5$0.3 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 20236.00% 2027 Notes is paid quarterly in arrears on March 15, June 15, September 15February 28, May 31, August 31 and December 15,November 30, at a rate of 6.75%6.00% per year, beginning March 30, 2017.year. The 20236.00% 2027 Notes mature on DecemberApril 30, 2023,2027 and commencing December 21, 2019,April 27, 2024, may be redeemed in whole or in part at any time or from time to time at ourthe Company’s option. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes, which amounted to $61.8 million, and for general corporate purposes in accordance with ourthe Company’s investment objective and strategies. The 2023 Notes are listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share. The remaining unamortized deferred debt financingFinancing costs of $1.5$3.3 million (including underwriting commissions and net of issuance premiums), was recorded within loss on debt extinguishment in the consolidated statements of operations in the fourth quarter of the fiscal year ended February 28, 2017, when the related 2020 Notes were extinguished. As of November 30, 2017, $2.8 million of financing costs related to the 20236.00% 2027 Notes have been capitalized and are being amortized over the term of the 20236.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note.

On August 15, 2022, the Company issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. Additional offering costs incurred were approximately $0.2 million. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Additional financing costs of $0.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.


As of November 30, 2017,2023, the carrying amount and fair value of the 20236.00% 2027 Notes was $74.5$105.5 million and $78.3$99.4 million, respectively. The fair value of the 20236.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $100.4 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $1.6 million and $1.6 million, respectively, of interest expense, $0.2 million and $0.2 million, respectively, of amortization of deferred financial costs and $0.01 million and $0.01 million, respectively, of amortization of discount related to the 6.00% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of 6.00% 2027 Notes outstanding was $105.5 million and $99.0 million, respectively.

For the nine months ended November 30, 2017,2023 and November 30, 2022, we recorded $1.3$4.7 million and $3.8$3.7 million, respectively, of interest expense, $0.6 million and $0.4 million, respectively, of amortization of deferred financial costs and $0.03 million and $0.01 million, respectively, of amortization of discount related to the 6.00% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022, the average dollar amount of 6.00% 2027 Notes outstanding was $105.5 million and $82.5 million, respectively.

7.00% 2025 Notes

On September 8, 2022, the Company issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Additional offering costs incurred were approximately $0.05 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.04 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

As of November 30, 2023, the carrying amount of the 7.00% 2025 Notes was $12.0 million. The 7.00% 2025 Notes are not listed. The carrying amount of the outstanding 7.00% 2025 Notes had a fair value of $11.7 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 7.00% 2025 Notes was $12.0 million and $11.5 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.2 million and $0.2 million, respectively, of interest expense, $0.03 million and $0.0 million, respectively, of amortization of deferred financial costs and $0.03 million and $0.03 million, respectively, of amortization of discount related to the 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022, the average dollar amount of 7.00% 2025 Notes outstanding was $12.0 million and $11.1 million, respectively.

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $0.6 million and $0.2 million, respectively, of interest expense, $0.09 million and $0.0 million, respectively, of amortization of deferred financial costs and $0.08 million and $0.03 million, respectively, of amortization of discount related to the 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022, the average dollar amount of 7.00% 2025 Notes outstanding was $12.0 million and $3.7 million, respectively.


8.00% 2027 Notes

On October 27, 2022, the Company issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds to the Company were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.7 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note.

As of November 30, 2023, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.6 million, respectively. The fair value of the 8.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.4 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.9 million and $0.3 million, respectively, of interest expense and $0.1$0.09 million and $0.3$0.03 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 Notes. Asand November 30, 2022, the average dollar amount of February 28, 2017, the carrying amount and fair value of the 20238.00% 2027 Notes outstanding was $74.5$46.0 million and $77.1$16.9 million, respectively.

For the three and nine months ended November 30, 2016, we2023 and November 30, 2022, the Company recorded $1.2$2.8 million and $3.5$0.3 million, respectively, of interest expense and $0.1$0.3 million and $0.3$0.03 million, respectively, of amortization of deferred financing costs related to the 20208.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three and nine months ended November 30, 2017,2023 and November 30, 2022, the average dollar amount of 20238.00% 2027 Notes outstanding was $74.5$46.0 million and $5.6 million, respectively.

8.125% 2027 Notes

On December 13, 2022, the Company issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.9 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds to the Company were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year, beginning February 28, 2023. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note.

As of November 30, 2023, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $60.4 million, respectively. The fair value of the 8.125% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $61.1 million, respectively.


For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $1.2 million and $0.0 million, respectively, of interest expense and $0.1 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022 the average dollar amount of 8.125% 2027 Notes outstanding was $60.4 million and $0.0 million respectively.

For the nine months ended November 30, 2016,2023 and November 30, 2022, the Company recorded $3.7 million and $0.0 million, respectively, of interest expense and $0.3 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022 the average dollar amount of 20208.125% 2027 Notes outstanding was $61.8$60.4 million and $0.0 million respectively.

8.75% 2024 Notes

On March 31, 2023, the Company issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2024 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, the Company issued an additional $10.0 million in aggregate principal amount of the 8.75% 2024 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2024 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. The 8.75% 2024 Notes mature on March 31, 2024. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through the SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2024 Notes have been capitalized and are being amortized over the term of the 8.75% 2024 Notes.

As of November 30, 2023, the total 8.75% 2024 Notes outstanding was $20.0 million. The 8.75% 2024 Notes are not listed. The carrying amount of the amount outstanding of 8.75% 2024 Notes had a fair value of $20.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.75% 2024 Notes was $0.0 million and $0.0 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $0.4 million and $0.0 million, respectively, of interest expense, $0.2 million and $0.0 million, respectively, of amortization of deferred financial costs and $0.2 million and $0.0 million, respectively, of amortization of discount related to the 8.75% 2024 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022 the average dollar amount of 8.75% 2024 Notes outstanding was $20.0 million and $0.0 million respectively.

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $1.1 million and $0.0 million, respectively, of interest expense, $0.5 million and $0.0 million, respectively, of amortization of deferred financial costs and $0.4 million and $0.0 million, respectively, of amortization of discount related to the 8.75% 2024 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022 the average dollar amount of 8.75% 2024 Notes outstanding was $16.7 million and $0.0 million respectively.


8.50% 2028 Notes

On April 14, 2023, the Company issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds to the Company were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year.  The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note.

As of November 30, 2023, the carrying amount and fair value of the 8.50% 2028 Notes was $57.5 million and $58.0 million, respectively. The fair value of the 8.50% 2028 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.50% 2028 Notes was $0.0 million and $0.0 million, respectively.

For the three months ended November 30, 2023 and November 30, 2022, the Company recorded $1.2 million and $0.0 million, respectively, of interest expense and $0.1 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2023 and November 30, 2022 the average dollar amount of 8.50% 2028 Notes outstanding was $57.5 million and $0.0 million respectively.

For the nine months ended November 30, 2023 and November 30, 2022, the Company recorded $3.1 million and $0.0 million, respectively, of interest expense and $0.3 million and $0.0 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2023 and November 30, 2022 the average dollar amount of 8.50% 2028 Notes outstanding was $47.8 million and $0.0 million respectively.


SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

Class and Year (1)(2) Total Amount
Outstanding
Exclusive of
Treasury
Securities(3)
  Asset
Coverage
per Unit(4)
  Involuntary
Liquidating
Preference
per Share(5)
  Average
Market
Value
per Share(6)
 
  (in thousands) 
Credit Facility with Encina Lender Finance, LLC            
Fiscal year 2024 (as of November 30, 2023) $35,000  $1,593   -   N/A 
Fiscal year 2023 (as of February 28, 2023) $32,500  $1,659   -   N/A 
Fiscal yaer 2022 (as of February 28, 2022) $12,500  $2,093   -   N/A 
Credit Facility with Madison Capital Funding(14)                
Fiscal year 2021 (as of February 28, 2021) $-  $3,471   -   N/A 
Fiscal year 2020 (as of February 29, 2020) $-  $6,071   -   N/A 
Fiscal year 2019 (as of February 28, 2019) $-  $2,345   -   N/A 
Fiscal year 2018 (as of February 28, 2018) $-  $2,930   -   N/A 
Fiscal year 2017 (as of February 28, 2017) $-  $2,710   -   N/A 
Fiscal year 2016 (as of February 29, 2016) $-  $3,025   -   N/A 
Fiscal year 2015 (as of February 28, 2015) $9,600  $3,117   -   N/A 
Fiscal year 2014 (as of February 28, 2014) $-  $3,348   -   N/A 
Fiscal year 2013 (as of February 28, 2013) $24,300  $5,421   -   N/A 
Fiscal year 2012 (as of February 29, 2012) $20,000  $5,834   -   N/A 
Fiscal year 2011 (as of February 28, 2011) $4,500  $20,077   -   N/A 
Fiscal year 2010 (as of February 28, 2010) $-  $-   -   N/A 
Fiscal year 2009 (as of February 28, 2009) $-  $-   -   N/A 
Fiscal year 2008 (as of February 29, 2008) $-  $-   -   N/A 
Fiscal year 2007 (as of February 28, 2007) $-  $-   -   N/A 
7.50% Notes due 2020(7)                
Fiscal year 2017 (as of February 28, 2017) $-  $-   -   N/A 
Fiscal year 2016 (as of February 29, 2016) $61,793  $3,025   -  $25.24(8)
Fiscal year 2015 (as of February 28, 2015) $48,300  $3,117   -  $25.46(8)
Fiscal year 2014 (as of February 28, 2014) $48,300  $3,348   -  $25.18(8)
Fiscal year 2013 (as of February 28, 2013) $-  $-   -   N/A 
Fiscal year 2012 (as of February 29, 2012) $-  $-   -   N/A 
Fiscal year 2011 (as of February 28, 2011) $-  $-   -   N/A 
Fiscal year 2010 (as of February 28, 2010) $-  $-   -   N/A 
Fiscal year 2009 (as of February 28, 2009) $-  $-   -   N/A 
Fiscal year 2008 (as of February 29, 2008) $-  $-   -   N/A 
Fiscal year 2007 (as of February 28, 2007) $-  $-   -   N/A 
6.75% Notes due 2023(9)                
Fiscal year 2020 (as of February 29, 2020) $-  $-   -   N/A 
Fiscal year 2019 (as of February 28, 2019) $74,451  $2,345   -  $25.74(10)
Fiscal year 2018 (as of February 28, 2018) $74,451  $2,930   -  $26.05(10)
Fiscal year 2017 (as of February 28, 2017) $74,451  $2,710   -  $25.89(10)
8.75% Notes due 2024                
Fiscal year 2024 (as of November 30, 2023) $20,000  $1,593   -  $25.00(12)
6.25% Notes due 2025(13)                
Fiscal year 2022 (as of February 28, 2022)  -   -   -    N/A 
Fiscal year 2021 (as of February 28, 2021) $60,000  $3,471   -  $24.24(11)
Fiscal year 2020 (as of February 29, 2020) $60,000  $6,071   -  $25.75(11)
Fiscal year 2019 (as of February 28, 2019) $60,000  $2,345   -  $24.97(11)
7.00% Notes due 2025                
Fiscal year 2024 (as of November 30, 2023) $12,000  $1,593   -  $25.00(12)
Fiscal year 2023 (as of February 28, 2023) $12,000  $1,659   -  $25.00(12)
7.25% Notes due 2025(17)                
Fiscal year 2023 (as of February 28, 2023)  -   -   -    N/A 
Fiscal year 2022 (as of February 28, 2022) $43,125  $2,093   -  $25.46(11)
Fiscal year 2021 (as of February 28, 2021) $43,125  $3,471   -  $25.77(11)
7.75% Notes due 2025                
Fiscal year 2024 (as of November 30, 2023) $5,000  $1,593   -  $25.00(12)
Fiscal year 2023 (as of February 28, 2023) $5,000  $1,659   -  $25.00(12)
Fiscal year 2022 (as of February 28, 2022) $5,000  $2,093   -  $25.00(12)
Fiscal year 2021 (as of February 28, 2021) $5,000  $3,471   -  $25.00(12)
4.375% Notes due 2026                
Fiscal year 2024 (as of November 30, 2023) $175,000  $1,593   -  $25.00(12)
Fiscal year 2023 (as of February 28, 2023) $175,000  $1,659   -  $25.00(12)
Fiscal year 2022 (as of February 28, 2022) $175,000  $2,093   -  $25.00(12)
4.35% Notes due 2027                
Fiscal year 2024 (as of November 30, 2023) $75,000  $1,593   -  $25.00(12)
Fiscal year 2023 (as of February 28, 2023) $75,000  $1,659   -  $25.00(12)
Fiscal year 2022 (as of February 28, 2022) $75,000  $2,093   -  $25.00(12)
6.00% Notes due 2027                
Fiscal year 2024 (as of November 30, 2023) $105,500  $1,593   -  $23.34(15)
Fiscal year 2023 (as of February 28, 2023) $105,500  $1,659   -  $23.97(15)
6.25% Notes due 2027                
Fiscal year 2024 (as of November 30, 2023) $15,000  $1,593   -  $25.00(12)
Fiscal year 2023 (as of February 28, 2023) $15,000  $1,659   -  $25.00(12)
Fiscal year 2022 (as of February 28, 2022) $15,000  $2,093   -  $25.00(12)
Fiscal year 2021 (as of February 28, 2021) $15,000  $3,471   -  $25.00(12)
8.00% Notes due 2027                
Fiscal year 2024 (as of November 30, 2023) $46,000  $1,593   -  $24.93(15)
Fiscal year 2023 (as of February 28, 2023) $46,000  $1,659   -  $25.08(15)
8.125% Notes due 2027                
Fiscal year 2024 (as of November 30, 2023) $60,375  $1,593   -  $24.97(15)
Fiscal year 2023 (as of February 28, 2023) $60,375  $1,659   -  $25.10(15)
8.50% Notes due 2028                
Fiscal year 2024 (as of November 30, 2023) $57,500  $1,593   -  $25.07(16)


(1)We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 150% asset coverage ratio we are required to maintain under the 1940 Act.

(2)This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.

(3)Total amount of senior securities outstanding at the end of the period presented.

(4)Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.

(5)The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.

(6)Not applicable for credit facility because not registered for public trading.

(7)On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.

(8)Based on the average daily trading price of the 2020 Notes on the NYSE.

(9)On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.45 million, respectively, in aggregate principal amount of the $74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.

(10)Based on the average daily trading price of the 2023 Notes on the NYSE.

(11)Based on the average daily trading price of the 2025 Notes on the NYSE.

(12)The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.

(13)On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes. The Company used a portion of the net proceeds from the 4.375% 2026 Notes offering, which was completed in July 2021, to redeem the 6.25% 2025 Notes in full.

(14)On October 4, 2021, the Company repaid all remaining amounts outstanding under the Madison Credit Facility and the credit agreement relating to the Madison Credit Facility was terminated.

(15)Based on the average daily trading price of the 2027 Notes on the NYSE.

(16)Based on the average daily trading price of the 2028 Notes on the NYSE.

(17)On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes.


Note 7.9. Commitments and contingenciesContingencies

Contractual obligationsObligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2017:2023:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $210,111   $—    $—    $—    $210,111 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Payment Due by Period 
Long-Term Debt Obligations Total  Less Than
1 Year
  1 - 3
Years
  3 - 5
Years
  More Than
5 Years
 
        ($ in thousands)       
Encina credit facility $35,000  $-  $35,000  $-  $- 
SBA debentures  205,000   -   -   -   205,000 
8.75% 2024 Notes  20,000   20,000   -   -   - 
7.00% 2025 Notes  12,000   -   12,000   -   - 
7.75% 2025 Notes  5,000   -   5,000   -   - 
4.375% 2026 Notes  175,000   -   175,000   -   - 
4.35% 2027 Notes  75,000   -   -   75,000   - 
6.00% 2027 Notes  105,500   -   -   105,500   - 
6.25% 2027 Notes  15,000   -   -   15,000   - 
8.00% 2027 Notes  46,000   -   -   46,000   - 
8.125% 2027 Notes  60,375   -   -   60,375   - 
8.50% 2028 Notes  57,500   -   -   57,500   - 
Total Long-Term Debt Obligations $811,375  $20,000  $227,000  $359,375  $205,000 

Off-balance sheet arrangements

TheOff-Balance Sheet Arrangements

As of November 30, 2023 and February 28, 2023, the Company’s off-balance sheet arrangements consisted of $5.9$128.4 million and $2.0$108.8 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2017 and February 28, 2017, respectively.interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.


A summary of the composition of the unfunded commitments outstanding as of November 30, 20172023 and February 28, 20172023 is shown in the table below (dollars in thousands):

 

   As of 
   November 30, 2017   February 28, 2017 

CLEO Communications Holding, LLC

  $3,000   $—  

GreyHeller LLC

   2,000    2,000 

Pathway Partners Vet Management Company LLC

   917    —  
  

 

 

   

 

 

 

Total

  $5,917   $2,000 
  

 

 

   

 

 

 
  November 30,
2023
  February 28,
2023
 
At Company’s discretion      
ActiveProspect, Inc. $10,000  $10,000 
Artemis Wax Corp.  23,500   - 
Ascend Software, LLC  5,000   5,000 
Granite Comfort, LP  750   15,000 
JDXpert  5,000   5,000 
LFR Chicken LLC  -   4,000 
Pepper Palace, Inc.  1,898   3,000 
Procurement Partners, LLC  4,250   4,250 
Saratoga Senior Loan Fund I JV, LLC  8,548   8,548 
Sceptre Hospitality Resources, LLC  5,000   5,000 
Stretch Zone Franchising, LLC  3,750   - 
VetnCare MSO, LLC  10,000   - 
Total $77,696  $59,798 
         
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required        
Alpha Aesthetics Partners OpCo, LLC $3,720  $- 
ARC Health OpCo LLC  2,585   10,773 
Artemis Wax Corp.  -   8,500 
Ascend Software, LLC  1,500   3,200 
Axero Holdings, LLC - Revolver  500   500 
Axiom Medical Consulting, LLC  2,000   - 
BQE Software, Inc.  3,250   - 
C2 Educational Systems  3,000   - 
Davisware, LLC  1,500   - 
Exigo, LLC  -   4,167 
Exigo, LLC - Revolver  1,042   833 
Gen4 Dental Partners Holdings, LLC  244   11,000 
GoReact  2,500   2,500 
JDXpert  -   1,000 
Inspect Point Holding, LLC  1,500   - 
Modis Dental Partners OpCo, LLC  7,500   - 
Pepper Palace, Inc. - Delayed Draw Term Loan  -   2,000 
Pepper Palace, Inc. - Revolver  2,500   2,500 
Procurement Partners, LLC  -   1,000 
Stretch Zone Franchising, LLC  1,500   - 
VetnCare MSO, LLC  15,319   - 
Zollege PBC  575   1,000 
   50,735   48,973 
Total $128,431  $108,771 

The Company believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of November 30, 2023, the Company had cash and cash equivalents and cash and cash equivalents, reserve accounts of $47.0 million and $30.0 million in available borrowings under the Encina Credit Facility.


Note 8.10. Directors Fees

The independent directors each receive an annual fee of $40,000.$70,000. They also receive $2,500$3,000 plus reimbursement of reasonable out-of- pocketout-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000$1,500 plus reimbursement of reasonable out-of- pocketout-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000$12,500 and the chairman of each other committee of the board of directors receives an annual fee of $2,000$6,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset valueNAV or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act). For the three months ended November 30, 20172023 and November 30, 2016, we2022, the Company incurred $0.04$0.1 million and $0.07$0.1 million for directors’ fees and expenses, respectively. For the nine months ended November 30, 20172023 and November 30, 2016, we2022, the Company incurred $0.2$0.3 million and $0.2$0.3 million for directors’ fees and expenses, respectively. As of November 30, 20172023 and February 28, 2017,2023, $0.0 million and $0.05$0.01 million in directors’ fees and expenses were accrued and unpaid, respectively. As of November 30, 2017, we2023, the Company had not issued any common stock to our directors as compensation for their services.

Note 9.11. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.Share Repurchases

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

On May 14, 2015, the Company declared a special dividend of $1.00 per share payable on June 5, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On July 8, 2015, the Company declared a dividend of $0.33 per share payable on August 31, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock.

On October 7, 2015, the Company declared a dividend of $0.36 per share payable on November 30, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock.

On January 12, 2016, the Company declared a dividend of $0.40 per share payable on February 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock.

On March 31, 2016, the Company declared a dividend of $0.41 per share payable on April 27, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock.

On July 7, 2016, the Company declared a dividend of $0.43 per share payable on August 9, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock.

On August 8, 2016, the Company declared a special dividend of $0.20 per share payable on September 5, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock.

On October 5, 2016, the Company declared a dividend of $0.44 per share payable on November 9, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock.

On January 12, 2017, the Company declared a dividend of $0.45 per share payable on February 9, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock.

On February 28, 2017, the Company declared a dividend of $0.46 per share payable on March 28, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock.

On May 30, 2017, the Company declared a dividend of $0.47 per share payable on June 27, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock.

On August 28, 2017, the Company declared a dividend of $0.48 per share payable on September 26, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements.statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On October 7, 2015,January 8, 2024, the Company’s board of directors extended the open market share repurchase plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, the Company’s board of directors extended the open market share repurchase planShare Repurchase Plan for another year to OctoberJanuary 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, the Company’s board of directors extended the open market share repurchase plan for another year to October 15, 2018, leaving the number of shares unchanged at 600,000 shares of its common stock.2025. As of November 30, 2017,2023, the Company had purchased 218,4911,035,203 shares of common stock, at the average price of $16.87$22.05 for approximately $3.7$22.8 million pursuant to this repurchase plan.the Share Repurchase Plan. During the three months ended November 30, 2023, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan. During the nine months ended November 30, 2023, the Company purchased 88,576 shares of common stock, at the average price $24.36 for approximately $2.2 million pursuant to the Share Repurchase Plan.

Public Equity Offering

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised. 

Equity ATM Program

On March 16, 2017, wethe Company entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offerthe Company offered for sale, from time to time, up to $30.0 million of ourthe Company’s common stock through an ATM offering. AsSubsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of November 30, 2017,the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, the Company had sold 266,1133,922,018 shares for gross proceeds of $6.0$97.1 million at an average price of $22.49$24.77 for aggregate net proceeds of $5.9$95.9 million (net of transaction costs).

Note 10. Summarized Financial Information of Our Unconsolidated Subsidiary

In accordance with SEC Regulation S-X Rules 3-09 and 4-08(g),On July 30, 2021, the Company must determineentered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg Thalmann & Co. Inc. and Compass Point Research and Trading, LLC (collectively the “Agents”), through which of its unconsolidated controlled portfolio companies, if any, are considered “significant subsidiaries.” After performing this analysis, the Company determinedmay offer for sale, from time to time, up to $150.0 million of the Company’s common stock through the Agents, or to them, as principal for their account (the “ATM Program”).


On July 6, 2023, the Equity Distribution Agreement was amended to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million, and on July 19, 2023, the Equity Distribution Agreement was amended to add an additional distribution agent, Raymond James & Associates. The sales price per share of the Company’s common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of the Company’s common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that oneno sales are made at a price below the then-current NAV per share.

As of its portfolio companies, Easy Ice, LLC (“Easy Ice”) is not a significant subsidiaryNovember 30, 2023, the Company sold 6,042,773 shares for gross proceeds of $158.3 million at an average price of $26.20 for aggregate net proceeds of $156.8 million (net of transaction costs). During the three months ended November 30, 2017 under2023, the Company sold 350,000 shares for gross proceeds of $10.0 million at least onean average price of $28.48 for aggregate net proceeds of $10.0 million (net of transaction costs). During the nine months ended November 30, 2023, the Company sold 1,202,412 shares for gross proceeds of $34.3 million at an average price of $28.54 for aggregate net proceeds of $34.3 million (net of transaction costs). The Manager agreed to reimburse the Company to the extent the per share price of the significance conditions ofshares to the public, less underwriting fees, was less than net asset value per share. For the three months ended November 30, 2023, the Manager reimbursed the Company $1.0 million. For the nine months ended November 30, 2023, the Manager reimbursed the Company $3.1 million.

The Company adopted Rule 4-08(g) of SEC3-04/Rule 8-03(a)(5) under Regulation S-X but was(Note 2). Pursuant to Regulation S-X, the Company has presented a reconciliation of the changes in each significant subsidiary forcaption of stockholders’ equity as shown in the year ended February 28, 2017. Accordingly, audited financial information for the year ended December 31, 2016 and as of December 31, 2016 has been included as follows (in thousands):tables below:

 

   As of 
Balance Sheet – Easy Ice, LLC  December 31, 2016 

Current assets

  $1,058 

Noncurrent assets

  $18,245 

Current liabilities

  $3,473 

Noncurrent liabilities

  $23,113 

Total deficit

  $(7,283
   For the year ended 
Statements of Operations – Easy Ice, LLC  December 31, 2016 

Rental income

  $14,463 

Rental expenses

  $8,463 

Gross margin

  $6,000 

Operating expenses

  $5,123 

Income from operations

  $877 

Net loss

  $(1,356
          Total    
  Common Stock  Capital
in Excess
  

Distributable

Earnings

    
  Shares  Amount  of Par Value  (Loss)  Net Assets 
Balance at February 28, 2022 12,131,350  $12,131  $328,062,246  $27,706,146  $355,780,523 
Increase (Decrease) from Operations:               
Net investment income  -   -   -   7,976,222   7,976,222 
Net realized gain (loss) from investments  -   -   -   162,509   162,509 
Income tax (provision) benefit from realized gain on investments  -   -   -   69,250   69,250 
Net change in unrealized appreciation (depreciation) on investments  -   -   -   (9,333,449)  (9,333,449)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   (361,951)  (361,951)
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (6,428,817)  (6,428,817)
Capital Share Transactions:                    
Stock dividend distribution  42,825   43   1,108,637   -   1,108,680 
Repurchases of common stock  (142,177)  (142)  (3,734,174)  -   (3,734,316)
Repurchase fees  -   -   (2,840)  -   (2,840)
Balance at May 31, 2022  12,031,998  $12,032  $325,433,869  $19,789,910  $345,235,811 
Increase (Decrease) from Operations:                    
Net investment income  -   -   -   7,698,014   7,698,014 
Net realized gain (loss) from investments  -   -   -   7,943,838   7,943,838 
Realized losses on extinguishment of debt  -   -   -   (1,204,809)  (1,204,809)
Net change in unrealized appreciation (depreciation) on investments  -   -   -   (13,258,456)  (13,258,456)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   (230,154)  (230,154)
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (6,369,981)  (6,369,981)
Capital Share Transactions:                    
Stock dividend distribution  48,590   49   1,088,139   -   1,088,188 
Repurchases of common stock  (153,350)  (154)  (3,685,951)  -   (3,686,105)
Repurchase fees  -   -   (3,071)  -   (3,071)
Balance at August 31, 2022  11,927,238  $11,927  $322,832,986  $14,368,362  $337,213,275 
                     
Increase (Decrease) from Operations:                    
Net investment income  -   -   -   9,877,437   9,877,437 
Net realized gain (loss) from investments  -   -   -   (740,434)  (740,434)
Income tax (provision) benefit from realized gain on investments  -   -   -   479,318   479,318 
Net change in unrealized appreciation (depreciation) on investments  -   -   -   (3,176,208)  (3,176,208)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   (425,848)  (425,848)
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (6,433,298)  (6,433,298)
Capital Share Transactions:                    
Stock dividend distribution  52,312   53   1,150,881   -   1,150,934 
Repurchases of common stock  (94,071)  (95)  (2,179,600)  -   (2,179,695)
Repurchase fees  -   -   (1,881)  -   (1,881)
Balance at November 30, 2022  11,885,479  $11,885  $321,802,386  $13,949,329  $335,763,600 
                     
Increase (Decrease) from Operations:                    
Net investment income  -   -   -   9,649,474   9,649,474 
Net realized gain (loss) from investments  -   -   -   80,683   80,683 
Realized losses on extinguishment of debt  -   -   -   (382,274)  (382,274)
Net change in unrealized appreciation (depreciation) on investments  -   -   -   10,549,981   10,549,981 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   (697,380)  (697,380)
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (8,081,306)  (8,081,306)
Capital Share Transactions:                    
Stock dividend distribution  53,615   55   1,300,405   -   1,300,460 
Repurchases of common stock  (48,594)  (49)  (1,224,175)  -   (1,224,224)
Repurchase fees  -   -   (972)  -   (972)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles  -   -   16,162   (16,162)  - 
Balance at February 28, 2023  11,890,500  $11,891  $321,893,806  $25,052,345  $346,958,042 
Increase (Decrease) from Operations:                    
Net investment income  -   -   -   15,958,950   15,958,950 
Net realized gain (loss) from investments  -   -   -   90,691   90,691 
Net change in unrealized appreciation (depreciation) on investments  -   -   -   (16,322,307)  (16,322,307)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   59,407   59,407 
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (8,193,402)  (8,193,402)
Capital Share Transactions:                    
Stock dividend distribution  45,818   47   1,058,797   -   1,058,844 
Repurchases of common stock  (88,576)  (90)  (2,157,515)  -   (2,157,605)
Repurchase fees  -   -   (1,772)  -   (1,772)
Balance at May 31, 2023  11,847,742  $11,848  $320,793,316  $16,645,684  $337,450,848 
Increase (Decrease) from Operations:                    
Net investment income  -   -   -   13,964,784   13,964,784 
Realized losses on extinguishment of debt  -   -   -   (110,056)  (110,056)
Net change in unrealized appreciation (depreciation) on investments  -   -   -   (5,737,571)  (5,737,571)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   (221,206)  (221,206)
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (8,352,335)  (8,352,335)
Capital Share Transactions:                    
Proceeds from issuance of common stock  852,412   852   22,497,265   -   

22,498,117

 
Capital contribution from manager  -   -   

2,050,288

   -   

2,050,288

 
Stock dividend distribution  29,627   30   749,283   -   749,313 
Offering costs  -   -   (213,427)  -   

(213,427

)
Balance at August 31, 2023  12,729,781  $12,730  $345,876,725  $16,189,300  $362,078,755 
Increase (Decrease) from Operations:                    
Net investment income  -   -   -   14,166,063   14,166,063 
Net realized gain (loss) from investments  -   -   -   60,565   60,565 
Net change in unrealized appreciation (depreciation) on investments  -   -   -   (17,866,353)  (17,866,353)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  -   -   -   (415,894)  (415,894)
Decrease from Shareholder Distributions:                    
Distributions of investment income – net  -   -   -   (9,286,642)  (9,286,642)
Capital Share Transactions:                    
Proceeds from issuance of common stock  350,000   350   

9,012,150

   -   9,012,150 
Capital contribution from manager  -   -   

1,043,000

   -   

1,043,000

 
Stock dividend distribution  35,196   35   858,960   -   858,995 
Offering costs  -   -   (92,240)  -   (92,240)
Balance at November 30, 2023  13,114,977  $13,115  $356,698,595  $2,847,039  $359,558,749 


Note 11.12. Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260, Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase (decrease) in net assets resulting from operations per share for the three and nine months ended November 30, 20172023 and November 30, 20162022 (dollars in thousands except share and per share amounts):

 

   For the three months ended   For the nine months ended 

Basic and diluted

  November 30,
2017
   November 30,
2016
   November 30,
2017
   November 30,
2016
 

Net increase in net assets resulting from operations

  $4,263   $1,574   $12,147   $10,133 

Weighted average common shares outstanding

   6,040,311    5,727,933    5,952,086    5,735,443 

Weighted average earnings per common share

  $0.71   $0.27   $2.04   $1.77 
  For the three months ended  For the nine months ended 
Basic and Diluted November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
Net increase (decrease) in net assets resulting from operations $(4,056) $6,014  $3,627  $5,475 
Weighted average common shares outstanding  13,052,896   11,893,173   12,355,815   11,989,811 
Weighted average earnings (loss) per common share $(0.31) $0.51  $0.29  $0.46 

Note 12.13. Dividend

On August 28, 2017,November 15, 2023, the Company declared a dividend of $0.48$0.72 per share which was paidpayable on September 26, 2017,December 28, 2023, to common stockholders of record as of September 15, 2017.on December 11, 2023. Shareholders hadhave the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ourthe DRIP.

Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.

On May 30, 2017,August 14, 2023, the Company declared a dividend of $0.47$0.71 per share which was paidpayable on June 27, 2017,September 28, 2023, to common stockholders of record as of June 15, 2017.on September 14, 2023. Shareholders hadhave the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ourthe DRIP.

Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

On February 28, 2017,May 22, 2023, the Company declared a dividend of $0.46$0.70 per share which was paidpayable on March 28, 2017,June 29, 2023, to common stockholders of record as of March 15, 2017.on June 13, 2023. Shareholders hadhave the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to ourthe DRIP.

Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

The following table summarizes dividends declared for the nine months ended November 30, 20172023 (dollars in thousands except per share amounts):

 

Date Declared

  Record Date   Payment Date   Amount
Per Share*
   Total
Amount
 

August 28, 2017

   September 15, 2017    September 26, 2017   $0.48   $2,866 

May 30, 2017

   June 15, 2017    June 27, 2017   $0.47   $2,792 

February 28, 2017

   March 15, 2017    March 28, 2017   $0.46   $2,666 
      

 

 

   

 

 

 

Total dividends declared

      $1.41   $8,324 
      

 

 

   

 

 

 
Date Declared  Record Date  Payment Date Amount
Per Share
  Total Amount* 
November 15, 2023 December 11, 2023 December 28, 2023 $0.72   8,888 
August 14, 2023 September 14, 2023 September 28, 2023  0.71  $9,287 
May 22, 2023 June 13, 2023 June 29, 2023  0.70  $8,352 
Total dividends declared     $2.13  $26,527 

 

*Amount per shareTotal amount is calculated based on the number of shares outstanding at the date of declaration.record.


The following table summarizes dividends declared for the nine months ended November 30, 20162022 (dollars in thousands except per share amounts):

 

Date Declared

  Record Date   Payment Date   Amount
Per Share*
   Total
Amount
 

October 5, 2016

   October 31, 2016    November 9, 2016   $0.44   $2,509 

August 8, 2016

   August 24, 2016    September 5, 2016   $0.20   $1,151 

July 7, 2016

   July 29, 2016    August 9, 2016   $0.43   $2,466 

March 31, 2016

   April 15, 2016    April 27, 2016   $0.41   $2,346 
      

 

 

   

 

 

 

Total dividends declared

      $1.48   $8,472 
      

 

 

   

 

 

 
Date Declared Record Date Payment Date Amount
Per Share
  Total Amount* 
November 15, 2022 December 15, 2022 January 4, 2023 $0.68  $8,081 
August 29, 2022 September 14, 2022 September 29, 2022  0.54   6,433 
May 26, 2022 June 14, 2022 June 29, 2022  0.53   6,370 
Total dividends declared     $1.75  $20,884 

 

*Amount per shareTotal amount is calculated based on the number of shares outstanding at the date of declaration.record.

Note 13.14. Financial Highlights

The following is a schedule of financial highlights as of and for the nine months ended November 30, 20172023 and November 30, 2016:2022:

Per share data November 30,
2023
  November 30,
2022
 
Net asset value at beginning of period $29.18  $29.33 
Net investment income(1)  3.57   2.13 
Net realized and unrealized gain and losses on investments(1)  (3.27)  (1.57)
Realized losses on extinguishment of debt  (0.01)  (0.10)
Net increase in net assets resulting from operations  0.29   0.46 
Distributions declared from net investment income  (2.10)  (1.60)
Total distributions to stockholders  (2.10)  (1.60)
Issuance of common stock(2)  (0.30)   
Capital contribution from manager for the issuance of common stock(14)  0.36    
Repurchases of common stock(3)  0.03   0.15 
Dilution(4)  (0.04)  (0.09)
Net asset value at end of period $27.42  $28.25 
Net assets at end of period $359,558,749  $335,763,600 
Shares outstanding at end of period  13,114,977   11,885,479 
Per share market value at end of period $26.21  $26.37 
Total return based on market value(5)(6)  3.62%  2.74%
Total return based on net asset value(5)(7)  2.35%  2.98%
Ratio/Supplemental data:        
Ratio of net investment income to average net assets(8)  17.15%  9.90%
Expenses:        
Ratios of operating expenses and income taxes to average net assets*(9)  8.09%  7.02%
Ratio of incentive management fees to average net assets(5)  1.37%  0.06%
Ratio of interest and debt financing expenses to average net assets(9)  13.87%  8.97%
Ratio of total expenses and income taxes to average net assets*(8)  23.33%  16.05%
Portfolio turnover rate(5)(10)  1.80%  17.77%
Asset coverage ratio per unit(11)  1,593   1,732 
Average market value per unit        
Revolving Credit Facility(12)                       N/A                        N/A 
SBA Debentures Payable(12)                       N/A                        N/A 
8.75% Notes Payable 2024(12)                       N/A                        N/A 
7.00% Notes Payable 2025(12)                       N/A                        N/A 
7.25% Notes Payable 2025(13)                       N/A                        N/A 
7.75% Notes Payable 2025(12)                       N/A                        N/A 
4.375% Notes Payable 2026(12)                       N/A   N/A 
4.35% Notes Payable 2027(12)                        N/A    N/A 
6.00% Notes Payable 2027 $23.34  $24.20 
6.25% Notes Payable 2027(12)   N/A   N/A 
8.00% Notes Payable 2027 $24.93   24.94 
8.125% Notes Payable 2027 $24.97   N/A 
8.50% Notes Payable 2028 $25.07   N/A 

 

   November 30, 2017  November 30, 2016 

Per share data:

  

Net asset value at beginning of period

  $21.97  $22.06 

Net investment income(1)

   1.58   1.49 

Net realized and unrealized gains and losses on investments

   0.46   0.28 
  

 

 

  

 

 

 

Net increase in net assets from operations

   2.04   1.77 

Distributions declared from net investment income

   (1.41  (1.48
  

 

 

  

 

 

 

Total distributions to stockholders

   (1.41  (1.48

Dilution(4)

   (0.02  (0.14

Net asset value at end of period

  $22.58  $22.21 

Net assets at end of period

  $138,846,223  $127,679,730 

Shares outstanding at end of period

   6,149,582   5,748,247 

Per share market value at end of period

  $22.30  $20.18 

Total return based on market value(2)

   4.96  56.98

Total return based on net asset value(3)

   10.00  11.37

Ratio/Supplemental data:

  

Ratio of net investment income to average net assets(8)

   10.21  9.54

Ratio of operating expenses to average net assets(7)

   7.95  7.10

Ratio of incentive management fees to average net assets(6)

   2.23  1.83

Ratio of interest and debt financing expenses to average net assets(7)

   8.30  7.42

Ratio of total expenses to average net assets(8)

   18.48  16.35

Portfolio turnover rate(5)

   14.08  31.25

Asset coverage ratio per unit(6)

   2,840   3,066 

Average market value per unit:

   

Credit Facility(9)

   N/A   N/A 

SBA Debentures(9)

   N/A   N/A 

2020 Notes

   N/A   25.35 

2023 Notes

   26.10   N/A 

*Certain prior period amounts have been reclassified to conform to current period presentation.

 


(1)Net investment income perPer share isamounts are calculated using the weighted average shares outstanding during the period.

(2)The continuous issuance of common stock may cause an incremental decrease in NAV per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company less than NAV per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the NAV per share on each share transaction date, divided by (ii) the total shares outstanding during the period.

(3)Represents the anti-dilutive impact on the NAV of the Company due to the repurchase of common shares.  See Note 11. Stockholders’ Equity.

(4)Represents the dilutive effect of issuing common stock below NAV per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 13. Dividend.

(5)Ratios are not annualized.

(6)Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.

(3)(7)Total investment return is calculated assuming a purchase of common shares at the current net asset valueNAV on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.

(4)(8)RepresentsRatios are annualized.  Incentive management fees included within the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 12, Dividend.ratio are not annualized.

(5)(9)Ratios are annualized.

(10)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

(6)(11)Ratios are not annualized.
(7)Ratios are annualized.
(8)Ratios are annualized. Incentive management fees included withinAsset coverage ratio per unit is the ratio areof the carrying value of our total consolidated assets, less all liabilities and indebtedness not annualized.represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.

(9)(12)The Revolving Credit Facility, and SBA Debentures, 8.75% Notes Payable 2024, 7.00% Notes Payable 2025, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2027 and 6.25% Notes Payable 2027 are not registered for public trading.

(13)On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.

(14)The Manager agreed to reimburse the Company to the extent the per share price of the shares to the public, less underwriting fees, was less than net asset value per share.

Note 14.15. Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements exceptas of and for the following:

Onquarter ended November 29, 2017, the Company declared a dividend of $0.49 per share payable on December 27, 2017, to common stockholders of record on December 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.30, 2023.


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Note about Forward-Looking Statements” and Part I.I, Item 1A1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2017.2023.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

our future operating results;

 

our business prospects and the prospects of our portfolio companies;
our future operating results;

 

the impact of investments that we expect to make;
the introduction, withdrawal, success and timing of business initiatives and strategies;

 

our contractual arrangements and relationships with third parties;
changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

 

the dependence of our future success on the general economy and its impact on the industries in which we invest;
the relative and absolute investment performance and operations of our Manager;

 

the ability of our portfolio companies to achieve their objectives;
the impact of increased competition;

 

our expected financings
our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

 

our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiary, and to continue to qualify to be taxed as a regulated investment company (“RIC”);
the unfavorable resolution of any future legal proceedings;

 

the adequacy of our cash resources and working capital;
our business prospects and the operational and financial performance of our portfolio companies, including their ability to achieve our respective objectives as a result of the current economic conditions caused by, among other things, elevated levels of inflation, and a rising interest rate environment, and the effects of the disruptions caused thereby on our ability to continue to effectively manage our business;

 

the timing of cash flows, if any, from the operations of our portfolio companies;

interest rate volatility, including the replacement of LIBOR with alternate reference rates and the rising interest rate environment, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

 

the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.
the impact of investments that we expect to make and future acquisitions and divestitures;

You should not place undue reliance on these forward-looking statements. The

our contractual arrangements and relationships with third parties;

the dependence of our future success on the general economy and its impact on the industries in which we invest;

the ability of our portfolio companies to achieve their objectives;

our expected financings and investments;


our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

the adequacy of our cash resources and working capital;

the timing of cash flows, if any, from the operations of our portfolio companies;

the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

the impact of changes to tax legislation and, generally, our tax position;

our ability to access capital and any future financings by us;

the ability of our Manager to attract and retain highly talented professionals; and
the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.

Such forward-looking statements mademay include statements preceded by, followed by or that otherwise include terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.


We have based the forward-looking statements included in this Quarterly Report on Form 10-Q relate onlyon information available to events as of the dateus on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to generatecreate attractive risk-adjusted returns by generating current income and to a lesser extent,long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle marketmiddle-market companies, which we define as companies having EBITDAearnings before interest, tax, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of its net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History and Recent Developments

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank, we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us.opportunities. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates, and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, whichLLC. The debt commitment letter indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Companywe entered into the Madison Credit Facility (as defined below), and the Companywe began doing business as Saratoga Investment Corp.


We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Madison Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale of the 986,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary,

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC LP (“SBIC LP”), Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC LP and SBIC II LP, the “SBIC Subsidiaries”), received an SBIC licenselicenses from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3SBA on March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBIC LP’s license provided up to $150.0 million in aggregate principaladditional long-term capital in the form of SBA debentures, while SBIC II LP’s and SBIC III LP’s SBIC licenses provide up to $175.0 million each. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of our 7.50% unsecured notes due 2020 (the “2020 Notes”) for net proceeds of $46.1outstanding SBA debentures cannot exceed $350.0 million after deducting underwriting commissions of $1.9with at least $175.0 million and offering costs of $0.3 million. The proceeds includedin combined regulatory capital. With all debentures repaid to the underwriters’ full exercise of their overallotment option. Interest on these 2020 Notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The 2020 Notes mature on May 31, 2020 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. The 2020 Notes were listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share. The 2020 Notes were redeemed in fullSBA, SBIC LP’s license was surrendered on January 13, 2017.3, 2024, providing the Company access to all undistributed capital of SBIC LP.

.

On May 29, 2015,February 26, 2021, we entered intocompleted the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033, and added a Debt Distribution Agreement with Ladenburg Thalmann & Co. through whichnon-call period ending February 2022. A non-call period ending February 2022 was also added. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, we may offer for sale, from time to time, up to $20.0invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the 2020Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid. 

We have formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC, a Delaware limited liability company (“SIF II”), for the purpose of entering into a $50.0 million senior secured revolving credit facility with Encina Lender Finance, LLC (the “Lender”), supported by loans held by SIF II and pledged to the Lender under the credit facility (the “Encina Credit Facility”). The Encina Credit Facility closed on October 4, 2021. During the first two years following the closing date, SIF II may request an increase in the commitment amount under the Encina Credit Facility to up to $75.0 million. The terms of the Encina Credit Facility required a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increased to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. The term of the Encina Credit Facility is three years. Advances under the Encina Credit Facility bear interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to our and the Lender’s selection of a replacement benchmark rate. Concurrently with the closing of the Encina Credit Facility, all remaining amounts outstanding on our existing revolving credit facility with Madison Capital Funding, LLC were repaid and the facility was terminated. On January 27, 2023, among other things, the borrowings available under the Encina Credit Facility was increased from up to $50.0 million to up to $65.0 million, the underlying benchmark rate used to compute interest changed from LIBOR to Term SOFR for one-month tenor plus a 0.10% credit spread adjustment, the applicable effective margin rate on borrowings increased from 4.00% to 4.25% and the maturity date was extended from October 4, 2024 to January 27, 2026.


On October 26, 2021, we entered into a limited liability company agreement with TJHA JV I LLC (“TJHA”) to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2021-1 Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

We and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, where we provide $43.75 million and TJHA proves $6.25 million, resulting in an At-the-Market (“ATM”) offering.87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note will pay a fixed rate of 10.0% per annum and is due and payable in full on June 15, 2023. As of November 30, 2017, the Company sold 539,725 bonds with a principal2023 our and TJHA’s investment in SLF JV consisted of $13,493,125 at an average priceunsecured note of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $72.1 million after deducting underwriting commissions of approximately $2.0$17.6 million and offering costs$2.5 million, respectively; and membership interest of approximately $0.5 million.$17.6 million and $2.5 million, respectively.

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The issuance included the exerciseunsecured note paid a fixed rate of substantially all10.00% per annum and is due and payable in full on October 20, 2033. The unsecured loan was repaid in full on October 28, 2022, as part of the underwriters’ optionCLO closing.

We have determined that SLF JV is an investment company under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies; however, in accordance with such guidance we will generally not consolidate our investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as we and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation, concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to purchase an additional $9.8consolidate the joint venture since neither has control. Accordingly, we do not consolidate SLF JV.

On October 28, 2022, SLF 2022 issued $402.1 million aggregate principal amount of 2023debt through the JV CLO trust. The 2022 JV CLO Notes within 30 days. Interest onwere issued pursuant to the 2023JV Indenture, with the Trustee. As part of the transaction, we purchased 87.50% of the Class E Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 20, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The 2023 Notes are listed on the NYSE under the trading symbol “SAB”SLF 2022 with a par value of $25.00 per share.

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering.$12.25 million. As of November 30, 2017,2023 and February 28, 2023, the Company sold 266,113 shares for gross proceedsfair value of $6.0these Class E Notes were $11.5 million at an average price of $22.49 for aggregate net proceeds of $5.9and $11.4 million, (net of transaction costs).respectively.

Critical Accounting Policies and Use of Estimates

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’sour consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies and estimates follows.


Investment Valuation

The Company accounts

We account for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)FASB ASC Topic 820,Fair Value Measurements and DisclosuresMeasurement(“ (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. Under ASC 820 requires the Companywe are required to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheetmeasurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third partythird-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers,Advisors, the audit committee of our board of directors and a third party independent valuation firm. Determinations ofWe use multiple techniques for determining fair value may involvebased on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgmentsjudgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which we determine a single best estimate. The types of factorsinputs and assumptions that may be considered in determining the fair valuerange of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flowflows and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-2-R-3 Notes tranche of the Saratoga CLO every quarter.

In addition, all our investments are subject to the following valuation process:

The audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

The audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow modelflows that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yieldsmarket comparables for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIASaratoga Investment Advisors and recommended to our board of

directors. Specifically, we use Intex cash flow models,flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The modelscash flows use a set of assumptionsinputs including projected default rates, recovery rates, reinvestment raterates and prepayment rates in order to arrive at estimated valuations. The assumptionsinputs are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.


Rule 2a-5 under the 1940 Act (“Rule 2a-5”) established a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides the recordkeeping requirements associated with fair value determinations. Finally, the SEC rescinded previously issued guidance on related issues, including the role of the board in determining fair value and the accounting and auditing of fund investments. While our board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, we have adopted certain revisions to its valuation policies and procedures in order comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stopsWe stop accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40,Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Payment-in-Kind Interest

The Company holds

We hold debt and preferred equity investments in itsour portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is paid-in-kind,PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring, amendment, redemption or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.


On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 andwith its reinvestment period ended inextended to October 2016.

On November 15, 2016, we completed thea second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to October 2018, andJanuary 2021, extended its legal maturity date to October 2025.January 2030, and added a non-call period of January 2020. Following thethis refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure ofincreased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $4.5$2.5 million in aggregate principal amount of the Class F notes trancheF-R-2 and $7.5 million in aggregate principal amount of the Saratoga CLOClass G-R-2 notes tranches at par, with a coupon of 3M USD LIBOR plus 8.5%.8.75% and 3M USD LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par and the $20.0 million CLO 2013-1 Warehouse Loan was repaid.

On February 11, 2020, we entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd. was repaid in full.

On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, we invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

On August 9, 2021, we exchanged our existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, we sold our Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. Following the refinancing, weWe receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the fee basisoutstanding principal amount at the beginning of the collection period,Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. WePrior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are alsono longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

We recognize interest

Interest income on our investment in the subordinated notes of Saratoga CLO is recorded using the effective interest method in accordance with the provisions of FASB ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.


Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company (“independent directorsdirectors”) and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviserManager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

organization;

 

calculating our net asset value (including the cost and expenses of any independent valuation firm);
organization;

 

expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;
calculating our net asset value (“NAV”) (including the cost and expenses of any independent valuation firm);

 

expenses incurred by our investment adviser payable for travel

expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

interest payable on debt, if any, incurred to finance our investments;
expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

 

offerings of our common stock and other securities;
interest payable on debt, if any, incurred to finance our investments;

 

investment advisory and management fees;
offerings of our common stock and other securities;

 

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

investment advisory and management fees;

 

transfer agent and custodial fees;
fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

federal and state registration
transfer agent and custodial fees;

 

all costs of registration and listing our common stock on any securities exchange;
federal and state registration fees;

 

federal, state and local taxes;
all costs of registration and listing our common stock on any securities exchange;

 

independent directors’ fees and expenses;
U.S. federal, state and local taxes;

 

costs of preparing and filing reports or other documents required by governmental bodies (including the Securities and Exchange Commission (“SEC”) and the SBA);
independent directors’ fees and expenses;

 

costs of any reports, proxy statements or other notices to common stockholders including printing costs;
costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

 

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;
costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs;
our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).
direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).


Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

The incentive fee had two parts:

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis on each investment in our portfolio, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007 and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.


Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

Capital Gains Incentive Fee

We record an expense accrual relating to the capital gains incentive fee payable by us to the Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if we were to liquidate our investment portfolio at such time. The actual incentive fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisorsthe Manager related to capital gains will be entitled to 20.0%determined and payable in arrears at the end of net gains that arise after May 31, 2010. In addition, the cost basis for computingeach fiscal year and will include only realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, andfor the gains were substantially outweighed by losses.period.

 

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

Recent Accounting Pronouncements

 

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. Dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

New Accounting Pronouncements

In March 2017,June 2022, the FASB issued Accounting Standards Update (“ASU”ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820) (“ASU 2022-03”) 2017-08,Receivables— Nonrefundable Fees, which clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities (“is not included in the equity security’s unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. In addition, ASU 2017-08”) which amends the amortization period for certain purchased callable debt securities held at2022-03 prohibits an entity from recognizing a premium, shortening such period to the earliest call date.contractual sale restriction as a separate unit of account. ASU 2017-08 does not require any accounting change for debt securities held at a discount; the discount continues to be amortized to maturity. ASU 2017-08 is2022-03’s amendments are effective for fiscal years, and interim periods within those fiscal years beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In August 2016, the FASB issued ASU 2016-15,Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which is intended to reduce the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02,Amendments to the Leases (“ASU Topic 842”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01,Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities(“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated2023, with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management ispermitted. We are currently evaluating the impact the adoption of this standard has on our consolidated financial statements and disclosures.

In May 2014, the FASB issued ASU 2014-09,Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period for annual periods beginning after December 15, 2017. Management has concluded that the majority of its revenues associated with financial instruments are scoped out of ASC 606. Management is evaluating the impact of the standardadoption of ASU 2022-03 on certain other income earned byour consolidated financial statements.

In March 2020, the Company.FASB issued Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) to provide optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. ASU 2020-04 established Topic 848 to provide relief during the temporary transition period and includes a sunset provision based on expectations of when the London Interbank Offered Rate (“LIBOR”) would cease being published. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. With the adoption of ASU 2022-06, there was no significant impact to our financial position.


Portfolio and investment activityInvestment Activity

Corporate DebtInvestment Portfolio Overview

 

   At November 30,
2017
   At February 28,
2017
 
   ($ in millions)   ($ in millions) 

Number of investments(1)

   57    52 

Number of portfolio companies(3)

   32    28 

Average investment size(1)

  $5.7   $5.4 

Weighted average maturity(1)

   3.7 yrs    3.8 yrs 

Number of industries(3)

   9    9 

Average investment per portfolio company(1)

  $9.9   $9.7 

Non-performing or delinquent investments

  $8.3   $8.4 

Fixed rate debt (% of interest bearing portfolio)(2)

  $48.2(16.0%)   $44.2(16.9%) 

Weighted average current coupon(2)

   11.4%    11.4% 

Floating rate debt (% of interest bearing portfolio)(2)

  $  252.7(84.0%)   $  217.6(83.1%) 

Weighted average current spread over LIBOR(2)(4)

   9.4%    9.3% 
  November 30,
2023
 February 28,
2023
 
  ($ in millions)
Number of investments(1)  137   115 
Number of portfolio companies(2)  55   49 
Average investment per portfolio company(2) $19.7  $19.0 
Average investment size(1) $8.1  $8.3 
Weighted average maturity(3)  2.6 yrs   2.9 yrs 
Number of industries (5)  43   40 
Non-performing or delinquent investments (fair value) $29.2  $9.8 
Fixed rate debt (% of interest earning portfolio)(3) $5.2(0.5)% $8.2(1.0)%
Fixed rate debt (weighted average current coupon)(3)  15.0%  12.2%
Floating rate debt (% of interest earning portfolio)(3) $978.5(99.5)% $817.1(99.0)%
Floating rate debt (weighted average current spread over LIBOR)(3)(4)  7.5%  7.0%

 

(1)Excludes our investment in the subordinated notes of Saratoga CLO.

(2)Excludes our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Notes tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E Note tranche of the SLF 2022.

(3)Excludes our investment in the subordinated notes of Saratoga CLO and equity interests.
(3)Excludes our investmentinterests, as well as the unsecured notes and equity interests in SLF JV and the subordinated notes of Saratoga CLO and Class F notesE Note tranche of Saratoga CLO.the SLF 2022.

(4)Calculation uses either 1-month or 3-month LIBOR, depending on the contractual terms, and after factoring in any existing LIBOR floors.

(5)Our investment in the subordinated notes of Saratoga CLO and Class F-R-3 Note tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E Note tranche of the SLF 2022 are included in Structured Finance Securities industry.

During the three months ended November 30, 2017,2023, we invested $5.2$35.6 million in new orand existing portfolio companies and had $1.8$2.1 million in aggregate amount of exits and repayments resulting in net investments of $3.4$33.5 million for the period. During the three months ended November 30, 2016,2022, we invested $30.1$87.5 million in new orand existing portfolio companies and had $23.8$56.9 million in aggregate amount of exits and repayments resulting in net repayments of $30.6 million for the period.

During the nine months ended November 30, 2023, we invested $202.9 million in new and existing portfolio companies and had $19.2 million in aggregate amount of exits and repayments resulting in net investments of $6.3 million for the period.

During the nine months ended November 30, 2017, we invested $86.9 million in new or existing portfolio companies and had $45.6 million in aggregate amount of exits and repayments resulting in net investments of $41.3$183.7 million for the period. During the nine months ended November 30, 2016,2022, we invested $85.9$345.0 million in new orand existing portfolio companies and had $94.7$162.1 million in aggregate amount of exits and repayments resulting in net repayments of $8.8$183.0 million for the period.


Portfolio Composition

Our portfolio composition at November 30, 20172023: and February 28, 20172023: at fair value was as follows:

Portfolio composition

 

   At November 30, 2017  At February 28, 2017 
   Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
  Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
 

Syndicated loans

   2.7  5.6  3.4  5.3

First lien term loans

   54.8   10.8   54.3   10.5 

Second lien term loans

   29.3   11.9   30.0   11.7 

Structured finance securities

   4.8   19.4   5.3   12.7 

Equity interests

   8.4   3.6   7.0   0.4 
  

 

 

  

 

 

  

 

 

  

 

 

 

Total

   100.0  11.3  100.0  10.9
  

 

 

  

 

 

  

 

 

  

 

 

 
  November 30,
2023
  February 28,
2023
 
  Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
  Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
 
First lien term loans  86.2%  12.5%  82.1%  12.3%
Second lien term loans  1.3   6.0   1.5   5.3 
Unsecured term loans  1.6   10.0   2.1   9.8 
Structured finance securities  2.6   10.7   4.3   7.4 
Equity interests  8.3   -   10.0   - 
Total  100.0%  11.4%  100.0%  10.7%

Our

At November 30, 2023, our investment in the subordinated notes of Saratoga CLO, representsa collateralized loan obligation fund, had a fair value of $8.9 million and constituted 0.8% of our portfolio. This investment constitutes a first loss position in a portfolio that, atas of November 30, 20172023 and February 28, 20172023, was composed of $308.6$643.5 million and $297.1$658.0 million, respectively, in aggregate principal amount of predominantlyprimarily senior secured first lien term loans. In addition, as of November 30, 2023, we also own $9.0 million in aggregate principal of the F-2-R-3 Notes in the Saratoga CLO, which only rank senior to the subordinated notes.

This investment is subject to unique risks. (See “RiskPart 1. Item 1A. Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2017)2023).

We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at November 30, 2017, $296.72023, $584.9 million or 98.0%98.2% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and onefour Saratoga CLO portfolio investment wasinvestments were in default with a fair value of $1.6$9.8 million. At February 28, 2017, $288.52023, $544.4 million or 98.7%89.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and onetwo Saratoga CLO portfolio investment wasinvestments were in default with a fair value of $1.4$2.8 million. For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year ended February 28, 2023.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.


Portfolio CMR distribution

The CMR distribution offor our investments at November 30, 20172023 and February 28, 20172023 was as follows:

Portfolio CMR distributionSaratoga Investment Corp.

  

   At November 30, 2017  At February 28, 2017 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $290,304    85.7 $245,678    83.9

Yellow

   8,276    2.4   8,423    2.9 

Red

   8    0.0   7,069    2.4 

N/A(1)

   40,250    11.9   31,491    10.8 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $338,838    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 
  November 30,
2023
  February 28,
2023
 
Color Score Investments
at
Fair Value
  Percentage
of Total
Portfolio
  Investments
at
Fair Value
  Percentage
of Total
Portfolio
 
     ($ in thousands)    
Green $972,181   87.3% $808,791   83.2%
Yellow  24,203   2.2   34,172   3.5 
Red  4,981   0.4   -   0.0 
N/A(1)  112,674   10.1   129,627   13.3 
Total $1,114,039   100.0% $972,590   100.0%

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The change in reserve from $0.2 million as of February 28, 2017 to $1.4 million as of November 30, 2017 primarily related to the increase in reserve for the nine months on the non-performing and delinquent investment, TM Restaurant Group L.L.C.

The CMR distribution of Saratoga CLO investments at November 30, 20172023 and February 28, 20172023 was as follows:

Portfolio CMR distribution

 

   At November 30, 2017  At February 28, 2017 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $268,903    88.8 $266,449    91.1

Yellow

   27,819    9.2   22,064    7.6 

Red

   5,968    2.0   3,925    1.3 

N/A(1)

   4    0.0   23    0.0 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $302,694    100.0 $292,461    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

Saratoga CLO

 

  November 30,
2023
  February 28,
2023
 
Color Score Investments
at
Fair Value
  Percentage
of Total
Portfolio
  Investments
at
Fair Value
  Percentage
of Total
Portfolio
 
     ($ in thousands)    
Green $543,304   91.3% $544,424   89.9%
Yellow  41,612   7.0   40,812   6.7 
Red  9,788   1.6   20,718   3.4 
N/A(1)  743   0.1   -   0.0 
Total $595,447   100.0% $605,954   100.0%

(1)Comprised of Saratoga CLO’s equity interests.


Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at November 30, 20172023 and February 28, 2017:2023:

 

   At November 30, 2017  At February 28, 2017 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Business Services

  $192,925    56.9 $161,212    55.1

Healthcare Services

   39,954    11.8   38,544    13.2 

Education

   26,783    7.9   10,928    3.7 

Media

   17,876    5.3   18,698    6.4 

Consumer Services

   17,226    5.1   20,748    7.1 

Structured Finance Securities(1)

   16,313    4.8   15,450    5.3 

Building Products

   14,850    4.4   —      —   

Food and Beverage

   8,275    2.4   8,423    2.9 

Metals

   4,342    1.3   851    0.3 

Consumer Products

   294    0.1   968    0.3 

Real Estate

   —      —     16,839    5.7 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $338,838    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

Saratoga Investment Corp.

 

 November 30,
2023
  February 28,
2023
 
 Investments
at
Fair Value
  Percentage
of Total
Portfolio
  Investments
at
Fair Value
  Percentage
of Total
Portfolio
 
     ($ in thousands)    
Healthcare Software $120,489   11.0% $119,124   12.2%
IT Services  78,672   7.1   87,167   9.0 
HVAC Services and Sales  69,278   6.2   54,450   5.6 
Consumer Services  63,972   5.7   63,642   6.6 
Real Estate Services  53,128   4.8   53,406   5.5 
Healthcare Services  46,423   4.2   26,286   2.7 
Education Software  44,945   4.0   44,955   4.6 
Hospitality/Hotel  38,178   3.4   37,972   3.9 
Mental Healthcare Services  38,080   3.4   16,922   1.7 
Education Services  36,679   3.3   34,489   3.5 
Health/Fitness Franchisor  32,002   2.9   -   - 
Dental Practice Management  31,657   2.8   12,151   1.2 
Structured Finance Securities(1)  29,387   2.6   41,363   4.4 
Talent Acquisition Software  27,100   2.4   25,999   2.7 
Sports Management  26,995   2.4   26,711   2.7 
Financial Services  26,109   2.3   26,218   2.7 
Investment Fund  25,411   2.3   30,726   3.2 
Direct Selling Software  25,124   2.3   25,771   2.7 
Architecture & Engineering Software  25,035   2.2   -   - 
Association Management Software  23,696   2.1   -   - 
 Restaurant  22,405   2.0   24,826   2.6 
Mentoring Software  21,963   2.0   21,359   2.2 
Legal Software  20,777   1.9   20,699   2.1 
Marketing Orchestration Software  18,631   1.7   18,715   1.9 
Corporate Education Software  17,919   1.6   19,063   2.0 
Insurance Software  17,398   1.6   16,761   1.7 
Non-profit Services  14,190   1.3   13,095   1.3 
Employee Collaboration Software  13,894   1.2   13,052   1.3 
Lead Management Software  12,120   1.1   12,090   1.2 
Alternative Investment Management Software  10,810   1.0   10,459   1.1 
Research Software  10,632   1.0   10,677   1.1 
Roofing Contractor Software  10,002   0.9   -   - 
Field Service Management  9,939   0.9   9,958   1.0 
Fire Inspection Business Software  9,900   0.9   -   0.0 
Financial Services Software  9,866   0.9   9,096   0.9 
Industrial Products  9,461   0.8   9,608   1.0 
Office Supplies  7,023   0.6   6,373   0.7 
Specialty Food Retailer  4,981   0.4   -   0.0 
Veterinary Services  4,690   0.4   -   - 
Cyber Security  2,716   0.2   2,509   0.3 
Staffing Services  2,089   0.2   2,079   0.2 
Facilities Maintenance  273   0.0   408   0.0 
Healthcare Supply  -   0.0   -   - 
Specialty Food Retailer  -   0.0   24,411   2.5 
Total $1,114,039   100.0% $972,590   100.0%

(1)ComprisedAs of November 30, 2023 and February 28, 2023, the foregoing comprised of our investment in the subordinated notes and Class F NoteF-2-R-3 Notes of Saratoga CLO.CLO, as well as the unsecured notes and equity interests in the SLF JV and E-Notes of SLF 2022.


The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at November 30, 20172023 and February 28, 2017:2023:

Saratoga CLO

 

   At November 30, 2017  At February 28, 2017 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Services: Business

  $41,880    13.8 $40,675    13.9

High Tech Industries

   29,052    9.6   17,851    6.1 

Healthcare & Pharmaceuticals

   26,287    8.7   33,002    11.3 

Telecommunications

   18,873    6.2   13,704    4.7 

Banking, Finance, Insurance & Real Estate

   17,316    5.7   14,752    5.0 

Retailers (Except Food and Drugs)

   16,987    5.6   14,706    5.0 

Chemicals/Plastics

   15,257    5.0   21,492    7.4 

Media

   11,192    3.7   11,283    3.9 

Aerospace and Defense

   10,690    3.5   11,643    4.0 

Automotive

   9,061    3.0   6,088    2.1 

Industrial Equipment

   8,068    2.7   9,853    3.4 

Services: Consumer

   7,769    2.6   788    0.3 

Leisure Goods/Activities/Movies

   7,484    2.5   9,627    3.3 

Transportation

   6,977    2.3   2,731    0.9 

Retail

   6,414    2.1   —     —  

Utilities

   5,936    2.0   4,944    1.7 

Financial Intermediaries

   4,504    1.5   9,476    3.2 

Publishing

   4,347    1.4   4,580    1.6 

Food Services

   4,174    1.4   5,932    2.0 

Oil & Gas

   4,143    1.4   3,209    1.1 

Beverage, Food & Tobacco

   3,971    1.3   3,013    1.0 

Drugs

   3,774    1.3   5,394    1.8 

Capital Equipment

   3,595    1.2   6,026    2.1 

Technology

   3,547    1.2   3,935    1.3 

Containers/Glass Products

   3,409    1.1   2,008    0.7 

Electronics/Electric

   3,391    1.1   8,036    2.7 

Construction & Building

   2,921    1.0   1,974    0.7 

Insurance

   2,911    1.0   3,001    1.0 

Conglomerate

   2,534    0.8   3,584    1.2 

Brokers/Dealers/Investment Houses

   2,426    0.8   2,479    0.8 

Lodging and Casinos

   2,304    0.8   4,311    1.5 

Hotel, Gaming and Leisure

   2,020    0.7   2,025    0.7 

Food/Drug Retailers

   1,860    0.6   2,877    1.0 

Food Products

   1,619    0.5   3,147    1.1 

Cable and Satellite Television

   1,602    0.5   1,617    0.6 

Consumer Goods: Non-Durable

   1,005    0.3   —     —  

Forest Products & Paper

   1,001    0.3   —     —  

Media, Broadcasting & Subscription

   1,001    0.3   —     —  

Consumer Goods: Durable

   503    0.2   —     —  

Metals & Mining

   502    0.2   —     —  

Broadcast Radio and Television

   387    0.1   343    0.1 

Nonferrous Metals/Minerals

   —     —    1,312    0.4 

Environmental Industries

   —     —    800    0.3 

Building and Development

   —     —    243    0.1 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $302,694    100.0 $292,461    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 
 November 30,
2023
  February 28,
2023
 
 Investments
at
Fair Value
  Percentage
of Total
Portfolio
  Investments
at
Fair Value
  Percentage
of Total
Portfolio
 
     ($ in thousands)    
Banking, Finance, Insurance & Real Estate $114,841   19.3% $114,570   18.9%
Services: Business  64,096   10.8   65,947   10.9 
High Tech Industries  52,504   8.8   52,636   8.7 
Healthcare & Pharmaceuticals  38,097   6.4   38,952   6.4 
Services: Consumer  29,948   5.0   34,544   5.7 
Chemicals, Plastics, & Rubber  29,228   4.9   23,857   3.9 
Retail  25,509   4.3   24,049   4.0 
Telecommunications  21,961   3.7   22,514   3.7 
Media: Advertising, Printing & Publishing  20,977   3.5   20,309   3.4 
Hotel, Gaming & Leisure  19,825   3.3   14,315   2.4 
Automotive  19,610   3.3   20,410   3.4 
Consumer goods: Durable  18,966   3.2   24,887   4.1 
Containers, Packaging & Glass  17,901   3.0   18,239   3.0 
Construction & Building  14,397   2.4   13,875   2.3 
Beverage, Food & Tobacco  14,246   2.4   14,501   2.4 
Aerospace & Defense  13,149   2.2   13,688   2.3 
Media: Broadcasting & Subscription  10,597   1.8   11,143   1.8 
Consumer goods: Non-durable  9,476   1.6   13,734   2.3 
Media: Diversified & Production  9,201   1.5   9,279   1.5 
Transportation: Cargo  8,885   1.5   8,236   1.4 
Utilities: Oil & Gas  7,283   1.2   7,246   1.2 
Wholesale  7,257   1.2   8,011   1.3 
Capital Equipment  5,695   1.0   8,450   1.4 
Transportation: Consumer  4,083   0.7   6,844   1.1 
Metals & Mining  3,829   0.6   3,239   0.5 
Energy: Oil & Gas  3,138   0.5   2,676   0.4 
Forest Products & Paper  2,933   0.5   3,190   0.5 
Environmental Industries  2,748   0.5   2,155   0.4 
Energy: Electricity  2,724   0.5   2,105   0.3 
Utilities: Electric  2,343   0.4   2,353   0.4 
Total $595,447   100.0% $605,954   100.0%


Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at November 30, 20172023 and February 28, 2017.2023. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

   At November 30, 2017  At February 28, 2017 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Southeast

  $153,313    45.2 $116,186    39.7

Midwest

   85,465    25.2   75,154    25.7 

Southwest

   36,800    10.9   34,060    11.6 

Northeast

   34,782    10.3   38,880    13.3 

Other (1)

   16,313    4.8   15,450    5.3 

Northwest

   7,729    2.3   7,780    2.6 

West

   4,436    1.3   5,151    1.8 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $338,838    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 
  November 30,
2023
  February 28,
2023
 
  Investments
at
Fair Value
  Percentage
of Total
Portfolio
  Investments
at
Fair Value
  Percentage
of Total
Portfolio
 
  ($ in thousands) 
Southeast $308,305   27.7% $247,192   25.4%
Midwest  246,172   22.1   199,944   20.6 
West  219,581   19.7   173,283   17.8 
Northeast  143,585   12.9   133,158   13.7 
Southwest  122,577   11.0   123,744   12.7 
Northwest  -   -   2,509   0.3 
Other(1)  73,819   6.6   92,760   9.5 
Total $1,114,039   100.0% $972,590   100.0%

 

(1)Comprised of our investmentinvestments in the subordinated notes, and Class F NoteF-2-R-3 Notes of Saratoga CLO.CLO, as well as the unsecured notes and equity interests in the SLF JV and foreign investments.

Results of operations

Operating results for the three and nine months ended November 30, 20172023 and November 30, 2016 were2022 was as follows:

 

   For the three months ended 
   November 30,
2017
   November 30,
2016
 
   ($ in thousands) 

Total investment income

  $9,526   $8,442 

Total operating expenses

   6,510    5,023 
  

 

 

   

 

 

 

Net investment income

   3,016    3,419 

Net realized gains from investments

   21    260 

Net change in unrealized appreciation (depreciation) on investments

   1,226    (2,105
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

  $4,263   $1,574 
  

 

 

   

 

 

 
   For the nine months ended 
   November 30,
2017
   November 30,
2016
 
   ($ in thousands) 

Total investment income

  $28,487   $24,799 

Total operating expenses

   19,076    16,238 
  

 

 

   

 

 

 

Net investment income

   9,411    8,561 

Net realized gains (losses) from investments

   (5,658   12,300 

Net change in unrealized appreciation (depreciation) on investments

   8,394    (10,728
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

  $12,147   $10,133 
  

 

 

   

 

 

 
  For the three months ended  For the nine months ended 
  November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
  ($ in thousands)       
Total investment income $36,340  $26,257  $106,487  $66,789 
Total operating expenses  22,174   16,380   62,397   41,238 
Net investment income  14,166   9,877   44,090   25,551 
Net realized gain (loss) from investments  61   (740)  151   7,366 
Income tax (provision) benefit from realized gain on investments  -   479   -   549 
Net change in unrealized appreciation (depreciation) on investments  (17,867)  (3,176)  (39,926)  (25,768)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments  (416)  (426)  (578)  (1,018)
Realized losses on extinguishment of debt  -   -   (110)  (1,205)
Net increase (decrease) in net assets resulting from operations $(4,056) $6,014  $3,627  $5,475 


Investment income

The composition of our investment income for three and nine months ended November 30, 2023 and November 30, 2022 was as follows:

  For the three months ended  For the nine months ended 
  November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
  ($ in thousands)       
Interest from investments $32,659  $23,517  $94,550  $59,356 
Interest from cash and cash equivalents  522   201   1,865   235 
Management fee income  820   818   2,454   2,451 
Dividend Income  1,811   437   5,284   950 
Structuring and advisory fee income  312   553   1,786   2,814 
Other income  216   731   548   983 
Total investment income $36,340  $26,257  $106,487  $66,789 

For the three months ended November 30, 2023, total investment income increased $10.1 million, or 38.4%, to $36.3 million from $26.3 million for the three months ended November 30, 2022. Interest income from investments increased $9.1 million, or 38.9%, to $32.7 million for the three months ended November 30, 2023 from $23.5 million for the three months ended November 30, 2022. Interest income from investments increased due to the increase of $132.0 million, or 13.4%, in total investments at November 30, 2023 from $982.0 million at November 30, 2022 to $1,114.0 million as of November 30, 2023, combined with the increase in the weighted average current yield on investments to 11.4%, up from 10.4% at November 30, 2022.

For the nine months ended November 30, 2023, total investment income increased $39.7 million, or 59.4%, to $106.5 million from $66.8 million for the nine months ended November 30, 2022. Interest income from investments increased $35.2 million, or 59.3%, to $94.5 million for the nine months ended November 30, 2023 from $59.4 million for the nine months ended November 30, 2022. Interest income from investments increased due to the increase of $132.0 million, or 13.4%, in total investments at November 30, 2023 from $982.0 million at November 30, 2022 to $1,114.0 million as of November 30, 2023, combined with the increase in the weighted average current yield on investments to 11.3%, up from 10.4% at November 30, 2022.

For the three and nine months ended November 30, 20172023 and November 30, 2016 were as follows:2022, total PIK income was $0.6 million and $0.4 million, respectively and $1.9 million and $0.7 million, respectively.

 

   For the three months ended 
   November 30,
2017
   November 30,
2016
 
   ($ in thousands) 

Interest from investments

  $8,891   $7,456 

Management fee income

   376    375 

Incentive fee income

   209    —   

Interest from cash and cash equivalents and other income

   50    611 
  

 

 

   

 

 

 

Total investment income

  $9,526   $8,442 
  

 

 

   

 

 

 
   For the nine months ended 
   November 30,
2017
   November 30,
2016
 
   ($ in thousands) 

Interest from investments

  $25,818   $22,040 

Management fee income

   1,128    1,124 

Incentive fee income

   477    —   

Interest from cash and cash equivalents and other income

   1,064    1,635 
  

 

 

   

 

 

 

Total investment income

  $28,487   $24,799 
  

 

 

   

 

 

 

For the three months ended November 30, 2017, total investment income2023 and November 30, 2022, interest from cash and cash equivalents was $0.5 million and $0.2 million, respectively. The increase of $9.5$0.3 million increased $1.1 million, or 12.8% comparedwas due to $8.4 million forthe fact that cash and cash equivalents were earning close to zero interest during the three months ended November 30, 2016. Interest income from investments increased $1.4 million, or 19.2%, to $8.9 million for the three months ended November 30, 2017 from $7.5 million for the three months ended November 30, 2016. This reflects an increase of 22.1% in total investments to $338.8 million at November 30, 2017 from $277.6 million at November 30, 2016, with the weighted average current coupon increasing from 10.8% to 11.3%.2022.

For the nine months ended November 30, 2017, total investment income2023 and November 30, 2022, interest from cash and cash equivalents was $1.9 million and $0.2 million, respectively. The increase of $28.5$1.7 million increased $3.7 million, or 14.9% comparedwas due to $24.8 million for the ninefact that cash and cash equivalents were earning close to zero interest during the three months ended November 30, 2016. Interest2022.

Management fee income from investments increased $3.8 million, or 17.1%, to $25.8 millionreflects the fee income received for managing the nine months ended November 30, 2017 from $22.0 million for the nine months ended November 30, 2016. This reflects an increase of 22.1% in total investments to $338.8 million at November 30, 2017 from $277.6 million at November 30, 2016, with the weighted average current coupon increasing from 10.8% to 11.3%.

Saratoga CLO. For the three months ended November 30, 20172023 and November 30, 2016,2022, total PIKmanagement fee income was $0.8 million and $0.2$0.8 million, respectively. For the nine months ended November 30, 20172023 and November 30, 2016,2022, total PIKmanagement fee income was $1.8$2.5 million and $0.5$2.5 million, respectively. The increase was primarily due to the investments in Easy Ice, LLC and My Alarm Center, LLC that increased PIK interest during these periods.

For the three and nine months ended November 30, 2017, incentive fee2023 and November 30, 2022, total dividend income was $1.8 million and $0.4 million, respectively and $5.3 million and $0.9 million, respectively. Dividends received is recorded in the consolidated statements of operations when earned, and the increase primarily reflects dividend income of $0.2$1.3 million received on our membership interest in SLF JV during the three months ended November 30, 2023, and $0.5$4.7 million respectively, was recognized related toreceived during the Saratoga CLO, reflecting the 12.0% hurdle rate that has been achieved. nine months ended November 30, 2023.

For the three and nine months ended November 30, 2016, we did not accrue any amounts related to2023 and November 30, 2022, total structuring and advisory fee income was $0.3 million and $0.6 million, respectively and $1.8 million and $2.8 million, respectively. Structuring and advisory fee income represents fee income earned and received performing certain investment and advisory activities during the incentive management fee from Saratoga CLO asclosing of new investments.


For the 12.0% hurdle rate had not yet been achieved.three and nine months ended November 30, 2023 and November 30, 2022, other income was $0.2 million and $0.7 million, respectively and $0.5 million and $1.0 million, respectively. Other income includes origination fees, monitoring and amendment fees and prepayment fees and is recorded in the consolidated statements of operations when earned.

Operating expenses

The composition of our operating expenses for the three and nine months ended November 30, 20172023 and November 30, 20162022 was as follows:

 

   For the three months ended 
   November 30,
2017
   November 30,
2016
 
   ($ in thousands) 

Interest and debt financing expenses

  $2,759   $2,369 

Base management fees

   1,485    1,220 

Professional fees

   388    330 

Administrator expenses

   438    342 

Incentive management fees

   1,055    395 

Insurance

   65    69 

Directors fees and expenses

   43    66 

General and administrative and other expenses

   277    232 

Excise tax expense (credit)

   —      —   
  

 

 

   

 

 

 

Total operating expenses

  $6,510   $5,023 
  

 

 

   

 

 

 
   For the nine months ended 
   November 30,
2017
   November 30,
2016
 
   ($ in thousands) 

Interest and debt financing expenses

  $8,245   $7,107 

Base management fees

   4,358    3,650 

Professional fees

   1,180    992 

Administrator expenses

   1,208    992 

Incentive management fees

   2,940    2,331 

Insurance

   197    210 

Directors fees and expenses

   154    192 

General and administrative and other expenses

   809    764 

Excise tax expense (credit)

   (15   —   
  

 

 

   

 

 

 

Total operating expenses

  $19,076   $16,238 
  

 

 

   

 

 

 
  For the three months ended  For the nine months ended 
  November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
  ($ in thousands)       
Interest and debt financing expenses $12,522  $8,450  $36,629  $23,243 
Base management fees  4,857   4,259   14,262   12,165 
Incentive management fees expense (benefit)  2,244   1,531   4,828   217 
Professional fees  434   559   1,407   1,344 
Administrator expenses  1,075   819   2,798   2,342 
Insurance  81   89   245   266 
Directors fees and expenses  81   80   281   300 
General & administrative and other expenses  660   525   1,958   1,492 
Income tax expense (benefit)  220   68   (11)  (132)
Total operating expenses $22,174  $16,380  $62,397  $41,237 

For the three months ended November 30, 2017,2023, total operating expenses increased $1.5$5.8 million, or 29.6%35.4%, compared to the three months ended November 30, 2016.2022. For the nine months ended November 30, 2017,2023, total operating expenses increased $2.8$21.2 million, or 17.5%51.3%, compared to the nine months ended November 30, 2016.2022.

For the three months ended November 30, 2023, interest and debt financing expenses increased $4.1 million, or 48.2%, compared to the three months ended November 30, 2022. The increase is primarily attributable to an increase of 18.8% in average outstanding debt from $679.0 million for the three months ended November 30, 2022 to $806.8 million for the three months ended November 30, 2023, primarily reflecting (i) the issuance of the 6.00% 2027 Notes, 8.00% 2027 Notes, 7.00% 2025 Notes, and 8.125% 2027 Notes during the year ended February 28, 2023, and (ii) the issuance of the 8.75% 2024 Notes and the 8.50% 2028 Notes during the three months ended May 31, 2023, all of which are now outstanding for the full period this year.

For the nine months ended November 30, 2023, interest and debt financing expenses increased $13.4 million, or 57.6%, compared to the nine months ended November 30, 2022. The increase is primarily attributable to an increase of 67.7% in average outstanding debt from $476.3 million for the nine months ended November 30, 2022 to $798.9 million for the nine months ended November 30, 2023, primarily reflecting (i) the issuance of the 6.00% 2027 Notes, 8.00% 2027 Notes, 7.00% 2025 Notes, and 8.125% 2027 Notes during the year ended February 28, 2023, all of which are now outstanding for the full period this year, and (ii) the issuance of the 8.75% 2024 Notes and the 8.50% 2028 Notes during the nine months ended November 30, 2023.


For the three and nine months ended November 30, 20172023 and November 30, 2016, the increase in interest and debt financing expenses is primarily attributable to an increase in outstanding debt as compared to the prior year, with increased levels of outstanding SBA debentures, additional notes being issued and our Credit Facility having an outstanding balance this quarter-end. Our SBA debentures increased from $112.7 million at November 30, 2016 to $134.7 million at November 30, 2017, while the 2020 Notes were repaid and the 2023 Notes issued, increasing the notes payable from $61.8 million outstanding to $74.5 million outstanding for these same periods. For the three months ended November 30, 2017,2022, the weighted average interest rate on our outstanding indebtedness was 4.47% compared to 4.66% for the three months ended November 30, 2016. For the nine months ended November 30, 2017, the5.52% and 4.43%, respectively and 5.43% and 5.74%, respectively. The increase in weighted average interest rate on our outstanding indebtedness was 4.52% compared to 4.73% for the nine months ended November 30, 2016. For both periods, the decrease was primarily driven by anthe issuance of higher rate borrowings over the past year, reflecting the increase in base rates in the market.

As of November 30, 2023 and February 28, 2023, the SBA debentures that carry a lower interest rate as well as the notes payable interest rate decreasing from 7.50% to 6.75% following the refinancing of the 2020 Notes. SBA debentures decreased from 64.6%represented 25.3% and 27.7% of overall debt, as of November 30, 2016 to 64.1% as of November 30, 2017, primarily due to the increase in notes issued and the $1.0 million outstanding on the Credit Facility.respectively.

For the three months ended November 30, 2017,2023, base management fees increased $0.3$0.6 million, or 21.8%14.0%, from $4.3 million to $4.9 million compared to the three months ended November 30, 2016. For the nine months ended November 30, 2017, base management fees increased $0.7 million, or 19.4% compared to the nine months ended November 30, 2016.2022. The increase in base management fees results from the 21.8%14.4% increase in the average value of our total assets, less cash and cash equivalents, from $279.6$976.1 million as offor the three months ended November 30, 20162022 to $340.5$1,108.5 million as offor the three months ended November 30, 2017.2023. For the nine months ended November 30, 2023, base management fees increased $2.1 million, or 17.2%, from $12.2 million to $14.3 million compared to the nine months ended November 30, 2022. The increase in base management fees results from the 17.6% increase in the average value of our total assets, less cash and cash equivalents, from $922.6 million for the nine months ended November 30, 2022 to $1,082.1 million for the nine months ended November 30, 2023.

For the three months ended November 30, 2023, incentive management fees increased $0.7 million, or 46.5%, compared to the three months ended November 30, 2022. The incentive fee on income increased from $2.3 million to $3.3 million for the three months ended November 30, 2022 and 2023, respectively, reflecting the increase in net investment income during the three months ended November 30, 2023 as compared to the three months ended November 30, 2022. The incentive fee on capital gains decreased from a $(0.8) million benefit for the three months ended November 30, 2022 to a $(1.0) million benefit for the three months ended November 30, 2023, both reflecting the incentive fee on net realized and unrealized depreciation recognized during both these periods.

For the nine months ended November 30, 2023, incentive management fees increased $4.6 million, or 2,126.0%, compared to the nine months ended November 30, 2022. The incentive fee on income increased from $4.0 million for the nine months ended November 30, 2022 to $9.8 million for the nine months ended November 30, 2023, reflecting the fact that net investment income increased during this current period, and was above the hurdle during the full nine months ended November 30, 2023. The incentive fee on capital gains decreased from a $(3.7) million benefit for the nine months ended November 30, 2022 to a $(5.0) million benefit for the nine months ended November 30, 2023, both reflecting the incentive fee income on net realized and unrealized depreciation recognized during both these periods.

For the three and nine months ended November 30, 2017,2023, professional fees decreased $0.1 million, or 22.2% and increased $0.1 million, or 17.6%, and increased $0.2 million, or 19.0%4.7%, respectively, compared to the three and nine months ended November 30, 2016. This primarily relates to accounting fees from the current Sarbanes-Oxley Act implementation.2022.

For the three months ended November 30, 2017, incentive management fees increased $0.7 million, or 167.3%, compared to the three months ended November 30, 2016. The first part of the incentive management fees increased this year from $0.76 million to $0.81 million as higher average total assets of 21.8% has led to increased net investment income above the hurdle rate pursuant to the investment advisory and management agreement. In addition, the incentive management fees related to capital gains increased from a reduction of incentive fees of $0.4 million for the three months ended November 30, 2016 to an increase of $0.3 million for the three months ended November 30, 2017, reflecting the $1.2 million net gain on investments for the three months ended November 30, 2017 as compared to the $1.8 million net loss on investments for the three months ended November 30, 2016.

For the nine months ended November 30, 2017, incentive management fees2023, administrator expenses increased $0.6$0.3 million, or 26.1%31.3% and increased $0.5 million, or 19.5%, respectively, compared to the three and nine months ended November 30, 2016. The first part of2022, reflecting the incentive management fees increased this year from $2.2 million to $2.5 million as higher average total assets of 21.8% has led to increased net investment income above the hurdle rate pursuantcontractual changes to the investment advisoryadministrator agreement cap.

For the three and management agreement. In addition, incentive management fees related to capital gains increased from $0.1 million for the nine months ended November 30, 20162023, general and other expenses increased $0.1 million, or 25.7% and increased $0.5 million, or 31.2%, respectively, compared to $0.4 million, reflecting the higher $2.7 million net gain on investments for thethree and nine months ended November 30, 2017 as compared to the $1.6 million net gain on investments for the nine months ended November 30, 2016.2022.


As discussed above, the increase in interest and debt financing expenses for the three and nine months ended November 30, 2017 as2023 compared to the three and nine months ended November 30, 20162022 is primarily attributable both to an increase in the average dollar amount of outstanding debt, as well as the higher cost of that debt. As ofDuring the three months ended November 30, 2017, there was $1.0 million of2023 and November 30, 2022, the average borrowings outstanding borrowings under the Encina Credit Facility whereas there were nowas $35.0 million and $32.8 million, respectively, and the average weighted average interest rate on the outstanding borrowingsborrowing under the Encina Credit Facility as of November 30, 2016.was 9.79% and 7.19%, respectively. For the three months ended November 30, 20172023 and November 30, 2016,2022, the average borrowings outstanding of SBA debentures was $200.4 million and $242.7 million, respectively. For the three months ended November 30, 2023 and November 30, 2022, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.14%3.25% and 3.08%2.86%, respectively.

As discussed above, the increase in interest and debt financing expenses for the nine months ended November 30, 2023 compared to the nine months ended November 30, 2022 is attributable both to an increase in the average dollar amount of outstanding debt, as well as the higher cost of that debt. During the nine months ended November 30, 2023 and November 30, 2022, the average borrowings outstanding under the Encina Credit Facility was $38.9 million and $25.9 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Encina Credit Facility was 9.62% and 6.16%, respectively. For the nine months ended November 30, 20172023 and November 30, 2016,2022, the average borrowings outstanding of SBA debentures was $201.7 million and $226.5 million, respectively. For the nine months ended November 30, 2023 and November 30, 2022, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.12%3.01% and 3.12%2.74%, respectively.

The weighted average dollar amount of our unsecured notes for the three and nine months ended November 30, 2023 and November 30, 2022 were as follows:

  Three Months Ended  Nine Months Ended 
(in millions) November 30,
2023
  November 30,
2022
  November 30,
2023
  November 30,
2022
 
7.25% 2025 Notes $  $  $  $18.0 
7.75% 2025 Notes  5.0   5.0   5.0   5.0 
6.25% 2027 Notes  15.0   15.0   15.0   15.0 
4.375% 2026 Notes  175.0   175.0   175.0   175.0 
4.35% 2027 Notes  75.0   75.0   75.0   75.0 
6.00% 2027 Notes  105.5   105.5   105.5   82.5 
7.00% 2025 Notes  12.0   11.0   12.0   3.7 
8.00% 2027 Notes  46.0   16.9   46.0   5.6 
8.125% 2027 Notes  60.4      60.4    
8.75% 2024 Notes  20.0      16.7    
8.50% 2028 Notes  57.5      47.8    

For the three months ended November 30, 2023 and November 30, 2022, there were income tax expense (benefits) of $0.2 million and $0.07 million, respectively. For the nine months ended November 30, 2023 and November 30, 2022, there were income tax expense (benefits) of ($0.01) million and ($0.1) million, respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in entities that are treated as corporations for U.S. federal income tax purposes, as well as current U.S. federal and state income taxes on those operating gains and losses when realized.


Net realized gains (losses) on sales of investments

For the three months ended November 30, 2017,2023, we had $2.1 million of sales, repayments, exits or restructurings. For the Companynine months ended November 30, 2023, we had $1.8$19.2 million of sales, repayments, exits or restructurings resulting in $0.02$0.2 million of net realized gains. 

Nine Months ended November 30, 2023
 
Issuer Asset Type Gross Proceeds  Cost  Net
Realized
Gain (Loss)
 
PDDS Buyer, LLC Equity Interests $     -  $    -  $41,350 
Censis Technologies, Inc. Equity Interests  -   -   6,773 
GreyHeller LLC Equity Interests  -   -   42,568 
Ohio Medical, LLC Equity Interests  -   -   60,565 

We received escrow payments from the prior sales of our investments in PPDS Buyer, LLC, Censis Technologies, Inc., Ohio Medical, LLC and GreyHeller LLC.

For the ninethree months ended November 30, 2017,2022, the Company had $45.6$56.9 million of sales, repayments, exits or restructurings resulting in $5.7$0.7 million of net realized losses. The most significant realized gains (losses) duringFor the nine months ended November 30, 2017 were as follows (dollars in thousands):

Nine Months ended November 30, 2017

Issuer

  Asset Type  Gross
Proceeds
   Cost   Net
Realized
Gain (Loss)
 

My Alarm Center, LLC

  Second Lien Term Loan  $2,617   $10,330   $(7,713

Mercury Funding, LLC

  Common Stock   2,631    858    1,773 

The $7.7 million of realized loss on our investment in My Alarm Center, LLC, was due to the completion of a sales transaction, following increasing leverage levels combined with declining market conditions in the sector.

The $1.8 million of realized gain on our investment in Mercury Funding, LLC, was driven by the completion of a sales transaction with a strategic acquirer.

For the three months ended November 30, 2016,2022, the Company had $23.8$162.1 million of sales, repayments, exits or restructurings resulting in $0.3$7.4 million of net realized gains. For the nine months ended November 30, 2016, the Company had $94.7 million of sales, repayments, exits or restructurings resulting in $12.3

Nine Months ended November 30, 2022
            
Issuer Asset Type Gross Proceeds  Cost  Net
Realized
Gain
 
PDDS Buyer, LLC Equity Interests $9,943,838  $2,000,000  $7,943,838 
Ohio Medical, LLC Equity Interests  770,161   380,353   389,808 
Targus Holdings, Inc. Equity Interests  294,087   1,424,329   (1,130,242)
Censis Technologies, Inc. Equity Interests  -   -   68,731 
Texas Teachers of Tomorrow, LLC Equity Interests  -   -   24,977 
V Rental Holdings LLC Equity Interests  -   -   68,800 

The $7.9 million of net realized gains. The most significant realized gains duringwas from the nine months ended November 30, 2016 were as follows (dollarssale of the equity position in thousands):the Company’s PPDS Buyer, LLC investment.

Nine Months ended November 30, 2016

 

Issuer

  Asset Type  Gross
Proceeds
   Cost   Net
Realized
Gain
 

Take 5 Oil Change, L.L.C

  Common Stock  $6,505   $481   $6,024 

Legacy Cabinets, Inc.

  Common Stock Voting A-1   2,320    221    2,099 

Legacy Cabinets, Inc.

  Common Stock Voting B-1   1,464    139    1,325 

The $6.0$0.4 million of net realized gain on our investmentwas from the sale of the equity position in Take 5 Oil Change, L.L.C. was due to the completion of a sales transaction with a strategic acquirer.Company’s Ohio Medical, LLC investment.

The $3.4$1.1 million of net realized gains on ourloss was from the sale of the equity position in the Company’s Targus Holdings, Inc investment.

The Company received escrow payments from the prior sales of its investments in Legacy Cabinets,Censis Technologies, Inc. were due to a period, Texas Teachers of steadily improving performance, leading up to our sale of shares in Legacy Cabinets, Inc.Tomorrow, LLC and V Rental Holdings LLC.


Net change in unrealized appreciation (depreciation) on investments

For the three months ended November 30, 2017, our investments had net unrealized appreciation of $1.2 million versus net unrealized depreciation of $2.1 million for the three months ended November 30, 2016.

For the nine months ended November 30, 2017,2023, our investments had a net unrealized appreciation of $8.4 million versus netchange in unrealized depreciation of $10.7$39.9 million versus a net change in unrealized depreciation of $25.7 million for the nine months ended November 30, 2016. 2022.

The most significant cumulative changesnet change in unrealized appreciation and depreciation(depreciation) for the nine months ended November 30, 2017,2023 were the following (dollars in thousands):

Nine Months ended November 30, 20172023

 

Issuer

  Asset Type  Cost   Fair
Value
   Total
Unrealized
Appreciation
(Depreciation)
   YTD Change
in Unrealized
Appreciation
 

Elyria Foundry Company, L.L.C.

  Common Stock  $9,685  $3,494  $(6,191  $2,614 

My Alarm Center, LLC

  Second Lien Term Loan   —     —     —     2,298 

Saratoga Investment Corp. CLO 2013-1 Ltd.

  Other/Structured Finance Securities   9,192    11,814    2,622    1,992 

Easy Ice, LLC

  Preferred Equity   8,543    10,336    1,793    1,793 
Issuer Asset Type Cost  Fair Value  Total Unrealized Appreciation (Depreciation)  YTD Change in Unrealized  Appreciation (Depreciation) 
Pepper Palace, Inc. First Lien Term Loan & Equity Interests $35,418  $4,981  $(30,437) $(20,592)
Saratoga Senior Loan Fund I JV, LLC Equity Interests  35,202   25,411   (9,791)  (5,315)
Netreo Holdings, LLC First Lien Term Loan & Equity Interests  38,935   35,672   (3,263)  (11,544)
Saratoga Investment Corp. CLO 2013-1, Ltd. Structured Finance Securities  23,412   8,939   (14,473)  (6,707)
ETU Holdings, Inc. First Lien Term Loan, Second Lien Term Loan & Equity Interests  15,806   13,521   (2,285)  (2,368)
Zollege PBC First Lien Term Loan & Equity Interests  17,516   14,604   (2,912)  (1,592)
Vector Controls Holding Co., LLC First Lien Term Loan & Equity Interests  1,465   9,461   7,996   1,478 
Chronus LLC First Lien Term Loan & Equity Interests  22,865   21,963   (902)  (1,399)

The $2.6$20.6 million of changeunrealized depreciation in our investment Pepper Palace, Inc. was driven by further declines in company performance.

The $5.3 million of unrealized depreciation in our investment Saratoga Senior Loan Fund I, JV, LLC was driven by the reduction in the carrying value of a defaulted loan in the portfolio, as well as overall market conditions.

The $11.5 million of unrealized depreciation in our investment Netreo Holdings, LLC was driven by increased company leverage and decreased company performance.

The $6.7 million of unrealized depreciation in our investment Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by the reduction in the carrying value of certain defaulted loans in the portfolio, as well as overall market conditions.

The $2.4 million of unrealized depreciation in our investment ETU Holdings, Inc. was driven by overall company performance.

The $1.6 million of unrealized depreciation in our investment Zollege PBC was driven by overall company performance.

The $1.5 million of unrealized appreciation in our investment in Elyria Foundry Company, L.L.C.Vector Controls Holding Co., LLC was driven by an increasedecreased company leverage and overall company performance.

The $1.4 million of unrealized depreciation in oil and gas markets since year-end, positively impacting the company’sour investment Chronus LLC was driven by overall company performance.


The $2.3 million ofmost significant cumulative net change in unrealized appreciation in our investment in My Alarm Center, LLC was driven by the completion of a sales transaction. In recognizing this loss as a result of the sale, unrealized depreciation was adjusted to zero, which resulted in a $2.3 million change in unrealized appreciation for the nine months.

The $2.0 million of change in unrealized appreciation in our investment in the Saratoga CLO was driven by continued improved performance of the Saratoga CLO.

The $1.8 million of change in unrealized appreciation in our investment in Easy Ice, LLC was driven by the completion of a strategic acquisition that increased the scale and earnings of the business.

The most significant cumulative changes in unrealized appreciation and depreciation(depreciation) for the nine months ended November 30, 2016,2022 were the following (dollars in thousands):

Nine Months ended November 30, 20162022

 

Issuer

  Asset Type  Cost   Fair
Value
   Total
Unrealized
Depreciation
   YTD Change
in Unrealized
Depreciation
 

Take 5 Oil Change, L.L.C.

  Common Stock  $—    $—    $—    $(5,755

Legacy Cabinets, Inc.

  Common Stock Voting A-1   —     —     —     (2,456

Legacy Cabinets, Inc.

  Common Stock Voting B-1   —     —     —     (1,550

Elyria Foundry Company, L.L.C.

  Common Stock   9,217    357    (8,860   (1,669
Issuer Asset Type Cost  Fair Value  Total
Unrealized
Appreciation
  YTD
Change in
Unrealized 
Appreciation
 
Pepper Palace, Inc. First Lien Term Loan & Equity Interests $34,314  $24,325  $(9,989) $(9,470)
Artemis Wax Corp. First Lien Term Loan & Equity Interests  64,663   68,576   3,913   2,453 
Vector Controls Holding Co., LLC First Lien Term Loan & Equity Interests  3,478   9,091   5,613   2,194 
Axero Holdings, LLC First Lien Term Loan & Equity Interests  10,546   12,506   1,961   1,412 
Destiny Solutions Inc. Equity Interests  3,969   8,743   4,774   1,111 
Zollege PBC First Lien Term Loan & Equity Interests  16,641   15,377   (1,264)  (1,130)
Netreo Holdings, LLC First Lien Term Loan & Equity Interests  33,419   42,394   8,975   (1,668)
PDDS Buyer, LLC First Lien Term Loan & Equity Interests  -   -   -   (5,094)
Saratoga Investment Corp. CLO 2013-1, Ltd. Structured Finance Securities  29,969   19,427   (10,542)  (6,923)
Saratoga Senior Loan Fund I JV, LLC Equity Interests  35,202   26,781   (8,421)  (7,312)

The $5.8$9.5 million of changeunrealized depreciation in our investment Pepper Palace, Inc. was driven by overall company performance.

The $2.5 million of unrealized appreciation in our investment in Artemis Wax Corp. was driven by growth and improved financial performance.

The $2.2 million of unrealized appreciation in our investment in Vector Controls Holdings Co., LLC was driven by overall company performance.

The $1.4 million of unrealized appreciation in our investment in Axero Holdings, LLC was driven by growth and improved financial performance.

The $1.1 million of unrealized appreciation in our investment in Destiny Solutions Inc. was driven by growth and improved financial performance.

The $1.1 million of unrealized depreciation in our investment in Take 5 Oil Change, L.L.C.Zollege PBC was driven by the completion of a sales transaction with a strategic acquirer. In realizing this gain as a result of the sale, unrealized appreciation was adjusted to zero, which resulted in a $5.8 million change in unrealized depreciation for the period.overall company performance.

The $4.0 million of change in unrealized depreciation in our investments in Legacy Cabinets, Inc. were driven by the completion of a sales transaction. In realizing these gains as a result of the sale, unrealized appreciation was adjusted to zero, which resulted in a $4.0 million change in unrealized depreciation for the period.

The $1.7 million of change in unrealized depreciation in our investment in Elyria Foundry Company, L.L.C.Netreo Holdings, LLC was driven by increased company leverage.

The $5.1 million of unrealized depreciation in our investment PDDS Buyer, LLC was driven by the sale of that investment, resulting in a declinereversal of previously recognized unrealized appreciation reclassified to realized gains.

The $6.9 million of unrealized depreciation in oilour investment Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by the increase in discount rates, the impact of changes in LIBOR rates and gas end markets since year-end, negatively impactingoverall market conditions.

The $7.3 million of unrealized depreciation in our investment Saratoga Senior Loan Fund I, JV, LLC was driven by the company’s performance.increase in discount rates and overall market conditions

Changes in net assets resulting from operations

For the three months ended November 30, 2017 and2023, we recorded a net decrease in net assets resulting from operations of $4.1 million. Based on 13,052,896 weighted average common shares outstanding as of November 30, 2016,2023, our per share net decrease in net assets resulting from operations was $0.31 for the three months ended November 30, 2023. For the three months ended November 30, 2022, we recorded a net increase in net assets resulting from operations of $4.3 million and $1.6 million, respectively.$6.0 million. Based on 6,040,31111,893,173 weighted average common shares outstanding as of November 30, 2017,2022, our per share net increase in net assets resulting from operations was $0.71$0.51 for the three months ended November 30, 2017. This compares to2022.


For the nine months ended November 30, 2023, we recorded a net decrease in net assets resulting from operations of $3.6 million. Based on 12,355,815 weighted average common shares outstanding as of November 30, 2023, our per share net increase in net assets resulting from operations of $0.27was $0.29 for the threenine months ended November 30, 2016 based on 5,727,933 weighted average common shares outstanding as of November 30, 2016.

2023. For the nine months ended November 30, 2017 and November 30, 2016,2022, we recorded a net increase in net assets resulting from operations of $12.1 million and $10.1 million, respectively.$5.5 million. Based on 5,952,08611,989,811 weighted average common shares outstanding as of November 30, 2017,2022, our per share net increasedecrease in net assets resulting from operations was $2.04$0.46 for the nine months ended November 30, 2017. This compares to a per share net increase in net assets resulting from operations of $1.77 for the nine months ended November 30, 2016 based on 5,735,443 weighted average common shares outstanding as of November 30, 2016.2022

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle marketmiddle-market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, the Encina Credit Facility, our continued access to the SBA debentures future borrowings and future offerings of debt and equity securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan (“DRIP”), the ATM Program, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset valueNAV per share and we are limited in our ability to sell our common stock at a price below net asset valueNAV per share, we have been and may continue to be limited in our ability to raise equity capital. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, we have in accordance with certain applicable provisions of the past relied onCode and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”) issued private letter rulings concluding that, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation onthat the aggregate amount of cash to be distributed to all stockholders which limitation must be at least 20.0%20% of the aggregate declared distribution. We may rely on these IRS private letter rulingsthe revenue procedure in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200.0%.200%, reduced to 150% effective April 16, 2019 following the approval received from our board of directors, including a majority of our independent directors, on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 284.0%159.3% as of November 30, 20172023 and 271.0%165.9% as of February 28, 2017.2023. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Due to the diverse capital sources available to us at this time, we believe we have adequate liquidity to support our near term capital requirements.

Madison revolving credit facilityEncina Credit Facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital FundingEncina Lender Finance, LLC on October 4, 2021.

Commitment. We entered into the Credit and Security Agreement (the “Credit Facility”Agreement”) on June 30, 2010, which was most recently amended on May 18, 2017.relating to the Encina Credit Facility in the initial facility amount of $50.0 million (the “Facility Amount”). 


Availability.Availability The Company. We can draw up to the lesser of (i) $40.0 million (the “Facility Amount”)the Facility Amount and (ii) the Borrowing Base. The Borrowing Base is an amount equal to (i) the difference of (A) the product of the applicable advance rate (whichwhich varies from 50.0% to 75.0% depending on the type of loan asset)asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”Base Value”), and (B) the Excess Concentration Amount, as calculated in each caseaccordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments the Company haswe have under any loan asset and which are not covered by amounts in(b) the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”)Haircut Percentage, and outstanding borrowings.less (iv) $100,000. Each loan asset we held by the Company as of the date on which the Encina Credit Facility was closed was valued as of that date and each loan asset that the Company acquireswe acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Encina Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Companywe may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

The Encina Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date and ended April 4, 2022, the minimum funding amount was $12.5 million. For the period beginning on April 5, 2022 through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Facility Amount in effect from time to time.

Collateral.Collateral. The Encina Credit Facility is secured by substantially all of the assets of SIF II and pledged to the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rightslender under the CLO Management Agreement (as defined below).credit facility. SIF II is a wholly owned special purpose entity formed for the purpose of entering into the Encina Credit Facility.

Interest Rate and Fees.Under the Encina Credit Facility, funds arewere borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 1.00%0.75%, plus an applicable margin of 4.75%4.00%. AtThe Credit Agreement includes benchmark replacement provisions which permit the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%,Administrative Agent and the applicable margin over such alternative baseborrower to select a replacement rate is 3.75%.upon the unavailability of LIBOR. In addition, the Company payswe pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility for the duration of the Revolving Period (defined below).term of the Encina Credit Facility. Accrued interest and commitment fees are payable monthly. The Company wasmonthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Encina Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests.Tests. It is a condition precedent to any borrowing under the Encina Credit Facility that the principal amount outstanding under the Encina Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

oInterest Coverage Ratio.The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Encina Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Encina Credit Facility for the last 6 payment periods must equal at least 175.0%.

oOvercollateralization Ratio.The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Encina Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.


 

Weighted Average FMV Test.The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Encina Credit Facility also requiresmay require payment of outstanding borrowings or replacement of pledged loan assets upon the Company’sour breach of itsour representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equalineligible collateral loans will be excluded from the lowercalculation of the amount by which the Borrowing Base is overstatedand may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the collection account cash and eligible investments, (B) repay outstanding borrowings (together with certain costs and expenses), (C) sell or substitute loan assets in accordance with the Encina Credit Facility, or (D) pledge additional loan assets as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement.collateral. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.us.

Priority of Payments.Payments During the Revolving Period, the. The priority of payments provisions of the Encina Credit Facility require, after payment of specified fees and expenses, and any necessary funding of the Unfunded Exposure Account, that collections of principalinterest from the loan assets and, to the extent that these are insufficient, collections of interestprincipal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account.The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

Operating Expenses.Expenses. The priority of payments provision of the Encina Credit Facility provides for the payment of certain of our operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Periodand principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.$200,000 per annum.

Covenants; Representations and Warranties; Events of Default.Default. The Credit FacilityAgreement contains certain negative covenants, customary representations and warranties, and affirmative covenants, negative covenants and events of default. The Credit FacilityAgreement does not contain grace periods for breach by the Companyus of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence negative pledge, change of name or jurisdiction and separate legal entity statusseparateness of the Company covenants and certain other customary covenants.Company. Other events of default under the Credit FacilityAgreement include, among other things, the following:

an Interest Coverage Ratio of less than 150.0%;

an Overcollateralization Ratio of less than 175.0%
oOur failure to maintain an Interest Coverage Ratio of less than 175%;

the filing of certain ERISA or tax liens;
oOur failure of the Company to maintain an Overcollateralization Ratio of less than 200%;

the occurrence of certain “Manager Events” such as:
othe filing of certain ERISA or tax liens on our assets or the Equityholder;

failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5.0 million at any time prior to the third anniversary of the closing date;
ofailure by Specified Holders to collectively, directly or indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or (ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially all of the assets of, Saratoga Investment Advisor;

failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;
oindictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed to replace such key person within 30 days;

indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;
oresignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed within 30 days.

resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses.Expenses The Company. We paid certain fees and reimbursed Madison Capital FundingEncina Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital FundingEncina Lender Finance, LLC in connection with the Encina Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates.closing. These amounts totaled $2.0$1.4 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:


 

expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014,January 27, 2023, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

extend the commitment termination date from February 24, 2015 to September 17, 2017;

extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

On May 18, 2017, we entered into a thirdfirst amendment to the Credit Facility with Madison Capital Funding LLCAgreement to, among other things:

extend the commitment termination date from September 17, 2017 to September 17, 2020;

extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025;
increase the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

reduce the floor on base rate borrowings from 2.25% to 2.0%;
change the underlying benchmark used to compute interest under the Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and
increase the applicable effective margin rate on borrowings from 4.00% to 4.25%;

reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.
extend the revolving period from October 4, 2024 to January 27, 2026;

extend the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to such Facility Increase from $75.0 million to $150.0 million;

revise the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

amend the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

As of November 30, 2017,2023, we had $1.0$35.0 million of outstanding borrowings under the Credit Facility and $134.7$205.0 million of SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2017, we had no outstanding borrowings under the Credit Facility and $112.7 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at November 30, 2017 and February 28, 2017 was $31.8 million and $24.7 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 284.0% as of November 30, 2017 and 271.0% as of February 28, 2017.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary,three wholly owned subsidiaries, sought and obtained a licenselicenses from the SBA to operate an SBIC. In this regard, our wholly owned subsidiaries, SBIC LP, SBIC II LP, and SBIC III LP, received an SBIC license from the SBA on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license fromAugust 14, 2019, and September 29, 2022, respectively. With all its debentures repaid to the SBA, to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958.LP’s license was surrendered on January 3, 2023. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiarySubsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten yearten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

The SBIC Subsidiaries are regulated by the SBA. SBA regulations currently limit the amount that our SBIC subsidiarySubsidiaries may borrow to a maximum of $150.0$175.0 million of SBA debentures when it has at least $75.0$87.5 million in regulatory capital, receives a capital commitmentsubject to the SBA’s approval. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. Our wholly owned SBIC Subsidiaries are able to borrow funds from the SBA against regulatory capital (which generally approximates equity capital in the respective SBIC) and has been through anis subject to customary regulatory requirements, including, but not limited to, periodic examination by the SBA subsequent to licensing. As of November 30, 2017, our SBIC subsidiary had $75.0 million in regulatory capital and $134.7 million SBA-guaranteed debentures outstanding.SBA.

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC subsidiarySubsidiaries guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200.0% asset coverage test by permitting us to borrow up to $150.0$350.0 million more than we would otherwise be able to absent the receipt of this exemptive relief.

On April 2, 2015,16, 2018, as permitted by the SBA issuedSmall Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a “green light” letter inviting the Company to continue our application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued reviewmajority of our application forindependent directors, approved of our becoming subject to a second license,minimum asset coverage ratio of 150% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150% asset coverage ratio became effective on April 16, 2019.


As of November 30, 2023 SBIC LP had $75.0 million in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materialsregulatory capital and invited us to reapply. As a result of this request, with which we are$0.0 million in the process of complying, the existing “green light” letter that the SBA issued to us has expired. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures outstanding, SBIC II LP had $87.5 million in addition to the $150.0regulatory capital and $175.0 million already approved under the first license.in SBA-guaranteed debentures outstanding and SBIC III LP had $66.7 million in regulatory capital and $30.0 million in SBA-guaranteed debentures outstanding.

Unsecured notes

In May 2013,

7.25% 2025 Notes

On June 24, 2020, we issued $48.3$37.5 million in aggregate principal amount of 7.25% fixed-rate notes due 2025 (the “7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% 2025 Notes. Net proceeds were $5.4 million after deducting underwriting commissions of approximately $0.2 million. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and were amortized over the term of the 7.25% 2025 Notes.

On July 14, 2022, we redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes. The 7.25% 2025 Notes were listed on the NYSE under the trading symbol of “SAK” and have been delisted following the full redemption on July 14, 2022. 

7.75% 2025 Notes

On July 9, 2020, we issued $5.0 million in aggregate principal amount of our 2020 Notes7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $46.1$4.8 million after deducting underwriting commissions of $1.9 million and offeringapproximately $0.2 million. Offering costs of $0.3incurred were approximately $0.1 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these 2020the 7.75% 2025 Notes is paid quarterly in arrears on February 15,28, May 15,31, August 1531 and November 15,30, at a rate of 7.50%7.75% per year, beginning August 15, 2013.year. The 20207.75% 2025 Notes mature on May 31, 2020July 9, 2025 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. In connectionoption, subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the issuance7.75% 2025 Notes have been capitalized and are being amortized over the term of the 2020 Notes, we agreed to the following covenants for the period of time during which the 2020Notes. The 7.75% 2025 Notes are outstanding:not listed and have a par value of $25.00 per note.

At November 30, 2023, the total 7.75% 2025 Notes outstanding was $5.0 million.

6.25% 2027 Notes

On December 29, 2020, we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as definedissued $5.0 million in the 1940 Act, equals at least 200.0% after such borrowings.

we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a) (1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a RIC under the Code. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any classaggregate principal amount of our capital stock, or purchasing any such capital stock if our asset coverage, as defined6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million.  Interest on the 1940 Act,6.25% 2027 Notes is below 200.0%paid quarterly in arrears on February 28, May 31, August 31 and November 30, at the timea rate of the declaration of the dividend or distribution or the purchase6.25% per year, beginning February 28, 2021. The 6.25% 2027 Notes mature on December 29, 2027 and after deducting the amount of such dividend, distribution or purchase.

The 2020 Notes weremay be redeemed in full on January 13, 2017 and are no longer listed on the NYSE.

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale,whole or in part at any time or from time to time upat our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to $20.0the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, we issued an additional $10.0 million in aggregate principal amount of the 2020 Notes through an ATM offering. As of November 30, 2017, the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 2023Second 6.25% 2027 Notes for net proceeds of $71.7$9.7 million after deducting underwriting commissions of approximately $2.3$0.3 million (the “Additional 6.25% 2027 Notes”). The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and offeringhave the same terms as the existing 6.25% 2027 Notes. Offering costs ofincurred were approximately $0.5$0.1 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 20236.25% 2027 Notes is paid quarterly in arrears on March 15, June 15, September 15February 28, May 31, August 31 and December 15,November 30, at a rate of 6.75%6.25% per year, beginning March 30, 2017.year. The 20236.25% 2027 Notes mature on December 30, 2023,January 28, 2027 and commencing December 21, 2019,January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.4 million related to repaythe 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.


At November 30, 2023, the total 6.25% 2027 Notes outstanding was $15.0 million.

4.375% 2026 Notes

On March 10, 2021, we issued $50.0 million in aggregate principal amount of the 4.375% fixed-rate notes due in 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.2 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026Notes.

On July 15, 2021, we issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.8 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting commissions of $2.5 million. Offering costs incurred were approximately $0.2 million. The net proceeds from the offering were used to redeem all of the outstanding indebtedness under the 2020 Notes on January 13, 2017, which amounts to $61.8 million,6.25% fixed rate notes due 2025, and for general corporate purposes in accordance with our investment objective and strategies. The 2020Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes.

At November 30, 2023, the total 4.375% 2026 Notes outstanding was $175.0 million.

4.35% 2027 Notes

On January 19, 2022, we issued $75.0 million in aggregate principal amount of our 4.35% fixed-rate Notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year, beginning August 28, 2022. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in fullwhole or in part at our option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

At November 30, 2023 the total 4.35% 2027 Notes outstanding was $75.0 million.

6.00% 2027 Notes

On April 27, 2022, we issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on January 13, 2017.the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 20236.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAB”“SAT” with a par value of $25.00 per share. In connectionnote.


On August 15, 2022, we issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. Additional offering costs incurred were approximately $0.2 million. The Additional 6.00% 2027 Notes are treated as a single series with the issuanceexisting 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Additional financing costs of $0.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

At November 30, 2023 the total 6.00% 2027 Notes outstanding was $105.5 million.

7.00% 2025 Notes

On September 8, 2022, we agreed toissued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Additional offering costs incurred were approximately $0.05 million. Interest on the following covenants for the period7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of time during which the notes are outstanding:

we will not violate (whether7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

if,part at any time we are not subjector from time to time at our option. The net proceeds from the reporting requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to file any periodic reports with the SEC, we agree to furnish to holders of the 2023 Notes and the Trustee,offering were used for the period of time during which the 2023 Notes are outstanding, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects,general corporate purposes in accordance with applicable United States generally accepted accounting principles.our investment objective and strategies. Financing costs of $0.04 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

At November 30, 20172023 the total 7.00% 2025 Notes outstanding was $12.0 million.

8.00% 2027 Notes

On October 27, 2022, we issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.1 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.7 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note.

At November 30, 2023 the total 8.00% 2027 Notes outstanding was $46.0 million.

8.125% 2027 Notes

On December 13, 2022, we issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year, beginning February 28, 2023. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note.


At November 30, 2023, the total 8.125% 2027 Notes outstanding was $60.4 million.

8.75% 2024 Notes

On March 31, 2023, we issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2024 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, we issued an additional $10.0 million in aggregate principal amount of the 8.75% 2024 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2024 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year.  The 8.75% 2024 Notes mature on March 31, 2024. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2024 Notes have been capitalized and are being amortized over the term of the 8.75% 2024 Notes.

At November 30, 2023, the total 8.75% 2024 Notes outstanding was $20.0 million.

8.50% 2028 Notes

On April 14, 2023, we issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year.  The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note.

At November 30, 2023, the total 8.50% 2028 Notes outstanding was $57.5 million.

At November 30, 2023 and February 28, 2017,2023, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:

  November 30,
2023
  February 28,
2023
 
  Fair Value   Percentage
of Total
  Fair Value   Percentage
of Total
 
  ($ in thousands) 
Cash and cash equivalents $21,387   1.9% $65,746   6.2%
Cash and cash equivalents, reserve accounts  25,640   2.2   30,330   2.8 
First lien term loans  959,892   82.7   798,534   74.7 
Second lien term loans  14,873   1.3   14,936   1.4 
Unsecured term loans  17,619   1.5   41,362   3.9 
Structured finance securities  29,387   2.5   20,661   1.9 
Equity interests  92,268   7.9   97,097   9.1 
Total $1,161,066   100.0% $1,068,666   100.0%

   At November 30, 2017  At February 28, 2017 
   Fair
Value
   Percentage
of
Total
  Fair
Value
   Percentage
of
Total
 
   ($ in thousands) 

Cash and cash equivalents

  $680    0.2 $9,307    3.0

Cash and cash equivalents, reserve accounts

   8,038    2.3   12,781    4.1 

Syndicated loans

   9,001    2.6   9,823    3.1 

First lien term loans

   185,661    53.4   159,097    50.5 

Second lien term loans

   99,427    28.6   87,750    27.9 

Structured finance securities

   16,313    4.7   15,450    4.9 

Equity interests

   28,436    8.2   20,541    6.5 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $347,556    100.0 $314,749    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

Equity Capital Activities

Share Repurchases

On September 24, 2014, we announced the approval of the Share Repurchase Plan. Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan. Most recently, on January 9, 2023, our board of directors extended the Share Repurchase Plan for another year to January 15, 2024, increasing the number of shares that may be repurchased under the Share Repurchase Plan to 1.7 million shares of common stock. As of November 30, 2023, we had purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended November 30, 2023, we did not purchase any shares pursuant to the Share Repurchase Plan. During the nine months ended November 30, 2023, we purchased 88,576 shares of common stock, at the average price $24.36 for approximately $2.2 million pursuant to the Share Repurchase Plan.


Public Equity Offering

On July 13, 2018, we issued 1,150,000 shares of common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. We also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock, which was not exercised.

Equity ATM Program

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. AsSubsequent to this, we amended our equity distribution agreement to add BB&T Capital Markets and B. Riley FBR, Inc. as sales agents in our ATM offering. On July 11, 2019, the amount of November 30, 2017, the Companycommon stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, we had sold 266,1133,922,018 shares for gross proceeds of $6.0$97.1 million at an average price of $22.49$24.77 for aggregate net proceeds of $5.9$95.9 million (net of transaction costs).

On September 24, 2014,July 30, 2021, we announced the approval ofentered into an open market share repurchase plan that allows itequity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg Thalmann & Co. Inc. and Compass Point Research and Trading, LLC, each as agents (the “Agents”), through which we may offer for sale, from time to repurchasetime, up to 200,000$150.0 million of our common stock through the Agents, or to them, as principal for their account (the “ATM Program”).

On July 6, 2023, we amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock at prices below our NAV as reported in its then most recently published consolidated financial statements, which was subsequently increased to 400,000 sharesbe sold through the ATM Program to $300.0 million from $150.0 million, and on July 19, 2023, we amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates. The sales price per share of our common stock. On October 5, 2016, our board of directors extendedstock offered under the open marketATM Program, less the Agents’ commission, will not be less than the NAV per share repurchase plan for another year to October 15, 2017 and increased the number of shares we are permitted to repurchase at prices below our NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of our common stock. On October 10, 2017,stock at the Company’s boardtime of directors extendedsuch sale. Consistent with the open market share repurchase plan for another yearterms of the ATM Program, the Manager may, from time to October 15, 2018, leavingtime and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the number of shares unchanged at 600,000 shares of its common stock. then-current NAV per share.

As of November 30, 2017,2023, we purchased 218,491sold 6,042,773 shares for gross proceeds of common stock,$158.3 million at thean average price of $16.87$26.20 for approximately $3.7aggregate net proceeds of $156.8 million pursuant(net of transaction costs). During the three months ended November 30, 2023, we sold 350,000 shares for gross proceeds of $10.0 million at an average price of $28.48 for aggregate net proceeds of $10.0 million (net of transaction costs). During the nine months ended November 30, 2023, we sold 1,202,412 shares for gross proceeds of $34.3 million at an average price of $28.54 for aggregate net proceeds of $34.3 million (net of transaction costs). The Manager agreed to this repurchase plan.

On November 29, 2017, our board of directors declared a dividend of $0.49reimburse the Company to the extent the per share payable on December 27, 2017, to common stockholders of record on December 15, 2017. Shareholders had the option to receive paymentprice of the dividendshares to the public, less underwriting fees, was less than net asset value per share. For the three months ended November 30, 2023, the Manager reimbursed the Company $1.0 million. For the nine months ended November 30, 2023, the Manager reimbursed the Company $3.1 million.


Dividend Distributions

We have distributed or intend to distribute sufficient dividends to eliminate taxable income for our completed tax years. If we fail to satisfy the 90% distribution requirement or otherwise fail to qualify as a RIC in cash, or receive sharesany tax year, we would be subject to tax in that year on all of common stock, pursuantour taxable income, regardless of whether we made any distributions to our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.

On August 28, 2017, our board of directors declared a dividend of $0.48 per share payable on September 26, 2017, to common stockholders of record on September 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.

On May 30, 2017, our board of directors declared a dividend of $0.47 per share which was paid on June 27, 2017, to common stockholders of record on June 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

On February 28, 2017, our board of directors declared a dividend of $0.46 per share, which was paid on March 28, 2017, to common stockholders of record as of March 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

On January 12, 2017, our board of directors declared a dividend of $0.45 per share, which was paid on February 9, 2017, to common stockholders of record as of January 31, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.

On October 5, 2016, our board of directors declared a dividend of $0.44 per share, which was paid on November 9, 2016, to common stockholders of record as of October 31, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.

On August 8, 2016, our board of directors declared a special dividend of $0.20 per share, which was paid on September 5, 2016, to common stockholders of record as of August 24, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

On July 7, 2016, our board of directors declared a dividend of $0.43 per share, which was paid on August 9, 2016, to common stockholders of record as of July 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

On March 31, 2016, our board of directors declared a dividend of $0.41 per share, which was paid on April 27, 2016, to common stockholders of record as of April 15, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.

On January 12, 2016, our board of directors declared a dividend of $0.40 per share, which was paid on February 29, 2016, to common stockholders of record as of February 1, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

On October 7, 2015, our board of directors declared a dividend of $0.36 per share, which was paid on November 30, 2015, to common stockholders of record as of November 2, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

On July 8, 2015, our board of directors declared a dividend of $0.33 per share, which was paid on August 31, 2015, to common stockholders of record as of August 3, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.

On May 14, 2015, our board of directors declared a special dividend of $1.00 per share, which was paid on June 5, 2015, to common stockholders of record on as of May 26, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.

On April 9, 2015, our board of directors declared a dividend of $0.27 per share, which was paid on May 29, 2015, to common stockholders of record as of May 4, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

On September 24, 2014, our board of directors declared a dividend of $0.22 per share, which was paid on February 27, 2015.shareholders. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

Also on September 24, 2014, our board of directors declared a dividend of $0.18 per share, which was paid onDRIP. Our distributions from November 28, 2014. Shareholders had the option30, 2023 back to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share, which was paid on December 27, 2013, to common stockholders of recordinception were as of November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.follows:

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

Payment date Cash
Dividend
 
Tax Year Ended February 28, 2024   
November 15, 2023 $0.72(44)
September 28, 2023  0.71(43)
June 29, 2023  0.70(42)
March 30, 2023  0.69(1)
  $2.92 
Tax Year Ended February 28, 2023    
January 4, 2023 $0.68(2)
September 29, 2022  0.54(3)
June 29, 2022  0.53(4)
March 28, 2022  0.53(5)
  $2.28 
Tax Year Ended February 28, 2022    
January 19, 2022 $0.53(6)
September 28, 2021  0.52(7)
June 29, 2021  0.44(8)
April 22, 2021  0.43(9)
  $1.92 
Tax Year Ended February 28, 2021    
February 10, 2021 $0.42(10)
November 10, 2020  0.41(11)
August 12, 2020  0.40(12)
  $1.03 
Tax Year Ended February 29, 2020    
February 6, 2020 $0.56(13)
September 26, 2019  0.56(14)
June 27, 2019  0.55(15)
March 28, 2019  0.54(16)
  $2.21 
Tax Year Ended February 28, 2019    
January 2, 2019 $0.53(17)
September 27, 2018  0.52(18)
June 27, 2018  0.51(19)
March 26, 2018  0.50(20)
  $2.06 
Tax Year Ended February 28, 2018    
December 27, 2017 $0.49(21)
September 26, 2017  0.48(22)
June 27, 2017  0.47(23)
March 28, 2017  0.46(24)
  $1.90 
Tax Year Ended February 28, 2017    
February 9, 2017 $0.45(25)
November 9, 2016  0.44(26)
September 5, 2016  0.20(27)
August 9, 2016  0.43(28)
April 27, 2016  0.41(29)
  $1.93 
Tax Year Ended February 29, 2016    
February 29, 2016 $0.40(30)
November 30, 2015  0.36(31)
August 31, 2015  0.33(32)
June 5, 2015  1.00(33)
May 29. 2015  0.27(34)
  $2.36 
 Tax Year Ended February 28, 2015    
February 27, 2015 $0.22(35)
November 28, 2014  0.18(36)
  $0.40 

On November 9, 2012, our board of directors declared a dividend of $4.25 per share, which was paid on December 31, 2012, to common stockholders of record as of November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.


Payment date Cash
Dividend
 
Tax Year Ended February 28. 2014    
December 27, 2013 $2.65(37)
  $2.65 
Tax Year Ended February 28, 2013    
December 31, 2012 $4.25(38)
  $4.25 
Tax Year Ended February 29, 2012    
December 30, 2011 $3.00(39)
  $3.00 
Tax Year Ended February 28, 2011    
December 29, 2010 $4.40(40)
  $4.40 
Tax Year Ended February 28, 2010    
December 31, 2009 $18.25(41)
  $18.25 

On November 15, 2011, our board of directors declared a dividend of $3.00 per share, which was paid on December 30, 2011, to common stockholders of record as of November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

(1)Based on shareholder elections, the dividend consisted of approximately $7.1 million in cash and 46,818 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 17, 20, 21, 22, 23, 24, 27, 28, 29, and 30, 2023.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

(2)Based on shareholder elections, the dividend consisted of approximately $6.8 million in cash and 53,615 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.26 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21, 22, 23, 27, 28, 29 and 30 2022 and January 3 and 4, 2023.
(3)Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 52,313 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.00 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 16, 19, 20, 21, 22, 23, 26, 27, 28 and 29, 2022.
(4)Based on shareholder elections, the dividend consisted of approximately $5.1 million in cash and 48,590 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.40 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 17, 21, 22, 23, 24, 27, 28 and 29, 2022.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

(5)Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 42,825 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.89 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 18, 21, 22, 23, 24, 25 and 28, 2022.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share, which was paid on December 31, 2009, to common stockholders of record as of November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.


Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

(6)Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 41,520 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 5, 6, 7, 10, 11, 12, 13, 14, 18 and 19, 2022.

(7)Based on shareholder elections, the dividend consisted of approximately $4.9 million in cash and 38,016 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.77 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2021.

(8)Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,100 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.

(9)Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.

(10)Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.
(11)Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.
(12)Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

(13)Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.
(14)Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.

(15)Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.


(16)Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.
(17)Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.
(18)Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.

(19)Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.
(20)Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.

(21)Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
(22)Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.
(23)Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

(24)Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.
(25)Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.


(26)Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.
(27)Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

(28)Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

(29)Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.
(30)Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.
(31)Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

(32)Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.

(33)Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.
(34)Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.


(35)Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.
(36)Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.
(37)Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.

(38)Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.
(39)Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
(40)Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

(41)Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.


(42)  Based on shareholder elections, the dividend consisted of approximately $7.6 million in cash and 29,628 newly issued shares of common stock, or 0.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.29 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 20, 21, 22, 23, 26, 27, 28, and 29, 2023.

(43)  Based on shareholder elections, the dividend consisted of approximately $8.4 million in cash and 35,197 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.41 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2023.

(44)  Based on shareholder elections, the dividend consisted of approximately $8.9 million in cash and 37,395 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 15, 18, 19, 20, 21, 22, 26, 27, and 28, 2023.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Our asset coverage ratio, as defined in the 1940 Act, was 159.3% as of November 30, 2023 and 165.9% as of February 28, 2023.

Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements as of and for the quarter ended November 30, 2023.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2017:2023:

     Payment Due by Period 
Long-Term Debt Obligations Total  Less Than
1 Year
  1 - 3
Years
  3 - 5
Years
  More Than
5 Years
 
  ($ in thousands) 
Encina credit facility $35,000  $-  $35,000  $-  $- 
SBA debentures  205,000   -   -   -   205,000 
8.75% 2024 Notes  20,000   20,000   -   -   - 
7.00% 2025 Notes  12,000   -   12,000   -   - 
7.75% 2025 Notes  5,000   -   5,000   -   - 
4.375% 2026 Notes  175,000   -   175,000   -   - 
4.35% 2027 Notes  75,000   -   -   75,000   - 
6.00% 2027 Notes  105,500   -   -   105,500   - 
6.25% 2027 Notes  15,000   -   -   15,000   - 
8.00% 2027 Notes  46,000   -   -   46,000   - 
8.125% 2027 Notes  60,375   -   -   60,375   - 
8.50% 2028 Notes  57,500   -   -   57,500   - 
Total Long-Term Debt Obligations $811,375  $20,000  $227,000  $359,375  $205,000 


 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $210,111   $ —     $ —     $ —     $210,111 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Off-balance sheet arrangements

The Company’s

As of November 30, 2023 and February 28, 2023, our off-balance sheet arrangements consisted of $5.9$128.4 million and $2.0$108.8 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2017 and February 28, 2017, respectively.interests. Such commitments are generally up to the Company’sour discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’sour consolidated statements of assets and liabilities and are not reflected in the Company’sour consolidated statements of assets and liabilities.

A summary of the composition of the unfunded commitments outstanding as of November 30, 20172023 and February 28, 20172023 is shown in the table below (dollars in thousands):

  November 30,
2023
  February 28,
2023
 
At Company’s discretion      
ActiveProspect, Inc. $10,000  $10,000 
Artemis Wax Corp.  23,500   - 
Ascend Software, LLC  5,000   5,000 
Granite Comfort, LP  750   15,000 
JDXpert  5,000   5,000 
LFR Chicken LLC  -   4,000 
Pepper Palace, Inc.  1,898   3,000 
Procurement Partners, LLC  4,250   4,250 
Saratoga Senior Loan Fund I JV, LLC  8,548   8,548 
Sceptre Hospitality Resources, LLC  5,000   5,000 
Stretch Zone Franchising, LLC  3,750   - 
VetnCare MSO, LLC  10,000   - 
Total $77,696  $59,798 
         
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required        
Alpha Aesthetics Partners OpCo, LLC $3,720  $- 
ARC Health OpCo LLC  2,585   10,773 
Artemis Wax Corp.  -   8,500 
Ascend Software, LLC  1,500   3,200 
Axero Holdings, LLC - Revolver  500   500 
Axiom Medical Consulting, LLC  2,000   - 
BQE Software, Inc.  3,250   - 
C2 Educational Systems  3,000   - 
Davisware, LLC  1,500   - 
Exigo, LLC  -   4,167 
Exigo, LLC - Revolver  1,042   833 
Gen4 Dental Partners Holdings, LLC  244   11,000 
GoReact  2,500   2,500 
JDXpert  -   1,000 
Inspect Point Holding, LLC  1,500   - 
Modis Dental Partners OpCo, LLC  7,500   - 
Pepper Palace, Inc. - Delayed Draw Term Loan  -   2,000 
Pepper Palace, Inc. - Revolver  2,500   2,500 
Procurement Partners, LLC  -   1,000 
Stretch Zone Franchising, LLC  1,500   - 
VetnCare MSO, LLC  15,319   - 
Zollege PBC  575   1,000 
   50,735   48,973 
Total $128,431  $108,771 

We believe our assets will provide adequate coverage to satisfy these unfunded commitments. As of November 30, 2023, we had cash and cash equivalents and cash and cash equivalents, reserve accounts of $47.0 million and $30.0 million in available borrowings under the Encina Credit Facility.


 

   As of 
   November 30, 2017   February 28, 2017 

CLEO Communications Holding, LLC

  $3,000   $ —   

GreyHeller LLC

   2,000    2,000 

Pathway Partners Vet Management Company LLC

   917    —   
  

 

 

   

 

 

 

Total

  $5,917   $2,000 
  

 

 

   

 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our business activities contain elements of market risk. We consider our principal market risk to be the fluctuation in interest rates. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes.

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest bearinginterest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

Our investment income is affected by fluctuations in various interest rates, including LIBORSOFR and the prime rate. A large portionSubstantially all of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize LIBOR.SOFR or an alternate rate. Since March 2022, the Federal Reserve has been rapidly raising interest rates and has indicated that it may consider an additional rate hike in response to ongoing inflation concerns. In a rising interest rate environment, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve’s tightening cycle could result in a recession in the United States, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR, are not offset by corresponding increases in the spread over such base rates that we earn on any portfolio investments, a decrease in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities. Our interest expense is affected by fluctuations in LIBOR onlySOFR on our revolving credit facility.Encina Credit Facility. In addition, all of our assets have been transitioned from LIBOR to an acceptable replacement rate, such as SOFR. At November 30, 2017,2023, we had $210.1$760.4 million of borrowings outstanding. In addition, there were $35.0 million borrowings outstanding under the Encina Credit Facility as of which $1.0 million was outstanding on the revolving credit facility.November 30, 2023.

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of November 30, 20172023 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $2.4$10.0 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $10.0 million to our interest income.

Changes in interest rates would have no impact to our current interest and debt financing expense, as all our borrowings except for our credit facility are fixed rate, and our credit facility is currently undrawn.

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in LIBORSOFR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, could have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.


For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of November 30, 2023.

   Increase  (Increase)  Increase  Increase  Increase 
Basis  (Decrease)  Decrease  (Decrease) in Net  (Decrease) in Net  (Decrease) in Net 
Point  in Interest  in Interest  Interest  Interest  Investment 
Change  Income  Expense  Income  Income*  Income per Share 
   ($ in thousands)       
 -100  $(10,134) $350  $(9,784) $(7,827) $(0.60)
 -50   (5,067)  175   (4,892)  (3,914)  (0.30)
 -25   (2,534)  88   (2,446)  (1,957)  (0.16)
 25   2,534   (88)  2,446   1,957   0.16 
 50   5,067   (175)  4,892   3,914   0.30 
 100   10,134   (350)  9,784   7,827   0.60 
 200   20,269   (700)  19,569   15,655   1.19 
 300   30,570   (1,050)  29,520   23,616   1.80 
 400   40,904   (1,400)  39,504   31,603   2.41 

*Adjusts Net Interest Income for the impact of the first incentive fee on Net Investment Income

ITEM 4. CONTROLS AND PROCEDURES

(a)As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

(b)There have been no changes in ourthe Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of Exchange Act) that occurred during the quarter ended November 30, 20172023 that have materially affected, or are reasonably likely to materially affect, ourthe Company’s internal control over financial reporting.


PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Neither we nor our wholly-ownedwholly owned subsidiaries, Saratoga Investment Funding LLC, andSaratoga Investment Funding II, LLC, Saratoga Investment Corp. SBIC LP, Saratoga Investment Corp. SBIC II LP, or Saratoga Investment Corp. SBIC III LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our most recent Annual Report on Form 10-K for the year ended February 28, 2017, filed with the SEC, on May 16, 2017, which could materially affect our business, financial condition and/or operating results. Other than asExcept for the risk factor set forth below, there have been no material changes during the threenine months ended November 30, 20172023 to the risk factors discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K.10-K for the fiscal year ended February 28, 2023. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

The tax legislation signed into lawalternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.

LIBOR, the London Interbank Offered Rate, is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on December 22, 2017 could haveprivate loans. Prior to June 30, 2023, LIBOR was typically the reference rate used in floating-rate loans identified by the Manager.

The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.

In the United States, the Secured Overnight Financing Rate (“SOFR”) is the preferred alternative rate for LIBOR. SOFR is a negative effectmeasure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the Companyimmediately preceding US. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.

Legislative


Substantially all of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”). CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other actions relatingfinancial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to taxes could have a negative effect onbe widely used, the Company. The rules dealing with U.S. federal income taxationtrading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Treasury Department. The U.S. House of Representatives and U.S. Senate recently passed tax reform legislation, which was recently signed by the President. Such legislation will make many changes to the Internal Revenue Code, including significant changes to the taxation of business entities, the deductibility of interest expense, and the tax treatment of capital investment. We cannot predict with certainty how any changes in the tax laws might affect the Company, investors, or the Company’s portfolio investments. New legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect the Company’s ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to the Company and its investors of such qualification, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in the Company’s securities.more widely used.

Item 2. Unregistered Sales of Equity Securities, and Use of Proceeds, and Issuer Purchases of Equity Securities

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

(a)None.

(b)None.

(c)For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company has entered into (i) any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

The Company has adopted insider trading policies and procedures governing the purchase, sale, and disposition of the Company’s securities by officers and directors of the Company that are reasonably designed to promote compliance with insider trading laws, rules and regulations.


ITEM 6. EXHIBITS

Listed below are the

The following exhibits which are filed as part of this report (accordingor hereby incorporated by reference to exhibits previously filed with the number assigned to them in Item 601 of Regulation S-K):SEC:

EXHIBIT INDEX

Exhibit


Number

 

Description of Document

3.1(a) Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q for the quarterly period ended May 31, 2007, File No. 001-33376)filed on July 13, 2007).
3.1(b) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
3.1(c) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 13, 2010).
3.2 Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s CurrentQuarterly Report on Form 8-K10-Q filed on March 5, 2008)January 6, 2021).


4.1 Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share.share (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).
4.2 Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
4.3 Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).
4.4 Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 12 to the Registration Statement on Form N-2, File No. 333-186323 filed on April 30, 2013).
4.5 Form  of First Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No.  333-186323 filed April 30, 2013).
4.6Form of Note (incorporated by reference to Exhibit 4.5 hereto, and Exhibit A therein).
4.7Form of Second Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-214182, filed on December 12, 2016).
4.8Form of Global Note (incorporated by reference to Exhibit 4.7 hereto, and Exhibit A therein).
4.9Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.14.6 Fifth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 7.75% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).
4.7Seventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 6.25% Notes due 2027 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).
4.8Eighth Supplemental Indenture between the Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021).
4.9Ninth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.35% Note due 2027 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 814-00732) filed on January 19, 2022).
4.10Tenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 6.00% Note due 2027 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 814-00732) filed on April 27, 2022).
4.11Eleventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 7.00% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).
4.12Twelfth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association, as trustee, relating to the 8.00% Notes due 2027 (incorporated by reference to the Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 813-00732) filed on October 27, 2022).
4.13Thirteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.125% Notes due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on December 13, 2022).


4.15Fifteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.50% Notes due 2028 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on April 14, 2023).
4.16Form of 7.75% Notes due 2025 (incorporated by reference to Exhibit 4.6 hereto).
4.17Form of 6.25% Notes due 2027 (incorporated by reference to Exhibit 4.7 hereto).
4.18Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.8 hereto).
4.19Form of 4.35% Notes due 2027 (incorporated by reference to Exhibit 4.9 hereto).
4.20Form of 6.00% Notes due 2027 (incorporated by reference to Exhibit 4.10 hereto).
4.21Form of 7.00% Notes due 2025 (incorporated by reference to Exhibit 4.11 hereto).
4.22Form of 8.00% Notes due 2027 (incorporated by reference to Exhibit 4.12 hereto).
4.23Form of 8.125% Notes due 2027 (incorporated by reference to Exhibit 4.13 hereto).
4.25Form of 8.50% Notes due 2028 (incorporated by reference to Exhibit 4.15 hereto).
10.1Investment Advisory and Management Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.2 Custodian Agreement dated March 21, 2007 between GSC Investment LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q for the quarterly period ended May 31,filed on July 13, 2007).
10.3 Administration Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.4 Trademark License Agreement dated July 30, 2010 between Saratoga Investment Advisors, LLC and GSC Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.5 Credit, Security and Management Agreement dated July  30, 2010 by and among GSC Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.6Form of Indemnification Agreement between Saratoga Investment Corp. and each officer and director of Saratoga Investment Corp. (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2 filed on January 12, 2007).

10.7 Amendment No. 1 to Credit, Security and Management Agreement dated February  24, 2012 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on February 29, 2012).
10.810.6 Indenture, dated as of January 22, 2008, among GSC Investment Corp. CLO 2007, Ltd., GSC Investment Corp. CLO 2007,  Inc. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-186323, filed on April 30, 2013).
10.9Indenture, dated as of October  17, 2013, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form  N-2, File No. 333-196526, filed on December 5, 2014).
10.10

Amended and Restated Indenture, dated as of November 15, 2016, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National AssociationAssociation. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on February 28, 2017).

10.1110.7 Amended and Restated Collateral Management Agreement, dated October  17, 2013,February 26, 2021, by and between Saratoga Investment Corp. and Saratoga Investment Corp. CLO 2013-1, Ltd. (incorporated by reference to Saratoga Investment Corp.’s Registration StatementCurrent Report on Form N-2, File No. 333-196526,8-K filed on December  5, 2014)March 4, 2021).
10.1210.8 Investment AdvisoryAmended and ManagementRestated Collateral Administration Agreement, dated July  30, 2010 between Saratoga Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.13Amendment No. 2 to Credit, Security and Management Agreement dated September  17, 2014February 26, 2021, by and among Saratoga Investment Funding LLC,between Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLCCorp. CLO 2013-1, Ltd. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 18, 2014)March 4, 2021).


10.1410.9 Amendment No. 3 to Credit, Security and ManagementEquity Distribution Agreement, dated May  18, 2017,July 30, 2021, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., and Saratoga Investment Advisors, LLC, Madison Capital Fundingon the one hand, and Ladenburg Thalmann & Co. Inc. and Compass Point Research & Trading, LLC, and U.S. Bank National Associationon the other hand (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on May 18, 2017)August 2, 2021).
10.1510.10 Amendment No. 2 to the Equity Distribution Agreement, dated March  16, 2017,July 30, 2021, by and among Saratoga Investment Corp., and Saratoga Investment Advisors, LLC, on the one hand, and Ladenburg Thalmann and& Co. Inc. and BB&T Capital Markets, a divisionCompass Point Research & Trading, LLC, on the other hand (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on July 10, 2023).
10.11Amendment No. 3 to the Equity Distribution Agreement, dated July 30, 2021, by and among Saratoga Investment Corp. and Saratoga Investment Advisors, LLC, on the one hand, and Ladenburg Thalmann & Co. Inc., Compass Point Research and Trading, LLC, and Raymond James & Associates, Inc. on the other hand (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on July 19, 2023).
10.12Credit and Security Agreement, dated as of BB&T Securities,October 4, 2021, by and among Saratoga Investment Funding II, LLC, Saratoga Investment Corp., as collateral manager and equityholder, the lenders party thereto, Encina Lender Finance, LLC, as administrative agent for the secured parties and the collateral agent, and U.S. Bank National Association, as collateral custodian for the secured parties thereto and as collateral administrator (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 7, 2021).
10.13First Amendment to the Credit and Security Agreement, dated as of January 27, 2023, by and among Saratoga Investment Fund II LLC, as borrower, Saratoga Investment Corp., as equityholder and as collateral manager, the lenders party thereto, Encina Lender Finance, LLC, as administrative agent and as collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association (successor in interest to U.S. Bank National Association), as collateral administrator (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K, filed on February 2, 2023).
10.14Equity Pledge Agreement, dated as of October 4, 2021, by and between Saratoga Investment Corp. and Encina Lender Finance, LLC, as collateral agent for the secured parties thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 7, 2021).
10.15Loan Sale and Contribution Agreement, dated as of October 4, 2021, by and between Saratoga Investment Corp., as seller, and Saratoga Investment Funding II LLC, as purchaser (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 7, 2021).
10.16Saratoga Senior Loan Fund I JV LLC Limited Liability Company Agreement, dated October 26, 2021, by and between Saratoga Investment Corp. and TJHA JV I LLC (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 1 to the Registration StatementCurrent Report on Form N-2, File No. 333-216344,8-K filed on March 16, 2017)October 27, 2021).
10.1610.17 Amendment No. 1 to the Equity DistributionNote Purchase Agreement dated October 12, 2017 by and amongbetween Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, and FBR Capital Markets & Co.the purchaser party thereto, dated July 9, 2020 (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 2 to the Registration StatementQuarterly Report on Form N-2, File No. 333-216344,10-Q filed on October 12, 2017)4, 2022).
1110.18 Computation of Per Share Earnings (included inFirst Supplemental Note 11Purchase Agreement by and between Saratoga Investment Corp. and the purchaser party thereto, dated January 28, 2021 (incorporated by reference to the consolidated financial statements contained in this report)Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed on October 4, 2022).


1410.19 Second Supplemental Note Purchase Agreement by and between Saratoga Investment Corp. and the purchaser party thereto, dated September 8, 2022 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed on October 4, 2022).
14Code of Ethics of the Company adopted under Rule 17j-1 (incorporated by reference to Amendment No.7 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-138051, filed on March 22, 2007).
21.1 List of Subsidiaries and jurisdiction of incorporation/organization: Saratoga Investment Funding LLC—Delaware; Saratoga Investment Corp. SBIC, LP—Delaware; and Saratoga Investment Corp. GP, LLC—Delaware.
31.1* Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2* Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1* Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)U.S.C.1350)
32.2* Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
101.INSInline XBRL Instance Document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Filed herewith


 

*Submitted herewith.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SARATOGA INVESTMENT CORP.
Date: January 10, 20189, 2024By:By:/s/ CHRISTIAN L. OBERBECK
Christian L. Oberbeck
Chief Executive Officer
By:By:/s/ HENRI J. STEENKAMP
Henri J. Steenkamp
Chief Financial Officer and
Chief Compliance Officer

 

65159

0001377936 sar:ComForCareHealthCareMember sar:SaratogaCLOMember sar:TotalHealthcareServicesMember 2023-11-30 0001377936 sar:InvestmentInSaratogaCLOMember sar:SaratogaInvestmentCorpCLO20131LtdMember sar:AxaltaCoatingSystemsUSHoldingsMember 2023-11-30 0001377936 sar:InvestmentInSaratogaCLOMember sar:AsplundhTreeExpertLLCMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2022-03-01 2023-02-28 0001377936 sar:SevenPointSevenFiveMember us-gaap:BorrowingsMember 2023-11-30 iso4217:USD xbrli:shares